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ABSTRACT
Pelizaeus-Merzbacher disease (PMD) is an X-linked neurological disorder 
characterised by dysmyelination of the central nervous system. The major molecular 
defect involved in PMD is a variably sized duplication of Xq22 including the PLP1 
gene.
Determining the copy number of PLP1 is the first line of enquiry when trying to 
establish a molecular diagnosis of PMD. Multiplex amplifiable probe hybridisation is 
a quantitative technique that has been explored as a method for diagnosing PLP1 
duplications in PMD patients and female carriers as part of this project.
The rearrangements in a number of PMD families were investigated using FISH, PCR 
and sequencing of chromosome breakpoints. One tandem duplication and two more 
complex rearrangements were characterised during this study. A bioinformatic 
investigation of sequences present at the breakpoints in these families, and the 
genomic sequence throughout Xq22, has provided some insights into possible 
mechanisms causing duplications of this region.
Increased dosage of Xq26-27 has been associated with pituitary hypoplasia and a 
mutation involving the SOX3 gene, located at Xq27.1, has been reported in a family 
with growth hormone deficiency. Characterisation of a duplication involving SOX3 in 
a family with X-linked hypopituitarism has been carried out using a similar strategy to 
the PLP1 duplications. This SOX3 duplication is the smallest yet reported and only 
contains two other genes. This provides strong evidence for increased dosage of 
SOX3 being involved in the aetiology of X-linked hypopituitarism.
Gene dosage is increasingly being recognised as a cause for human genetic disorders, 
and it is important for diagnosis that changes in gene dosage can be reliably detected. 
As more cases of human genetic disease involving gene dosage become apparent, it is 
clear that duplications are frequent occurrences in the human genome, which may 
often be undetected as a cause of human genetic variation and disease.
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1.0. INTRODUCTION
1.1. Pelizaeus-Merzbacher Disease
Pelizaeus-Merzbacher disease (PMD) is an X-linked recessive dysmyelinating 
disorder of the central nervous system (CNS). Absence or a severe deficit of white 
matter is seen on MRI scans, due to the failure of CNS oligodendrocytes to myelinate 
axons. The symptoms of PMD vary in severity, but often include nystagmus, ataxia 
and spasticity, with onset of symptoms usually within the first year of life (Hodes et 
al., 1993). Other symptoms include stridor and seizures. PMD is a progressive 
disease, and premature death usually occurs from childhood into the third decade of 
life. The most severely affected cases, where symptoms are apparent form birth (the 
“connatal” form), are associated with early mortality, often before the first birthday. 
PMD is allelic with a milder disorder, spastic paraplegia type 2 (SPG2), which 
exhibits symptoms of progressive spasticity and weakness of the lower extremities. 
SPG2 has a generally later onset and mildly affected patients may survive into the 
seventh decade of life, and be able to talk and walk (Saugier-Veber et al., 1994). 
Severity of PMD/SPG2 varies from the most severe connatal forms, where symptoms 
are seen soon after birth, with severe developmental delay and seizures, with rapid 
disease progression leading to a very early death, to the mildest SPG2 phenotype. 
Affected individuals are usually male, and females are often carriers, with no apparent 
symptoms, although there is a small subset of affected females, who generally show 
mild symptoms with a later onset (Hodes et al., 1995;Nance et al., 1996;Hodes et al., 
1997;Inoue et a l, 2001).
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1.2. Myelin
Myelin is a multilammellar spiral membrane structure that surrounds axons in the 
nervous system in higher vertebrates. Each segment of myelin sheath is separated by 
a gap, where the axon is exposed, called a node of Ranvier. The insulation of the 
axons by the myelin sheath facilitates faster conduction of nerve impulses, as the 
impulse jumps from one node of Ranvier to the next by saltatory conduction. Myelin 
in the peripheral nervous system (PNS) is formed by Schwann cells, each cell 
wrapping itself around a single axon to create a single intemodal section of myelin 
sheath. In the CNS, a single oligodendrocyte can send out multiple cytoplasmic 
processes from the cell body and myelinate several axons at once (Figure 1.1). 
Electron microscopy of cross-sections of compact myelin shows a layered structure 
consisting of alternating electron-dense and electron-light layers (Figure 1.1). The 
major dense line is formed by the cytoplasmic faces of the cell surface membrane in 
close proximity to each other and the extracellular sides of the membranes form the 
less intense double intraperiod line (Figure 1.1). The electron-light layers of myelin 
represent the middle of the cell surface membrane (Figure 1.1). In humans, 
myelination starts in the spinal cord during the second half of the gestational period, 
and the peak of myelin formation in the CNS occurs during the first year after birth, 
although myelination of some areas may not actually finish until the age of 20 
(Baumann and Pham-Dinh, 2001).
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Figure 1.1. Myelin structure in the central nervous system. Axons are encircled by 
myelin sheath, which is formed from cytoplasmic projections of oligodendrocytes. A 
magnified view of a cross-section through the myelin sheath is shown. Adapted from 
(Baumann and Pham-Dinh, 2001).
15.7Kb
Figure 1.2. Genomic structure of PLP1, adapted from the Ensembl genome browser. 
Coding regions are shaded, exon 3B {PLP1 -specific) is shaded grey and the rest of the 
coding region (present in both PLP1 and DM20) is shaded black. 5' and 3' 
untranslated regions are white. Exons are numbered underneath, and splicing patterns 
are shown.
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1.3. Proteolipid protein and DM20
PMD/SPG2 is caused by mutations involving the proteolipid protein (PLP1) gene.
PLP1 is located at Xq22, covers 15.7 kilobases of genomic sequence and has 7 exons,
coding for a 276 amino acid, 30kDa protein, known as proteolipid protein 1 (PLP1)
(Diehl et a l , 1986) (Figure 1.2). PLP1 also encodes an alternatively spliced isoform,
DM20, which is a 241 amino acid, 25kDa protein. DM20 is generated by activation
of a cryptic splice site within the third exon that removes the second half of exon 3,
termed exon 3B, and causes an in-frame deletion of 35 codons (Figure 1.2).
PLP1/DM20 are very hydrophobic integral membrane proteins predicted to have 4
trans-membrane helices, linked together by one intracellular and two extra-cellular
loops (Weimbs and Stoffel, 1992) (Figure 1.3). The N- and C- termini are located in
the cytoplasm and the 35 amino acids that are absent in DM20 are within the
intracellular loop (Figure 1.3). An additional alternatively spliced exon has been
found in mice, where an additional exon (exon 1.1) is located in intron 1 (Bongarzone
et a l , 1999). This exon contains an alternative translational start site which produces
PLP1/DM20 proteins containing an extra 12 amino acids at the N-terminus
(Bongarzone et a l, 1999). The presence of this short leader sequence alters the
targeting of the PLP1/DM20 proteins within the cell, and these isoforms are located
within the oligodendrocyte cell bodies, associated with trafficking vesicles and
endosomes, and not within the myelin sheath, where PLP1/DM20 proteins are usually
localised (Bongarzone et a l, 1999;Bongarzone et a l, 2001). These soma-restricted
isoforms of PLP1 and DM20 have been found to be expressed in neurons during
mouse development, at higher levels than found in oligodendrocytes (Jacobs et a l,
2003). A similar additional exon has not been identified in humans. Together, PLP1
and DM20 proteins are the most abundant proteins in CNS myelin, making up 50% of
the total protein content (Baumann and Pham-Dinh, 2001). PLP1 and DM20 also
have some post-translational modification in the mature proteins. The N-terminal
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methionine residue is removed post-translationally (Milner et al., 1985). There are 
two disulphide bridges between two pairs of cysteine residues in the large 
extracellular loop; and some of the cysteine residues on the cytoplasmic face of the 
protein are acylated (Figure 1.3) (Weimbs and Stoffel, 1992). PLP1 has up to six 
fatty acids covalently attached to cysteine residues, mostly palmitic acid, and DM20 
has four, as two of the acylated cysteine residues are within the PLP1-specific section 
of the protein, and this difference in acylation may confer different properties on the 
two isoforms (Weimbs and Stoffel, 1992;Bizzozero et a l , 2002) (Figure 1.3). The 
structural model for PLP1 described in Figure 1.3 is frequently shown in publications, 
but some slightly different potential topologies have also been suggested. These 
include having the three acylated residues in the large intra-cytoplasmic loop being 
inserted into an adjacent cell membrane instead of the lipid bilayer in which the PLP1 
protein is located, thereby stabilising the major dense line of myelin (Weimbs and 
Stoffel, 1992;Sporkel et al., 2002). This uncertainty about the structure of 
PLP1/DM20 has not yet been resolved by the publication of a structure based on X- 
ray crystallographic or nuclear magnetic resonance data, which may be partly due to 
the inherent difficulties in purifying and crystallising these extremely hydrophobic 
proteins.
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.C O O H
Intracellular
Figure 1.3. Diagram of possible PLP1 structure, showing the position of the protein 
within the cell surface membrane. The 35 amino acids specific to PLP1 within the 
intracellular loop are shaded in lighter grey. The two disulphide bonds in the larger 
extracellular loop are shown as black lines, and the fatty acid groups covalently 
bonded to cysteine residues in the intracellular parts of PLP1 are shown as zigzags 
inserted in the phospholipid bilayer. Adapted from (Weimbs and Stoffel, 
1992;Garbem et al., 1999;Greer and Lees, 2002).
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1.3.1. Evolutionary conservation of PLP1/DM20
PLP1/DM20 is highly conserved between species, with human, mouse and rat having 
identical amino acid sequences, the dog and rabbit proteins each have only one amino 
acid change from the human protein sequence and the bovine sequence differs by only 
two amino acids (Milner et a l, 1985;Diehl et a l, 1986;Wight and Dobretsova, 2004). 
PLP1/DM20 is part of a family of proteins found in most vertebrates that also 
includes the M6a and M6b proteins in mammals, which show 56% and 46% identity 
with DM20 protein sequence (Yan et a l,  1993). The functions of M6a and M6b are 
unknown, but in mice M6a is neuronal-specific and M6b is expressed in neurons and 
myelin (Yan et a l, 1993). Proteins similar to DM-20 (DMa, DMp and DMy) are 
present in cartilaginous fish, but the PLP1-specific segment is not found in these 
proteins (Kitagawa et a l, 1993;Yoshida and Colman, 1996). Invertebrates, such as 
Drosophila melanogaster, have also been found to have genes related to DM20, but 
without PLP1 -specific segment similarity (Stecca et a l, 2000). It seems likely that 
PLP1 is a more recent evolutionary innovation than DM20, and emerged after 
insertion of the PLP1-specific segment into the DM20 ancestral gene, at the same 
time as the evolution of amphibians, which do express PLP1 (Gow, 1997).
1.3.2. PLP1 mutations
Several different types of mutations involving PLP1 can cause PMD and SPG2.
PLP1 was associated with PMD when a mouse model for the condition, jimpy, was
found to have a splicing defect which led to a 74bp deletion in PLP1 mRNA and was
due to a mutation in the 3' splice acceptor site of intron 4 (Nave et a l, 1987). Point
mutations within the PLP1 gene were subsequently found in the genomic sequence of
patients with PMD, and PLP1 mutations were also found to cause the milder allelic
disorder SPG2 (Gencic et a l, 1989;Hudson et a l, 1989;Saugier-Veber et a l, 1994).
Other genetic mechanisms frequently cause PMD, and account for at least half of all
33
cases. An individual with a cytogenetically visible duplication of Xql3-q22 including 
PLP1 was described with the symptoms of PMD, along with other abnormalities 
(Cremers et a l , 1987). It was later recognised that several individuals with PMD also 
had increased dosage of PLP1 caused by whole gene duplications, and this is the most 
common genetic alteration found in PMD patients (Ellis and Malcolm, 
1994;Woodward et al., 1998;Sistermans et al., 1998;Mimault et al., 1999). Deletions 
of the whole PLP1 gene, although rare, have also been reported in a few PMD 
patients (Raskind et al., 1991;Inoue et al., 2002). Other functionally null alleles, 
resulting from truncating point mutations very near the start of the gene, have also 
been described (Sistermans et al., 1996).
1.3.3. Function of PLP1 and DM20
The function of these proteins is not fully understood, but they seem to play a
structural role in the setting up and maintenance of the myelin sheath and formation of
the intraperiod line, but may also have additional functions (Griffiths et a l, 1998a).
There are several different animal models of PMD/SPG2, which have led to many
insights into the function of PLP1. PLP1/DM20 are predominantly expressed in CNS
oligodendrocytes, but are also expressed in Schwann cells, and at a low level in other
tissues, including skin, heart, foetal thymus and spleen (Campagnoni et al.,
1992;Carango et al., 1995;Pribyl et al., 1996). DM20 expression starts before the
onset of myelination and declines after the early stages of myelination, when PLP1
production increases and this becomes the major isoform in oligodendrocytes.
PLP1/DM20 proteins are not necessary for the formation of myelin, as knockout mice
with no PLP1/DM20 expressed are able to form compacted myelin (Klugmann et al.,
1997). However, in null mice some ultrastructural changes in myelin structure are
visible with electron microscopy, but the reported abnormalities vary, which may be
due to differences in the genetic background of the null mutant (Boison and Stoffel,
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1994;Klugmann et al., 1997). PLP1/DM20 proteins are both needed for the 
maintenance of axonal integrity, as knockout mice and PMD patients with null 
mutations show signs of axonal damage (Griffiths et al., 1998b;Garbem et al., 
1999;Garbem et al., 2002). PLP1 and DM20 have been shown to associate during 
intracellular transport as well as within the myelin sheath and may interact to form an 
oligomeric complex (Gow and Lazzarini, 1996;McLaughlin et al., 2002). Also, PLP1 
(but not DM20) has been found to interact with av-integrin in oligodendrocytes, 
indicating that this isoform may play a role in integrin receptor signalling (Gudz et al., 
2002). PLP1 and DM20 have different functions, as mutations that only affect PLP1 
still cause symptoms, albeit generally milder, in humans, and mice models that only 
express DM20 have some myelin abnormalities (Stecca et al., 2000;Sporkel et al.,
2002). PLP1 or DM20 transgenes individually were not able to rescue the phenotype 
of a naturally occurring Plpl mutant mouse strain, but when both isoforms were 
present together, some myelination was seen, suggesting that the two isoforms do 
have distinct functions, or that some interaction between the two proteins is necessary 
for normal myelination (Nadon et al., 1994).
1.3.4. Animal models
Naturally occurring mouse mutants have been described, such as the jimpy,
rumpshaker and myelin synthesis deficient mice (Nave et al., 1986;Gencic and
Hudson, 1990;Schneider et al., 1992). Transgenic mice have also been produced,
including PLP1 knockout mice and mice with increased dosage of PLP1 (Boison and
Stoffel, 1994;Readhead et al., 1994;Kagawa et al., 1994;Klugmann et al., 1997).
Other naturally occurring PLP1 mutants are the myelin deficient rat, the dog mutant
shaking pup and the paralytic tremor rabbit (Boison and Stoffel, 1989;Nadon et al.,
1990;Tosic M et al., 1994). The severity of the phenotype of these animal models
varies with different mutations, as is seen with the human disease, and the phenotype
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has also been demonstrated to be dependent on the genetic background in some cases 
(Yool et a l, 2001). Some of the mutations are identical to those described in human 
patients, and show similar patterns of severity (Yamamoto et al., 1998;Aoyagi et al.,
1999). In mice with increased dosage of PLP1 transgenes, increasing severity of 
symptoms correlating with increased transgene copy number has been reported 
(Kagawa et al., 1994;Inoue et a l, 1996b;Anderson et al., 1999).
1.3.5. Gene duplication
The most common PMD mutation in PLP1, found in 60-70% of cases, is a duplication
involving the whole PLP1 gene (Ellis and Malcolm, 1994;Sistermans et al., 1998).
Typically the duplication involving PLP1 is sub-microscopic and has a size range
from lOOkb to 4.6Mb (Hobson et al., 2003). PLP1 is not the only gene present within
the duplicated interval, as there are several other genes in the vicinity which may or
may not be duplicated depending on the duplication size (Figure 1.4). It is not clear if
the size of the duplication is correlated with the severity of disease, but patients with a
duplication frequently have a classical PMD phenotype (Sistermans et al., 1998;Inoue
et al., 1999). In PMD, the duplication breakpoints have not been found to be similar
between patients and are at different positions for almost every family studied
(Woodward et al., 1998;Inoue et a l, 1999;Hobson et al., 2003). The duplications
usually appear to be tandem in orientation and in most cases arise by an
intrachromosomal event that occurs during male meiosis, with mothers of affected
males almost always being carriers (Inoue et al., 1996;Woodward et a l,
1998;Sistermans et al., 1998;Inoue et al., 1999;Mimault et a l, 1999). Involvement of
duplication of a perfectly normal gene shows that gene dosage is an important
mechanism in the pathogenesis of PMD. A few PMD patients have been found to
carry (or are suspected to have) a triplication of PLP1 (Ellis and Malcolm,
1994;Woodward et al., 1998;Wolf et al., in preparation). These individuals with three
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times the normal dosage of PLP1 are particularly severely affected, and have had the 
early-onset, connatal form of the disease, including seizures and death often within 
the first year of life (Wolf et al., in preparation). This parallels the correlation of 
greater disease severity with increased transgene copy number that occurs in 
transgenic mouse models (Kagawa et al., 1994;Inoue et al., 1996b;Anderson et al.,
1999).
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Figure 1.4. Genomic context of the PLP1 gene. 1Mb either side of PLP1 is shown, 
with the approximate boundaries of the chromosomal bands in the region also shown. 
Genes in the region are shown above or below the chromosome, those above are 
transcribed from left to right (centromere to telomere), and those underneath the 
chromosome are transcribed from the opposite strand. Genes with supporting 
evidence (from EST, cDNA, and protein sequences) are shaded in black, predicted 
genes just based on nucleotide sequence are dark grey, and pseudogenes are shaded in 
lighter grey. Adapted from the Ensembl genome browser, release 19.34al.
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1.3.6. Atypical duplications
A small subset of duplications including PLP1 have been shown to move to a
different chromosomal location. In three cases the second copy of PLP1 has moved
to elsewhere on the X chromosome, with two insertions into Xp and one insertion into
Xq26 (Hodes et a l , 2000). Another case has been found where PLP1 has been
duplicated and inserted on Yq (unpublished data). The mechanism behind these
atypical duplications is unknown and must involve at least three chromosomal
breakages. One of the Xp duplications also has an inversion of a large section of the
X chromosome between the two copies of PLP1 associated with it (Hodes et a l ,
2000). The Xq26 insertion has been demonstrated to be associated with mosaicism
for a large deletion of the long arm of the X chromosome in a female carrier of the
duplication (Woodward et a l , 1998;Woodward et al., 2003). In this family, the
affected male has inherited the duplication from his mother, and the duplication can
be seen by FISH on one of her chromosomes in approximately half of her metaphase
spreads in lymphoblastoid cells. Further examination of the mother’s cells showed
that a proportion of her cells from blood carried a deletion of one of her X
chromosomes, so that in these cells there was one normal X chromosome with one
copy of PLP1 visible on metaphase, and an X chromosome carrying a deletion of
most of the long arm, including the PLP1 locus. Interphase FISH results are
confusing with respect to the mother due to her mosaicism and quantitative PCR also
gave results for the mother that were consistent with her not being a carrier
(Woodward et a l, 1998). This family had two unusual rearrangements involving the
X, an atypical duplication of PLP1 on Xq26, which appeared to be de novo in the
mother, and was subsequently shown to have occurred on her paternal X
chromosome, which she then passed on to her affected son, and a large deletion of the
long arm of the X that had contained the duplication (Woodward et a l,  2003).
Another case has been reported in the literature where an atypical PLP1 duplication
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was associated with other cytogenetic rearrangements, namely a pericentromeric 
inversion of the X chromosome (Saito-Ohara et a l, 2002). This patient exhibited 
symptoms of Duchenne muscular dystrophy, and also had profound mental 
retardation, nystagmus and reduced white matter was found at post mortem 
examination (Saito-Ohara et a l,  2002). Two copies of PLP1 could be visualised by 
FISH on the abnormal X chromosome at either end of the inversion, the normal copy 
at Xq22.2, and the other at Xp21 (Saito-Ohara et a l, 2002). The inversion breakpoint 
within Xq21 was within the DMD gene, leading to a deletion of exons 43-60, and 
within Xq22 a breakpoint was sequenced and located within the promoter region of 
the more proximal copy of the RAB40A gene (Figure 1.4) (Saito-Ohara et a l, 2002). 
Disruption of the expression of RAB40A may also have contributed to the severe 
phenotype seen in this patient along with the DMD and PLP1 abnormalities (see 
section 3.5.2.1.) (Saito-Ohara et a l, 2002).
In addition to these cases where an atypical duplication of PLP1 is associated with
PMD, one individual has been reported with an atypical duplication of PLP1 that did
not result in a PMD phenotype. A male with PMD was demonstrated to have an Alu-
Alu recombination-mediated deletion of the PLP1 gene, and examination of other
members of the family revealed a translocation of PLP1 to the subtelomeric region of
the long arm of chromosome 19 (Inoue et a l, 2002). The mother of the affected boy
was a carrier of the translocation and presented in the third decade of life with
spasticity, gradual mental deterioration and abnormal white matter upon MRI analysis
(Inoue et a l, 2002). She was found to carry the deletion on one X chromosome and
the PLP1 translocation to 19q (Inoue et a l, 2002). The unaffected brother of the
proband had inherited the normal X chromosome but also the chromosome 19 that
harboured the translocation, so he carried two copies of PLP1 (Inoue et a l, 2002). In
this family it seems most likely that the translocated copy of PLP1 is either not
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expressed or is non-functional, possibly due to sequence changes associated with the 
rearrangement or position effects relating to its new location.
1.3.7. Point mutations and PLP1 deletions
Point mutations in PLP1 including single nucleotide changes, small insertions and 
deletions, can be found in 15-20% of cases. These are usually missense, nonsense 
and frameshift mutations that generate abnormal proteins. Most changes are within 
the coding region of PLP1, but non-coding regions can also be important locations for 
mutations affecting PLP1 splicing (Hobson et al., 2000). Different point mutations in 
PLP1 cause dysmyelinating disease throughout the range of the PMD/SPG2 
phenotype. In some cases point mutations cause a relatively mild SPG2-type 
phenotype (Hodes et al., 1997;Cailloux et a l, 2000). This is frequently the case when 
the point mutation falls within the alternatively spliced exon 3B, which would only 
affect the PLP1 isoform, leaving DM20 unaffected (Hodes et al., 1997;Cailloux et al.,
2000). Other point mutations can lead to a classical PMD phenotype similar to what 
is typically seen for duplication patients. In other affected individuals, however, point 
mutations can give rise to the particularly severe connatal phenotype, especially when 
they change an amino acid that is highly conserved in PLP1/DM20 and related 
proteins (Cailloux et al., 2000).
In a very small proportion of cases (1-2%) a complete deletion or a null mutation of 
PLP1 is found (Raskind et al., 1991;Inoue et a l, 2002). Functionally null point 
mutations have been reported, including missense changes in the initiation codon, 
which result in a similar phenotype to the deletion (Sistermans et a l, 1996;Garbem et 
al., 1997;Mimault et al., 1999).These patients have mild symptoms, more like SPG2, 
and some have been found to also show peripheral nerve demyelination (Garbem et
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al., 1997). This shows that PLP1/DM20 must have a function in the peripheral 
nervous system as well as the major functions in the CNS.
The remaining 10-15% of patients with a clinical diagnosis of PMD do not have a 
defined molecular defect involving PLP1, with the most likely explanations being 
either mutations in regulatory sequences or involvement of another locus in these 
cases (Sistermans et a l , 1998). Mutations in an autosomal gene, GJA12, which 
encodes the gap junction protein a l2  (connexin 46.6) have recently been reported in 
patients with autosomal recessive Pelizaeus-Merzbacher-like disease (PMLD) 
(Uhlenberg et al., 2004). It is likely that there is at least one more autosomal locus 
involved in PMD/PMLD, as some individuals with PMD symptoms have been shown 
not to have mutations involving either PLP1 or GJA12 (Uhlenberg et al., 2004).
1.3.8. Disease mechanisms
The mechanisms by which PLP1 mutations cause PMD/SPG2 are not yet fully 
understood. It is thought that different types of mechanisms may be involved in the 
different types of mutations -  duplications, point mutations and deletion/null 
mutations.
I.3.8.I. Duplications
Duplications of the PLP1 gene, and subsequent over-expression of PLP1, will lead to
the accumulation of excess protein within the cell (Garbem et al., 1999).
Overexpressed PLP1 is missorted within the cell, which has additional effects on
oligodendroctye function (Simons et al., 2002). In cultured oligodendrocytes, PLP1
was found to accumulate in the late endosomal/lysosomal compartment along with
cholesterol, instead of being transported to the myelin sheath from the Golgi
apparatus (Simons et al., 2002). It is thought that PLP1 may be associated with other
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myelin membrane components, such as cholesterol and glycosphingolipids, in lipid 
rafts which transport their components to the developing myelin sheath (Simons et al., 
2000;Simons et al., 2002). Accumulation of PLP1 in an abnormal cellular location 
may also lead to other membrane components being sequestered, as has been found 
for cholesterol, and leads to reduced levels of these components in the myelin 
membrane. This may cause some of the defects in myelination seen in PMD, and 
may also lead to other myelin proteins being abnormally located in the 
oligodendrocyte, further affecting function (Simons et al., 2002;Vaurs-Barriere et al.,
2003).
1.3.8.2. Point mutations
Point mutations that cause a severe phenotype may do so by a gain of function
mechanism, possibly by the misfolded protein not being transported to the cell surface
membrane and instead accumulating within the cell, eventually triggering apotosis
(Gow et al., 1998;Garbem et al., 1999). The unfolded protein response pathway has
been found to be activated in oligodendrocytes expressing a mutated PLP1 gene, and
may be important in triggering apoptosis in PMD oligodendrocytes (Southwood et al.,
2002). Point mutations can affect the properties of the two isoforms differently,
which could have an effect on disease severity via differences in trafficking of the two
mutated isoforms (Gow and Lazzarini, 1996). Most point mutations in PLP1 lead to
the accumulation of PLP1 within the endoplasmic reticulum (ER) (Gow and
Lazzarini, 1996;Tosic et al., 1997;Southwood and Gow, 2001). Only mutations
which cause a severe phenotype lead to the sequestering of mutant DM20 within the
ER, as in milder forms of the disease mutant DM20 is transported to the cell surface
membrane (Gow and Lazzarini, 1996;Tosic et al., 1997;Southwood and Gow, 2001).
Missense mutations with a milder phenotype often alter amino acid residues that are
less highly conserved in PLP1 and related proteins, and these mutations may lead to a
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less severe defect in protein folding and trafficking, which has fewer adverse 
consequences for the cell, with perhaps some myelination being possible (Gow and 
Lazzarini, 1996;Gow etal., 1998).
1.3.8.3. Deletions/null mutations
Null mutations of PLP1, either rare whole gene deletions or truncating point 
mutations at the 5' end of the gene, generally result in relatively mild symptoms, and 
the milder phenotype is presumably a result of the loss of function of the proteins 
(Garbem et al., 1999).
1.3.8.4. Affected females
As PMD is an X-linked recessive disorder, the majority of affected individuals are
males, with females that carry a mutation usually being non-symptomatic carriers.
There are a small number of females affected, however. X-inactivation studies have
shown that in female carriers of the duplication, the X chromosome carrying the
duplication is preferentially inactivated in lymphocytes (Woodward et a l,  2000). It
has been shown that females with point mutations usually have random X-inactivation
(Woodward et al., 2000). Occasionally heterozygous females for point mutations and
null alleles have been found to manifest signs of PMD with adult onset
leukodystrophies (Hodes et al., 1995;Nance et al., 1996;Hodes et al., 1997). These
females are generally from families with a mutation that produces a mild phenotype in
males, whereas females that carry a severe PLP1 mutation are usually phenotypically
normal. Assuming that females with point mutations have random X inactivation in
their oligodendrocytes as well as in blood, those cells expressing a severe point
mutation may have severe PLP1 trafficking problems or other defects and most likely
die by apoptosis. The surviving oligodendrocytes would express the normal PLP1
allele and go on to myelinate normally. In females carrying a milder PLP1 point
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mutation, where the mutation was not so immediately toxic or detrimental to 
oligodendrocyte function, a mixed population of oligodendrocytes may be able to 
survive for a while. However, eventually the defect in PLP1/DM20 may cause cell 
death or failure of myelination, leaving only patchy myelination within the CNS, and 
causing the later-onset symptoms seen in some female carriers of point mutations. 
There have been only two cases reported of females with symptoms of PMD that have 
been shown to have a duplication (Inoue et a l , 2001). The two girls had early onset 
neurological signs and were found to have random X-inactivation patterns, but 
showed improvement in their symptoms over time (Inoue et al., 2001). This may be 
because oligodendrocytes expressing the duplicated genes undergo early apoptosis, 
leaving the cells expressing a normal dosage of PLP1 able to compensate by 
myelinating unsheathed axons, leading to the observed clinical improvement (Inoue et 
a l, 2001).
1.4. Gene dosage
Changes in gene dosage are an increasingly significant mutational mechanism in
many human genetic diseases. A number of genes within the human genome, and in
other organisms, as well as PLP1, have been shown to be dosage sensitive.
Haploinsufficiency has been recognised as an important factor in the pathogenesis of
numerous genetic disorders, both involving single genes or in contiguous gene
syndromes, and is generally more frequently associated with a phenotype than
increased gene dosage has been. However, increased gene dosage is increasingly
being discovered in a small, but growing number of conditions. A common human
syndrome where increased gene dosage is a factor is trisomy 21 (Down syndrome),
where increased dosage of several genes located on chromosome 21 causes a well-
recognised phenotype. Increased dosage of a whole human chromosome is rarely
compatible with life, with only two other autosomal full trisomies, trisomy 13 (Patau
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syndrome) and trisomy 18 (Edwards syndrome) being viable following gestation and 
birth, and even then few will survive beyond one year of age. The other human 
trisomies that are seen in live births are copy number changes involving the sex 
chromosomes, which have a relatively mild phenotype. Changes in sex chromosome 
number are less detrimental for two main reasons; X-inactivation will silence the 
majority of genes on supernumerary X chromosomes, suppressing dosage imbalances, 
and the Y chromosome is very gene-poor, so very few genes will be present in 
increased dosage. Of the chromosomes that are involved in viable trisomies, these 
(13, 18, X and Y) have some of the lowest gene densities of all the human 
chromosomes, and chromosome 21 is the smallest autosome, so also contains 
relatively few genes compared to larger chromosomes (Hattori et a l , 2000;Venter et 
al., 2001;Dunham et al., 2004). As increased gene dosage of most chromosomes is 
not viable in humans, it is likely that most chromosomes harbour at least one gene that 
will cause failure of normal development when present in increased copy number, or 
that a combination of several genes from the same chromosome, all present in 
increased dosage, is severely harmful to development.
Most cases of altered gene dosage involve just one gene or a handful of dosage
sensitive genes. Charcot-Marie-Tooth disease type 1A, an autosomal dominant
peripheral neuropathy, can be caused by duplication of the PMP22 gene (Lupski et
al., 1991;Raeymaekers et a l , 1991). PMP22 is flanked by two highly homologous
24kb repeat sequences and misalignment of these repeats and recombination between
them leads to duplication of a 1.5Mb region including PMP22. Most of the de novo
PMP22 duplications causing CMT1A are paternal in origin and occur as a result of
interchromosomal recombination between the misaligned 24Kb repeated sequences
(Lopes et a l , 1997). As well as being sensitive to an increase in gene dosage, a
reduction in dosage of the functional PMP22 gene caused by a gene deletion leads to
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another peripheral neuropathy, hereditary neuropathy with liability to pressure palsies 
(HNPP) (Chance et al., 1994). The HNPP deletion is also mediated by the flanking 
24Kb repeats, but occurs less frequently and is generally maternal in origin (Lopes et 
a l , 1997). The rearrangement of maternal origin resulting in a deletion is an 
intrachromosomal event, and rarely PMP22 duplications are found to be of maternal 
origin, but in these cases the duplication is also intrachromosomal in origin, in 
contrast to the more frequent interchromosomal paternal duplications (Lopes et al., 
1997;Lopes etal., 1998).
Smith-Magenis syndrome (SMS) is a microdeletion syndrome with a characteristic
physical and behavioural phenotype resulting from an interstitial deletion of 3.7Mb of
part of the chromosome band 17pll.2 (Smith et al., 1986;Potocki et al., 2000). A
milder phenotype has also been described associated with the reciprocal duplication
of 17pll.2 (Potocki et al., 2000). The reciprocal deletions and duplications of the
SMS region are mediated by flanking highly homologous 200Kb repeats (Chen et al.,
1997). Triplication of approximately 2Mb of chromosome 4q including the a-
synuclein gene has recently been reported in a family with autosomal dominant
Parkinson’s disease (Singleton et al., 2003). 500kb tandem duplications within 10q24
have been associated with split hand-split foot malformation 3 (SHFM3) in several
individuals, and the duplicated region contains genes involved in limb development
(de Mollerat et al., 2003). Duplication of 6p25 has been found in families with
autosomal dominant anterior chamber eye defects including iris hypoplasia and
glaucoma (Lehmann et al., 2000;Lehmann et al., 2002). 6p25 contains the FOXC1
gene, in which point mutations have been found in individuals with glaucoma
phenotypes, and haploinsufficiency of FOXC1 has also been described in other
individuals with glaucoma and other eye anomalies (Lehmann et a l , 2000;Nishimura
et al., 2001). Variations in drug metabolism can be caused by alterations in gene copy
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number. The CYP2D6 gene on chromosome 22, which produces a cytochrome P450 
protein, the debrisoquine hydroxylase enzyme, has been found to have several extra 
copies present, in some cases as many as 12 on one allele, in the genome of some 
individuals who show ultra-rapid metabolism of many commonly used drugs which 
are metabolised by the CYP2D6 gene product (Johansson et a l , 1993;Agundez et a l , 
1995;Aklillu et a l , 1996). Deficiency of CYP2D6 activity causes the recessive poor 
metaboliser phenotype, either by a deletion of the whole gene or due to inactivating 
point mutations in this gene (Gonzalez et a l, 1988;Gaedigk et a l, 1991).
1.4.1. Genomic disorders
Many of the conditions that are caused by alterations in gene dosage have been 
described as “genomic disorders” (Lupski, 1998). Features of the genome can 
mediate or predispose to sequence rearrangements. Genomic disorders are those 
where such a rearrangement leads to a pathogenic change, such as deletion or 
duplication of a dosage sensitive gene. Many disorders in which gene dosage is a 
substantial factor in pathogenesis have been recognised as genomic disorders. Most 
commonly the genomic features that mediate the disease-causing rearrangement are 
low copy repeats (LCRs), repeated sequences specific to the deletion and/or 
duplication-prone region, which are generally greater than 10Kb in length and exhibit 
>95% identity (Lupski, 1998;Shaw and Lupski, 2004) . Non-allelic homologous 
recombination (NAHR) between misaligned LCR sequences during crossing-over 
leads to rearrangement of the genomic region, giving rise to deletions, duplications 
and inversions. Genomic disorders frequently cause rearrangements that are 
submicroscopic, but larger abnormalities that are apparent at the chromosomal level 
can also occur.
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1.4.1.1. Direct repeats
NAHR between directly orientated LCRs creates reciprocal recombinant crossover 
products, one with the DNA between the repeats deleted out, and the other carrying 
two copies of the intervening sequence (Figure 1.5). Some recognised genomic 
disorders where directly repeated LCRs are found include CMT1A/HNPP, SMS, as 
well as many other conditions. Velo-cardio-facial syndrome (VCFS), also known as 
DiGeorge syndrome, is commonly caused by a microdeletion of 3Mb from 22qll.2, 
and this common deleted region is flanked by two 200Kb repeats, LCR22, which 
contain both directly repeated and inverted sections (Edelmann et al., 1999a). These 
repeats, of which there are several on chromosome 22, including a copy within the 
VCFS commonly deleted region may also mediate rarer DNA rearrangements 
(Edelmann et al., 1999b). Cat-eye syndrome results from a supernumerary 
chromosome, inv dup(22), with the breakpoints located at one or more of the LCR22 
sequences (McTaggart et al., 1998). The reciprocal duplication of the VCFS deletion 
has now been detected in an increasing number of cases (Edelmann et al., 
1999b;Ensenauer et al., 2003;Hassed et al., 2004). The 22qll.2  microduplication 
results in a milder phenotype, which may be why it has been so rarely reported, and 
the microduplications are often larger in size than the 3Mb common VCFS/DiGeorge 
deletion, with the size range of microduplications ranging between 3Mb to 
approximately 6Mb (Ensenauer et al., 2003). The endpoints of the 22qll.2 
microduplication are associated with various LCR22 sequences, including the copies 
that are most frequently involved in the VCFS/DiGeorge microdeletion (Ensenauer et 
al., 2003).
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are disorders with very
distinct phenotypes that can result from the same 4Mb deletion of chromosome
15qll-ql3 (Magenis et al., 1990). This region contains imprinted genes, which are
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either maternally or paternally expressed. Inheritance of a deletion from the mother 
results in no expression of the maternally expressed genes in the region, resulting in 
an AS phenotype. A paternally inherited deletion of 15ql l-q l3  will cause PWS, due 
to the absence of expression of paternally expressed genes from the maternally 
inherited normal chromosome 15. The 4Mb deletion is mediated by recombination 
between LCRs on chromosome 15, which each contain a copy of HERC2, a 
transcribed gene, and are up to 200Kb in size (Amos-Landgraf et al., 1999;Ji et a l , 
1999). There are several copies of this repeat unit on chromosomes 15 and 16, and 
there are also other recurrent rearrangements involving chromosome 15 that may be 
mediated by these LCRs (Amos-Landgraf et al., 1999).
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Non-allelic homologous recombination
*
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Figure 1.5. Non-allelic homologous recombination between directly repeated 
sequences can lead to both duplications and deletions. The direct repeats are shown 
as arrows filled in black and grey to distinguish between the two copies, and a gene 
between the two repeats (which may or may not be dosage sensitive) is represented by 
an open box. Misalignment of two homologous repeats, be it either interchromosomal 
(between homologous chromosomes) or intrachromosomal (between sister 
chromatids), can then lead to recombination between the two repeats. This can result 
in either a duplication of the intervening region, or a deletion of the region, which 
may lead to a phenotype through gene dosage effects. The recombination event 
creates a chimaeric repeat in both cases, consisting of part of the distal and part of the 
proximal repeat.
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1.4.1.2. Inverted repeats
If the LCRs are inverted in orientation with respect to each other, recombination
between the repeats leads to inversion of the sequence flanked by the inverted repeats
(Figure 1.6). The factor VIII gene (located at Xq28) is mutated in cases of
haemophilia A. Nearly half of severe cases have an inversion of around 600kb
including part of the factor VIII gene, and the underlying molecular defect is gene
disruption (Lakich et a l , 1993). The inversion takes place between two inverted
transcribed repeats, known as the A gene (Lakich et a l , 1993). One of these is
located in exon 22 of the factor VIII gene, with two other A gene sequences 5' to the
gene, which are inverted with respect to the intronic A copy (Lakich et a l,  1993).
Inversion of the factor VIII gene results in an abnormal transcript which contains
exons 1-22 of the gene plus additional sequences, without the 3' end of the gene
(Naylor et a l, 1993). As well as the inversion itself causing the pathogenic genomic
change (as in haemophilia A), several polymorphic inversions have been discovered
in human populations, which have been found to predispose to subsequent genomic
rearrangements, generally in the offspring of individuals who are heterozygous for the
inversion. One example of a common polymorphic genomic inversion is found near
the FXA7/emerin region, also in Xq28. Two 11.3Kb inverted repeats flank 48Kb of
sequence containing the FLN1 and emerin genes, and an inversion of this whole
region, mediated by the flanking repeats, is found in 18% of human chromosomes
(Small et a l, 1997). Deletions of the emerin gene are sometimes found in patients
with Emery-Dreifuss muscular dystrophy, and the polymorphic inversion may
contribute to deletions in the region, especially in a parent heterozygous for the
inversion (Small et a l, 1997;Small and Warren, 1998). Another example of this
phenomenon has been studied in Williams-Beuren syndrome (WBS). Features of the
WBS phenotype include characteristic facial features, vascular stenoses, growth
retardation and specific cognitive defects (Osborne et a l,  2001). WBS is usually
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caused by a heterozygous deletion of 1.55Mb of genomic DNA from 7qll.23, a 
region containing between 25-30 genes (Ewart et al., 1993;Bayes et al., 2003). The 
common deleted region is flanked by two LCRs, each about 400Kb in size (Robinson 
et al., 1996;Osbome et a l , 2001). These LCRs contain various duplicated blocks of 
sequence, some of which are repeated in a direct orientation between the two 
duplications, and others which are inverted in orientation between the two repeats 
(Osborne et al., 2001). The 1.55Mb deletion is mediated by NAHR between the 
directly orientated portions of the flanking LCRs, and an inversion polymorphism of 
between 1.79-2.56Mb including the WBS common deletion region is caused by 
NAHR between the inverted sections of the flanking repeats (Osborne et al., 
2001;Bayes et al., 2003). The inversion polymorphism has been found in nearly one- 
third of progenitors who were found to have transmitted the affected chromosome and 
has also been found in the parents of individuals with atypical deletions and larger 
chromosome rearrangements involving the region (Osborne et al., 2001;Bayes et al.,
2003).
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Figure 1.6. Recombination between inverted repeats leads to an inversion of 
sequences between the repeats, which may disrupt a gene or regulatory sequences, or 
cause a predisposition to other rearrangements.
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1.4.1.3. Gross chromosomal rearrangements
Some large cytogenetically visible chromosomal rearrangements such as 
translocations have been found to be recurrent events, mediated by repeated regions at 
the breakpoints. Several recurrent chromosomal rearrangements involving 
chromosome 8 have been shown to be mediated by LCRs containing clusters of 
olfactory receptor (OR) genes (Giglio et al., 2001;Giglio et al., 2002). Two 400Kb 
repeats containing OR genes map to 8p23.1 and 8p23.2, and were found to be 
involved in the breakpoints of several abnormal chromosome rearrangements, such as 
inv dup(8p), +der(8)(8p23.1pter), del(8)(p23.1p23.2) and t(4;8)(pl6;p23)
translocation (Giglio et al., 2001;Giglio et al., 2002). Many of these chromosome 8 
rearrangements also involve a polymorphic inversion of a 4.7Mb region flanked by 
the OR repeats, as this inversion is heterozygous in the parent transmitting the 
affected chromosome in many cases (Giglio et a l, 2001;Giglio et a l, 2002;Sugawara 
et al., 2003). This inversion polymorphism has been reported to be present in the 
normal population at a frequency of about 26-27% (Giglio et al., 2001;Sugawara et 
al., 2003). In the case of the 4;8 translocation, the two OR clusters at 4pl6 are also 
associated with a polymorphic inversion of the interstitial 6Mb of sequence, and 
mothers of translocation cases were found to be heterozygous for both the 8p23 and 
4pl6 inversions, which presumably predispose to this particular chromosomal 
rearrangement (Giglio et al., 2002). Another genetic disorder, Kabuki syndrome, has 
recently been reported to be caused by a 3.5Mb duplication of 8p22-8p23.1, with the 
duplicated region flanked by OR-containing repeats (Milunsky and Huang, 2003). 
Additionally, two of the mothers of Kabuki syndrome cases were investigated by 
FISH and were found to be heterozygous for the inversion polymorphism in this 
region (Milunsky and Huang, 2003).
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1.4.1.4. Partial gene deletions and duplications
Rearrangement of genomic DNA does not always involve a whole gene. Partial 
deletions and duplications of genes or just individual exons, leading to altered protein 
sequence, with frameshifts occurring in many case, are also found in human genetic 
disease. A notable example of this is in Duchenne and Becker muscular dystrophies, 
where a deletion or duplication of one or more exons within the enormous dystrophin 
gene leads to a truncated or interstitially deleted protein being produced (Koenig et 
al., 1987;Hu et a l , 1988). Rearrangement breakpoints within the dystrophin gene are 
scattered throughout the gene, but some hotspots for deletions and duplications have 
been reported in particular introns or regions of the gene (den Dunnen et al., 
1989;Koenig et a l, 1989;McNaughton et al., 1998). Sequenced breakpoints have 
usually shown no homology to each other, although a minority of breakpoints have 
interspersed repeat elements such as Alu at both ends (McNaughton et al., 1998). 
Incontinentia pigmenti, an X-linked dominant disorder, is caused by mutations in the 
NEMO (NF-kB essential modulator) gene (Smahi et al., 2000). 80% of new
mutations in the NEMO gene are a deletion of exons 4-10, with the breakpoints of the 
deletion falling within highly similar 870bp MER67B repeats in intron 3 and 3' to 
exon 10, the final exon of the NEMO gene (Smahi et al., 2000). Deletions and 
duplications of one or more exons within the BRCA1 gene make a significant 
contribution to the mutational spectrum of this gene, accounting for between 10 and 
30% of germline mutations within BRCA1 in different populations; these 
rearrangements are often found to be due to illegitimate recombination between Alu 
elements (Petrij-Bosch et al., 1997;Puget et al., 1999;The BRCA1 Exon 13 
Duplication Screening Group, 2000).
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1.4.2. Gene dosage in cancer
Gene dosage is not only an important factor in inherited disease; it is also crucial for 
the development of many tumours. In many human cancers, loss | or amplification of 
most parts of the genome have been found using various techniques to detect changes 
in gene dosage (Knuutila et al., 2000). Genomic instability, including chromosome 
aneuploidy, translocations and changes in dosage of smaller regions, is present in 
many cancer cell genomes (reviewed in (Lengauer et a l , 1998;Balmain et a l,  2003)). 
The nature of genomic instability in cancers is still unclear, with uncertainty as to 
whether genomic instability is a primary factor in early carcinogenesis or just a 
secondary event in tumours that does not play a great role in cancer development 
(reviewed in Lengauer et a l, 1998;Marx, 2002;Balmain et a l, 2003;Pihan and 
Doxsey, 2003;Duesberg et a l, 2004). In general, regions that are recurrently 
amplified in particular tumours often contain oncogenes that promote the 
establishment and growth of tumours, such as MDM2, MYC and CMYC (Schwab et 
a l, 1983;Alitalo et a l, 1983;01iner et a l, 1992, reviewed in Schwab, 1999). Parts of 
the genome that are recurrently deleted in cancer will frequently contain tumour 
suppressor genes, and loss of function due to deletion of both alleles, or deletion of 
one allele accompanied by a mutation or epigenetic silencing on the other allele, 
contributes to carcinogenesis (Balmain et a l, 2003). It is also becoming apparent that 
haploinsufficiency of some tumour suppressor genes, such as p27, is also an important 
factor during tumour development (Philipp-Staheli et a l, 2001;Balmain, 2002).
1.4.3. PMD -  is it a genomic disorder?
In contrast to most “genomic disorders” described above, such as CMT1A, VCFS and
SMS, in PMD patients the duplication containing PLP1 varies considerably in size
between individuals, and no LCRs have been found to date flanking the gene
(Woodward et a l, 1998;Inoue et a l, 1999;Hobson et a l, 2003). However, other
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features of the genomic sequence within Xq22.2 may be involved in the 
rearrangements of this region, which include tandem duplications, atypical transposed 
duplications and deletions (Inoue et a l , 2002). Determination of the sequence at and 
near the breakpoints in PMD patients may help to understand the mechanisms behind 
these rearrangements. The breakpoints that have been sequenced and reported so far 
mostly do not show large stretches of homology at the breakpoints, and non- 
homologous end joining (NHEJ) has been implicated in these rearrangements (Inoue 
et a l , 2002). Many of the breakpoints that have been sequenced have one end located 
in an interspersed repeat and the other end within unique sequence, and several 
duplication or deletion endpoints have been located in distal LCRs (see section 3.4.) 
(Inoue et a l , 2002;Hobson et a l , 2003;Iwaki et a l, 2003;Woodward et a l, in 
preparation). NHEJ is the most commonly used pathway for repair of double-strand 
breaks in multicellular eukaryotic organisms, and typically the two ends are joined at 
short regions of microhomology (l-4bp) between the two sequences (reviewed in 
Lieber et a l, 2003).
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1.5. Detection of gene dosage
Many methods have been used to detect changes in PLP1 gene dosage. Interphase 
FISH is routinely used to detect PLP1 duplications in a diagnostic setting, and has 
been found to be reliable for male patients and female carriers, although time- 
consuming (Woodward et al., 1998). Quantitative fluorescent multiplex PCR and 
comparative multiplex PCR have also been used to detect dosage changes in PLP1, 
but can give problems with detecting carrier status in females (Inoue et a l , 
1996a;Wang et a l, 1997;Woodward et a l, 1998;Sistermans et a l,  1998). Southern 
blotting can also be used to detect dosage changes in PLP1, but is not a rapid 
technique and requires large amounts of DNA (Ellis and Malcolm, 1994). Analysis of 
RFLP alleles or other polymorphisms within or near PLP1 can be used if the mother 
or patient is heterozygous for polymorphisms within the gene. Heterozygosity for 
polymorphic markers within the duplicated region in males could be used as evidence 
for duplications of the region, but as the duplication is usually intra-chromosomal in 
origin, marker analysis is generally uninformative (Inoue et a l, 1996a;Woodward et 
a l, 1998).
1.5.1. Real-time PCR
Real-time PCR is a method that can be used to measure DNA sequence copy number.
A reaction is designed so that fluorescence increases in proportion with the amount of
PCR product present in the reaction, and detection of the amount of fluorescence
present throughout the reaction allows quantitation of the product while the PCR is
still in the exponential phase (Ginzinger, 2002). Various methods can be used to
produce the fluorescence; intercalating dyes can be used that only fluoresce when
bound to double stranded DNA, or fluorescent probes that are specific to the PCR
product can be used. Real-time PCR has been shown to be a rapid method of
detecting changes in gene dosage in many cases, such as the PMP22 gene (Aarskog
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and Vedeler, 2000;Thiel et a l , 2003). Real-time quantitative PCR technology does 
not enable the PCR products to be identified by size, so multiplexing several different 
sets of primers, as is possible for many conventional quantitative PCR strategies, is 
limited by the different types of fluorophores available.
1.5.2. MLPA
One method that has been recently developed that can assay dosage at several loci 
simultaneously (at least 40), is multiplex ligation-dependent probe amplification 
(MLPA) (Schouten et a l , 2002). Each target sequence, which is between 50-70 
nucleotides in length, is detected by a pair of probes, each hybridising to one half of 
the target. Genomic DNA is mixed with the various probes and allowed to hybridise. 
Following hybridisation, a ligation reaction is carried out, joining together any probes 
that are hybridised to adjacent sequences, then PCR is carried out using primers that 
are specific to tag sequences present at the ends of all the probes. Each probe pair 
produces a differently sized amplification product, so following electrophoresis each 
probe can be identified and quantified. MLPA has been used to assay gene dosage for 
a number of applications, such as screening BRCA1 for copy number changes in 
exons and detection of aneuploidies (Hogervorst et a l , 2003;Slater et a l , 2003). An 
MLPA kit containing all exons of the PLP1 gene has recently become commercially 
available from MRC-Holland (Wolf et a l , in preparation).
1.5.3. Comparative genomic hybridisation
Most methods for assaying gene dosage only look at the copy number of a limited
number of target sequences, but some methods can be used to survey the whole
genome for copy number changes. One such method is comparative genomic
hybridisation (CGH), which was initially developed as a tool for looking at copy
number changes in cancer, but can also be used to detect changes in gene dosage that
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may cause genetic disease (Kallioniemi et a l, 1992). The principles of CGH are as 
follows: a test DNA sample and reference DNA sample are each labelled with a 
different fluorophore, and hybridised to a metaphase spread from a normal individual, 
along with unlabelled C0t-1 DNA. The amounts of each of the two samples relative to 
each other along all the chromosomes can then be quantified, giving a genome-wide 
assessment of changes in copy number at a resolution of 20Mb. A later modifcation 
of CGH, array- CGH, gave the technique a much higher resolution by hybridising the 
test and reference DNA to individual genomic clones spotted on a glass slide (Pinkel 
et al., 1998). Using array-CGH, the resolution is brought down to the level of single 
genomic clones. Recently, a tiling path DNA microarray used for CGH has been 
developed, with complete coverage of the human genome, consisting of 32433 BAC 
clones (Ishkanian et a l, 2004). Lower resolution genome-wide arrays are also in use, 
some that can survey the whole human genome at a 1Mb level, using equally spaced 
clones, and many other smaller-scale arrays have been developed for specific regions 
(Vissers et a l, 2003;Fiegler et al., 2003). An X-chromosome tiling path BAC array 
has been shown to detect increased dosage of 3 BAC clones surrounding and 
including the PLP1 gene in a sample with a known PLP1 duplication (Veltman et al.,
2004).
1.5.4. MAPH
Multiplex amplifiable probe hybridisation (MAPH) is a technique that can be used to
assess sequence copy number in genomic DNA, and has been used as part of this
project (Figure 1.7) (Armour et al., 2000). The protocol involves hybridisation of
short probes to genomic DNA, which are then recovered and amplified. The probes
each consist of sequence complementary to a specific region of genomic DNA (150-
450bp), which is flanked by 59bp of sequence common to all probes. Each probe is a
different size, so they can be distinguished from each other by their gel mobility
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following electrophoresis. After hybridisation to genomic DNA, and washing to 
ensure sequence-specific binding, probes are amplified using PCR, and the amount of 
PCR product obtained from the reaction should be directly proportional to the copy 
number of the sequence in the sample (Armour et al., 2000). The MAPH technique 
has been shown to be able to detect duplications and deletions of exons of the DMD 
gene, various subtelomeric deletions using a subtelomeric set of probes, a deletion of 
the TBX5 gene, and duplications and deletions of PMP22 (Armour et al., 
2000;Akrami et al., 2001;Sismani et al., 2001;White et al., 2002;Akrami et al., 
2003;White et al., 2003).
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Figure 1.7. Diagram showing principles of MAPH. Adapted from Armour et al, 
2000.
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I.5.4.I. MAPH and PLP1 gene dosage
Many different laboratory techniques can be used to detect changes in PLP1 gene 
dosage, with interphase FISH being a widely used diagnostic technique, which is used 
in our laboratory (Woodward et a l , 1998). However, alternative techniques may be 
preferable, by shortening the experimental procedure, requiring less time-consuming 
analysis, or by other improvements inherent to the methodology. Some techniques 
may require substantial investment in specialised equipment (Real-time PCR, array- 
CGH), or may not be amenable to multiplexing of different target loci (Real-time 
PCR, FISH). Recently developed techniques such as MAPH and MLPA use 
equipment that is already available to most laboratories, and are able to target several 
loci (at least 40 in each case) simultaneously. MAPH probes are easily produced by 
cloning into a specific plasmid vector followed by PCR using flanking vector primers, 
and MLPA probes are produced from phage M13-derived vectors (Armour et a l , 
2000;Schouten et a l , 2002). Development of a MAPH probe set including PLP1 
probes and also probes from the surrounding region would enable detection of PLP1 
duplications and also detect the extent of the duplication in a single experiment.
62
1.6. SOX3 gene dosage and X-linked hypopituitarism
Hypopituitarism is characterised by the reduced secretion of one (isolated 
hypopituitarism), several (partial hypopituitarism) or all (panhypopituitarism) of the 
various different hormones secreted by the pituitary gland (see sections 1.6.2.1-4) 
(Pinzone, 2001). Anterior pituitary development is dependent on a complex genetic 
cascade of signalling molecules and transcription factors. Mutations have been 
reported in several transcription factors involved in pituitary development in 
individuals with varying degrees of hypopituitarism, including HESX1, PROP1, 
POU1F1, LHX3 and LHX4 (Pfaffle et a l , 1992;Radovick et al., 1992;Dattani et a l, 
1998;Wu et a l, 1998;Netchine et a l,  2000;Machinis et a l, 2001;Cohen and 
Radovick, 2002).
The inheritance of hypopituitarism may be autosomal recessive, dominant or X-
linked. Recent advances have suggested that X-linked hypopituitarism may be due to
abnormalities in gene dosage. One indication that gene dosage might be a factor in X-
linked hypopituitarism came with two reports of interstitial duplications within the
long arm of the X-chromosome segregating with X-linked hypopituitarism (Hoi et a l,
2000;Solomon et a l, 2002). One report involved a family where a 13Mb duplication
of Xq26.1-q27.3 was found in two brothers with X-linked hypopituitarism and spina
bifida (Hoi et a l,  2000). Another family with X-linked hypopituitarism which had
previously been linked to Xq25-q26 was then also found to carry a 9Mb duplication
of the chromosomal region Xq26.1-q27.3 (Lagerstrom-Fermer et a l,  1997;Solomon
et a l, 2002). As both duplications were of a different size, and had different
endpoints, the most likely explanation for the phenotype is that a dosage-sensitive
gene located in the common duplicated region was responsible for the pituitary
phenotype. Further evidence for this region being involved in pituitary disease came
with the report of an expansion of a polyalanine tract (from 15 alanines to 26
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alanines) within the S0X3 gene in a family where the affected individuals showed 
mental retardation, facial dysmorphism and short stature (Laumonnier et a l, 2002).
1.6.1. SOX3
SOX3 (SRT-related HMG-box gene 3) is a transcription factor that is part of a family 
o f 20 human proteins including the SRY gene that all contain a HMG domain (high 
mobility group), a DNA-binding motif of approximately 79 amino acids, with at least 
50% similarity to the SRY HMG-box domain (Figure 1.8) (Stevanovic et a l, 
1993;Schepers et al., 2002). The HMG-box domain binds to DNA in the minor 
groove and causes bending of the target DNA when bound (Figure 1.8). SOX3 is one 
of the B1 group of SOX proteins, along with SOX1 and SOX2, all three of which show 
a high degree of sequence similarity throughout the protein sequence (Bowles et al.,
2000). Many of the other SOX proteins only show homology to SOX3 within the 
HMG-box, and have very different N- and C-terminal sequences The SOX3 gene is 
located on the X chromosome, at the chromosomal position Xq27.1, and contains just 
one exon, 1.3Kb in length, coding for a 446 amino acid protein (Stevanovic et al., 
1993). Of all the SOX family of proteins, SOX3 is the most similar to SRY, and it is 
likely that SRY evolved from an ancestral SOX3 gene (Graves, 1998;Katoh and 
Miyata, 1999). SOX3 is well conserved between species, and the mouse and human 
sequences are 97.2% identical (Stevanovic et al., 1993). SOX3 is expressed 
throughout the developing CNS, and in the genital ridge, with an expression pattern 
that largely overlaps that of SOX1 and SOX2, in developing mouse embryos 
(Collignon et a l, 1996). SOX1-3 are also involved in lens differentiation and 
development (Kamachi et a l, 1998). SOX3 is able to bind an SRY consensus motif, 
AACAAT, but has lower affinity than SRY or SOX2 at binding this sequence 
(Collignon et a l, 1996). SOX-group proteins are thought to bind DNA in conjunction
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with other DNA-binding transcription factors, such as POU homeodomain proteins, 
which gives greater target specificity (Kamachi et a l , 2000;Remenyi et al., 2003).
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Figure 1.8. SOX3 protein structure, (a) shows the domains present in the SOX3 
protein, the HMG-box DNA binding domain is shaded with diagonal lines and four 
polyalanine tracts are shaded black, (b) shows a three-dimensional representation of 
the SRY HMG-box domain (which is highly similar to the SOX3 HMG-box) bound 
to DNA, showing the way the DNA is bent by the bound HMG-box protein domain. 
SRY HMG-box protein is shown in purple, with the DNA backbone shaded red, and 
the bases in yellow and orange. From (Remenyi et al., 2003).
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1.6.2. Pituitary function
The pituitary gland is a pea-sized midline structure located under the hypothalamus in 
a bony cavity, the sella tumica, and is directly connected to the hypothalamus by the 
hypophysial stalk, or infundibulum (Figure 1.9a) (Thapar et al., 2001). In humans, 
the gland comprises two lobes, the anterior pituitary (adenohypophysis) and posterior 
pituitary (neurohypophysis), which are derived from different embryonic origins 
during development (Figure 1.9b) (Thapar et a l, 2001). The pituitary gland is the 
“master gland” of the endocrine system, and secretes many different hormones into 
the bloodstream, regulating numerous physiological processes involved in growth, 
metabolism and reproductive development.
1.6.2.1. Anterior pituitary gland
In the anterior pituitary, each hormone is synthesised and secreted by one of six
specialised cell types. Somatotrophs secrete growth hormone (GH), also known as
somatotrophin, which has numerous effects on metabolism and growth (Baumann,
2001). Thyrotroph cells secrete thyroid stimulating hormone (TSH), or thyrotrophin,
which as the name suggests, stimulates the thyroid gland to secrete thyroid hormones
(Cohen, 2001). Adrenocorticotrophic hormone (ACTH), or corticotrophin, is secreted
from corticotroph cells in the pituitary as part of the stress response (Torpy and
Jackson, 2001). It stimulates the adrenal gland to produce cortisol and other
glucocorticoids (Torpy and Jackson, 2001). Lactotroph cells in the pituitary gland
produce prolactin (PRL), a hormone that is involved in lactation and has some effects
on the immune system (Thapar et al., 2001). The two gonadotrophin hormones,
luteinising hormone (LH) and follicle-stimulating hormone (FSH) are synthesized in
gonadotroph cells in the pituitary (Thapar et al., 2001;Bremner et al., 2001). LH and
FSH have effects in the ovary and testes, stimulating the production of the hormones
oestrogen and testosterone, and are also crucial to the maturation of oocytes and
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sperm production (Bremner et al.t 2001). TSH, LH and FSH are all dimer molecules, 
with all three hormones containing a common alpha subunit, which is non-covalently 
bound to a different beta subunit for each different hormone type (Cohen, 
2001;Bremner et a l , 2001). Melanotroph cells within the human foetal pituitary 
gland secrete melanocyte stimulating hormone (MSH), which may be involved in 
regulation of energy homeostastis and body weight (Torpy and Jackson, 
2001;MacNeil et al., 2002). MSH and ACTH are both produced from the same 
precursor peptide, pro-opiomelanocortin, which is differentially cleaved to produce 
the two different hormones (Torpy and Jackson, 2001).
1.6.2.2. Posterior pituitary gland
The posterior lobe of the pituitary is composed of neural projections from the 
hypothalamus, and also secretes important hormones (Figure 1.9b) (Thapar et a l , 
2001). Antidiuretic hormone (ADH), or vasopressin, is secreted by hypothalamic 
neuroendocrine neurons in the posterior pituitary, and increases the rate of water 
resorption by acting on the kidney (Robertson, 2001). ADH levels are regulated by 
osmoreceptor neurons in the hypothalamus, which sense plasma solute concentration 
and then stimulate the ADH-producing cells if plasma osmolarity is above a threshold 
level (Robertson, 2001). The other hormone secreted by the posterior pituitary is 
oxytocin, which again is released by neuroendocrine axonal projections from the 
hypothalamus into the posterior pituitary (Robertson, 2001). Oxytocin has its main 
effects in causing the uterus to contract during labour and in stimulating milk flow 
during lactation (Robertson, 2001).
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1.6.2.3. Intermediate pituitary gland
In many species, including almost all mammals, but not in adult humans, there is a 
distinct third lobe of the mature pituitary between the anterior and posterior lobes, 
known as the intermediate lobe (Saland, 2001). The intermediate lobe is present 
during early development in humans, but involutes during development and is not 
present in adults (Saland, 2001). MSH is secreted from the intermediate lobe in those 
species in which this lobe is present (Saland, 2001).
1.6.2.4. The hypothalamic-pituitary axis
The hypothalamus secretes many hormones that control the release of pituitary 
hormones and the two are directly connected by hypothalamic-hypophyseal portal 
veins, so that factors secreted from the hypothalamus are carried directly to the 
pituitary gland (Figure 1.9b) (Thapar et a l, 2001). Growth hormone releasing 
hormone (GHRH) is released from the hypothalamus and stimulates the production 
and release of GH from the pituitary (Baumann, 2001). Somatostatin is also released 
by the hypothalamus and inhibits the release of GH (Baumann, 2001). Prolactin 
release is not stimulated by the hypothalamus, but factors including dopamine that are 
produced in the hypothalamus inhibit prolactin production (Katznelson and Klibanski,
2001). Thyrotrophin releasing hormone from the hypothalamus stimulates the release 
of TSH from the anterior pituitary (Cohen, 2001). Corticotrophin-releasing hormone, 
produced by the hypothalamus, stimulates ACTH production in the pituitary gland 
(Torpy and Jackson, 2001). ACTH production is also stimulated by the action of 
ADH/vasopressin, secreted from the posterior pituitary (Torpy and Jackson, 2001). 
LH and FSH production within the pituitary gland is controlled by the action of 
gonadotrophin releasing hormone (GnRH), which stimulates hormone production 
from the gonadotrophs, and is secreted by the hypothalamus (Bremner et a l, 2001).
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Figure 1.9. Anatomy of the pituitary gland and hypothalamus, (a) Position of the
pituitary gland and hypothalamus in the human brain. From the Merck Manual -  
Second Home Edition (http://www.merck.com/mrkshared/mmanual_home2/fg/fgl62 
_l.jsp). (b) Diagram of the general anatomy of the human pituitary gland, showing 
the relationship with the hypothalamus. Simplified structures of the blood vessels in 
the pituitary are shown, including the hypothalamic-hypophyseal portal veins 
connecting the capilliary beds in the anterior pituitary and the hypothalamus. The 
general location of the hormone-secreting neurons, with axons extending from the cell 
bodies in the hypothalamus into the posterior pituitary, is shown.
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1.6.3. Pituitary development
The development of the pituitary has been studied in detail, particularly in the mouse, 
but also in other model systems such as Xenopus and chick. The anterior and 
posterior pituitary are derived from different embryological origins. The anterior 
pituitary is derived from the oral ectoderm, and the posterior pituitary is derived from 
the neural ectoderm (Thapar et al., 2001). In mouse, pituitary formation is recognised 
to start at about embryonic day 8.5 (e8.5) when the previously most anterior part of 
the embryo, the anterior neural ridge, moves ventrally to form the oral roof ectoderm 
(Dasen.J.S. and Rosenfeld, 1999). From e8.5 to e9.0, thickening and then invagination 
of part of the oral ectoderm begins, which starts to form a structure known as 
Rathke’s pouch (Figure 1.10a). When Rathke’s pouch is forming, evagination of the 
adjacent neural ectoderm layer also occurs, in a region known as the infundibulum 
(Figure 1.10a). Over time, Rathke’s pouch invaginates further, and by el2 it has 
closed and separated from the oral ectodermal layer (Figure 1.10b,c). Cells 
proliferate from the epithelial cells in Rathke’s pouch and become the progenitors of 
the hormone-secreting cell of the anterior pituitary, and each lineage is located in a 
distinct part of the anterior pituitary initially, although in the mature pituitary gland 
the hormone-secreting cells are not organised in such discrete domains (Figure 1.1 Od) 
(Dasen.J.S. and Rosenfeld, 1999).
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Figure 1.10. Development of the pituitary gland in the mouse. The approximate 
position of the hormone secreting cell types in the developing anterior pituitary are 
shown in (d). Abbreviations: IF -  infundibulum, VD -  ventral diencephalon, OE -  
oral ectoderm, RP -  Rathke’s pouch, M -  melanotrophs, C -  corticotrophs, S -  
somatotrophs, L -  lactotrophs, T -  thyrotrophs, G -  gonadotrophs. Adapted from 
(Dasen.J.S. and Rosenfeld, 1999)
1.6.3.1. Signalling molecules and transcription factors in pituitary development
Many of the factors that are important for pituitary development have been studied in
various animal models, and mutations in many of the genes that are expressed during
pituitary development have been found in individuals with pituitary disorders.
Signalling molecules are important in the early development and specification of
Rathke’s pouch. Around e9.5 in the mouse (equivalent to the third week of gestation
in humans), signals from the infundibulum induce the development of Rathke’s
pouch, including Bmp4 (Bone morphogenic protein 4), along with Wnt5a (Wingless-
type MMTV integration site family member 5a) and Fgf8 (Fibroblast growth factor 8)
(Figure 1.11a) (Takuma et al., 1998;Treier et al., 1998). In the region of oral
ectoderm that forms Rathke’s pouch, Wnt4 and Bmp2 are expressed as it becomes
committed to forming the anterior pituitary (Treier et al., 1998;Savage et al., 2003)
(Figure 1.11a). Sonic hedgehog is initially expressed throughout the oral ectoderm,
but it is excluded from the Wnt4- and Bmp2-expressing region as Rathke’s pouch
begins to form (Treier et al., 1998). The paired-like homeodomain transcription
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factors Pitxl and Pitx2 are both expressed in the oral epithelium and endoderm when 
Rathke’s pouch begins to form, and the LIM homeobox genes Lhx3 and Lhx4 are 
expressed in the rudimentary pouch (Figure 1.11b) (Savage et al., 2003). The 
homeobox gene Hesxl has a restricted expression pattern at e9.5, and is only 
expressed in Rathke’s pouch at that time during development although its earlier 
expression pattern is more widespread (Figure 1.1 lb) (Hermesz et al., 1996). As the 
pouch further invaginates, around e l0.5, other transcription factors are expressed, 
including Propl (Prophet of P itl) within Rathke’s pouch, Nkx3.J in the most dorsal 
part of the pouch, closest to the infundibulum, and Pax6 is also expressed in Rathke’s 
pouch (Figure 1.11b) (Dasen.J.S. and Rosenfeld, 1999). As the anterior pituitary 
differentiates, Hesxl expression is turned off, in a ventral to dorsal direction, which 
coincides with the initiation of expression of P oulfl (Pitl) (Hermesz et al., 1996). 
The distinct spatial and temporal expression patterns of these and other genes within 
the developing anterior pituitary allow the specification of the different hormone- 
releasing cell types within the mature pituitary gland.
(a) (b)
Nkx2.1
e9.5
Pitxl/2
Figure 1.11. Expression of some signalling molecules and transcription factors 
during early mouse pituitary development. The infundibulum is shaded black, and 
Rathke’s pouch is light grey. Adapted from (Dasen.J.S. and Rosenfeld, 1999;Cohen 
and Radovick, 2002)
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1.6.3.2. S0X3 in pituitary development
Sox3 is expressed throughout the CNS, including the ventral diencephalon and 
infundibulum, but not in Rathke’s pouch (Rizzoti et al., 2004). Mice that have a 
targeted deletion of Sox3 show variable defects in pituitary morphology and function, 
and defects in CNS midline structures, as well as craniofacial anomalies (Rizzoti et 
a l , 2004). During development in Sox3 deficient mice, the infundibulum is flattened 
and Rathke’s pouch is expanded dorsally and contains a bifurcated cleft (Rizzoti et 
al., 2004). Within the infundibulum Bmp4 and FgfS showed a transient expanded 
expression domain in the absence of Sox3 before any changes in Rathke’s pouch 
became apparent, and proliferation is reduced in the infundibulum (Rizzoti et al., 
2004). Sox3 expression was also found to persist postnatally in the ventral 
hypothalamus, and it may also be involved in the regulation of pituitary hormone 
secretion (Rizzoti et al., 2004).
1.6.4. Screening for changes in SOX3 gene dosage
The evidence published so far does suggest that SOX3 dosage could play a role in the 
aetiology of X-linked hypopituitarism. Screening a cohort of male patients with, or 
who are suspected to have, X-linked hypopituitarism for changes in dosage in Xq26- 
27 may enable further refinement of the X-linked hypopituitarism critical region. 
These studies may also clarify the role of SOX3 gene dosage in this disorder.
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1.7. Objectives:
To investigate the nature of tandem genomic duplications in Xq22 involving PLP1, 
by mapping the extent of different duplications, and determining the sequences 
present at the breakpoints, to further understand the mechanisms behind these types of 
duplications.
To study the complex rearrangements present in the family with insertion of PLP1 
into Xq26, including both the insertion and the mosaic deletion in the carrier mother, 
to help determine if the insertion and deletion rearrangements are related in some 
way, and to further understand the events that gave rise to these rearrangements.
To develop MAPH as an alternative technique to interphase FISH for the diagnosis of 
duplications of PLP1 and the surrounding genomic region.
To screen a cohort of patients with X-linked hypopituitarism for duplications of 
Xq26-27 involving the SOX3 gene, and further investigation of any found, using a 
similar strategy to that pursued for the PLP1 duplications.
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2.0. MATERIALS AND METHODS
2.1. General materials
2.1.1. Products and reagents
All chemicals were obtained from Sigma-Aldrich or BDH, except for the following: 
Genescan-500 Tamra size standard and BigDye Terminator version 3.1 reaction mix was 
obtained from Applied Biosystems
LB broth base, RPMI 1640 medium, Penicillin/Streptomycin, L-glutamine, KaryoMAX 
colcemid, herring sperm DNA, agarose, lOObp ladder, X/Hindlll DNA, §X\14IHae\\l 
DNA, BIONICK labelling kits, Zero Background/Kan cloning kits (including plasmid 
pZErO-2) and One Shot TOP 10 competent cells were all supplied by Invitrogen.
New England Biolabs supplied T4 DNA ligase, Klenow fragment, and all restriction 
enzymes, except for the following: Mval from MBI Fermentas; BamRl and Rsal supplied 
by Promega; EaeI from Roche; and EcoT14l was obtained from Amersham Biosciences. 
Amersham Biosciences also supplied Hybond N+ nylon membrane, MegaBACE Long 
Read Matrix and LPA buffer.
Foetal Calf Serum was supplied by PAA Laboratories.
Biopro Taq, 10 x NH4 buffer, MgCL and dNTPs were supplied by Bioline.
HotStarTaq, 10 x PCR buffer, Q solution, Proofstart enzyme, Proofstart 10 x PCR buffer 
and QIAquick gel extraction kits all were obtained from Qiagen.
Roche Applied Science supplied mouse anti-digoxigenin antibody, DIG-Nick translation 
mix and C0t-\ DNA.
Sequagel concentrate, diluent and buffer were obtained from National Diagnostics.
Vysis supplied Spectrum Green and Spectrum Orange dUTP, Nick translation kit and 
CEP-X centromere probes in both Spectrum Orange and Spectrum Aqua.
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Vectashield mounting medium containing DAPI, Texas Red Avidin DCS antibody, 
Fluorescein Avidin DCS antibody and biotinylated anti-avidin DCS antibody were all 
supplied by Vector labs.
Vulcanising rubber solution was supplied by Weldtite.
Non fat dried milk was manufactured by Premier Brands.
Shandon coverplates were supplied by Thermo Electron.
Human genomic clones were supplied by the Wellcome Trust Sanger Institute.
2.1.2. Buffers, solutions and mixes
2.I.2.I. PCR Buffers
NH4 10 x reaction buffer: 160mM (NH4)2S 04) 670mM Tris-Cl pH 8.0, 0.1%
Tween 20
10 x PCR buffer: Tris-Cl, KC1, (NH4)2S04,1.5mM MgCl2
Proofstart buffer: Tris-Cl, KC1, (NH4)2S04, 1.5mM MgS04, BSA,
Triton X-100
2.1.2.2. Solutions
TE: lOmM Tris, ImM EDTA pH 8.0
5 x TBE: 0.089M Tris, 0.089M Boric acid, 2mM EDTA pH
8.0
20 x SSC 2.9M NaCl, 0.3M sodium citrate
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Loading dye 50% glycerol, Orange G
Phenol:chloroform:isoamyl alcohol: 50% buffered phenol, 48% chloroform, 2% isoamyl
alcohol
Lysis solution for fibre slides: 50mM NaOH, 28.6% ethanol
FISH hybridisation mix: 50% formamide, 10% dextran sulphate, 2 x SSC
MAPH prehybridisation solution: 0.5M sodium phosphate pH 7.2, 7% SDS, O.lmg/ml
heat-denatured herring sperm DNA
2.1.2.3. Media solutions
LB broth: 1% Bactotryptone, 0.5% Bacto-yeast extract, 1%
NaCl
LB agar: 1% Bactotryptone, 0.5% Bacto-yeast extract, 1%
NaCl, 15gbacto-agar
SOC medium: 2% Tryptone, 0.5% Yeast extract, 0.05% NaCl,
2.5mM KC1, lOmM MgCb, 20mM Glucose
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2.1.2.4. Plasmid alkaline lysis extraction solutions
Solution 1:
Solution 2:
Solution 3:
2.1.2.5. Probe labelling kits 
BIONICK labelling kit
lOx dNTP mix:
Enzyme mix:
DIG-Nick Translation kit
DIG-Nick Translation Mix:
50mM glucose, 25mM Tris-Cl pH 8.0, lOmM 
EDTA
0.2N NaOH, 1%SDS
5M potassium acetate, 11.5% glacial acetic acid
0.2mM each dCTP, dGTP and dTTP, 0.1 mM 
dATP, O.lmM biotin-14-dATP, 500mM Tris-HCl, 
pH 7.8, 50mM MgCl2, 100 mM p-mercaptoethanol, 
lOOpg/ml nuclease-free BSA
0.5U/pl DNA polymerase I, 0.007 U/pl DNase I, 
50mM Tris-HCl pH 7.5, 5mM MgCl2, O.lmM 
phenylmethylsulphonyl fluoride, 50% glycerol, 
lOOpg/ml nuclease-free BSA
Stabilised reaction buffer in 50% glycerol (v/v), 
DNA polymerase I, DNase I, 0.25mM each dATP, 
dCTP, dGTP, 0.17mM dTTP, 0.08 Digoxigenin-11- 
dUTP
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Nick Translation Kit
10 x nick translation buffer: 500mM Tris-HCl, pH 7.2, lOOmM HgS0 4 , ImM
DTT
Nick translation enzyme mix: DNA polymerase I and DNase I in 50% glycerol,
50mM MgSC>4, O.lmM DTT, 0.5 mg/ml nuclease- 
free BSA
2.1.2.6. Polyacrylamide gel solutions
Sequagel concentrate (1 litre): 236.5g acrylamide, 12.5g methylene, 500g 7M urea,
pH 8.3, bisacrylamide
Sequagel diluent (1 litre): 500g 7M urea, pH 8.3
Sequagel buffer (200ml): 50% 8.3M urea in 10 x TBE, pH 8.3
Loading buffer for A B I377: 60% formamide, 20% Genescan-500 Tamra, with
20mM EDTA, 20% loading buffer (contains 
50mg/ml blue dextran, 25mM EDTA)
2.1.3. Primers
All oligonucleotide primers were synthesised by MWG-Biotech and all nucleotide 
sequences and reaction conditions are listed in Appendix A.
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2.2. Methods
2.2.1. Polymerase Chain Reaction (PCR)
PCR was carried out using one of two DNA polymerase enzymes. Reactions using 
Biopro DNA polymerase contained a 1 in 10 dilution of 10 x NH4 reaction buffer, 
200pM each dNTP, 1.5mM MgCh, 0.5-1 pi of template DNA (50-250ng) and 20pmol 
each oligonucleotide primer in a total volume of 25pi. Reactions were initially heated to 
94°C for five minutes, after which 0.75U Biopro DNA polymerase (0.15pl) was added to 
the PCR and cycling was carried out, for 30 cycles unless stated otherwise; denaturation 
at 94°C for 30 seconds, primer annealing at 55°C (unless otherwise stated in Appendix C) 
for 30 seconds, and elongation at 72°C for between 45 seconds to 1 minute. After 30 
cycles, there was a final elongation step at 72°C for 10 minutes.
PCR using HotStarTaq DNA polymerase was carried out in a total reaction volume of 
25pl containing a 1 in 10 dilution of 10 x PCR buffer, 200pM each dNTP, 0.5-1 pi of 
template DNA (50-250ng), 20pmol each oligonucleotide primer and 0.75 units of 
HotStarTaq (0.15pl). Cycling was carried out, with an initial hotstart at 95°C for 15 
minutes, followed by 30 cycles (unless otherwise stated) of denaturation at 95°C for 30 
seconds, primer annealing at 55°C (or other stated temperature) for 30-45 seconds, then 
an elongation step at 72°C for 45 seconds to one minute. After cycling, the reaction was 
held at 72°C for 10 minutes for a final elongation step.
PCR reactions were carried out on either an Omn-E thermal cycler (Hybaid), or a 
Mastercycler machine (Eppendorf). If a heated lid was not used, PCR reaction mixes 
were overlaid with 25 pi mineral oil.
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2.2.1.1. Long range PCR
Long-range PCR was carried out using oligonucleotide primers with a length generally 
between 25 and 30 nucleotides, in a lOpl, 20pl or 25pl reaction. For a 25jnl reaction the 
components were as follows: 0.5pl DNA (approximately 50-100ng); 2.5pl 10 x PCR 
buffer; 280mM dNTPs; 5pi Q solution; 20pmol each primer; 0.5pi (0.2 units) diluted 
Proofstart enzyme (2 units (0.8pl) diluted in 9.2pl lx  Proofstart PCR buffer); 2.5 units 
HotStarTaq and H2O to a volume of 25pl. For a smaller volume such as 20pl the 
quantities were reduced accordingly, e.g. by 20%. Cycling conditions were: a 95°C hot 
start for 15 minutes, then the following was repeated for 40 cycles - 95°C denaturation for 
15 seconds; primer annealing temperature for 30 seconds (typically 65°C); 68°C for 2-15 
minutes depending on the length of product expected, allowing approximately one minute 
for each kilobase of DNA. Then there was a final elongation step at 68°C for 10 minutes 
before holding at 4°C.
2.2.1.2. Degenerate oligonucleotide primed PCR
A reaction was set up containing 50 flow-sorted chromosomes (in 33pi H2O), 5pi lOx 
PCR buffer, 200mM each dNTP, lOOpmol 6MW primer, 2.5U HotStarTaq and water to a 
volume of 50pl. Cycling conditions on an Eppendorf Mastercycler machine were: 94°C 
for 9 minutes followed by eight cycles of 94°C for 1 minute, 30°C for 1.5 minutes, and 
72°C for 3 minutes, then 25 cycles of 94°C for 1 minute, 62°C for 1 minute, 72°C for 1.5 
minutes, and a final extension at 72°C for 8 minutes.
2.2.1.3. UPQFM-PCR
Primary reactions were set up in a total volume of lOpl with quantities of dNTPs, buffer 
and HotStarTaq in proportion to the amounts used in a 25pl reaction (see above) and
lOOng genomic DNA. 1, 2 or 4pmol of each tagged primer was used in each reaction, and
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up to 6 pairs of tagged primers were used. Cycling conditions on an Eppendorf 
Mastercycler were as follows: 95°C hot start for 15minutes, then 10 cycles of 94°C 
denaturation for 30 seconds, 56°C primer annealing for 45 seconds and 72°C elongation 
for 45 seconds, followed by holding at 72°C for 10 minutes.
Secondary PCR reactions were then carried out in a total volume of 20pl, seeded with 2pl 
of the primary reaction as a template. The reaction mix also contained 2pl lOx PCR 
buffer, 200pM each dNTP, 20pmol each universal primer and 1.6U HotStarTaq. PCR 
conditions were similar to the primary reaction conditions, but 20 cycles were carried out.
2.2.1.3.1. UPQFM-PCR dosage analysis
2-4 pairs of UPQFM-PCR primers were used alongside two pairs of control UPQFM- 
PCR primers in each experiment, one from exon 6 of PLP1 (PLP1) and one from the 
CFTR locus on chromosome 7 (CF). Dosage of the sequence amplified by each primer 
pair was calculated from the ratio obtained by dividing the ratio of the fluorescent signal 
from each primer pair against each control primer by the same ratio in a group of normal, 
sex-matched controls. For a male with PLP1 duplication, the expected value for a single­
copy sequence when compared against this primer pair is 0.5, and the expected value for 
a duplicated sequence is 1. For a female PLP1 duplication carrier, who has three copies 
of PLP1, the expected ratio from a non-duplicated sequence (two copies) is 0.67, and the 
expected value for a duplicated target sequence is 1. For ratios against the autosomal 
control CF primer pair, the male ratio expected for a non-duplicated sequence is 1; for a 
duplicated target sequence a ratio of 2 is expected. Female ratios against CF are expected 
to be 1 for normal copy number and 1.5 for one extra copy of a target sequence. To 
classify UPQFM-PCR results as either normal copy number or duplicated, a threshold 
that was halfway between the two expected ratios was used as the boundary between
normal and increased copy number. Thus for males, when dosage ratios are calculated
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relative to the PLP1 primers, sequences were classed as single copy when < 0.75, and 
duplicated when > 0.75. Similarly for male/CF ratios, single-copy <1.5 and duplicated >
1.5. The ratios for females were classified as follows: against PLP1 normal copy number 
<0.83, duplicated >0.83, against CF normal copy number < 1.25 and duplicated >1.25.
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2.2.1.4. Inverse PCR
Restricti m  digestion
Ligati on
CR
Figure 2.1. Diagram showing the principles of inverse PCR. Bold lines show known 
sequences, PCR primers (and orientation) are shown by arrows, and vertical lines show 
restriction sites. In summary, DNA is digested with a restriction enzyme, and the 
fragments are then ligated at a low concentration, which promotes circularisation. PCR 
primers used for the inverse PCR are in the opposite orientation to normal PCR primers, 
so would not normally be able to amplify. Following digestion and ligation, the primers 
should then be able to amplify the sequences that surround the restriction sites. If the 
junction between known and unknown sequence is located between a primer binding site 
and a restriction site then it will be amplified by the inverse PCR, as well as the junction 
created by the circularisation.
84
2.2.1.4.1. Genomic DNA restriction digestion
2pg genomic DNA, or DNA obtained from a human genomic clone, was digested with 
20-40 units of the appropriate restriction enzyme, in a total volume of 40pl with 4pl of 
the appropriate enzyme buffer (10 x stock concentration), for 4.5 hours in a waterbath at 
the temperature recommended by the manufacturer. The reaction was stopped by heating 
to 68°C for 15 minutes.
2.2.1.4.2. Ligation
200ng genomic DNA that had been completely digested by a restriction enzyme was 
incubated at 16°C in a reaction mixture containing 1500 units T4 DNA ligase and lOpl 10 
x T4 ligase buffer in a total volume of lOOpl, to ensure a low concentration of DNA 
(2ng/pl) and promote circularisation. The reaction was stopped after 16 hours by heating 
to 94°C for 15 minutes. The ligation reaction was then ethanol precipitated (see 2.2.3.2.). 
The pellet was completely air-dried, and resuspended in 5pl H2O.
2.2.1.4.3. PCR reaction
The 5pi of resuspended ligation reaction was used in a 25 pi PCR reaction using 
HotStarTaq (see section 2.2.1.) in 0.5ml thin walled PCR tubes. The reaction was 
incubated on an Eppendorf Mastercycler machine, initially at 94°C for 15 minutes, then 
taken through 35 cycles of 94°C for one minute, 57°C for one minute and 72°C for three 
minutes, followed by 72°C for 10 minutes, and the reactions were held at 4°C afterwards. 
PCR products were electrophoresed on a 1% agarose gel (see section 2.2.2.2.). Altered 
size bands were cut out of the gel and DNA was extracted from the agarose slice prior to 
sequencing (see section 2.2.1.4.4.).
85
2.2.1.4.4. Extraction of DNA from agarose gels
DNA was extracted from excised agarose gel slices using the QIAquick gel extraction kit 
protocol recommended by the manufacturer. Each gel slice gel slice was placed in a 
1.5ml tube and weighed, three gel volumes of buffer QG were added (3 pi per lmg of gel) 
and incubated in a water bath at 50°C for 10 minutes. For DNA fragments <500bp and 
>4Kb, one gel volume of isopropanol was added and mixed. The dissolved sample was 
added to a QIAquick spin column, which was placed in a 2ml collection tube, and spun at 
13000rpm for 10 minutes in a microcentrifuge. The flow-through was discarded and 
0.5ml buffer QG was added to the column and spun at 13000rpm for 10 minutes in a 
microcentrifuge to remove all traces of agarose. 0.75ml buffer PE was added to the spin 
column, which was allowed to stand for 2-5 minutes before spinning at 13000rpm for 10 
minutes in a microcentrifuge. The flow-through was discarded and the spin tube and 
collection tube were re-centrifuged under the same conditions to remove all residual 
buffer. The column was then placed in a clean 1.5ml tube and 30pl lOmM Tris-Cl or 
H2O was added to the centre of the QIAquick membrane, allowed to stand for one 
minute, then spun at 13000rpm for 10 minutes in a microcentrifuge to elute the DNA.
2.2.2. Electrophoresis
2.2.2.1. Electrophoresis of PCR products using A B I377 DNA sequencer
For analysis and quantitation of gene dosage, by UPQFM-PCR and MAPH, and 
genotyping polymorphic microsatellite markers, fluorescently labelled PCR products 
were electrophoresed on an ABI 377 automated sequencer (Applied Biosystems).
2.2.2.1.1. Preparation of polyacrylamide gels
A 4% polyacrylamide gel solution was used. For 12cm plates, 16.7ml of gel mix was 
prepared by mixing 12.3ml Sequagel diluent, 2.7ml Sequagel concentrate and 1.7ml
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Sequagel buffer. If longer 36cm plates were used, a greater volume (40ml) of gel mix was 
made, consisting of 29.6ml diluent, 6.4ml concentrate and 4ml buffer. Just prior to 
pouring the gel, 133pl 10% APS and 8pl TEMED were added to the mixture (320pl 10% 
APS and 16pl TEMED for the 40ml gel solution). Plates were washed with anionic 
detergent, rinsed thoroughly with purified water, and then air-dried. Plates were 
assembled in the gel cassette with 0.2mm plastic spacers. The gel solution was drawn 
into a 50ml syringe and quickly poured into the horizontal prepared plates. The flat end 
of a plastic shark’s-tooth comb was inserted into the top of the gel, between the two glass 
plates, and the top of the gel was held together with metal clips. Gels were left to set for 
at least one hour before use. Once the gel was set, the clips and flat comb were removed 
and any excess dried acrylamide was wiped from the outside of the plates. A paper 
shark’s-tooth comb, with either 36 or 48 wells, was placed in the top of the gel and then 
the gel cassette was loaded in the ABI 377 DNA sequencer. 1 or 2pl of product was 
mixed with 2pl loading dye/Tamra size standard and denatured by heating to 95°C for 1- 
3minutes before chilling on ice. The buffer tanks were filled with 1 x TBE and 2pl of 
product and loading solution was loaded in each lane. The gel was electrophoresed until 
all PCR products and size standard had been detected. Electrophoresis conditions were 
3KV, 60mA and 200W, the gel was kept at a constant temperature of 51°C, and the laser 
power was 40mW. Gels were analysed using Genotyper software (Applied Biosystems).
2.2.2.2. Agarose gel electrophoresis
lg, 0.5g, or 0.4g electrophoresis grade agarose was dissolved in 50ml 1 x TBE in a glass
bottle or flask, then melted by heating in a microwave for 1-2 minutes, to make agarose
gels of concentrations 2%, 1% and 0.8% respectively. 2pl ethidium bromide (lOmg/ml)
was added to the melted gel solution, which was mixed and allowed to cool slightly
before pouring into a minigel tank, with appropriate combs inserted (Flowgen). The gel
87
2.2.4. Sequencing
Sequencing reactions were carried out using 5pi of gel extracted PCR product in a total 
reaction volume of lOpl containing 4pl BigDye Terminator version 3.1 reaction mix and 
3.2pmol primer. Cycle sequencing was carried out as follows: 96°C for 1 minute, then 35 
cycles of 96°C for 10 seconds, 50°C for 10 seconds and 60°C for 4 minutes, after which 
the reactions were stored at 4°C.
2.2.4.1. Sephadex sequencing reaction clean-up (carried out by Kerra Pearce)
Prior to electrophoresis, unincorporated dye terminators, small molecule contaminants 
and salts were removed from the sequencing reactions by gel filtration. 45 pi dry 
Sephadex G-50 Superfine beads was loaded into each well of a 96-well MultiScreen HV 
plate (Millipore). 300pl H2O was added to each well and left for 3 hours at room 
temperature to allow the resin to swell. The HV plate was centrifuged at 910 x g  for 5 
minutes, after being placed on top of a standard 96-well microplate, held in place with a 
centrifuge alignment frame, to pack the columns. The columns were pre-rinsed with 
150pl H2O, which was removed by centrifuging at 910 x g  for 5 minutes. Sequencing 
reactions were made up to 20pl by the addition of lOpl H2O, and applied to the centre of 
each well. The HV plate was then placed on top of a skirted 96 well plate and centrifuged 
at 910 x g  for 5 minutes.
2.2.4.2. MegaBACE sequencing (carried out by Kerra Pearce)
Sequencing reactions were electrophoresed on the MegaBACE 1000 capilliary
electrophoresis system (Amersham Biosciences), according to the manufacturers
instructions. 6 tubes of MegaBACE Long Read Matrix (at room temperature) were spun
at 4000rpm in a microcentrifuge for 4 minutes. The capilliaries were injected with
MegaBACE Long Read Matrix, and prerun with LPA buffer. The samples were
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was left to set completely, then the combs were removed and 50ml of lx  TBE buffer was 
added to the tank. 3-5pl loading dye was added to 5-20pl of each product to be run on 
the gel, and loaded into the wells. Molecular weight markers appropriate to the expected 
sizes of product were used; for smaller products (up to 2000bp) a lOObp ladder was used 
and for larger fragments a X DNAJHindlll marker was used. 0.5pg molecular weight 
marker was used in each marker lane. Electrophoresis was carried out at a voltage 
between 75-125V for between 20 minutes to one hour. Gel imaging and capture was 
carried out using the ChemiDoc gel documentation system and Quantity One software 
(version 4.4.0) (BioRad Laboratories).
2.2.3. DNA precipitation
2.2.3.1. Phenol/chloroform extraction
Phenol/ chloroform extraction of DNA was carried out by addition of an equal volume of 
phenol:chloroform:isoamyl alcohol mixture, vortexing until thoroughly mixed, then 
separating the aqueous and organic layers by spinning at 13000rpm for 10 minutes in a 
microcentrifuge. The upper aqueous layer was then removed to a clean 1.5ml tube.
2.2.3.2. Ethanol precipitation of DNA
Il_
DNA was ethanol precipitated by addition of 1/10 volume 3M sodium acetate pH 5.2 
and 2.5 times the total volume of cold 100% ethanol, then leaving at -80°C for at least 
one hour or -20°C overnight. The precipitated DNA was pelleted by spinning at 
13000rpm in a microcentrifuge for 10 minutes, and the supernatant was removed. The 
pellet was washed by adding 0.5ml cold 70% ethanol and spinning in a microcentrifuge 
for 5 minutes at a speed of 13000rpm. The supernatant was completely removed, and the 
pellet allowed to completely air-dry, before it was resuspended in the appropriate volume 
of H20  or TE (pH 8.0).
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denatured by heating to 95 °C for two minutes and then cooled on ice. Samples were 
electrokinetically injected into the capilliary from a skirted with an injection voltage of 
3KV and an injection time of 1 minute. The sequencing samples were then 
electrophoresed at 9KV for 100 minutes.
2.2.5. Preparation of FISH probes from human genomic clones
2.2.5.1. Glycerol stocks
Human genomic clones were initially received as stabs growing on LB agar. These were 
streaked on LB plates, with the appropriate antibiotic selection (either 30pg/ml 
kanamycin for cosmids, 25pg/ml kanamycin for PACs or 20pg/ml chloramphenicol for 
BACs) and grown at 37°C overnight. Single colonies were inoculated into 10ml LB 
broth, with appropriate antibiotic selection as before, and grown at 37°C overnight with 
225rpm shaking. 0.5ml of the growing culture was mixed with 0.5ml 30% glycerol in a 
1.5ml tube and stored at -80°C.
2.2.5.2. Cosmid/PAC/BAC/plasmid alkaline lysis minipreparation
A single bacterial colony, or lp l from a glycerol stock, was inoculated into 10ml LB
broth in a 50ml tube and incubated at 37°C overnight with 225rpm shaking. Antibiotic
selection was used, as in section 2.2.5.1. The following day, the overnight cultures were
centrifuged at 2000rpm at 4°C for 10 minutes, before discarding the supernatant and
gently resuspending the bacterial pellet in lOOpl ice-cold solution 1. At this point the
suspension was transferred to a 1.5ml tube. 200pl freshly made solution 2 at room
temperature was added, the tube was inverted to mix the contents and then left on ice for
5 minutes. 150pl ice-cold solution 3 was added, the contents were mixed by inversion,
and stored on ice for a further 10 minutes. The tubes containing the lysed cells were then
spun at 13000rpm in a microcentrifuge for 10 minutes, and the supernatant was
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transferred to a fresh 1.5ml tube. The supernatant was phenol extracted (see 2.2.3.1) and 
ethanol precipitated (see 2.2.3.2.) and the pellets allowed to dry thoroughly, either at 
room temperature or at 37°C, before being resuspended in 30pl TE (pH 8.0). 20pg 
RNAse A was added to each resuspended pellet which was then incubated in a 37°C 
water bath for 10-30 minutes.
2.2.6. Cell culture of lymphoblastoid cell lines
EBV transformed human B cell lymphoblastoid cell lines (ECACC) were grown in RPMI 
1640 medium containing additional 10% foetal calf serum, 2mM L-Glutamine, 5000 units 
Penicillin and 5000pg Streptomycin. Vials of cells were removed from storage in liquid 
nitrogen and quickly thawed by holding in a plastic beaker containing water at 37°C.
Cells were pelleted by spinning at 1500rpm in a centrifuge for 5 minutes and the freezing 
medium was removed from the pellet, which was gently resuspended in 2ml pre-warmed 
growth medium and transferred into a flask already containing 3ml pre-warmed medium. 
The flasks containing the cells were then placed in a 37°C incubator with 5% CO2. Every 
2-3 days, the medium was removed and replaced with fresh pre-warmed medium, and 
growing cell suspensions were split as necessary.
2.2.6.I. Freezing down of lymphoblastoid cell lines
15ml of healthy growing lymphoblastoid culture was pelleted by centrifuging at 1500rpm 
for 5 minutes. The growth medium was removed and replaced with 70% RPMI 1640 
(including FCS, L-Glutamine and Penicillin/Streptomycin, as above), 20% FCS and 10% 
DMSO to a volume of 1.8ml. The cells were resuspended in this freezing medium, and 
transferred into 2ml cryotubes. The tubes were placed in an isopropanol bath and placed 
in a -80°C freezer for at least 24 hours, to allow gradual cooling at a rate of 1°C per 
minute, after which they were stored in liquid nitrogen.
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2.2.6.2. Preparation of cell suspensions for interphase and metaphase FISH from 
lymphoblastoid cell line
For primarily interphase FISH cell suspensions, lymphoblastoid cell lines were starved 
for up to five days, to reduce the number of dividing cells present. For a cell line that was 
going to be used for mainly metaphase FISH experiments, healthy growing cells were 
used. 150pl KaryoMAX colcemid (10pg/ml) was added to 15ml cell suspension, which 
was then incubated at 37°C for 1 hour, before being spun in a centrifuge at 1500rpm for 5 
minutes. The supernatant was removed and the cell pellet gently flicked to resuspend. 
0.075M KC1 was steadily added to the cells, dropwise up to a volume of lOmls. Cells 
were incubated at 37°C until 15 minutes had elapsed since the first drop was added, to 
prevent nuclear lysis, and then centrifuged at 1500rpm for 5 minutes. The procedure was 
then repeated three times, but instead of using 0.075M KC1, a mixture of 3:1 
methanol:acetic acid was used, and no incubation step was required. On the final 
repetition of the procedure the cell suspension was not centrifuged and the 15ml fixed cell 
suspension was stored at -20°C until required.
2.2.6.3. Slide preparation for DNA fibres
3ml of cell suspension from a growing lymphoblastoid cell line was centrifuged at 1200
rpm for 5 minutes. The supernatant was removed and the cell pellet resuspended in 1ml
PBS, and centrifuged at 1200 rpm for 5 minutes. The supernatant was removed again and
the cell pellet resuspended in PBS, to give a concentration of approximately 2 x 106/ml.
10pl of this cell suspension was spread over a 1cm diameter circle on the upper part of a
clean microscope slide, and allowed to dry for 30 minutes. Microscope slides that had
been previously stored in 96% ethanol and then air-dried were used. A slide was then
fitted onto a plastic Shandon coverplate, and held together vertically with the dried cell
spot at the top of the slide facing the chamber. 150pl lysis solution was added to the gap
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at the top of the slide chamber and allowed to flow through the slide chamber until the 
meniscus had reached the top of the cell spot. 150pl 96% ethanol was then applied to the 
top of the slide chamber and allowed to drain for about 30 seconds. The slide was then 
pulled slowly away from the slide chamber, and allowed to air-dry. Slides were fixed in 
acetone for 10 minutes, and left at room temperature for at least 24 hours before 
hybridisation.
2.2.7. Probe labelling for FISH
2.2.7.1. Biotin labelling
DNA from human genomic cosmid, PAC or BAC clones grown in E.coli and obtained by 
an alkaline lysis minipreparation protocol (see 2.2.5.2.) was labelled with biotin-14-dATP 
by nick translation in a 50pl reaction using a BIONICK kit. 500ng DNA from each 
miniprep was used in each labelling, along with 5pi lOx dNTP mix and 5pl enzyme mix. 
The labelling reactions were incubated at 16°C in a waterbath for 2 hours, and then placed 
on ice. 5pi from each labelling reaction was electrophoresed on a 2% agarose gel 
alongside a lOObp ladder size standard (see 2.2.2.2.) to check that the fragments were 
within the optimum size range (300-500bp) before the reaction was stopped by addition 
of 2.5pmol EDTA.
2.2.7.2. Digoxigenin labelling
DNA from human genomic cosmid, PAC or BAC clones grown in E.coli and obtained by
an alkaline lysis mini-preparation protocol (see 2.2.5.2.) was labelled with digoxigenin-
11-dUTP by nick translation using the DIG-Nick Translation Mix. lpg  DNA was made
up to a volume of 16pl with sterile water, and 4pl 5x DIG-Nick Translation Mix was
added. The labelling reaction was mixed, and incubated at 16°C for 1.5 hours in a water
bath, then chilled on ice. 2pl from each labelling reaction was electrophoresed on a 2%
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agarose gel alongside a lOObp size standard (see 2.22.2.) to check that the fragments 
were within the optimum size range (300-500bp), before the reaction was stopped by the 
addition of 0.5pmol EDTA and incubation at 70°C for 10 minutes.
2.2.7.3. Direct labelling of probes
Cosmid, PAC or BAC DNA miniprep containing cloned human genomic DNA was 
directly labelled with either Spectrum Green dUTP or Spectrum Red dUTP using a Nick 
Translation Kit. 500ng miniprep DNA was used in each labelling reaction, to which was 
added 2 .5j l i1 lOx nick translation buffer, 500pmol each dATP, dCTP and dGTP, 250pmol 
dTTP, 5pi nick translation enzyme mix, and 250pmol Spectrum Green or Spectrum 
Orange labelled dUTP. The contents of each reaction were thoroughly mixed by 
pipetting up and down repeatedly, and the nick translation reactions were incubated at 
16°C for 16 hours, before being placed on ice. 5pi from each labelling reaction was run 
on a 2% agarose gel stained with ethidium bromide with a lOObp size standard ladder (see
2.2.2.2.) to check that the size of the fragments was around the optimal 300bp. The 
reaction was stopped by heating to 70°C for 10 minutes.
2.2.8. Fluorescence in-situ hybridisation
2.2.8.1. Slides/suspensions
Slides were prepared from cell suspensions in 3:1 methanokacetic acid obtained from
lymphoblastoid cell lines or peripheral blood cultures (see section 2.2.6.2.). Glass slides
(dimensions 76 x 26 x 1-1.2mm) were kept at -20°C until required, then removed from
the freezer and moistened by breathing on the slide. A single drop of cell suspension was
dropped onto the middle of the slide and allowed to partially air-dry while the extent of
the spot was marked on the underside of the slide using a diamond pen. Then the slide
was flooded with a mixture of 3:1 methanokacetic acid, immediately drained and then
completely air-dried. Once dry, the slides were held horizontally and flooded with 70%
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acetic acid for a couple of minutes, then drained and completely air-dried. Slides were 
stored at 4°C for up to a week until used, and were made at least one day before they were 
used.
2.2.8.2. FISH using probes labelled with biotin and digoxigenin
2.2.8.2.1. Probe precipitation
The probes labelled by nick translation were ethanol precipitated with excess competitior 
DNA. For PAC and BAC probes, 30pg C0t-\ DNA and 20pg herring sperm DNA were 
added to 200ng of biotin or digoxigenin labelled probe and ethanol precipitated (as 
above). For cosmid probes, the same amounts of biotin or digoxigenin labelled probe 
were used as for PAC and BAC probes, but lOpg C0t-1 DNA and 20pg herring sperm 
DNA were added, and then ethanol precipitated (see section 2.2.3.2.). The precipitated 
and thoroughly dried pellet was resuspended in lOpl hybridisation mix, if  just a single 
probe was used on the slide, or otherwise in 5pl hybridisation mix (if two probes were 
going to be used in the hybridisation).
2.2.8.2.2. Slide and probe preparation
Resuspended probes were denatured by heating in a 75°C waterbath for 5 minutes and
they were then transferred to a 37°C waterbath for 30-90 minutes to allow repetitive
sequences to preanneal. Slides were washed in 2 x SSC at 37°C for 30-60 minutes. The
slides were dehydrated through a series of 70%, 90% and 100% ethanol baths for five
minutes each, then drained and allowed to air-dry. Slides were then denatured at 75°C in
prewarmed 70% deionised formamide/2 x SSC for 3 minutes. They were transferred to
ice-cold 70% ethanol for two 3 minute washes, further dehydrated through 90% and
100% ethanol baths at room temperature for three minutes each, and drained and left to
air-dry. A CEP-X centromere probe directly labelled with Spectrum Orange or Spectrum
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Aqua was used in all interphase and metaphase FISH experiments. For each slide 0.15|il 
X centromere probe was added to 2\i\ hybridisation mix. This was denatured by heating 
at 75 °C for 3 minutes and then cooled on ice.
2.2.8.2.3. Overnight hybridisation
Each lOjal denatured and preannealed probe suspension was mixed with 2.15pl diluted 
and denatured X centromeric probe and applied to a 22mm x 22mm glass cover slip. The 
slide was then gently lowered onto the coverslip, ensuring no bubbles were formed. The 
edges of the cover slip were sealed using vulcanising rubber solution. Slides were 
incubated overnight at 37°C or 42°C in a moist atmosphere.
2.2.8.2.4. Washes and antibodies
On the following morning the rubber sealant and coverslips were removed, then the slides 
were washed at 45°C in 50% formamide for 15 minutes with gentle agitation, changing 
the wash solution every 5 minutes. Slides were washed at 60°C in 0.1 x SSC for 15 
minutes, changing the wash solution every 5 minutes. Slides were subsequently 
transferred to 4 x SSC/0.1% Tween 20 and washed with moderate shaking at room 
temperature for 5 minutes. The slides were incubated at room temperature for at least 20 
minutes in 4 x SSC/5% non-fat dried milk. Excess liquid was drained from the slides, 
which were incubated for 20 minutes with solution 1 under a 22mm x 50mm glass cover 
slip (see Table 2.1 for details of antibodies in each detection antibody solution). Unbound 
antibody was removed by carrying out three 5-minute washes with agitation using 4 x 
SSC/0.1% Tween 20. Slides were then drained and the hybridisation and washes 
repeated sequentially with solutions 2 and 3. Slides were protected from light during 
these stages. After the final wash, slides were drained and mounted in 25p,l Vectashield 
mounting medium containing 1.5 jig/ml DAPI counterstain.
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.................. Biotin labelled probe 
only
Digoxigenin labelled probe 
only
Both biotin and digoxigenin probes
Solution 1 lfig Fluorescein avidin 
DCS
0.1 |ig Mouse anti- 
digoxigenin
lpg Texas Red Avidin DCS
Solution 2 0.5 fig biotinylated anti- 
avidin D lpg Goat anti-mouse FITC
0.5pg biotinylated anti-avidin D, 
0.1 jig Mouse anti-digoxigenin
Solution 3 lpg Fluorescein avidin 
DCS
- 1 jig Texas Red Avidin DCS, ljig 
Goat anti-mouse FITC
Table 2.1. Antibody solutions used for indirect detection of probes for FISH. Quantities 
shown are for detection of signal on one slide. Antibodies were diluted in lOOpl 4 x 
SSC/5% non-fat dried milk per slide
2.2.8.3. FISH using directly labelled probes
2.2.8.3.I. Probe precipitation
For cosmid clones, lOpl from the labelling reaction (200ng) was mixed with lOjig C0t-l 
DNA and 20pg herring sperm DNA, and this was ethanol precipitated (see section
2.2.3.2.). For PAC and BAC clones, lOpl from the labelling reaction (200ng) was mixed 
with 30pg C0t-\ DNA, 20pg herring sperm DNA, then the mixture was ethanol 
precipitated (see section 2.2.3.2.). Precipitated probes were then resuspended in 5pl (if 
two probes were going to be used in the hybridisation) or lOpl hybridisation mix, if just a 
single probe was used on the slide.
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2.2.8.3.2. Slide and probe preparation
Slides were washed at 37°C in 2 x SSC for 30-60 minutes, dehydrated through a series of 
70%, 90% and 100% ethanol baths for five minutes in each, then drained and allowed to 
air-dry. CEP-X centromere probe directly labelled with Spectrum Orange was used 
where a single clone (labelled using Spectrum Green) was used for the hybridisation, and 
if the single clone had been labelled using Spectrum Red, a CEP-X Spectrum Aqua 
labelled centromere probe was used in the hybridisation. In all dual probe experiments 
Spectrum Aqua labelled CEP-X centromere probe was used (where one probe had been 
labelled using Spectrum Green dUTP and the other with Spectrum Red dUTP). 0.15pi 
centromere probe was diluted in 2pi hybridisation mix, and added to the lOpl 
hybridisation mix containing the appropriate preannealed and ethanol precipitated 
probe(s). Hybridisation proceeded under a 22mm x 22mm glass cover slip and the edges 
were sealed using vulcanising rubber solution.
2.2.8.3.3. Denaturation and hybridisation
The slides were placed on the heated block of the Omnislide in situ hybridisation system 
(Hybaid) and a simulated slide control programme was used which allowed denaturation 
at 70°C for 1 minute and then reduced the temperature to 42°C and incubated for at least 
16 hours, in a moist atmosphere.
2.2.8.3.4. Washes and mounting
After removal of the seal the slides were washed in a prewarmed solution of 0.4 x SSC / 
0.3% NP-40 at 73°C for 2 minutes with a short initial gentle agitation for 1-3 seconds. 
This was followed by a wash in 2 x SSC / 0.1% NP-40 at room temperature for 1 minute. 
Excess fluid was drained from each slide, which was then mounted in 25pl of Vectashield 
mounting medium containing 1.5pg/ml DAPI counterstain.
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2.2.8.4. Viewing of FISH slides and capture of images
All FISH slides were examined using a Zeiss Axiophot fluorescent microscope with a 
triple band pass filter and separate Aqua filter with images recorded by Photometries 
CCD KAF1400 camera (Photometries) and controlled with SmartCapture imaging 
software (Digital Scientific).
2.2.8.5. Scoring FISH slides
FISH was carried out on interphase nuclei that had been obtained from lymphoblastoid 
cell cultures that had been starved for 5 days, to enrich for non-dividing cells. Interphase 
nuclei from males were scored when one red signal from the X centromere was present, 
to minimise scoring G2 and S phase nuclei where replication had already occurred. 
Similarly, when nuclei from females were scored, only those with two visible X 
centromere signals were scored. However, as the whole X chromosome does not 
replicate simultaneously, when cells are in S phase it is likely that the region of interest 
may have replicated before the X centromere, especially as the X centromere region in 
males has been reported to replicate late during S phase (Ten Hagen et a l , 1990). It is 
therefore possible that if nuclei are in early S phase a pattern of hybridisation may be 
observed that is consistent with a duplication of the target sequence (such as a single X 
centromere signal and a pair of signals from the target sequence), which may in fact just 
be a result of replication of the target region prior to replication of the centromere. 
However, it has been reported that the X chromosome as a whole on average replicates in 
the later stages of S phase so this may reduce the numbers of pseudo-duplicated signals 
seen (Woodfine et al., 2004). Where replication of a bona fide duplicated region has 
occurred before replication of the X centromere sequence, this could result in signal 
patterns such as four closely associated signals from the genomic clone probe (when both 
copies of the duplicated sequence have replicated) or three copies of a probe signal 
(where just one of the two duplicated sequences has been replicated).
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2.2.9. MAPH
2.2.9.1. Probe design
Probe sequences were chosen from publicly available sequence from the human genome 
project, genome databases, and from exons of the PLP1 gene (Figures 2.3. and 2.4.). 
Primer design was carried out using Primer3 (Table 2.3.). Each potential probe sequence 
was compared against sequences at the NCBI using BLASTn (see section 2.2.10.1.1.). 
Only sequences with no similarities greater than 30 nucleotides in length to other 
submitted sequences were used. Probe G+C content varied from 39.6-54%. The size 
range of probes was from 244 - 390bp and each probe differed from the nearest one in 
size by at least 4 base pairs (Table 2.2.).
2.2.9.2. PCR of probe target sequence
Probe sequences were amplified using PCR (for conditions see sections 2.1.3., 2.2.1., and 
Appendix A) from normal human genomic DNA, and Xenopus genomic DNA for the 
non-human control probe. The PCR products were run on a 2% agarose gel, and the 
bands were cut out the DNA extracted from the gel (see section 2.2.1.4.4.).
2.2.9.3. Cloning MAPH probes
The PCR products from the target sequences were cloned into the EcoRV site of the 
pZErO-2 plasmid (Figure 2.2.). This disrupts a fusion gene carried on the plasmid, 
lacZa-ccdB, which is lethal to E.coli when expressed (Bernard et al., 1994). pZErO-2 
also contains a kanamycin resistance gene, so after transformation only those cells 
carrying the plasmid, but with the lethal lacZa-ccdB gene disrupted, should be able to 
grow on media containing kanamycin.
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2.2.9.4. Removal of 3' A residues
To remove extra untemplated 3' A residues from PCR products and allow blunt-end end 
cloning, the purified products were incubated with Klenow polymerase which has 3' to 5' 
exonuclease activity. 14pl H2O, 5 pi 10 x EcoPol buffer and lp l Klenow fragment were 
added to 30pl gel-purified PCR product (see section 2.2.1.4.4.). Following incubation at 
37°C for 5 minutes, 4pmol of each dNTP was added to the mixture, which was then 
incubated at room temperature for 20 minutes. Following treatment with Klenow DNA 
polymerase, DNA was purified by phenol extraction (see section 2.2.3.1.) and ethanol 
precipitated (see 2.2.3.2.). The pellet was completely dried and then resuspended in 15pl 
1 xTE.
2.2.9.5. Ligation and transformation
2.2.9.5.1. Vector digestion
The plasmid vector p-ZErO-2 was linearised by digestion with the blunt-end cutting 
restriction enzyme, EcoRV. lpg supercoiled p-ZErO-2 was digested with 20U EcoRV in 
a total volume of lOpl with a 1 x concentration of NEB buffer 3 and lOOpg/ml BSA. The 
linearised vector was extracted using phenol/chloroform/isoamyl alcohol, ethanol 
precipitated (see sections 2.2.3.1-2) and resuspended in 90pl TE buffer, giving a 
concentration of 10ng/pl.
2.2.9.5.2. Ligation
Ligations were set up using lOng of linearised pZErO-2, 7.5pl of gel-purified insert PCR 
product, and 2U T4 DNA ligase, with a 1 x concentration of T4 ligase buffer in a total 
volume of lOpl. Ligations were incubated at 16°C for one hour.
101
2.2.9.5.3. Transformation
2pl from each ligation reaction was chemically transformed into E.coli TOP 10 chemically 
competent cells. For each ligation to be transformed, one 50pl vial of One Shot TOP 10 
cells was thawed on ice. 2pl from each ligation reaction was added directly to each vial 
of cells, which were mixed by tapping gently and then incubated on ice for 20 minutes. 
The cells were incubated at 42°C in a water bath for 30-45 seconds and then removed and 
swiftly placed on ice. 250pl of SOC medium was added to each vial, and the 
transformations were incubated at 37°C with shaking at 225rpm for one hour, with the 
vials placed on their side. 50j j ,1 of each transformation was spread on an LB-kanamycin 
agar plate, with a kanamycin concentration of 25pg/ml, and incubated at 37°C overnight. 
Controls used in the transformation procedure were a cells only plate, no DNA in the 
ligation reaction, a vector-only ligation, and a ligation using test inserts provided with the 
kit. The following day, colonies containing recombinant pZErO-2 were grown in 5ml LB 
broth with 25pg/ml kanamycin antibiotic selection at 37°C with shaking overnight, and 
then the plasmids were recovered by alkaline lysis mini-preparation (see section 2.2.5.2.). 
If a colony was found to contain the required recombinant plasmid, a glycerol stock was 
made (see section 2.2.5.1.).
2.2.9.6. Probe preparation
PCR was carried out on the recombinant plasmids using primers that flanked the insertion 
site, PZA and PZB (see section 2.2.1.). The structures and orientation of the inserts 
within the probes were checked using restriction digestion with one or two enzymes 
(Table 2.2.). 7pl of PCR product was digested in a reaction mix containing 1.5pl 
restriction enzyme and 1.5 pi of the appropriate 10 x enzyme buffer in a total volume of 
15pl, by incubating at 37°C for at least 2 hours. Restriction digested PCR products were
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electrophoresed alongside undigested PCR products on an agarose gel together with a 
lOObp ladder size standard, to check that the fragments produced following restriction 
digestion were of the expected sizes (Table 2.2.). PCR products were gel-extracted to 
purify the MAPH probes (see section 2.2.1.4.4.). Gel-extracted probes were 
electrophoresed in an agarose gel along with DNA of known concentration, to estimate 
the concentration of each probe. The probes were combined together to make a probe 
mix, containing approximately lOOpmol of each probe in lpl of probe mixture.
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Probe Probe size (bp) G+C (%) Enzyme(s) Sizes expected after digest
ch7q31 244 44.9
Mval 129+115/140+104
BamHl 124+120/135+109
XLnkx 253 48.7
Mval 106+146/117+135
Mwol 169+83 / 180+72
plp5 258 45.7 Mval 112+146/101+157
144al0 264 43.4 HinFl 144+120/155+109
chl7pl3 268 44 Rsal 185+83/ 174+94
240c2 273 50 Alul 132+141 / 143+130
79pll 282 40.4 Alul 170+112/159+123
chlq24 289 46 Mwol 108+181/97+192
plp6 298 41.8
Mval 111+187/100+198
Rsal 254+44/243+55
ch6p24 322 45.6 Mspl 212+110/201+121
SRY 330 50.2 Mval 77+253 / 88+242
ch4q26 335 44 Rsal 189+146/200+135
Xql2 340 48
EcoT14l 113+227/102+238
BamHl 253+87 / 242+98
198p4 352 39.6 Alul 240+112/251+101
43hl3 359 46.3 Alul 34+165+106+54/34+165+95+65
plp3 368 54 Mwol 210+158/ 199+169
plp7 381 49
EcoT14l 237+124/246+135
Mwol 311+70/300+81
chl7q21 390 51 Rsal 133+277/122+268
Table 2.2. Table showing the panel of MAPH probes used in the PMD probe set. Sizes
of cloned and amplified probes are given in base pairs. The restriction enzymes that were 
used to confirm the structure of the probes, together with the fragment sizes that were 
expected, are also shown.
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* The two Nsi I site!
Figure 2.2. Features of the pZErO-2 plasmid. The multiple cloning site is near the start 
of the lacZa-ccr/B fusion gene, and the position of the kanamycin resistance gene is also 
shown. Taken from the Zero Background/Kan Cloning kit manual (Invitrogen).
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2.2.9.7. MAPH protocol
2.2.9.7.1. DNA and filter preparation
lpg  genomic DNA was denatured by heating to 95°C then placed on ice. lp l 1M NaOH 
was added to the genomic DNA and the mixture was spotted onto an individual nylon 
filter (Hybond N+) with approximate dimensions 2mm x 4mm. Cutting the filters into 
unique shapes identified individual filters. The denatured genomic DNA was irreversibly 
bound to the filter by UV irradiation, 50mJ to each side of the filter (UV Stratalinker 
2400, Stratagene). The filters were then prehybridised together in 1ml of prehybridisation 
solution at 65°C for at least 2 hours. This prehybridisation solution was replaced with 
200pl of prehybridisation solution with the addition of lOpg/ml C0t-\ DNA that had been 
boiled for two minutes, and incubated at 65°C for 30-60 minutes.
2.2.9.7.2. Hybridisation
lp l of probe mix was mixed with lpg C0t-\ DNA, 7pg E.coli DNA that had been 
digested with HaeIII, 0.5pg 20pmol of each blocker primer PZAX and
PZBX, and denatured by addition of 2pl 1M NaOH. The mixture was heated to 37°C for 
1 minute, neutralised by the addition of 3pi 1M NaH2P0 4 , and then added to the 
hybridisation, which was left at 65°C overnight.
2.2.9.7.3. Washes
Filters were then washed to remove unbound and non-specifically bound probes, initially 
with two 1ml changes of hybridisation solution, after which the filters were transferred to 
a 50ml tube. Washing was carried out using a total of 500ml 1 x SSC/1% SDS at 65°C 
for 15-20 minutes, then using a total of 500ml 0.1 x SSC/0.1%SDS for the next 30-40 
minutes at 65°C, with frequent changing of the wash solution. Following the washes,
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filters were air-dried and transferred into 50jil PCR reactions and amplified for 5 cycles 
of 95°C for one minute, 60°C for one minute and 70°C for one minute with PZA and PZB 
primers, lp l from this “primary” PCR was used to seed a secondary 25pl PCR with FAM 
labelled PZA and PZB, for 20 cycles. To increase signal on the gel, 20pl from the 
secondary PCR was precipitated by adding 20pl 0.4M NaCl and lOOpl 100% ethanol. 
This was left at room temperature for 15 minutes, then spun at 13000rpm in a 
microcentrifuge for 10 minutes. Excess ethanol was removed and the pellet was air- 
dried, then 3pi loading buffer, containing Genescan 500 Tamra size standard, was used to 
redissolve the pellet. The loading mixture was denatured by heating to 95°C, and then 
placed on ice. 2pl of the precipitated and resuspended product was electrophoresed on a 
4% polyacrylamide gel using an ABI 377 DNA sequencer and analysed with Genotyper 
software (see section 2.2.2.1).
2.2.9.8. MAPH Analysis
For analysis of each DNA sample, the area underneath the peaks of each probe was used
to obtain normalised ratios for the probes. Initially, the area under each peak was divided
by the sum of the nearest sized 4 autosomal control peaks. In later analyses the area
under each peak was divided by the sum of four autosomal control probe peaks, but not
using the two control probes with the highest variability, ch7q31.2 and chl7q21.32, in
calculating these ratios. An average ratio for each probe was calculated across all
samples for the normal control individuals for each experiment. Normalised ratios were
then calculated for each probe for each sample by dividing the ratio for each peak by the
corresponding mean ratio. For autosomal probes a normalised ratio of 1 should
correspond to a diploid copy number. For probes whose target sequences were located on
the X chromosome, the mean ratios were calculated taking into account the different copy
numbers of the X chromosome in males and females. For an X-linked probe, if  the mean
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ratio was being calculated from a panel of three males and three females, the total was 
divided by 4.5, to give the mean ratio expected for two X chromosomes. Hence for the 
individual X-linked normalised ratios, a value of 1 indicates that there are two copies of 
that sequence present, and a value of 0.5 is expected if there is only one copy of the 
sequence, as for normal males. For Y-linked probes, the mean ratio was calculated using 
only the control males, so a value of 1 corresponds to there being one copy of the target 
sequence present.
2.2.10. Bioinformatics
All the websites used for analysis of sequence characteristics and other bioinformatic 
applications are listed in Table 2.3.
2.2.10.1. Sequence database searches and pairwise sequence comparisons
BLAST-based (Basic Local Alignment Search Tool) sequence comparison methods were 
used for most sequence comparisons, either when searching for sequence similarities to 
one query sequence within a sequence database, or when comparing two sequences to one 
another (Altschul et al., 1990).
2.2.10.1.1. BLASTn
BLASTn was used to search databases for significant similarities to a query sequence 
(Altschul et a l , 1990;Altschul et al., 1997). In most instances, BLASTn was used to 
search the nr database at NCBI, which contains all GenBank, RefSeq Nucleotides, 
EMBL, DDBJ and PDB sequences. In most cases, the BLASTn search was restricted to 
sequences of human origin within the nr database, and default settings were used (low 
complexity filter, expect =10, word size =11).
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2.2.10.1.2. BLAST2
BLAST 2 Sequences (BLAST2) was used for pairwise sequence comparisons, either 
between two nucleotide sequences (blastn) or between one nucleotide and one protein 
sequence (tblastn) (Tatusova and Madden, 1999). Default parameters were used unless 
otherwise stated (match = 1, mismatch = -2, open gap = -5, gap extension = -2, gap_x 
dropoff= 50, expect =10, wordsize =11, filter on).
2.2.10.1.3. BLASTz
BLASTz is an algorithm that is designed for aligning long DNA sequences, using a gap 
scoring system that tolerates longer gaps in aligned sequences than most sequence 
alignment tools (such as BLASTn) (Schwartz et al., 2000). Output from a BLASTz 
based comparison is given as both a percentage identity plot and a dotplot-type output 
(Schwartz et al., 2000;0vcharenko et al., 2004). For all of the BLASTz comparisons in 
this study the output was visualised in the form of a dotplot, which shows an overview of 
the relationships between the two sequences by plotting one sequence on the x axis and 
one on the y axis. Any significant alignments between any regions of the two sequences 
are shown as shaded areas on the dotplot, with short regions of similarity visible as dots 
and longer homologies shown as diagonal lines. Two web-based BLASTz comparison 
tools were used in this study, Pipmaker and zPicture (Schwartz et al., 2000;0vcharenko 
et al., 2004). In all comparisons, default settings were used (match = 1, mismatch = -1, 
gap open = -6, gap extension = -0.2) (Schwartz et a l, 2003).
2.2.10.1.4. ClustalW and Consensus
ClustalW was used for producing nucleotide sequence alignments, and a consensus 
sequence was derived from the ClustalW alignment where necessary using the Consensus 
program (Thompson et al., 1994). ClustalW is a multiple alignment method which uses a
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distance matrix based on individual alignments to calculate a guide tree, then the 
sequences are progressively aligned according the branching order of the guide tree 
(Thompson et a l , 1994). The Consensus program uses the multiple alignment output 
from ClustalW to calculate a consensus sequence.
2.2.10.2. Repeatmasker
Repeatmasker was used to mask out common interspersed repetitive elements from 
genomic DNA sequences. In most cases the program was run from the EMBL website, 
using Repeatmasker version 2002/07/13, using Repbase update version 7.4 (Table 2.3.) 
(Jurka, 2000). When large amounts of repeat masked genomic sequence was needed, the 
appropriate region was downloaded from the UCSC genome browser after repetitive 
sequence was masked based on June 2003 versions of Repeatmasker and the repeat 
libraries.
2.2.10.3. DNA Pattern Finder
Short sequence motifs were searched for by the DNA Pattern Find program, which can 
search for several different sequence motifs simultaneously in a given DNA sequence, 
providing an output showing the position and orientation of each occurrence of each 
motif (Table 2.3.).
2.2.10.4. MAR-Wiz
Potential matrix attachment regions (MARs) in genomic DNA sequence were searched 
for using the MAR-Wiz program, which searches for various sequence characteristics 
associated with MARs and combines these into a MAR-potential value which is 
calculated within a sliding window throughout the region in question (Singh et a l , 1997). 
The parameters used to calculate the MAR-potential are: motifs associated with origins of
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replication, T+G richness, the presence of sequences known to curve or kink DNA, 
topoisomerase II recognition sites, A+T content, the presence of an MAR consensus 
sequence motif, and the presence of stretches of 20 or more A, T or C nucleotides (Wang 
et al., 1995;Singhef <z/., 1997)
2.2.10.5. Oligorep
Repeated regions (direct, inverted, symmetric and complementary repeats) within a DNA 
sequence were found using the Oligorep program, with the minimum length of repeats set 
at 6bp, maximum at 30bp, and a maximum mismatch of 4 (Babenko et al., 1999).
2.2.10.6. Tandem repeats finder
Tandemly repeated sequences were predicted using the Tandem repeats finder program, 
using the default settings (Benson, 1999).
2.2.10.7. Genome browsers
Frequent use of genomic databases was made during this study, for applications such as 
checking the position of genes and genomic clones within the human genomic sequence, 
interspersed repeat and G+C content, recombination rates, the position of polymorphic 
markers, and comparison of syntenic regions between species. The Ensembl genome 
browser was most frequently utilised for these purposes, with substantial use also made of 
the UCSC genome browser (Table 2.3.) (Karolchik et a l, 2004;Bimey et al., 2004).
I l l
Program Website address 1
BLASTn http://www.ncbi.nih.gov/BLAST/Blast.cgi
BLAST2 http://www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html
BLASTz http://pipmaker.bx.psu.edu/cgi-bin/pipmaker7basic http ://zpicture.dcode.org/
ClustalW http://www.ebi.ac.uk/clustalw/
Consensus http://www.bork.embl-heidelberg.de/Alignment/consensus.html
Repeatmasker http://woody.embl-heidelberg.de/repeatmask/
DNA Pattern 
Finder http://bioinformatics.ccr.buffalo.edu/ToolBox/seqsuite/dna_pattem.html
MAR-Wiz http://www.futuresoft.org/MAR-Wiz/
Oligorep http://wwwmgs.bionet.nsc.ru/mgs/programs/oligorep/InpForm.htm
Primer3 http:// fiodo. wi .mit. edu/cgi-bin/primer3/primer3_www.cgi
Ensembl http://www.ensembl.org
UCSC genome 
browser http://genome.ucsc.edu
Repbase
Update http://www.girinst.org/Repbase_Update.html
Sanger
Institute http://www.sanger.ac.uk
Tandem 
repeats finder http ://tandem.bu.edu/cgi-bin/trdb/trdb.exe?taskid= 1
NCBI
homepage http ://www.ncbi.nih.gov/
Table 2.3. Websites of bioinformatic tools used during the course of this study.
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Motif Sequence(s) References
X element GCTGGTGG (Smith et al., 1981)
Ade-M26 heptamer ATGACGT (Schuchert et al., 1991)
LTR-IS TGGAAATCCCC (Edelmann etal., 1989)
Retrotransposon LTR TCATACACCACGCAGGGGTAGAGGACT
(Zimmerer and Passmore, 
1991)
XY32 \  \GGGAGAARGGGTATAGGGRAAGAGGGAA (Rooney and Moore, 1995)
Human minisatellite core GGGCAGGARG (Jeffreys etal., 1985)
Human hypervariable 
minisatellite 
recombination sequence
GGAGGTGGGCAGGARG (1), 
AGAGGTGGGCAGGTGG (2)
(Jeffreys etal., I985;Wahls 
etal., 1990)
Pur binding site GGNNGAGGGAGA RRRR
(Bergemann and Johnson, 
1992)
Translin binding sites GCNCWSSWN0 -2GCCCWSSW (1), MTGCAGNo. 
4 GCCCWSSW (2), ATGCAG (3), GCCCWSSW (4)
(Aoki et al., 1995)
Human replication origin 
consensus WAWTTDDWWWDHWGWHMAWTT (Dobbs et a l, 1994)
S.cerevisiae ARS WTTTATRTTTW (Broach et al., 1983)
S.pombe ARS WRTTTATTTAW (Maundrell et al., 1988)
Scaffold attachment 
region consensuses
AATAAAYAAA (1), TTWTWTTWTT (2), 
WADAWAYAWW (3), TWWTDTTWWW (4)
(Gale etal., 1992)
Topoisomerase II binding 
site GTNWAYATTNATNNR (Sander and Hsieh, 1985)
tetranucleotide repeats 
from mouse MHC 
recombination hotspots
(T C T G )^ (l), (CAGG)7-9 (2)
(Kobori et al., 1986; 
Uematsu et al., 1986)
Vertebrate/plant 
topoisomerase I 
consensus cleavage sites
CAT (1), CTY (2), GTY (3), RAT (4) (Been et al., 1984)
Vaccinia topoisomerase I 
consensus cleavage site YCCTT (Shuman, 1991)
Vertebrate topoisomerase 
II consensus cleavage site RNYNNCNNGYNGKTNYNY (Spitzner and Muller, 1988)
Heptamer recombination 
signal CACAGTG (Early et al., 1980)
Nonamer recombination 
signal ACAAAAACC (Early et al., 1980)
Immunoglobulin heavy 
chain class switch repeats
GAGCT (1), GGGCT (2), GGGGT (3), TGGGG (4), 
TGAGC (5)
(Rabbitts etal., 1981; 
Ohno, 1981)
Human minisatellite 
conserved sequence/x- 
like sequence
GCWGGWGG (Krowczynska etal., 1990)
Mariner transposon-like 
element (3' end) GAAAATGAAGCTATTTACCCAGGA (Reiter et al., 1996)
Deletion hotspot 
consensus sequence TGRRKM
(Krawczak and Cooper, 
1991)
Mouse parvovirus 
recombination hotspot CTWTTR (Hogan and Faust, 1986)
Murine MHC deletion 
hotspot (CAGR)„ (Steinmetz et al., 1986)
Murine LTR 
recombination hotspot TGGAAATCC (Edelmann et al., 1989)
DNA polymerase a pause 
site core sequences GAG (1), ACG (2), GCS (3)
(Weaver and DePamphilis, 
1982)
DNA polymerase arrest 
site WGGAG
(Weaver and DePamphilis, 
1982)
Table 2.4. Continued on next page.
113
—Motif Sequence(s) References
DNA polymerase a 
frameshift hotspots TCCCCC (1), CTGGCG (2) (Kunkel, 1985b)
DNA polymerase P 
frameshift hotspots ACCCW R (1), TTTT (2) (Kunkel, 1985a)
DNA polymerase a/p 
frameshift hotspots
TGGNGT (1), ACCCCA (2)
(Kunkel, 1985a;Kunkel, 
1985b)
DNA bending TTTAAA (Crothers etal., 1990)
Table 2.4. (continued) Table showing some DNA motifs that have been associated with 
rearrangements, mutation and cleavage. Where more than one sequence is in the same 
motif category, each separate motif is identified by the number in brackets after each 
sequence.
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2.3. Clinical details
2.3.1. Family 1
The proband (1:9) was diagnosed at the age of 8 with probable PMD (Figure 2.2.). 
Nystagmus had been noted during the first month of life, which became less noticeable 
with age. Development was delayed, particularly motor development and he could crawl 
and stand at age 2, but he never achieved ambulation. He was wheelchair-bound by age 8 
and exhibited dystonic quadriplegia and ataxia. MRI at age 8 showed absence of myelin 
in much of the brain. He has no speech, but shows reasonable understanding. He has two 
younger siblings, a sister (1:10) and brother (1:11) who are unaffected and there is no 
other family history of PMD (Figure 2.2.).
2.3.2. Family 2
The proband (2:9) presented at age 3 with motor developmental delay, ataxia and 
nystagmus, which had become apparent at about 2 years of age (Figure 2.2.). MRI 
showed greatly reduced myelination for his age. He has some speech, and can 
communicate in two-word sentences. There was a possible family history of PMD; his 
great uncle (2:3) had shown normal development until 2 years old, after which he had 
shown developmental regression (Figure 2.2.). He was diagnosed with cerebral palsy, 
and died aged 40. Another great uncle (2:4) had died aged 1, and may have had some 
motor developmental delay having never sat unsupported. The younger brother (2:10) of 
the proband is unaffected.
2.3.3. Family 3
The proband (3:6) presented at 13 months of age with slight developmental delay, 
titubation and some ataxia (Figure 2.2.). Nystagmus had been noticed at 2-3 months of 
age, and MRI scans showed very little myelination. He has a fairly mild PMD phenotype
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and can talk and walk with assistance, although this is slowly deteriorating with time. 
There is no previous family history of PMD, and a recent prenatal diagnosis was made for 
his younger sister (3:7), who was found to carry the same mutation as her brother 
(Woodward et a l , 2003).
2.3.4. Family 4
The proband (4:6) initially presented with short stature at the age of 7 years (Figure 2.2.). 
He had been noted to have hypoglycaemia and hyponatraemia in the neonatal period. 
Investigations revealed GH insufficiency with normal TSH, cortisol and gonadotrophin 
secretion. His MRI scan revealed anterior pituitary hypoplasia with hypoplasia of the 
infundibulum, an absent posterior pituitary and dysgenesis of the corpus callosum. He has 
been treated with recombinant human growth hormone and has progressed satisfactorily 
through puberty unaided. His half-brother (4:7) presented with neonatal hypoglycaemia 
and was diagnosed as having severe cortisol, TSH, GH and probable gonadotrophin 
deficiencies. His MRI scan revealed hypoplasia of the anterior pituitary gland and 
infundibulum with an ectopic/undescended posterior pituitary. The corpus callosum is 
normal. He has subsequently been treated with GH, hydrocortisone and thyroxine and is 
currently 2.5 years old. There is no other family history of pituitary disorders known.
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Figure 2.2. Pedigrees showing the families investigated as part of this study.
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3.1. INSILICO ANALYSIS OF PLP1 GENOMIC REGION
Duplications and deletions of dosage sensitive genes, in many genomic disorders, have been 
found to be mediated by non-allelic homologous recombination between flanking low-copy 
repeats (see section 1.4.1.) (Lupski, 1998). Following the completion of the sequencing of 
the human genome, the genomic sequence of the region surrounding PLP1 is freely available 
(Lander et al., 2001). To determine if there were any low-copy repeats flanking PLP1 that 
could be mediating the PLP1 duplications and deletions, a detailed analysis of any repeats 
present in this region was carried out, using a variety of bioinformatic tools.
3.2. Repeats specific to the 2Mb region flanking PLP1
Initially, 2Mb of human genomic sequence surrounding PLP1 was investigated looking for 
the presence of flanking repeats. Most duplications and deletions involving PLP1 are shorter 
than 2Mb, with the duplication endpoints falling within this region (Woodward et al., in 
preparation). Therefore it seems most likely that any sequence features involved in 
producing genomic rearrangements involving PLP1 will be within this region, close to the 
gene. 2Mb from the human genomic sequence, centred on the transcription start site of 
PLP1, and masked for interspersed repetitive elements by the UCSC genome browser, was 
compared against itself using the BLASTz algorithm by the Pipmaker program, and the 
dotplot output is shown in Figure 3.1. (see section 2.2.10.1.3.) (Schwartz et al., 2000). 
Although no obvious large repeat regions were found on either side of PLP1, it was apparent 
that there were some local repetitive elements within this 2Mb region (Figure 3.1.). Most of 
the repetitive regions shown on the dotplot were found either only proximal to PLP1, mostly 
within Xq22.1 (bottom left-hand quadrant of the dotplot), or distal to PLP1 within Xq22.2 
(top right-hand quadrant of the dotplot in Figure 3.1.). There were a few very small regions 
of similarity on both sides of PLP1 (Figure 3.1.). One of the repeat regions either side of
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PLP1 (indicated by an oval outline on the dotplot) appeared to have similarities with parts of 
a large block of mainly distal-specific repeats (see section 3.4.4., Figure 3.4., Tables 3.2. and
3.3.).
3.3. Repetitive sequences flanking PLP1
Further investigations of the small repetitive regions found proximal and distal to PLP1 were 
carried out using BLASTn, BLAST2 and also using more dotplots of the relevant regions 
from Pipmaker using BLASTz (see sections 2.2.10.1.1-3.) (Altschul et al., 1990;Tatusova 
and Madden, 1999;Schwartz et a l , 2000;Schwartz et al., 2003). Comparison was also made 
with chained BLASTz alignments annotated on the UCSC genome browser for verification 
of repeated regions (Karolchik et al., 2003;Schwartz et al., 2003). Chained alignments have 
been derived by comparing the human genome against itself using BLASTz, after which 
trivial alignments of a sequence to itself are filtered out of the chained alignment, along with 
known interspersed repetitive elements (Karolchik et a l , 2004).
3.3.1. Repeated flanking sequences close to PLP1
One repeated region was located relatively close to PLP1, with two copies present 69Kb 
apart and PLP1 located in between (the similarity between these two regions is picked out by 
the diamond outline in Figure 3.1.). Combining the information generated from all these 
sources showed that the extent of the similarity found between the sequence at the proximal 
end in genomic clone cU35G3, extended for over 3Kb, although the regions of similarity 
were fragmented and only 555 nucleotides were included in the alignment in total (Figure
3.2. and Table 3.1.). The distal repeat sequence was similarly fragmented, and although it 
covered nearly 3Kb of sequence in human genomic clone cV698D2, just 585bp was included 
in the alignments (Figure 3.2., Table 3.1.). Much of the unaligned intervening sequence
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consisted of interspersed repeat sequences, with 73.29% of the proximal repeat region 
mapping to cU35G3 and 50.26% of the distal repeat sequence from cV698D2 classed as 
interspersed repetitive elements by Repeatmasker (Repbase update version 7.4). Of the 
nucleotides actually included in the alignment, there was 87% identity between the two 
sequences. The two copies of this repeated sequence were inverted with respect to each 
other. Database searches using BLASTn did not reveal any similarities between the rest of 
the human genome and these short repeated sequences.
3.3.2. More distant repeated sequences either side of PLP1
There were two other very small hits seen using Pipmaker between the regions proximal and 
distal to PLP1 (regions of similarity on the dotplot are indicated by the grey circle and square 
in Figure 3.1.). The exact position of these two regions was checked by carrying out further 
comparisons using Pipmaker between individual genomic clones in the regions where the 
similarity was found, and verified by BLAST2 comparisons. Both of these matches found by 
BLASTz and shown on the dotplot were very short and did not have very high percentage 
identity between the two sequences (Figure 3.1., Table 3.1.). Both of these small repeats 
were inverted in orientation. As both of these regions, which had been picked up by the 
BLASTz algorithm used by Pipmaker, had fairly low levels of similiarity and were very short 
the BLAST2 comparisons were unable to confirm the alignments initially, but after 
adjustments of the parameters from the default values to make them less stringient (Match:2; 
wordsize:7), BLAST2 was also able to detect the alignments (see section 2.2.10.1.2.).
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Figure 3.1. Region-specific repeats in the genomic region surrounding PLPl. 2Mb of 
human genomic sequence was masked for interspersed repetitive elements (UCSC genome 
browser, July 2003 release) and compared against itself using Pipmaker (BLASTz), with the 
resulting dotplot shown above. Matches are shown as black areas on the dotplot. Repeats 
within this region are shown as diagonal lines on the dotplot, upwards-facing diagonals (/) 
indicate directly repeated sequences, and inverted repeated sequences are downwards-sloping 
diagonals (\). The small regions of similarity found either side of PLPl are identified by the 
grey outlines. The approximate location of the chromosome bands in the region are shown 
underneath the dotplot, and the position of the PLPl gene is indicated by the black box. 
Regions of similarity either side of PLPl are outlined (see Table 3.1.).
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Clone Position within clone Total size % identity
Distance from 
PLPl
cU35G3 22975-2617 lbp 3197bp 17.3% (+) 32.4Kb
CV698D2 36996-39898bp 2903bp 20.2% (-) 30.6Kb
□  CV857G6 9469-9554bp 86bp 68.6% (+) 154.0Kb
□  dJ513M9 111144-11123lbp 88bp 67.0% (-) 513.6Kb
O  bA522L3 26638-26549bp 90bp 65.6% (+) 969.2Kb
O  bA541I12 102438-102527bp 90bp 65.6% (-) 622.9Kb
Table 3.1. Summary of the short regions of sequence similarity identified by BLASTz either 
side of PLPl. The symbols next to each entry correspond to the ones used to highlight these 
regions in Figure 3.1. The position of each repeat sequence within the sequence for each 
genomic clone is shown, and the percentage of identical nucleotides within each alignment is 
also shown. The distance from the transcription start site of PLPl is indicated, (+) is next to 
sequences proximal to PLPl, (-) is next to the distal sequence.
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Figure 3.2. Position of small inverted repeat sequences just either side of PLPl. 100Kb of
human genomic sequence including the PLPl gene is shown, based on data from the
Ensembl human genome browser. Distances shown are in Mb from the Xq telomere
(Ensembl release 19.34b.2). Interspersed repeat content of the region is shown by the grey
bars above the scale bar, and is taken from the Ensembl genome browser. Sequenced human
genomic clones are shown (grey boxes) as well as the positions of genes in the region,
represented by black filled boxes (PLPl and the 3' UTR of RAB9B). The location of the
short sections of inverted repeats are shown as grey arrows above the genomic clones, with
black lines underneath the arrows indicating where the actual regions of similarity lie. The
start and finish of the regions of similarity is also shown as the distance in base pairs from the
start of the appropriate genomic clone, underneath the arrows representing the position of the
repeats.
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3.4. Repeats distal to PLPl
Within the 1Mb of sequence distal to PLPl, a 200Kb section starting approximately 125Kb 
telomeric to PLPl appeared to contain several repeats as shown by the initial dotplot of the 
whole region (Figure 3.1.). Further analysis of this repetitive region was carried out, initally 
creating a dotplot of a 250Kb region containing all the repeats (Figure 3.3.)- This showed 
that there was a complicated repeat structure, comprising both inverted and directly repeated 
regions (Figure 3.3.). Further analysis, using BLASTn, BLAST2, BLASTz, ClustalW, and 
Repeatmasker was carried out to determine the boundaries of the various repeat elements 
(see sections 2.2.10.1.1-4. and 2.2.10.2.) (Thompson et al., 1994).
3.4.1. Previously described LCRs distal to PLPl
Some of the low-copy repeats within this region have been described as consisting of two 
LCRs, LCR-PMDA and LCR-PMDB (Figure 3.4.) (Inoue et a l , 2002). Each of the LCRs 
has been found to contain a pair of inverted repeats, A la and A2 in LCR-PMDA, and A3 and 
Alb in LCR-PMDB (Figure 3.4.) (Inoue et a l , 2002). LCR-PMDA and LCR-PMDB are 
mainly contained within the human genomic clones dJ839Mll and cU240C2 (Figures 3.3. 
and 3.4.). The four copies of the repeat unit (Ala, Alb, A2 and A3) that make up the LCRs 
PMDA and PMDB all show a high degree of sequence identity, particularly the repeats Ala 
and Alb, which have over 99% of their sequence in common (Table 3.3.). The sequences 
from repeats A2 and A3 are both between 89-90% identical to repeats A la and Alb, but only 
show 62.91% similarity with each other when the percentage identity is calculated from the 
number of identical bases out of the entire length of the shortest member of the pair (Table 
3.3.). However, this low level of identity is partly because these two repeat units only share 
homology over some of the sequence as they are similar to different overlapping sections of 
the Ala/Alb consensus (Figure 3.4.). When the percentage similarity between repeats A2
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and A3 is calculated just out of the total sequence included in the alignment, not including 
the most proximal part of both repeats, the percentage identity within the alignment increases 
to 88.95%. This is similar to the degree of similarity found between either of A2 or A3 and 
A la or A lb (Table 3.3.)
3.4.2. Novel distal LCRs
As well as these previously described LCRs, there are additional novel LCRs present in this 
region. A pair of inverted repeats, here designated LCR-PMDC and LCR-PMDD, which are 
35.6Kb and 27.7Kb in length respectively, lie on either side of LCR-PMDA and LCR-PMDB 
(Figures 3.3. and 3.4., Table 3.2.). This pair of large inverted repeats are also very similar to 
each other, with over 25Kb of identical sequence shared between the two, as found by 
comparison with BLASTz (92.43% identity). No annotated genes map to either LCR- 
PMDC or LCR-PMDD., and both contain a high proportion of interspersed repetitive 
elements (65.38% and 54.40%, see Table 3.2.). The major differences between these two 
regions are two regions of sequence within LCR-PMDC that are not present in LCR-PMDD, 
which both contain numerous interspersed repeats.
3.4.3. Short regions of similarity to the large distal LCRs
There are also a few small regions of similarity to LCR-PMDA and LCR-PMDB lying 
proximal to the main distal LCR region, but still distal to PLP1, within genomic clones 
bA370B6 and cUl 16E7 (Figures 3.3. and 3.4, Tables 3.2. and 3.3.).
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3.4.4. Sequence similarity between distal repeats and sequence proximal to PLP1
A small section of the distal repeats (Ala, Alb and A2) is also present proximal to PLP1 
(Figures 3.1. and 3.4., Tables 3.2. and 3.3.). The matched sequence similarities between the 
short proximal sequence and the distal repeats is marked by the oval outlines on the dotplot 
shown in Figure 3.1. The similarity extended for just 104bp, with 73.08% identity, within 
sequence contained in human genomic clone cV857G6 (Figures 3.1. and 3.4., Table 3.2.). 
This short sequence was located approximately 164Kb proximal to the start of the PLP1 
gene.
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dJ540A!3 bA370B6 CV467E10
Figure 3.3. Dotplot (using Pipmaker software) comparing 250Kb of human genomic 
sequence, starting 70Kb distal to PLP1 and including the large repetitive region, against 
itself. Repeats within this region are shown as diagonal lines on the dotplot, upwards-facing 
diagonals (/) indicate directly repeated sequences, and inverted repeated sequences are 
downwards-sloping diagonals (\). The sequence was masked for interspersed repeats and 
obtained from the UCSC genome browser (July 2003 version). The human genomic clones 
in the region are aligned underneath the dotplot.
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Figure 3.4. Organisation of repeats distal to PLP1. For legend, see next page
oo
Figure 3.4. Legend.
(a) shows the position of the various repeat elements relative to genomic clones in the 
region. Interspersed repeats (as annotated for this region on Ensembl) are shown above 
the scale bar as grey bars, (b) shows all the separate repeats within LCRs PMDA and 
PMDB aligned together, with dotted lines between the repeats to more clearly define the 
alignment. The position of interspersed repetitive elements in each repeat is shown by the 
different patterned boxes, the H2b-like genes are shown in yellow and the Xrep enhancer­
like sequences are shown in red.
Repeat/
Clone
Size
(bp)
Start point in 
(clone)
End point in 
(clone)
G+C
content
Interspersed 
repeat content Orientation
CV857G6 104 41948 42051 53.85% 0% -
bA370B6 356 6611 6969 58.15% 0% -
CU116E7 277 4991 5267 38.71% 29.60% +
CU116E7 332 10210 10541 38.55% 56.63% -
PMDC 35585 10858(cU116E8)
19867
(cV362H12) 41.84% 65.38%
+
A la 20338 35373(CV362H12)
13821
(dJ839M ll) 43.78% 41.31%
+
A2 11751 26748(dJ839M ll)
38498
(dJ839M ll) 47.43% 33.69% -
A3 14858 28716(CU240C2)
13859
(cU240C2) 44.43% 46.63%
+
A lb 20340 13858(cU240C2)
6580
(cV467E10) 43.75% 41.15% -
PMDD 27712 2029(CU46H11)
29740
(CU46H11) 42.46% 54.40% -
Table 3.2. Summary of the repeated regions distal to PLP1. The positions of the start 
and end of each repeat are given from the start of the genomic clone in which it is 
contained. Where repeats start and finish in sequence covered by different genomic 
clones the name of the relevant clone is given underneath the position within that clone. 
Interspersed repeat content is as found using Repeatmasker. (+) orientation is going from 
centromere to telomere, (-) is the opposite direction.
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CV857G6 1
(41948-42051) |
bA370B6
(6969-6611)
-
CU116E7
(4991-5267)
- -
CU116E7
(10541-10210)
- - -
Ala 79.52%(264)
69.31%
(192)
76.40%
(272)
73.08%
(76)
A2 89.69%(10539)
74.70%
(295)
71.84%
(199)
78.93%
(281)
73.08%
(?6)
A3 62.91%(7393)
89.55%
(13305) -
71.84%
(199)
77.53%
(276)
I Alb 89.89%(13286) 89.42%(10508) 99.31%(20198) 81.02%(269) 70.04%(194) 76.40%(272) 73.08%(76)
Table 3.3. Similarity of the repeats that make up LCRs PMD-A and PMD-B (along with
other related sequences) to each other as reported from BLASTz alignments. The 
pairwise similarity between sequences is expressed as the percentage of identical bases 
out of the total length of the shorter of the two sequences in the alignment. The number 
of identical nucleotides included in each alignment is given in brackets underneath the 
percentage similarity for each comparison. Where there was no significant similarity 
found between two sequences by the BLASTz algorithm, this is shown by a dash (-).
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3.4.5. H2b-like genes
Part of the sequence making up the repeats in LCRs PMDA and PMDB has similarity at 
both the nucleotide and protein level to the H2b family of histone genes. Two of these 
H2b-like sequences have been annotated on the Ensembl genome browser (Ensembl gene 
IDs: ENSG00000101812; ENSG00000123569), in repeats A2 and A3 respectively, as 
predicted genes both with similarity to H2b genes at the N-terminal half of the translated 
sequence. The part of the distal repeat block that has similarity to a section of clone 
bA370B6 contains H2b-like sequence, and this has also been annotated as a gene on the 
Ensembl genome browser (Ensembl gene ID: ENSG00000172450) and has been named 
BA370B6.1 (Figures 3.4. and 3.5.). As with the other two annotated genes, BA370B6.1 
also has similarity to H2b protein sequences at the N-terminus. Analysis of the 
nucleotide sequence of the inverted repeats A la and A lb and comparison with the other 
repeats A2 and A3, as well as the consensus H2b, showed that a part of these repeats also 
had similarity to the H2b genes (Figure 3.5.). There are several copies of all of the five 
types of histone genes within the genome, which are distributed in clusters, with the 
largest on chromosome 6 containing 55 histone genes (Marzluff et a l , 2002). Histone 
mRNAs are unique in that they do not contain a poly(A) tail and instead all end with a 
conserved sequence that forms a stem-loop secondary structure (Marzluff et a l , 2002). 
The five H2b-like gene/nucleotide sequences were all compared against the published 
consensus H2b protein sequence using BLAST2 and ClustalW, and also against a 
published consensus stem-loop sequence, showing that there was a large degree of 
similarity between the sequences (Figure 3.5.) (Marzluff et al., 2002).
3.4.5.I. H2b-like genes in other sequenced genomes
Some other mammalian genome sequences with synteny to this region of the human X
chromosome were examined for the presence of H2b-like genes by comparing sequence
from the human transcripts in this region against the syntenic sequence by BLAST2.
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There was no similarity found between the human H2b-like genes and either the mouse or 
rat syntenic genomic sequence, and as these two species do not seem to have a similar 
large repeated region distal to PLP1 this finding was not surprising (see section 3.6.). 
Comparison of H2b-like transcripts with the chimpanzee genome found one short 
sequence with similarity to the H2b-like genes, which appeared to be orthologous to the 
BA370B6.1 gene based on its position relative to other orthologous chimpanzee genes 
annotated in the region. The sequence had not been annotated as a gene in its own right 
in the chimpanzee sequence (NCBI Build 1 version 1). It is quite possible that the 
chimpanzee may harbour further orthologous H2b-like genes distal to PLP1, as the 
available sequence at the time of writing contained a large gap in the region that was 
syntenic to the major human distal repeats (see section 3.6.1. and Figure 3.9.).
3.4.6. Xrep enhancer
Part of the LCR-PMDA and PMDB repeats also consists of a 973bp sequence that has 
been described as “Xrep”, and has been found to stimulate plasmid growth in E.coli and 
S. cerevisiae, either by increasing the rate of replication or increasing the stability of 
Xrep-containing plasmids (Riley et al., 1986). Xrep was found to contain sequences very 
similar to the replication origins of some human DNA viruses, such as the human BK 
virus, as well as viral enhancer-like sequences (Rosenthal et al., 1983;Riley et al., 1986). 
It has been suggested that, given the similarities between Xrep and viral replications of 
origin, that Xrep may function as an X chromosome replication origin (Riley et al., 1986). 
However, Xrep sequences only showed very weak replicative activity in yeast, and the 
Xrep sequence was found not to contain a modular sequence element associated with 
several origin regions in eukaryotes (Riley et al., 1986;Dobbs et al., 1994). The position 
of the Xrep-related sequences within the four repeat units A la, A lb, A2 and A3 is 
indicated by the red shading in Figure 3.4b.
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3.4.7. G+C and interspersed repeat content of distal repeats
The 1Mb region distal to the transcription start sit of PLP1, which contains all the distal 
repeats, has a G+C content of 40.43% and an interspersed repeat content of 55.27% 
(Repeatmasker, Repbase version 7.4). The G+C and interspersed repeat content of many 
of the distal repeats differ from these average values (Tables 3.2.). The repeated regions 
within LCRs PMDA and PMDB had a slightly higher G+C content (the mean of Ala, 
Alb, A2 and A3 is 44.85% G+C), and a lower mean incidence of interspersed repetitive 
elements (40.70%) (Table 3.2.). The two other main LCRs PMDC and PMDD, however, 
had G+C contents closer to the regional mean, but a relatively high interspersed repeat 
content (mean of 59.89%) (Table 3.2.). The shorter stretches of similarity to the large 
distal repeats had very divergent G+C and interspersed repeat sequence content, which is 
because these are such short stretches of sequence, so are likely to have a skewed 
sequence content by chance and some of which are also associated with coding sequences 
(Figure 3.4. and Table 3.2.).
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H 2 b  c o n s e n s u s  E S Y S V Y V Y K V L K Q V H P D T G I S S K A M G I M N S
A 3 TTCGGG AGC CCCTATTTCCCC GTGCTGAAGCAGGTTCACCAGGGCCTCAGC TCCCAG GCC AGT ATG TCT
A l b  TTCGGG AGC GCCTATTTCCCC GTGCTGAAGCAGGTTCACCAGGCCCTCAGC TCCCAG GCC AGT ATG TCT
A l a  TTCGGG AGC GCCTATTTCCCC GTGCTGAAGCAGGTTCACCAGGCCCTCAGC TCCCAG GCC AGT ATG TCT
A 2 CGCGGG AGC ACCTATTTCCGC GTGCTGAAGCAGGTTCACCAGGGCCTCAGC TCCCGG GCC AGT ATG TCT
3 7 0 B 6  6 9 6 9  GG AGC ACCTATTTTCCC GTGCTGAAGCAGGTTCACGCGGGCCTCAGC TCCCCC GCA GAT TCC
H 2 b  c o n s e n s u s  F V N D I F E R I A G E A S R L A H Y N K R S T I T S R E I Q T
A 3 ATG GACATATTG CGCATCGCCACCGAGGCTGGT CTGGCCCATTACACCAAGCGCGTGACCATCACCTCCCGG ATCCAGATG
A l b  ATGGTTCGTGACATACTG CGCATCGCCACCGAGGCTGGTCACCTGGCCCACTAC AAGTGCGTGACCATCACCTCCCGG ATT ATG
A l a  ATGGTTCGTGACATACTG CGCATCGCCACCGAGGCTGGTCACCTGGCCCACTAC AAGTGCGTGACCATCACCTCCCGG ATT ATG
A 2 TTGGTT GACATATTG CGCATCGCCACCGAGGCTGGTCGCCTGGCCCGCTCCACCAAGCGCCAGACCATCACT TGGGAGACC ATG
3 7 0 B 6  TTCGTT GACATCTTGGAGCACATCGCCACC GCCGGCCACTTGGCCCACTATACCAAGTGC ACCATCACCTCCTGCGAGATGCAGACC
H 2 b  c o n s e n s u s  A V R L L L P G E L A K H A V S E G T K A V T K Y T S S K X
A 3 GCCGTGCGACTGCTGCTGCCGGGG GGCAAGCTCGCCGAG GGCACGAATGCCGCCCTC TACAC CAAAAGCAAGTGAGCTGTC
A l b  GCCGTGTGCCTGCTGCTGCCGGGG GGCAAGCTCGCTGAGTCT GGCACGAATGCCACCCTC TACAC CAAAAGCAAGTGAGCTATC
A l a  GCCGTGTGCCTGCTGCTGCCGGGG GGCAAGCTCGCTGAGTCT GGCACGAATGCCACCCTC TACACCAAAAGCAAGTGAGCTATC
A 2 GCTGTGCGCCTGCTGCTGCCGGGG GGCAAGCTCGCCGAGTCCGAAGGCACGAAGGCTGTCCTC TACACCAGGAGCAAGTGCGCTCCC
3 7 0 B 6 ATTCGCCTGATGTTC CCGGGG GGCAAGCACGCCATATCCAGGGGCTCCAAGACTCTGCTCCACTACACCAGGAGCAAGTGAGCTGCC
3 ' e n d  h i s t o n e  mRNAs N 1 7 - 7 2  c c A A a G G c u C U U u U c A G a G C C a c c - c a c n u u u u c n n a a a a g a g c u g u
A 3 TCAGGAGCGCCTGAGCACCTGGGAAACCCAAAGGCTCTATTCAGAACCACCGCCCGTGG-CCCTATAGGCCAGTGGCCCGCCAAGGGGGGGA 5 9 5 0
A l b  TCAGGAGCGCCCGAGCACCCGGGAAAGCCAAATGCTCTGTTCAGAACCACCACACGTGG-CCCTAAAGACCAGTGGCCTGCCAAGGAGGGGA 7 3 2 7
A l a  TCAGGAGCGCCCGAGCACCCGGGAAAGCCAAATGCTCTGTTCAGAACCACCACACGTGG-CCCTAAAGACCAGTGGCCTGCCAAGGAGGGGA 7 3 2 6
A 2 TCAGGAGCACCCGAGCACCACGGGAACCCAAAGGGTCTTTTCAGAGCCACTGAATGTGG-CCTGAAAGACCAGTGGCTCGCCAAGG— GGGA 1 0 5 8
3 7 0 B 6  TCAGGAGCGCCTGAGCACCA AAACCCAAAAGCTCTTTTCAGAGCCACCGCACTTGG-CTTGAAAAACCTGTAGCCC 6 6 1 1
Figure 3.5. ClustalW alignment of the H2b-like regions. Legend on next page
Figure 3.5. Legend.
ClustalW alignment of the H2b-like regions contained within the various repeated regions
distal to PLP1, with the consensus H2b protein sequence (from Marzluff et al., 2002)
\
also shown. Sequence that codes for an identical amino acid to the consensus is 
highlighted in red, sequence coding for a similar class of amino acid is shaded grey, and 
stop codons are shaded maroon. Positions from the start of the various repeats are shown, 
except for the sequence from clone bA370B6, where the numbers refer to the distance in 
base pairs from the start of the sequence of this clone. The region similar to the 3' end of 
histone mRNAs (from Marzluff et al., 2002) in the repeats is highlighted in green, the 
consensus is shown above, with invariant bases shown as capital letters in the consensus.
3.5. Repeats proximal to PLP1
The region upstream of PLP1 appeared to contain numerous short locally repeated 
sequences, which seemed to fall into two major alternating blocks, creating a 
chequerboard-like pattern when this region was compared against itself using BLASTz by 
the Pipmaker program and shown as a dotplot (Figures 3.1. and 3.6.). The nature of these 
repeats was investigated using a combination of BLASTn and BLASTz sequence 
comparison tools to delineate the borders of the repeats. Four different types of repeated 
DNA sequence were found in this PLP1-proximal region, which have been here 
designated as types P1-P4, and a summary of all the repeats is shown in Figure 3.8. Some 
of these repetitive sequences were also found to be associated with genes.
3.5.1. Proximal repeat group PI
The set of repeats arbitrarily designated as “P I” included 9 different sections of sequence
in the 1.1Mb region examined proximal to PLP1 (Figure 3.8., Table 3.4.). The average
length of the PI repeat sequences was 8640bp, and the mean G+C content of the repeats
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(40.71%) was close to the G+C content of the 1.1Mb region proximal to the start of 
PLP1, which contained all of the proximal repeated sequences considered in this chapter 
(40.67%) (Table 3.4.). The interspersed repeat content of the various PI repeats varied, 
with a mean of 41.94%, which was considerably lower than the average (55.67%) for the 
whole region (Tables 3.4. and 3.5.). Most of the alignments amongst the PI repeats only 
included part of each repeat unit, and alignments were often fragmented due to the 
presence of other sequences, such as common interspersed repetitive elements, within the 
boundaries of the PI repeats (Table 3.5.). The PI repeats were the most widely dispersed 
of all the repeats found in the PLP1-proximal region, with the two most proximal and 
distal repeats in the group located almost 800Kb apart, and none were found to be 
associated with annotated genes (Figure 3.8.).
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Xq22.1 |y  -f
PLPl
M  1.1Mb  ►
Figure 3.6. Dotplot produced by Pipmaker using BLASTz comparison of sequence from 
1.1Mb proximal to PLPl against itself (finishing at the end of PLPl). Regions of 
similarity are shown as black areas on the dotplot. Repeats within this region are shown 
as diagonal lines on the dotplot, upwards-facing diagonals (/) indicate directly repeated 
sequences, and inverted repeated sequences are downwards-sloping diagonals (\). The 
location of the chromosomal bands in the region (taken from the Ensembl genome 
browser) are shown underneath the dotplot. The position of PLPl is indicated by the 
black shaded area in Xq22.2. Genomic sequence (taken from the UCSC genome 
browser) was masked for human interspersed repetitive elements before the BLASTz 
comparison was made.
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Clone Size
(bp)
Start End G+C (%) Repeat content 
(%)
Orientation on 1 
chromosome |
dJ769N13 11350 139630 150979 41.80 38.17 +
bA522L3 7961 58300 66260 40.52 30.13 +
CU157D4 15210 6231 21440 41.60 43.89 -
dJ635G19 1925 130 2824 42.41 52.65 +
dJ635G19 3695 33007 36901 35.51 57.37 +
bB349O20 11556 35037 46592 42.13 35.63 +
dJ421I20 7605 15230 22834 40.88 39.91 +
dJ43H13 9137 9332 196 41.70 35.04 -
CU246D9 9322 9328 7 39.87 44.65 -
Table 3.4. Summary of proximal PI repeats. The positions of the start and end of each 
repeat are given from the start of the sequence from the genomic clone in which it is 
contained. Interspersed repeat content is as found using Repeatmasker. (+) orientation is 
going from centromere to telomere, (-) is the opposite direction.
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dJ769N13
139630-150979
bA522L3
58300-66260
60.92%
(3368)
CU157D4
6231-21440
74.48%
(3792)
74.62%
(4645)
dJ635G19
130-2824
71.22%
(693)
71.53%
(515)
69.66%
(675)
dJ635G19
33007-36901
67.26%
(452)
82.60%
(1182)
70.08%
(923)
68.61%
(483)
bB349O20
35037-46592
66.74%
(1240)
74.88%
(903)
92.22%
(5100)
65.48%
(3893)
68.48%
(6950)
dJ421I20
15230-22834
69.70%
(3612)
70.61%
(370)
73.27%
(551)
70.38%
(3712)
70.78%
(2807)
59.60%
(2400)
dJ43H13 77.04% 60.75% 69.59% 75.36% 74.81% 76.13% 73.81%
9332-196 (3420) (4346) (1301) (923) (6795) (3965) (4503)
CU246D9 75.45% 70.78% 75.49% 73.53% 77.46% 64.13% 75.05% 75.69%
9328-7 (1718) (2807) (3480) (1711) (976) (5173) (3478) (2923)
Table 3.5. Similarity of the PI repeats to each other as reported from BLASTz alignments. The pairwise similarity between sequences is expressed as 
the percentage of identical bases out of the total number of base pairs included in each alignment. The size ranges given for each repeat are for the 
maximum extent of the repeat based on comparisons to all of the other repeats in the group, the percentage given is only for the parts of two sequences 
that are aligned by BLASTz. Not all of an individual repeat unit is necessarily aligned in a particular pairing; the number of base pairs included in each 
alignment is given underneath the percentage similarity in brackets. Where at least half of either sequence is included in the alignment, the figures are 
in bold type.
3.5.2. P2 repeats
This group of repeated sequences, referred to as “P2” repeats in this study, proximal to 
PLPl, were found to contain coding sequences in a minority of the repeat units, by 
comparisons with the annotation of the genomic sequence (Ensembl genome browser). 
BLASTz and BLASTn searches were used to determine the extent of the similarity 
between the different sequences (Tables 3.6. and 3.7.). The P2 group of repeats contained 
the largest number of individual repeats out of the four classes of repeat types, with 15 
whole or partial copies present (Figure 3.8., Table 3.6.). The P2 group of repeats also 
contained the most sequence in total out of the four repeat groups, 125.1Kb (Table 3.6.).
3.5.2.I. RAB genes
Two of the repeats contained genes belonging to the RAB gene family of small GTP-
binding proteins. These two genes were both annotated as RAB40A on the Ensembl
genome browser and were located in regions with very high sequence similarity, and both
the DNA and protein sequence were 97% identical to each other. RAB proteins comprise
the largest subgroup within the Ras superfamily of GTPases, and the human genome
contains at least 60 RAB genes (Bock et a l, 2001). RAB proteins contain various
conserved motifs, including a GTP-binding domain and a prenylation motif at the C-
terminal end of the protein (Pereira-Leal and Seabra, 2000). There is also another gene
from the RAB protein family located within Xq22.2, RAB9B, which is just proximal to
PLPl (Figure 1.4.). However, RAB9B is not particularly closely related to the RAB40A
genes within the wider RAB gene family (Pereira-Leal and Seabra, 2001). There is only
31% identity at the protein level between RAB9B and either of the two RAB40A copies.
No significant similarity was found between the transcript sequences at the nucleotide
level using BLASTn, and no similarity was found between the sequences within and
around these three sequences using BLASTz comparisons (Figure 3.1.). The RAB40A
proteins differ from many of the other RAB proteins (including RAB9B) in the
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prenylation motif present in the protein. The RAB40A isoforms have a C-terminal 
CAAX box as a target for prenylation modification of the protein, whereas most RAB 
proteins, including RAB9B, contain a different prenylation motif consisting of one, or 
usually two, cysteine residues at the very end of the protein (Pereira-Leal and Seabra, 
2000;Pereira-Leal et a l, 2001). RAB proteins are prenylated by the covalent addition of 
a geranylgeranyl isoprenoid group to a C-terminal cysteine residue, by the protein RAB 
geranylgeranyl transferase (RGGT), which recognises RAB proteins only when bound to
the 95KDa RAB escort protein (REP) (reviewed in Pereira-Leal et a l, 2001). The 
RAB40A proteins (as well as the closely related proteins RAB40B and RAB40C, present 
in genomic locations 17q25.3 and 16pl3.3 respectively) also differ from other RAB 
proteins, including RAB9B, in the presence of a SOCS box (suppressor of cytokine 
signalling) protein motif near the C-terminus of the protein, a motif which may have a 
function involving the regulation of protein turnover (Hilton et al., 1998;Pereira-Leal and 
Seabra, 2000;Kile et a l, 2002). The RAB40A isoform located in genomic clone cU237Hl 
has been found to be expressed most highly in the brain, and is also expressed in heart, 
skeletal muscle, kidney and liver (Saito-Ohara et a l , 2002). Immunocytochemistry on 
this RAB40A protein showed intracellular localisation of the protein to the mitochondria 
(Saito-Ohara et al., 2002).
3.5.2.2. Sequence characteristics of P2 repeats
Most of the P2 repeat units did not contain sequences coding for RAB genes, however,
and most of the similarities found were between non-coding sequences. As found with
the PI repeats, many of the alignments between different members of the P2 family only
included part of each sequence, and many of the alignments were fragmented by
interspersed repetitive elements (Table 3.7.). Although the mean interspersed repeat
content (as found by Repeatmasker) was below the average for the region, at 42.67%, the
interspersed repeat content of the different repeats varied widely between P2 sequences
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with some being much higher than the regional average of 56.67% (Tables 3.4. and 3.7.). 
The G+C content of the P2 repeats was not as variable, and the average G+C content 
(39.42%) was close to the regional average of 40.67% (Tables 3.4. and 3.7.).
Clone Size
(bp)
Start End G+C(%)
Repeat 
content (%)
Orientation on 
chromosome Gene name
I dJ1054G24 5045 5268 224 37.62 20.61 -
1 CU237H1 9243 29180 19938 37.91 54.40 +
CU237H1 1842 13364 15205 37.68 6.95 -
CU237H1 10283 10285 3 41.97 20.32 + RAB 40A
CU235H3 9693 9963 271 38.37 51.20 +
CU61F10 4306 39008 34703 38.16 27.71 +
CU73E8 12976 25387 12412 40.26 69.22 +
CU101D3 2931 10528 7598 41.28 62.71 +
(U635G19 3819 14246 18064 39.28 58.34 +
dJ635G19 8440 26734 18295 43.53 46.88 -
dJ635G19 10455 46750 57204 38.27 80.87 +
CU250H12 11433 37916 26484 38.62 53.04 +
CU250H12 21841 3169 25009 39.70 33.41 - RAB40A
dJ43H13 5004 9573 14576 39.91 20.00 +
dJ43H13 7789 14573 22361 38.80 34.37 +
Table 3.6. Summary of proximal P2 repeats. The positions of the start and end of each 
repeat are given from the start of the genomic clone in which it is contained. Interspersed 
repeat content is as found using Repeatmasker. (+) orientation is going from centromere 
to telomere, (-) is the opposite direction.
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dJ1054G24
5268-224
CU237H1
29180-19938
73.03%
(685)
cU237Hl
13364-15205
77.09%
(773)
74.47%
(455)
CU237H1
10285-3
65.23%
(1272)
75.57%
(1262)
74.92%
(1146)
cU235H3
9963-271
66.77%
(1879)
76.46%
(1023)
75.18%
(4478)
76.49%
(1402)
cU61F10
39008-34703
73.32%
(1154)
64.34%
(1721)
77.38%
(335)
69.19%
(1534)
71.50%
(961)
cU73E8
25387-12412
64.33%
(2047)
68.66%
(4743)
72.49%
(2443)
73.20%
(1319)
72.79%
(4576) -
cUlOl D3
10528-7598
69.95%
(752)
72.16%
(1130)
76.29%
(428)
60.85%
(1413)
75.54%
(451)
76.57%
(402) -
dJ635G19
14246-18064
58.60%
(1240) - - - - - - -
dJ635G19
26734-18295
70.57%
(885)
75.55%
(674)
75.36%
(1847)
74.49%
(1594)
71.98%
(2300)
75.76%
(1303)
77.08%
(817)
71.35%
(1843)
73.92%
(788)
dJ635G19
46750-57204
67.47%
(701)
56.52%
(2080) -
63.67%
(1616) -
73.81%
(834) - -
60.53%
(1833)
70.55%
(206)
CU250H12
37916-26484
72.34%
(761)
71.64%
(2059)
54.55%
(109)
72.29%
(934)
69.45%
(4315)
74.69%
(1959)
70.29%
(3477)
71.99%
(2950)
65.31%
(1365)
74.16%
(2471)
74.36%
(1453)
CU250H12
3169-25009
77.45%
(2473)
71.27%
(655)
77.23%
(831) -
78.95%
(465)
72.34%
(2111)
75.87%
(1736)
74.92%
(2557)
87.09%
(8133)
78.28%
(1067)
56.53%
(1725)
71.73%
(1573)
dJ43H13
9573-14576
80.84%
(1974)
67.72%
(3443)
68.24%
(232)
69.38%
(2017) -
83.55%
(122)
72.46%
(2713)
63.89%
(1575)
70.15%
(2080)
69.08%
(1834)
76.77%
(945)
87.50%
(1568)
73.83%
(1470)
dJ43h13
14573-22361
80.08%
(2130)
77.52%
(4731)
74.83%
(3167) -
77.15%
(1341) -
61.76%
(1221)
71.51%
(2670)
69.50 % 
(1894)
71.28%
(1777)
69.19%
(2958)
72.58%
(1347)
75.25%
(1861)
73.34%
(1205)
Table 3.7. Similarity of the P2 (7L4#-containing) repeats to each other as reported from BLASTz alignments. For table legend, see next page.
Table 3.7. Legend.
The pairwise similarity between sequences is expressed as the percentage of identical 
bases out of the total number of base pairs included in each alignment. The size ranges 
given for each repeat are for the maximum extent of the repeat based on comparisons to 
all of the other repeats in the group, the percentage given is only for the parts of two 
sequences that are aligned by BLASTz. Not all of an individual repeat unit is necessarily 
aligned in a particular pairing; the number of base pairs included in each alignment is 
given underneath the percentage similarity in brackets. Where at least half of either 
sequence is included in the alignment, the figures are in bold type
3.5.3. P3 repeats
Another group of repeats proximal to PLPl was identified by BLASTn searches and 
BLASTz alignments. This group of sequences, designated as P3 repeats, were found to 
contain several known and predicted genes, in this instance belonging to the BEX/NADE 
(brain expressed X-linked/p75NTR-associated cell death executor) family of genes.
3.5.3.1. BEX/NADE genes
BEX1 is located in human genomic clone dJ198P4 and has found to be expressed at a
high level in mouse brain, kidney and testis (Table 3.8. and Figure 3.8.) (Yang et al.,
2002). Other members of the BEX/NADE family in Xq22 include BEX2,
NGFRAP1/BEX3 (Nerve growth factor receptor (TNFRSF16) associated protein 1) and a
less well-characterised gene annotated in Ensembl as Q9NMD9 (Table 3.8. and Figure
3.8.). BEX/NADE proteins have been found to play a role in mediating apoptosis in
response to nerve growth factor, by interacting with the p75 neurotrophin receptor (Mukai
et al., 2000;Mukai et a l , 2003). Several genes homologous to BEX  genes (Bex 1/Rex-3,
Bex2, Bex3) are present in the syntenic region of the murine X chromosome (Figure 3.9.)
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(Brown and Kay, 1999). All the BEX/NADE proteins located in Xq22 contain a CAAX 
box at the C-terminal end of the protein, which acts as a substrate for post-translational 
modification by adding either a geranyl-geranyl or famesyl group to the cysteine residue, 
resulting in the protein being attached to cellular membranes (Brown and Kay, 
1999;Yang et al., 2002).
3.5.3.2. Sequence characteristics of P3 repeats
The DNA sequence similarity between the different P3 repeats is relatively short, 
compared to some of the other proximal repeats, at 1146bp on average, but it was found 
to usually include most of the sequence in the repeat units (Table 3.9.). In the cases 
where there is an annotated gene in the sequence, the similarity does not extend very far 
outside this gene sequence. The G+C content of the P3 repeats was generally higher than 
for the other types of proximal repeats, and the G+C content of each P3 copy was always 
higher than the proximal region average of 40.67% (Table 3.8.). The interspersed repeat 
content was strikingly low, for a couple of P3 repeats no interspersed repeat units were 
found by Repeatmasker, which is due to most of these P3 repeated sequences consisting 
of coding sequence (Table 3.8.).
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Clone Size
(bp) Start End
G+C
(%)
Repeat 
content (%)
Orientation on 
chromosome Gene ID
dJ198P4 1974 25616 23643 55.52 0 - BEX1
dJ635G19 1978 62956 64933 57.18 0 + Q9NWD9
dJ79Pll 3128 32901 29774 49.58 1.92 - BEX2
CU105G4 3739 10057 13795 44.80 19.42 + (NM_ 152278)
CU104G4 1901 29100 27200 42.61 12.36 -
bB349O20 2004 14882 16885 55.84 6.59 + NGFRAP1
Table 3.8. Summary of proximal P3 (REX-like) repeats. The positions of the start and 
end of each repeat are given from the start of the genomic clone in which it is contained. 
Interspersed repeat content is as found using Repeatmasker (EBI). (+) orientation is 
going from centromere to telomere, (-) is the opposite direction.
dJ198P4
25616-23643
dJ635G19
62956-64933
70.77%
(1087)
dJ79Pll
32901-29774
80.44%
(1534)
75.75%
(1293)
CU105G4
10057-13795
62.87%
(1717) -
-
CU105G4
29100-27200
-
60.59%
(1127)
71.90%
(755)
62.76%
(787)
bB349O20
14882-16885
71.80%
(802)
56.16%
(1085)
71.66%
(1052)
66.54%
(1078)
77.18%
(1437)
Table 3.9. Similarity of the P3 {BEX-like) repeats to each other as reported from 
BLASTz alignments. The pairwise similarity between sequences is expressed as the 
percentage of identical bases out of the longer of the two sequences in the alignment. The 
size ranges given for each repeat are for the maximum extent of the repeat based on 
comparisons to all of the other repeats in the group, the percentage given is only for the 
parts of two sequences that are aligned by BLASTz, not all of an individual repeat unit is 
necessarily aligned in a particular pairing. The number of identical nucleotides included 
in each alignment is given in brackets underneath the percentage similarity for each 
comparison. Where there was no significant similarity found between two sequences by 
the BLASTz algorithm, this is shown by a dash (-).
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3.5.4. P4 repeats
The final group of repeated sequences proximal to PLPl were named “P4” for the 
purposes of this study. Members of this group of PLPl-region specific repeats were 
located closest to the PLPl gene out of all the proximal repeats and were also found to 
consist of a family of genes and related sequences, as had been found for the P3 repeats 
(see section 3.5.3.). Seven short blocks of similar nucleotide sequence were found, 
between 2-5.4Kb in length, all of which contained known or predicted genes. These 
genes included TCEAL1 (Transcription elongation factor A-like J_), which codes for the 
21kDa protein p21/SIIR (Pillutla et al., 1999).
3.5.4.1. TCEALl-\ike genes
p21/SIIR is a nuclear phosphoprotein, found to have 48% similarity to the transcription 
factor SII, which can modulate transcription (Yeh and Shatkin, 1994;Pillutla et al., 1999). 
The other genes found within the P4 repeats did show some degree of amino acid 
sequence similarity to TCEAL1, as well as the DNA sequence similarity (Table 3.11.). 
The P4 repeats, which also contained a large proportion of coding sequence, had higher 
G+C content than the regional average (Table 3.10.).
3.5.4.2. Sequence characteristics of P4 repeats
Some interspersed repetitive elements were found (by Repeatmasker software) within the 
P4 repeats (Table 3.10.). A short fragment of an LlME4a element was found in all seven 
copies of the P4 (TCEAL1-like) repeat, with homology between bases 5846-6117 of the 
LlME4a repeat consensus and this repeat element was located within or near the 3' UTR 
of the genes in the repeat unit (Figure 3.7.). Four of the repeat units also contained partial 
sequence homologous to the L1MC/D LINE consensus, and some of the repeat units also 
contained other interspersed repeats (Figure 3.7.). The interspersed repeat content of the 
repeats (16.25%) was lower than the average for the proximal region (Table 3.10.).
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Clone Size
(bp)
Start End G+C
(%)
Repeat 
content (%)
Orientation on 
chromosome Gene name
CU177E8 5280 23297 28576 45.25 15.08 - NM_153333
CU177E8 2073 3937 6009 45.49 19.92 - ENSESTG00000020633
CU105G4 3464 10341 13804 45.06 20.96 + NM_152278
CU105G4 3521 36822 40342 44.59 18.74 + NM_016303
CV857G6 2186 27125 24940 46.29 11.71 + NM_024863
CV857G6 2388 4724 2337 48.12 13.15 + NM_032926
1 dJ1055C14 5334 10539 15872 46.51 14.17 + TCEAL1
Table 3.10. Summary of proximal P4 repeats. The positions of the start and end of each 
repeat are given from the start of the genomic clone in which it is contained. Interspersed
repeat content is as found using Repeatmasker. (+) orientation is going from centromere 
to telomere, (-) is the opposite direction.
CU177E8
23297-28576
CU177E8
3937-6009
56.16%
(770)
CU105G4
10341-13804
-
64.23%
(2219)
CU105G4
36822-40342
56.35%
(1841)
48.09%
(792)
53.15%
(1867)
CV857G6
27125-24940
61.12%
(679)
60.60%
(706)
70.97%
(1327)
62.21%
(826)
CV857G6
4724-2337
72.27%
(1407) -
64.83%
(864)
78.02%
(1514)
64.76%
(900)
(U1055C14
10539-15872
-
62.39%
(740)
57.52%
(1679)
53.31%
(1617) -
61.41%
(3149)
Table 3.11. Similarity of the P4 repeats to each other as reportec from BLASTz
alignments. The pairwise similarity between sequences is expressed as the percentage of 
identical bases out of the longer of the two sequences in the alignment. The size ranges 
given for each repeat are for the maximum extent of the repeat based on comparisons to 
all of the other repeats in the group, the percentage given is only for the parts of two 
sequences that are aligned by BLASTz, not all of an individual repeat unit is necessarily 
aligned in a particular pairing. The number of identical nucleotides included in each 
alignment is given in brackets underneath the percentage similarity for each comparison. 
Where there was no significant similarity found between two sequences this is shown by 
a dash (-). Comparisons highlighted in bold type are those where at least half of the 
nucleotides in at least one of the sequences are included in the alignment.
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CV857G6
4724-2337
CV857G6
27125-24940
CU105G4
36822-40342
dJ1055C14
10539-15872
CU177E8
23297-28576
CU105G4
10341-13804
CU177E8
3937-6009
v V >
>
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Figure 3.7. Repeat content and other features of the P4 (TCEAL1-like) repeats found in 
Xq22 proximal to PLPl. The relative sizes of the repeat units are shown by the large 
block arrows. Coding regions of genes are shown by red boxes, untranslated regions by 
pink colouring, and predicted coding regions (Ensembl Genscan prediction) are shown as 
blue boxes. Splicing patterns are shown above the repeats. Interspersed repeat content, 
as found by Repeatmasker software is shown by the patterned boxes.
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3.5.5. Similarities between P3 (ITEX-like) repeats and P4 {TCEAL1-like) repeats
A fraction of the sequence from genomic clone cU105G4 (3.5-3.75Kb, between bases 
10057 and 13804) was picked up by BLASTz alignments as being similar to some of the 
repeated sequences in both the P3 and P4 repeats (Tables 3.8. and 3.10.). However, this 
sequence was among the least similar to the other sequences in the two sets of repeats, as 
it did not show similarity to some of the other sequences in the both groups, which was 
most apparent for the P3 (BEX-Xiko) repeats, where only two of the other sequences 
showed any similarity (Tables 3.8. and 3.9.). Further investigation of the composition of 
this part of clone cU105G4 showed that much of the alignments found in the P3 repeats 
were due to common repetitive elements within this sequence, including a partial LlM4a 
element (Figure 3.7.). The gene found within this sequence (NM_152278) showed 
similarity at the amino acid level to TCEAL1 and other genes in the P4 repeats, but no 
significant homology was found to the various BEX-like genes in the region (Figure 3.7.).
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Figure 3.8. Summary of the local repeat structure, genes and clones proximal to PLP1. 1.1 Mb spanning Xq22.1 -Xq22.2 is shown, ending at the end of 
PLP1, with the left hand side of the diagram closest to the X centromere. Genomic clones are shown as grey boxes labelled with the clone name; those 
in darker grey have been sequenced in the direction centromere —► telomere, those shaded in lighter grey have been sequenced in the alternative 
orientation. The four types of repeat found (P1-P4) are shown as coloured arrows above the contig, with the direction of the arrows showing the 
orientation of the repeat. Genes in the region are shown as boxes above the genomic clones if transcribed centromere —► telomere, below if transcribed 
telomere —*■ centromere. Genes are coloured according to which repeat unit they fall into, if not located within a repeat genes are shaded black.
3.6. Comparison of local repeat content near PLP1 with other species
Several region-specific repeats have been identified in the human genomic sequence 
around PLP1 as part of this study. It is possible that similar repetitive regions are present 
in the genomes of other organisms. Many of the repeats identified were found to share 
only a moderate degree of sequence similarity, indicating that if they had originated from 
a single ancestral sequence, this was likely to have occurred at a relatively distant point in 
the evolutionary past. 2Mb regions of the available genomic sequence from three species, 
the chimpanzee (Pan troglodytes), the mouse (Mus musculus) and the brown rat (Rattus 
norvegicus) were investigated for the presence of region-specific repeats as had been 
carried out for the human genomic sequence. For each organism, the 2Mb of genomic 
sequence was centred on the PLP1 homologue on the X chromosome, as this region of 
the X chromosome shows synteny between all four species, according to data from the 
various genome projects. Each 2Mb of sequence was compared against itself using 
BLASTz and displayed by Pipmaker as a dotplot, after common interspersed repetitive 
elements had been masked by the UCSC genome browser (Figure 3.9.). Substantial 
regions of locally repeated sequence were observed in all three species, but these repeated 
regions did not necessarily resemble the repeat distribution observed for the syntenic 
human sequence (Figures 3.1. and 3.9.).
3.6.1. Regional repeats in the chimpanzee syntenic region
Not surprisingly, the chimpanzee genomic sequence had the most similar repeat
distribution to the human sequence, which reflects the close evolutionary relationship
between the two species. Proximal to the chimpanzee homologue of PLP1, a very similar
pattern of repeats was apparent on the dotplot, with a similar chequerboard pattern to that
seen in the human sequence proximal to PLP1 (see section 3.5., Figures 3.1. and 3.9a.).
Most of the very short similarities between sequences either side of PLP1 were also still
present in the chimpanzee sequence (Figures 3.1. and 3.9a.). Distal to the PLP1
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homologue, however, no region of repeated sequences as was seen in the human sequence
is apparent in the chimpanzee genomic sequence (Figures 3.1., 3.3. and 3.9a.). However,
the chimpanzee sequence for this region at the time of writing is incomplete, with several
gaps in the assembly (November 2003 assembly - NCBI build 1 version 1) (Figure 3.9a).
The largest gap between the contigs in this 2Mb region roughly coincides with the region
syntenic to the region containing the distal repeats (LCRs PMDA, B, C and D) in the
human sequence (Figures 3.1., 3.4. and 3.9a.). The chimpanzee draft genome is
constructed from a 4x shotgun sequence coverage which has then been assembled mostly
by alignment to the human genome sequence (Reich et al., 2002). This method of
assembly causes difficulties when attempting to align chimpanzee sequence to highly
similar duplicated regions in the human genome, as it may not be possible to determine
which copy of the repeat the sequence should be aligned to (Reich et al., 2002). A
comparison of the human and chimpanzee sequences throughout this region by BLASTz,
with a consistent upwards diagonal shown for most of the dotplot indicating directly
repeated sequence, apart from where gaps are present in the chimpanzee sequence (Figure
3.10a). Part of the region flanking the large gap in the chimpanzee contig does appear to
be similar to part of the distal repeat region mapped in humans, supporting the idea that
the chimpanzee genome does contain some sequence with similarity to the human repeats
distal to PLP1 (Figure 3.10a). The proximal repeat regions look very similar between the
two genomes, with the same chequerboard pattern also generated as when the human
sequence was compared against itself (Figure 3.1.). The two repeat units A la and A lb
are highly similar (>99% sequence identity), and sequences with such high sequence
identity are estimated to have originated by duplication within the last 2.5 million years
(Table 3.3.) (Samonte and Eichler, 2002). This is much more recent than the estimated
date of human-chimpanzee divergence, at approximately 7 million years ago, indicating
that the A la/A lb duplication is very likely to be human-specific (Samonte and Eichler,
2002). Such a difference between the organisation of the repetitive region distal to PLP1
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between human and chimpanzee could lead to difficulties in the chimpanzee assembly 
and hence the gap in this region. Future versions of the chimpanzee genome assembly 
will hopefully give more insight into the evolutionary history of this genomic region.
3.6.2. Repetitive regions close to the murine Plpl gene
BLASTz comparisons using Pipmaker were also performed for 2Mb of the murine 
genomic sequence (October 2003 assembly - NCBI build 32) around Plpl, against itself 
and against the human sequence (Figures 3.9b and 3.10b). Proximal to P lp l, a highly 
repetitive ~300Kb region was picked up by the BLASTz analysis (Figure 3.9b). This 
repetitive region appeared to consist of two densely arrayed regions of short repeated 
sequences, flanking a longer pair of inverted repeat sequences (Figure 3.9b). This main 
repetitive region in the mouse did not bear much resemblance to any of the human repeats 
from the syntenic region, and there was little similarity between the human and mouse 
sequences in this particular region once the two sequences were aligned by BLASTz 
(Figure 3.10b). Much of the regions just proximal to, and all of the 1Mb distal to PLP1 
and Plpl, showed a reasonable degree of synteny between the two species, as represented 
by the roughly diagonal line on the dotplot in Figure 3.10b. The rest of the proximal 
region did not show such a direct relationship between the two sequences, but there was 
some similarity between some of the proximal repeat regions (P1-P4) and the mouse 
sequence, with some vestiges of the chequerboard-like pattern that was seen for the 
human and chimpanzee sequences being evident in the human-mouse comparison 
(Figures 3.10a, 3.10b, and 3.6.). There was very little similarity between the human distal 
repeats region and the corresponding part of the mouse genome, and the diagonal line of 
syntenic sequence similarity between the two genomes was interrupted at this 
approximate point, showing that this region had probably expanded by sequence 
duplication to create this repetitive region in the lineage leading to humans, but not during
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the corresponding period of mouse evolution, or alternatively there could have been a 
deletion of this region in the mouse lineage (Figure 3.10b).
3.6.3. Repetitive regions near the brown rat PLP1 homologue
Further highly repetitive regions, specific to the rat genome, were found close to the 
PLP1 homologue in the available genomic sequence for this species. A BLASTz self- 
comparison of the 2Mb flanking the gene (June 2003 assembly, Atlas version 3.1.) 
showed no major region-specific repeats in the distal half of the region, but a large region, 
approximately 600Kb in length and proximal to the gene, was highly repetitive and 
consisted of both direct and inverted repeated sequences (Figure 3.9c). Fewer regions of 
similarity was seen between the rat and human sequences than for the other two 
interspecies comparisons, with virtually no similarity between the two sequences in the 
region of the rat proximal repeat (Figure 3.10c). Although sequence in the vicinity of 
PLP1, and also distal to the gene did show synteny in places, a lot of the sequence just 
distal to PLP1 in humans was not present in this region in the rat genome (Figure 3.10c).
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Figure 3.9. Locally repetitive sequences are present in syntenic regions of other genomes. Dotplots created by the Pipmaker program following
BLASTz self-comparisons of 2Mb of genomic sequence taken from (a.) chimpanzee, (b.) mouse and (c.) rat, centred on the PLP1 homologue in each 
organism. Sequence data, masked for common interspersed repetitive elements, was taken from the UCSC genome browser. Underneath the dotplots 
are shown the relevant regions of the X chromosome in each species, taken from the Ensembl genome browser. Repeats within this region are shown as 
dark areas on the dotplot, upwards-facing diagonals (/) indicate directly repeated sequences, and inverted repeated sequences are downwards-sloping 
diagonals (\).
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Figure 3.10. Comparisons of 2Mb of sequence around the PLP1 homologue with human genomic sequence in (a.) chimpanzee, (b.) mouse and (c.) rat. 
The same regions of the genome of these three species as used for Figure 3.9. is compared against 2Mb of sequence from the human genome centred on 
PLP1 , and was also masked for interspersed repeats before downloading from the UCSC genome browser using Pipmaker. In each dotplot the human 
sequence is aligned on the horizontal axis and the sequence from the other species is aligned on the vertical axis. The position on the human X 
chromosome and gene content is shown underneath one of the dotplots, and is the same for all three comparisons. Repeats within this region are shown 
as diagonal lines on the dotplot, upwards-facing diagonals (/) indicate directly repeated sequences, and inverted repeated sequences are downwards- 
sloping diagonals (\).
3.7. Discussion
3.7.1. LCRs/segmental duplications near PLP1
Most low-copy repeats or segmental duplications that are associated with disease-causing 
rearrangements are relatively large (>10Kb) and share a high degree of sequence identity 
(>90% for segmental duplications, while LCRs associated with recurrent disease-causing 
rearrangements usually have a higher degree of identity, >95%) (Bailey et al., 
2002;Stankiewicz and Lupski, 2002;Shaw and Lupski, 2004). The only repeats found 
near PLP1 that meet these more stringent criteria for LCRs are the two inverted repeat 
sequences distal to the gene, A la  and Alb, with over 99% similarity to each other for 
over 20Kb, which had been previously identified by Inoue et al. (2002) (Tables 3.2. and
3.3.). The other two long repeats with some homology to A la  and Alb, A2 and A3, 
nearly meet the criteria for segmental duplications, having similarity to A la and A lb for 
more than 10Kb, with the percentage of identical nucleotides ranging between 89-90% 
(Tables 3.2. and 3.3.). The longest pair of segmental duplications, LCR-PMDC and 
LCR-PMDD, also distal to PLP1, are also nearly similar enough to be classed as bona 
fide LCRs (92.43% similarity over 25Kb). The various repeated sequences proximal to 
PLP1 (PI, P2, P3, P4) are not nearly similar enough or individually large enough to be 
classified as LCRs. There do not appear to be any LCRs either side oiP LP l, as is found 
with many genomic disorders (Lupski, 1998). This is not unexpected, as duplications and 
deletions involving PLP1 have been found to vary in size and do not appear to have 
recurrent breakpoints, making it unlikely that non-allelic homologous recombination is 
the mechanism behind these rearrangements (Inoue et al., 2002;Hobson et al., 2003;Iwaki 
et a l, 2003).
3.7.2. Interspersed repeats
The 2Mb of genomic sequence surrounding PLP1 is relatively enriched for interspersed
repetitive elements (55.47%), as found by Repeatmasker, relative to the X-chromosome
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wide average repeat density of 46% (Venter et a l , 2001). The total combined length of 
all of the region-specific repeats examined in this chapter comes to 379942bp, or 19% of 
the total sequence, which only amounts to one third of the sequence covered by 
interspersed repeats. Some of the individual region-specific repeat families occupy a 
proportion of the sequence which is comparable to that taken up by some families of 
interspersed repetitive elements: P2 repeats take up 6.26% of the sequence and PI repeats 
take up 3.89%, Alus make up 8.41% of the sequence and MaLR-type LTR elements 
account for 4.04% of the 2Mb of sequence (Repeatmasker).
Some reports have suggested that regions with high G+C and Alu repeat content are more 
likely to be involved in segmental duplications (Jurka et a l , 2004). Many of the larger 
distal repeats did have a higher G+C content than the regional average, but all of the 
distal repeats were found to have lower Alu content than was expected for this region 
(Table 3.2.). It is possible that some aspects of the sequence composition of the distal 
repeats, reflected in the G+C content, such as the presence of GC rich, recombination- 
promoting sequence motifs, may have been important for generating duplication events in 
this region during evolution (Abeysinghe et a l , 2003). There were no Alu elements 
mapped close to the ends of the major distal repeats, so it seems unlikely that Alu- 
mediated recombination was responsible for creating these particular LCRs, although this 
has been shown to be a significant mechanism in the formation of segmental duplications 
(Figure 3.4.) (Bailey et al., 2003). Many of the numerous proximal repeated sequences 
showed a higher than average G+C content, but in many cases this was likely to be due to 
the high proportion of genes in some of these sequences. A high proportion of coding 
sequences within the proximal region-specific repeats may also explain their relatively 
low interspersed repeat content.
159
3.7.3. Gene families in the PLP1 region
Many of the genes near to PLP1 show a degree of homology to other genes in the region 
and do form parts of the various PLP1-region specific repeats (7/25-like, BEX-liks, 
RAB40A and TCEAL1-like genes). One addition to this number is the gene NXF3, which 
is a member of a family of nuclear RNA export factors (Jun et a l, 2001) (Figure 3.8.). 
Three other NXF genes (NXF5 and two copies of NXF2) are located within 1.26Mb of 
NXF3, which is the most distally located of this repeated gene family in Xq22.1. The 
Ensembl genome browser (Release 20.34c. 1) has 32 genes annotated within the 2Mb 
around PLP1, including the EST that is part of the TCEAL1 -relaxed sequences (Table 
3.11). 19 out of these 32 genes are part of a locally repeated set of genes (7 TCEAL1-like, 
5 //25-like, 4 BEX-like, 2 copies of RAB40A, and NXF3), or nearly 60% of the annotated 
coding sequences in the region. If just the genes proximal to PLP1 are considered, the 
numbers become even more striking, with 14/19 genes belonging to a repeat family, 
leaving PLP1 as one of a minority of genes with no related sequences in the region 
(Figure 3.8.). Given that increases in PLP1 gene dosage are pathogenic in humans and 
mice, it is unsurprising that there are no genes closely related to PLP1 located in the 
region, or even elsewhere in the genome. PLP1/DM20 does show homology with M6a 
and M6b membrane proteins, but it has been shown that the three members of this gene 
family predate mammalian evolution, so there have not been any more recent duplications 
within this gene family (see section 1.3.1.) (Kitagawa et al., 1993;Yan et a l, 1993). It is 
interesting to note that most of the genes located closest to the PLP1 locus, such as 
MORF4L2, RAB9B and TYBN, also do not have closely related homologues in the region 
(Figures 1.4 and 3.8.). It is possible that duplications of these genes may not have 
occurred as for other sequences in the region partly because any duplications involving 
these genes would have been more likely to include PLP1, and would probably be 
selected against due to the resulting deleterious phenotype.
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3.7.4. Repetitive regions in human and other species
Duplicated regions near PLP1 are found in different species, but the actual sequences 
involved and the extent of the duplicated sequence differs between species (Figures 3.9. 
and 3.10.). Comparisons of the genomic sequence around PLP1 between human and 
other species has shown that stretches of conserved synteny are broken up by expansions 
of repeated sequences, especially between the rodent and human lineages (see section 3.6. 
and Figure 3.10.). Some repetitive sequences in the region are apparently more 
evolutionarily ancient than others. There is a degree of apparent conservation between 
parts of some of the human PLP1-proximal repeats (PI-4) and some very repetitive 
sequences proximal to Plpl in the mouse and to a lesser extent in the rat (Figure 3.10.). 
These particular repetitive regions most likely predated the primate-rodent split j ~75 
million years ago, but the similarities between these repeats has declined more within the 
rodent lineage than the primate lineage, as a much greater similarity between these 
proximal repeats is seen in the human and chimp sequence (Figures 3.1., 3.9. and 3.10.). 
It is possible that the greater similarity between these repeats is a result of concerted 
evolution, or gene conversion between repeats in the primate lineage (see section
6.4.5.1.). Another explanation is that there has been some selective constraint on the 
primate PLP l-proximal repeats, as many (P2, P3 and P4) are associated with coding 
sequences (Figure 3.8.).
The human proximal repeats are probably evolutionarily older than the distal repeat
regions as the sequence identity between the different copies of each proximal repeat is
not as great as the sequence similarity between most of the distal LCRs (Tables 3.3., 3.5.,
3.7., 3.9. and 3.11.). In addition the distal repeats are not present in the syntenic regions
of the rat or mouse (Figure 3.9.). The expansion of the rodent-specific repeat region
proximal to Plpl has been noticeably greater in the rat genome as compared to the mouse,
which may be due to a generally higher rate of tandem segmental duplications in the rat
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genome as compared to the mouse, as has been reported (Figure 3.9.) (Tuzun et al., 
2004). Overall, these limited comparisons between the human, chimpanzee, mouse and 
rat genomes near the PLP1 gene have indicated that the major difference between these 
regions is in the composition and distribution of local segmental duplications between the 
species, particularly the primates and rodents, rather than major changes in the syntenic 
sequence.
The rate of duplication of individual genes or other sequences in the human genome has
Q Qbeen estimated to be between 2.2 x 10' - 1 x 1 0 '  duplicates per gene per year, which is 
comparable to estimated rates of point mutation per nucleotide per year (2.2 x 10'9 -  2.5 x 
10'8) (Lynch and Conery, 2000;Nachman and Crowell, 2000;Kumar and Subramanian, 
2002;Bensasson et al., 2003). The numerous segmental duplications in this region 
reflects the high rate of sequence duplication during evolution.
3.8. Summary
Analysis of the genomic regions flanking PLP has shown that this region contains several 
repetitive regions, with varying degrees of similarity. Most of the genes close to PLP1 
are duplicated and map within these repetitive regions. It is clear that sequence 
duplication within this genomic region, as well as elsewhere in the genome, has been an 
important force in the past. Duplications of this region are still occurring now, which is 
demonstrated by the PMD-causing duplications including PLP1 that have been detected 
in this area.
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4.1 DUPLICATION BREAKPOINT MAPPING IN FAMILY 1
Patient 1:9 and his unaffected carrier mother 1:4 were one of the first families to be 
described with a diagnosis of PMD associated with a duplication of PLP1, as 
determined by quantitative analysis of Southern blots (Figure 2.2.) (Individuals CO 
and KO in Ellis and Malcolm, 1994). Subsequent published work on this family has 
included both quantitative PCR and interphase FISH confirmation of PLP1 
duplication in both the boy and mother (Family NO in Woodward et a l, 1998). In 
addition, mapping of the extent of the duplication by interphase FISH has been carried 
out (see section 4.1.1.) and the duplication has been shown to be tandem in orientation 
(see section 4.3.) (Woodward et al., 1998;Family PMD9 in Woodward et a l, 2000).
4.1.1. Duplication breakpoint mapping -  previously published work
Previous interphase FISH data had shown that in this family the proximal end of the 
duplication was between PAC dJ198P4, which had been found not to be duplicated, 
and cosmid cU65A4, which was shown to be duplicated (Woodward et a l, 1998) 
(Figure 4.1.). These two genomic clones are spaced approximately 180Kb apart, and 
cosmid cU65A4 is approximately 540Kb proximal to PLP1 (Figure 4.1.). The 
mapping of the distal end of the duplication using interphase FISH had found that 
cosmid cU240C2, located ~250Kb distal to the transcription start site of PLP1 was 
duplicated (Woodward et a l, 2000). Another cosmid, cU85Bll, which is located 
approximately 100Kb distal to cU240C2, although not mapped to the current human 
genome assembly (NCBI Build 34), was scored as not being duplicated (Figure 4.1.) 
(Woodward et a l, 2000).
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dJ198P4 cU65A4
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PLPl cU240C2 CU85B11
Figure 4.1. Extent of the duplication containing PLP1 in family 1, as has been 
previously published. Adapted from (Woodward et al., 1998;Woodward et al., 2000). 
Location and boundaries of chromosomal bands Xq22.1 and Xq22.2, and the relative 
positions of PLPl (black box) and genomic clones dJ198P4, cU65A4 and cU240C2 
(grey boxes) are taken from the Ensembl genome browser, version 21.34d.l. Cosmid 
cU85Bll is not mapped to the current genome assembly (NCBI Build 34 at time of 
writing), but is estimated to lie approximately 100Kb distal to cU240C2 (Woodward 
et al., 2000). The minimum extent of the duplication is shown by the arrowed line 
and the boundaries are marked by X.
4.2. Fine mapping of duplication breakpoints in family 1 by interphase FISH 
and UPQFM-PCR
Further mapping of the locations of the duplication breakpoints in family 1 was 
carried out with the aim of sequencing the breakpoints, to hopefully gain a greater 
understanding of the mechanism of the rearrangement. Initially a combination of 
interphase FISH and UPQFM-PCR techniques at the proximal breakpoint and just 
UPQFM-PCR at the distal end of the duplication were used for finer mapping of the 
breakpoint (Woodward et al., 1998;Heath et al., 2000).
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4.2.1. Proximal breakpoint mapping by interphase FISH
Interphase FISH using human genomic clones close to cosmid cU65A4, which had 
already been found to be duplicated, revealed that the proximal duplication breakpoint 
was most probably contained within the adjacent clone, PAC &T635G19 (Figure 4.2., 
Table 4.1.). Interphase FISH using this clone showed that just over half of the nuclei 
were scored as duplicated (Table 4.1.). In many of these duplicated nuclei one signal 
was smaller than the other, suggesting that only a fraction of the clone was duplicated 
(Figure 4.2.).
4.2.2. UPQFM-PCR mapping of proximal breakpoint in family 1
Further mapping of the proximal end of the duplication was carried out by UPQFM- 
PCR (Table 4.2., Figure 4.3.). 2-4 pairs of UPQFM-PCR primers mapping to the 
region of interest were used alongside two pairs of control UPQFM-PCR primers in 
each experiment, one from exon 6 of PLP1 (PLP1) and one from the CFTR locus on 
chromosome 7 (CF). Dosage ratios for each primer pair were calculated by 
comparing against sex-matched, normal control individuals (see section 2.2.1.3.1.).
UPQFM-PCR results for primer pairs located throughout the clones near the
breakpoint further refined the breakpoint-containing region to 12Kb of genomic
sequence (Figure 4.3., Table 4.2.). This 12Kb region was contained mostly within
cU65A4, but also just included the end of the sequence from dJ635G19 (Figure 4.3.,
Table 4.2.). One primer pair within cU65A4 (6833-7109) gave mean dosage ratios
that were consistent with that sequence being single-copy, despite being flanked by
two pairs of primers that were apparently duplicated (Table 4.2.). These data were
only based on two experiments in one individual, however, and the raw data from
these two experiments was quite discordant. One result was compatible with the
target sequence being duplicated (PLP1 ratio 0.9, CF ratio 1.56) and the other was
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suggestive of the target sequence only being present once (PLP1 ratio 0.47, CF ratio 
1.07). Given that all the other nearby primers appeared duplicated, and the two 
experiments for this primer gave such different results, it is most likely that this 
represents a false negative result for this primer pair.
4.2.3. UPQFM-PCR mapping of distal breakpoint.
Further mapping of the location of the distal breakpoint in family 1 was carried out 
using UPQFM-PCR. Sequence contained within the genomic clone cU240C2 has 
previously been found to be duplicated by interphase FISH in this family, but a 
UPQFM-PCR primer pair located in the proximal half of the sequence of this clone 
was found not to be duplicated in both the boy and carrier mother from family 1 
(Figures 4.1. and 4.3., Table 4.2.). cU240C2 is located in a region containing several 
highly similar LCRs, and in fact contains almost the whole of LCR-PMDB (Figure
3.4.). Due to the highly repetitive nature of this region, it was only possible to design 
a few primer pairs in unique regions (Figure 3.4.). Preliminary data from these 
UPQFM-PCR primer pairs indicated that the location of the distal breakpoint in this 
family might be between the primer pair located in cV362H12 and dJ839Ml 1 (Figure
4.3., Table 4.2.). However, few experiments had been carried out using these distal 
UPQFM-PCR primers, and many of the results were not particularly consistent. 
These UPQFM-PCR data were treated with caution, and additional techniques were 
used to verify the locations of the duplication endpoints (see sections 4.3. and 4.4.)
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Figure 4.2. Interphase FISH results from the proximal duplication breakpoint using a 
cell line from the affected boy in family 1. Genomic clones around the proximal and 
breakpoint region are shown underneath the images of interphase nuclei, with scale 
bar underneath. In each image, the X centromere is labelled red, and the genomic 
clone used in the experiment is labelled green.
Clone
0,1• 0,2• 0,39 0,4• OdjerA Conclusions |
cU101D3 65.75% 10.96% 0% 0% 23.29% Notduplicated
dJ635G19 38.83% 43.27% 7.23% 2.90% 7.77% Breakpoint?
CU65A4 23.53% 56.86% 4.90% 0% 14.71% Duplicated
Table 4.1. Interphase FISH scores for patient 1:9 near the proximal duplication 
breakpoint. The mean percentage of nuclei falling into each category is shown for 
each clone (results taken from one slide for cU101D3 and cU65A4 and three slides 
for dJ635G19). An average of 75 interphase nuclei were scored for each slide. Some 
of these FISH experiments were carried out by Dr Karen Woodward or Sarah Knight.
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Figure 4.3. Diagrams showing the proximal (a.) and distal (b.) breakpoint regions in family 1. Clones around the proximal and distal breakpoint 
regions are shown in the upper section of the figure, with scale bar underneath (position on the X chromosome taken from the Ensembl human genome 
browser, release 21.34d.l). The UPQFM-PCR primers used are shown as vertical black arrows, with the area within the clone amplified by these 
primers shown above the arrow. (+) underneath a primer pair indicates that this primer pair was duplicated in family 1, (-) is shown underneath those 
UPQFM-PCR primer pairs that were single-copy. The lower sections of the figure shows a smaller region around the breakpoint, with UPQFM-PCR 
primers at the proximal end shown as before. The relative position of LCRs (Ala, A2; see Figure 3.4.) around the distal breakpoint, are also shown.
Clone Position in clone of 
UPQFM primer pairs
Mean ratio of UPQFM PCR 
product compared to ...
Number of 
experiments 
performedPLP1 CF
dJ635G19 30902-31157 0.47 (0.29) 0.96 (0.12) 3(1)
dJ635G19 48059-48309 0.55 (0.73) 1.42(1.1) 2(1)
&J635G19 60570-60728 0.64 (0.69) 1.31 (1.12) 7(2)
dJ635G19 68207-68454 0.52 1.08 2
dJ635G19 69048-69265 0.55 1.27 3
cU65A4 11590-11756 1.01 2.87 1
CU65A4 9959-9747 0.89 2.05 3
cU65A4 6833-7109 0.69 1.32 2
cU65A4 4480-4704 1.05 (1.33) 2.04 (2.00) 2(1)
CU177E8 38464-38658 1.20 2.26 3
CV362HJ2 34770-34963 1.18(0.92) 1.13(1.12) 2(1)
dJ839M ll 37922-38082 -  (0.48) 0.59 (0.58) 1(1)
cU240C2 29788-29983 0.36(0.47) 0.66 (0.67) 5(3)
cU46HU 32229-32404 0.56(1.25) 0.77(1.55) 4(1)
Table 4.2. UPQFM ratios for the proximal and distal duplication breakpoint in 
family 1 (as compared against both PLP1 exon 6 and CF control primers). The last 
four pairs of primers in the table are distal to PLPl. Average ratios were taken from 
all experiments carried out that included that primer pair, and the number of 
experiments is indicated. Values are for dosage measurements from the affected 
male, where experiments had been additionally carried out using the carrier mother, 
these results are shown in brackets. Ratios consistent with duplication are highlighted 
in bold, and the zigzag lines show the assumed location of the breakpoint regions. The 
position of each target sequence within the relevant genomic clone is shown. Some of 
the UPQFM-PCR results in this table are from experiments carried out by Dr Karen 
Woodward, these results are shown in italic type.
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4.3. Fine mapping of duplication breakpoints by fibre FISH
Fibre FISH was then carried out on this family to fine map the duplication 
breakpoints. Previously published work had shown that the duplication was tandem 
in orientation in the mother by dual colour interphase FISH using two cosmid clones 
within the duplicated region (Woodward et al., 1998). If the duplication in family 1 is 
indeed a tandem rearrangement, then duplicated sequence from the distal end should 
be joined to duplicated sequence at the proximal end of the duplicated region, forming 
a junction that should not be present in normal genomic DNA. Fibre-FISH using 
genomic clones spanning the breakpoints should therefore be able to demonstrate the 
presence of any breakpoint junctions, and provide further positional mapping 
information for the breakpoint to back up the interphase FISH and UPQFM-PCR data.
4.3.1. Fibre-FISH to determine normal relationships between clones
Initially it was necessary to verify the positions and relationships between genomic 
clones present at the proximal and distal ends of the duplication. Human genomic 
clones from either the proximal or distal ends of the duplication were hybridised 
together on fibres from both the affected male and normal individuals. The clones 
used in the fibre-FISH experiments were those thought to contain or be very close to 
the breakpoint location, based on interphase FISH and UPQFM-PCR data (Figures
4.2. and 4.3., Tables 4.1. and 4.2.). At the proximal end of the duplication cosmid 
cU65A4 and PAC dJ635G19 were used, as the breakpoint had been mapped to a 
12Kb region containing the junction of the sequences from these two clones (Figure
4.1.). At the distal end, cosmid cV362H12 and PAC dJ839Ml 1 were used in the fibre
FISH hybridisations (Figure 4.3.). The 45Kb breakpoint region provisionally mapped
by UPQFM-PCR included sequence from both these genomic clones (Figure 4.3.).
Initial hybridisations were carried out using the two proximal or two distal clones
together on fibres from a normal cell line, to determine what the normal relationship
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was between these clones (Figure 4.4.). The method used to produce the DNA fibres 
for the hybridisation does not stretch the DNA uniformly, so inferences about signal 
size can only be made on the basis of comparison to other signals on the same fibre, 
as different fibres may be stretched to different degrees.
4.3.1.1. Fibre-FISH for the proximal breakpoint region
For the two proximal clones, dJ635G19 and cU65A4, the signals from the two clones 
appeared to overlap, and the smaller signal, from the cosmid cU65A4, was almost 
entirely contained within the longer green dJ635G19 signal (Figure 4.4a). According 
to data from the human genome assembly (NCBI Build 34), sequence from these two 
clones is adjacent, with just a lOObp overlap. As the sequence submitted to the 
databases for the human genome is non-redundant (except for short overlaps between 
adjacent clones) the sequence from each genomic clone is often not the whole insert 
of a particular clone, so it is not uncommon for such overlaps between supposedly 
adjacent clones to be present (also see section 6.2.2.1.). Data showing the size and 
relative positioning of genomic clones based on restriction fragment fingerprint data 
available from the Sanger Institute showed that dJ635G19 and cU65A4 do overlap 
substantially, similar to what had been seen with fibre-FISH (Figures 4.4a and 4.5.). 
Fibre-FISH using both cU65A4 and dJ635G19 was carried out on fibres from the 
affected male in the family as well as on normal cell lines, and the same relationship 
between the two clones was observed in both cases.
4.3.1.2. Fibre-FISH for the distal breakpoint region
Fibre-FISH results from experiments co-hybridising genomic clones cV362H12 and
dJ839Mll showed two main signals of similar size lying next to each other without
any overlap (Figure 4.4b). However, there was an additional smaller signal from
cV362H12 (red) present at the other end of the green dJ839M ll signal (Figure 4.4b).
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As much of the region covered by the sequence submission for clone dJ839Mll, as 
well as the distal part of cV362H12, has been found to contain inverted repeat 
sequences (A la and A3) as part of LCR-PMDA, it is probable that this extra site that 
cV362H12 hybridises to represents part of the A3 repeat unit (Figure 3.4.). Fibre- 
FISH using both cV362H12 and dJ839Mll was carried out on fibres from the 
affected male in the family as well as on normal cell lines, and the same relationship 
between the two clones was observed for both normal and 1:9 fibres.
4.3.2. Demonstrating tandem duplication breakpoint junctions by fibre-FISH
Fibre-FISH experiments were carried out using all four combinations of one proximal 
and one distal genomic clone, on stretched DNA fibres from both a cell line from the 
boy 1:9 and a normal lymphoblastoid cell line. As the proximal and distal breakpoint 
regions are normally located approximately 800Kb apart in normal sequence, no 
relationship should be seen between a proximal clone (dJ635G19 or cU65A4) and a 
distal clone (cV362H12 or dJ839Ml 1) when hybridised together to fibres, as they will 
be too widely separated. However, with all four combinations of a proximal and a 
distal clone on fibres from a cell line taken from the affected boy, a consistent 
relationship was seen between the pair of clones (Figure 4.6b). This provided 
additional confirmation that the duplication was a tandem rearrangement within this 
family, and was consistent with the positions of breakpoints as determined using 
UPQFM-PCR and interphase FISH (Figures 4.3. and 4.6.). Hybridisations using all 
these four combinations of proximal and distal clones on fibres taken from a normal 
cell line showed no relationship between any of the proximal and distal clones.
When cosmid cV362H12 was hybridised along with either cU65A4 or dJ635G19, a
gap was seen between the signals, and the red cV362H12 signal generally appeared
slightly larger than the green cU65A4 signal, and of a similar size to the dJ839Mll
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signal (Figure 4.6b). When dJ839Ml 1 was used in the fibre-FISH experiments, it was 
seen adjacent to either of the two proximal clone signals, showing the breakpoint 
between distal and proximal sequence (Figure 4.6b). This was consistent with the 
distal duplication breakpoint lying within dJ839Mll, most probably within the 
proximal half, as the junction signals from this clone appeared relatively short (Figure 
4.6b-d). Both clones at the proximal end, cU65A4 and dJ635G19, were found 
adjacent to dJ839Mll on fibres from 1:9 (Figure 4.6b). As there is a large overlap 
between these two clones, and they both appeared the same approximate size as 
dJ839Ml 1 at the breakpoint, it seemed most likely that the breakpoint was near to the 
sequence junction between dJ635G19 and cU65A4 (Figures 4.4., 4.5. and 4.6b,c).
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Figure 4.4. Fibre FISH on normal cell lines. The position on the X chromosome is 
shown as a distance in Mb from the most telomeric Xp sequence (taken from Ensembl 
release 20.34c. 1). The diagram of the clones above the fibres shows the clones as 
taken from Ensembl. The diagram of the clones below the fibre pictures show the 
relationship between the clones as based on the fibre-FISH data, the colour of the box 
representing each clone corresponds to the colour of each labelled clone hybridised to 
the fibres, (a.) The two clones at the proximal duplication breakpoint, (b.) The two 
clones closest to the distal duplication breakpoint. The fibre images shown are 
composites of several different fibres from the same experiment. Where red and 
green signals overlap, a yellow signal results. Several images of fibres were captured 
for each experiment, but only 4-5 individual fibres are shown from each hybridisation 
for simplicity. The fibres shown are representative of the images captured from each 
slide.
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Detailed view: X:98.0Mbp-100.0Mbp
CU65A4
dJ635G19
Figure 4.5. Screenshot from Sanger Institute X chromosome FPC (fingerprinted 
contig) map based on restriction analysis of the whole clones showing relative 
positions and sizes of genomic clones, including dJ635G19 and cU65A4, in a 2Mb 
window. Relative sizes of genomic clones are shown by the horizontal boxes, which 
are colour-coded according to the sequencing status at the time this map was last 
modified (on 12/12/2002 according to information on the website).
URL: http://www.sanger.ac.uk/cgi-bin/humace/fpcwebmap.cgi?mode=map&map=bac.X.98.html
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Figure 4.6. Fibre FISH to confirm tandem rearrangement in family 1.
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Figure 4.6. Legend
Fibre FISH to confirm tandem rearrangement in family 1. Fibre FISH images are 
shown on patient 1:9 fibres using clones from both the proximal and distal breakpoint 
regions, (a.) represents the relative sizes of the clones used in the hybridisations, as 
based on submitted sequence data, and position on the X chromosome, in Mb from 
the most centromeric Xp sequence, Ensembl version 20.34c. 1. The PLP1 gene is 
located between 101.80-101.82Mb in this version of the browser, (b.) Composite 
images of fibres taken from four separate experiments on 1:9 fibres, each combining 
different proximal and distal clones. Underneath each fibre-FISH image is a 
representation of the relationship between these clones, as deduced from the fibre- 
FISH data. The two clones in each hybridisation are shown as coloured boxes, and 
the colour of each clone in the diagram is the same as that clone in the corresponding 
FISH picture, (c.) The likely position of both breakpoints based on fibre-FISH data, 
indicated by the arrows. Relative position of genomic clones in this diagram is based 
on previous fibre-FISH experiments shown in Figure 4.2. (d.) The probable
orientation of clones relative to the breakpoint, shown by the dashed line. Several 
images of fibres were captured for each experiment, but only 4-5 individual fibres are 
shown from each hybridisation for simplicity. The fibres shown are representative of 
the images captured as a whole from each slide.
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4.4. Long-range PCR and direct sequencing to span the breakpoint junction
The UPQFM-PCR and fibre-FISH data were consistent with each other, both placing 
the proximal duplication breakpoint between the very distal end of dJ635G19 and the 
proximal part of cU65A4 (Figures 4.3. and 4.6.). The distal breakpoint was similarly 
mapped using both methods to the proximal part of the genomic clone dJ839Mll 
(Figures 4.3. and 4.6.). As the results from the fibre-FISH experiments had confirmed 
that the duplication was tandem in orientation, and shown that the breakpoints did lie 
in the regions mapped by UPQFM-PCR, long range PCR (LR-PCR) was attempted in 
an effort to obtain sequence spanning the breakpoint.
4.4.1. Long-range PCR across duplication breakpoint
LR-PCR primers (30mer oligonucleotides) were designed within and close to the 
breakpoint regions as had been found by UPQFM-PCR (Figure 4.3.). Initial LR-PCR 
experiments were carried out using all combinations of distal primers from cV362H12 
and dJ839Ml 1 with proximal primers mapping to cU65A4 (Figure 4.7.). These initial 
LR-PCR combinations did produce products in some combinations (Figure 4.7.). A 
reaction using primers 10069F (from dJ839Mll) and 14986F (from cU65A4) resulted 
in a band approximately 3Kb in size that was not present in normal individuals 
(Figure 4.8.). There was an additional larger band seen in the lanes for reactions 
where normal DNA was used, but as the primer in cU65A4, 14986F, consisted of 
sequence that was entirely contained in an LI LINE repeat unit, the presence of extra 
bands was not unexpected (Figures 4.8. and 4.10., Table 4.3.) (Smit et al., 1995). 
These extra bands were not seen in the lanes using DNA from family 1, which is 
probably as a result of preferential amplification of the smaller PCR product that is 
only produced when this breakpoint is present (Figure 4.8.).
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4.4.2. Sequencing the duplication breakpoint in family 1
The 3Kb band was gel purified and sequenced (see sections 2.2.1.4.4. and 2.2.4.). 
Using the nested distal sequencing primer 10232F, sequence across the breakpoint in 
this family was obtained (Figures 4.7. and 4.9.). BLASTn analysis showed that 543bp 
of the sequence matched the distal clone dJ839M ll, with the similarity ending at 
position 10809 (Figure 4.9.). This distal sequence was then followed by 
approximately lOObp of sequence mapping proximal to PLP1, starting at position 
69210 within genomic clone dJ639G19 (Figure 4.9.). There was a 3 base-pair overlap 
(CAG) between the two sequences (Figure 4.9.). The reverse sequence across the 
duplication breakpoint in this family was obtained by using one of the UPQFM-PCR 
primers used to map the duplication (69265R, one of the pair that amplified the region 
between positions 69048-69265 from clone dJ635G19) as a sequencing primer in a 
nested reaction (Figure 4.7.). Assuming that there were no further rearrangements 
within the duplicated region in family 1, the size of the duplication, based on the 
NCBI Build 34 human genome assembly, was 765Kb.
4.5. Interspersed repetitive sequences and G+C content at the duplication 
breakpoints in family 1
Both the proximal and distal duplication breakpoints were found to map within
common human interspersed repetitive sequences (Figure 4.10., Tables 4.3. and 4.4.).
The proximal breakpoint was in a LI PA 13 element (Table 4.3.) (Smit et al., 1995).
The distal breakpoint in dJ839Mll fell within a long terminal repeat (LTR) from the
MLT1H1 subfamily (Smit, 1993;Jurka, 2000). The 5Kb sequence immediately
around the proximal duplication breakpoint was rich in interspersed repeats (81.1%),
mainly due to the presence of LI repetitive elements near the breakpoint, and had a
G+C content of 45.08% (Repeatmasker, RepBase v7.4) (Figure 4.10 and Table 4.3.).
The 5Kb sequence immediately around the distal duplication breakpoint consisted of
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24.56% known human interspersed repeats and had a G+C content of 47.44% (data 
obtained from Repeatmasker, RepBase v7.4). The G+C content of both breakpoint 
regions was higher than the G+C content of either of the 1Mb regions proximal or 
distal to PLP1 (40.60% and 40.43% respectively).
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Figure 4.7. Long-range PCR across the tandem breakpoint in family 1. (a.) and (b.) show the distal and proximal breakpoint regions, as shown in 
Figure 4.3. The positions and orientation of the various long-range and sequencing primers are shown by the arrows underneath the clones in (a.) and 
(b.). The sizes of LR-PCR products that were obtained with various combinations of primers are shown in (c.). UPQFM-PCR primers used around the 
proximal breakpoint are shown as vertical black arrows in (b.), with the area within the clone amplified indicated by these primers shown above the 
arrow. (+) underneath a primer pair indicates that this primer pair was duplicated in family 1, (-) is shown underneath those primer pairs that were 
single-copy. The relative position of LCRs (Ala, A2; see Figure 3.4.) around the distal breakpoint, are also shown in (a.).
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Figure 4.8. Agarose gel stained using ethidium bromide showing LR-PCR product 
spanning the duplication breakpoint in family 1. LR-PCR was carried out using a 
primer mapping between bases 14986-15015 in genomic clone dJ839Mll at the distal 
end, and at the proximal end a primer mapping to between bases 10069-10098 in 
cosmid cU65A4 was used. Strong bands of about 3Kb in size were seen in both the 
mother and boy from family 1, and were not seen in the normal controls used in the 
experiment. /VHindlll digest is used in the two outer lanes as a size standard.
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Figure 4.9. Electropherogram showing sequence from the duplication breakpoint in 
family 1. The regions of homology to the different Xq22 sequences are shown 
underneath the sequence data, numbers indicate positions within the sequence of each 
genomic clone.
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Figure 4.10. Interspersed repeat content and other sequence features found in the 
5Kb regions centred on the proximal (a.) and distal (b.) duplication breakpoints in 
family 1. Interspersed repetitive elements are as found by Repeatmasker software, 
and shown as patterned boxes above the genomic clones in the region. The submitted 
sequences for dJ635G19 and cU65A4 overlap by lOObp, as shown in (a.). For more 
information about these repeats, see Tables 4.3 and 4.4. The distal breakpoint is also 
close to an Xrep enhancer-like sequence, shown as a red box in (b.) (see section 3.4.6. 
and Figure 3.4.)
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Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation
(.) 1647-1490 MLT1A0 (LTR/MaLR) 1-151 (151/365) +
(-) 1489-1189 AluSc (SINEA4/w) 1-299 (299/309) +
(-) 1189-998 MLT1A0 (LTR/MaLR) 151-365 (206/365) +
(-) 905-1864 (+) L1PA13 (LINE/LI) 2-2867 (2866/6797) +
(+) 1865-5389 L1PA13 (LINE/LI) 3263-6816(630/6816) +
Table 4.3. Interspersed repetitive elements from the 5Kb region surrounding the 
proximal duplication breakpoint in dJ635G19. The first column shows how far in 
base pairs each repeat element is from the duplication breakpoint, (-) indicates that the 
repeat element is proximal to the breakpoint and (+) that the repeat is distal relative to 
the breakpoint. The type of repeat and the class of repeat element to which it belongs 
are given in the second column. The third column shows which portions within the 
appropriate repeat consensus sequence each repeat has similarity to, and also how 
many bases out of the total repeat unit consensus is present in the sequence. In the 
fourth column, the orientation of each repeat is shown; + indicates a repeat is on the 
forward strand {i.e. running from centromere to telomere), - the repeat is on the 
reverse strand. A partial L1PA13 element was found to coincide with the end of the 
5kb segment, so the adjacent sequence was also analysed with Repeatmasker, until the 
true end of the repeat was found. The L1PA13 repeat element that the duplicated 
breakpoint is contained within (at position 933 within the consensus) is in bold type.
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Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation
(-) 2433-2331 MER94 (DNA/AcHobo) 35-134 (100/134) -
(-) 2063-1844 MIR (SINE/MIR) 13-258 (246/262) +
(-) 1628-1105 Xrep-like enhancer 1-522 (522/529)
(-) 1467-1276 MIR (SINE/MIR) 46-230 (185/262) +
(-) 266-42 (+) MLT1H1 (LTR/MaLR) 37-365 (329/555) -
(+) 925-994 (TA)n (Simple repeat) 1-73 -
(+) 995-1164 AluJb (SINEA4/W) 124-301 (178/302) -
(+) 1166-1195 (TG)n (Simple repeat) 1-32 +
(+) 1196-1321 AluVo (SINE/^/m) 1-124(124/302) -
(+) 2401-2498 L1M4 (LINE/LI) 2694-2793 (100/6146) +
Table 4.4. Interspersed repetitive elements from the 5Kb region surrounding the 
distal duplication breakpoint in dJ839Mll. The first column shows how far in base 
pairs each repeat element is from the duplication breakpoint, (-) indicates that the 
repeat element is proximal to the breakpoint and (+) that the repeat is distal relative to 
the breakpoint. The type of repeat and the class of repeat element to which it belongs 
are given in the second column. The third column shows which portions within the 
appropriate repeat consensus sequence each repeat has similarity to, and also how 
many bases out of the total repeat unit consensus is present in the sequence. In the 
fourth column, the orientation of each repeat is shown; + indicates a repeat is on the 
forward strand (i.e. running from centromere to telomere), - the repeat is on the 
reverse strand. The repeat element that the duplicated breakpoint segment is 
contained within is highlighted in bold type. The distal breakpoint in family 1 is at 
position 88 within the consensus sequence for MLT1H1. The position of the Xrep 
enhancer-like sequence relative to the breakpoint is also shown (Riley et al., 1986).
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4.6. Searching for similarities between the proximal and distal duplication 
breakpoints
The two 5Kb regions surrounding the proximal and distal breakpoints were compared 
against each other to search for any large regions of homology near the breakpoints 
that could be involved in mediating the duplication. Comparisons were made using 
both BLAST2 and BLASTz, and only one short region of similarity between the two 
sequences was found, which mapped to Alu repeat elements which were 
approximately 1Kb distant from either breakpoint (Figure 4.11, Tables 4.3. and 4.4.). 
Additionally, lOObp regions flanking the duplication breakpoint were also aligned 
together, using ClustalW. There was no extensive homology found close to the 3bp 
breakpoint region and no regions of similarity extending for more than 4bp (Figure
4.12.). Although there was 50% similarity seen between dJ635G19 and dJ839Mll 
proximal to the breakpoint, and 43% similarity was seen between the two sequences 
after the breakpoint, the nucleotides included in the alignment were only in small 
clusters (Figure 4.12.).
4.7. Location of proximal duplication breakpoint relative to PLPi-proximal 
repeats
The location of the proximal end of the duplication, at position 69210 within genomic 
clone dJ635G19, did not fall into any of the short repetitive regions that had been 
mapped proximal to PLP1 (see Figure 3.8.). The closest copy of one of these repeats 
(one of the “P3” grouping), was 4.3Kb proximal to the breakpoint location, and 
consisted mostly of the Q9NWD9 gene, one of the BEXINADE family of genes in this 
region, (see Table 3.9.). The closest gene to the breakpoint that was contained within 
the duplicated region was a transcript 32Kb away annotated on the Ensembl genome 
browser as NM_153333, which has similarities to the TCEAL1 gene and is also 
contained within one of the distal “P4” repeats (see Table 3.11.).
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4.8. Location of distal breakpoint within low-copy repeats.
The distal duplication breakpoint was located within one of the LCRs located distal to 
PLP1, namely repeat unit A la that forms part of LCR-PMDA (Figure 3.4.). It is 
located within the distal third of this repeat unit, at position 17327 (distance from the 
start of the repeat). As well as a few interspersed repetitive elements in the 5Kb 
surrounding the breakpoint, there is also a copy of the Xrep enhancer-like sequence 
1105bp proximal to the breakpoint (Table 4.4., Figures 4.10. and 3.4.). As the distal 
breakpoint region is contained within a large repeated sequence (Ala), similar 
sequence is also present in other copies of this repeat. The 5Kb surrounding the distal 
breakpoint at 10809bp within dJ839Mll was compared to the other three large 
repeats that share sequence identity with A la (Alb, A2, A3) (Table 4.5). Sequence 
similarity was found between some of the 5Kb breakpoint region sequence and the 
other three copies of the distal repeat, but the actual breakpoint sequence was only 
present in two of the other repeats, A lb and A2 (Table 4.4.). Only the first 1757bp of 
the 5Kb around the breakpoint were aligned to repeat unit A3, which does not include 
sequence homologous to the actual breakpoint as it ends before this point in repeat 
A la (Table 4.5., Figure 3.4., Table 3.2.). The nearest genes to the distal duplication 
breakpoint were the various copies of the H2b-like genes, which mapped within the 
distal LCRs (see section 3.4.5. and Figure 3.4.).
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Figure 4.11. Comparison of 5Kb around the proximal and distal breakpoints against 
each other by BLASTz using the Pipmaker program. The results of the comparison 
are shown as a dotplot, where any similarities are shown as black dots on the white 
background. The human genomic clones and interspersed repeat content are shown in 
the relevant positions next to the dotplot. The position of each breakpoint is indicated 
by the dashed line. For more expanation of the repeat content, see Figure 4.10. and 
Tables 4.3. and 4.4. Upwards-facing diagonal lines on the dotplot (/) are indicative of 
directly repeated sequences; downwards-sloping lines on the dotplot (\) represent 
areas present in both sequences in an inverted orientation. The position of Xrep is 
shown by the red box.
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dJ635G 19 69160 T G A G T G C A C C C C G C C C C C T T C C C C A A --C C A C C A T T G T T G T T G G A G A G T T G  
Junction GTCCACCATTCTCCATGTGTCAAAGCCATCACAGGC -TTGTCGGGAGC
dJ839M 1 1 10759 GTCCACCATTCTCCATGTGTCAAAGCCATCACAGGC-TTGTCGGGAGC
dJ635G19 GCAGGCAGAGTGCCCCACCCGTGTGCGTGGAAATGGCCTCCAGGTGCGAAA 69259
Junction CC AGGCAGAGTGC CC CACCCGTGTGCGTGGAAATGGC CTCC AGGTGC GAAA
dJ839Ml 1 CCAGAGGGAGGGGCAAAC— AGATGCGA CCAATGGGCCAACGGGAAGAGCATTCA 10859
Figure 4.12. Alignment of duplication breakpoint junction from family 1 and lOObp 
flanking the two duplication breakpoints. Each breakpoint region was individually 
aligned by ClustalW to the sequence from the junction breakpoint and the two 
alignments were then combined together manually. Proximal junction sequence that 
originated from dJ635G19 is highlighted in red, and nucleotides aligned with this 
sequence from the genomic sequence around the distal breakpoint are also highlighted 
in red. Similarly, junction sequence originating from dJ839Ml 1 is highlighted in
blue, and any bases from the proximal genomic sequence aligned with this sequence 
are also shown in blue. The 3bp overlap at the junction between the two sequences is 
shaded purple.
Repeat
unit
Percentage
identity
Percentage
gaps
Position within 
repeat unit
Range of 5Kb breakpoint 
region in alignment
Alb 98.26% 0% 14829-19825 1-5000
A2 93.24% 0% 6866-11457 3-4535
A3 89.70% 0.11% 13103-14856 1-1757
Table 4.5. Comparison of 5Kb surrounding the distal duplication breakpoint in 
family 1 against the related distal repeat units Alb, A2 and A3. Comparisons and 
alignments were carried out using the BLASTz algorithm. Positions within the repeat 
unit are given in base pairs from the beginning of each repeat unit. Not all the 5 Kb 
region around the breakpoint was included in every alignment, the amount that is 
contained in the alignment is shown in the table.
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4.9. Analysis of sequence from breakpoint regions for recombination and 
rearrangement-associated motifs
4.9.1. 5Kb regions around breakpoints
Various sequence motifs have been reported to be associated with rearrangement 
breakpoints and 5kb centred on each breakpoint was searched for the presence of 
various motifs (Table 2.4.).
4.9.1.1. Calculating relative occurrence of motifs in the 5Kb regions around 
breakpoints
5Kb either side of each duplication breakpoint was examined for the presence of such 
motifs on both strands using the DNA Pattern Find program (see Table 2.4. for details 
of each sequence motif). When motifs were found within the two 5Kb regions, the 
number of times each sequence was found was compared against the number of times 
it was expected to occur given the nucleotide content of the region (Day and Blake, 
1982). The difference between the number of times that a motif was observed and the 
number of times it was expected to be seen was then expressed as a proportion of the 
expected occurrence. Those motifs that were found at a frequency more than five 
times the expected prevalence were considered to be moderately enriched and 
investigated further. Any motifs that were present at more than 20 times the expected 
occurrence were classified as being highly enriched in the region. However, just 
because a motif is not enriched near a breakpoint does not necessarily imply that it is 
not involved in the breakpoint mechanism, so any motifs that occurred near a 
breakpoint, whether “enriched” or not, were noted.
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4.9.1.2. Matrix attachment regions
It is possible that features of the DNA that have a role in chromosome and chromatin 
structure may be important in the mechanisms leading to DNA sequence 
rearrangements. One such structural feature that does play an important part in 
chromosome and chromatin dynamics are matrix attachment regions (MARs), which 
anchor chromatin fibres to the nuclear matrix, with the intervening DNA forming 50- 
100Kb looped domains (Vogelstein et a l, 1980). Although the ability of a sequence 
to function as a MAR can only be confirmed by in vitro studies, regions with the 
potential to act as MARs can be predicted to some degree by in silico methods (Singh 
et al., 1997). One program that can be used to predict MARs is MAR-Wiz, which 
searches for various motifs and sequence patterns associated with MARs, returning a 
matrix-binding potential across the region examined (see section 2.2.10.4.). MAR- 
Wiz was used to determine the matrix-binding potential throughout a 5Kb region 
surrounding each breakpoint.
4.9.2. Sequence features found in lOObp regions around breakpoints
It is likely that any features of the DNA sequence that may have contributed to the 
duplication rearrangement will be found near to the breakpoints. For this reason, a 
short stretch of sequence (lOObp) surrounding each breakpoint was searched for local 
properties of the sequence that could conceivably be involved in a sequence 
rearrangement at this locus.
4.9.2.1. Alternating purine/pyrimidines, polypurine and polypyrimidine tracts
It has been found that alternating tracts of purines and pyrimidines may stimulate both
homologous and illegitimate recombination (Bullock et al., 1986;Boehm et al.,
1989;Stary and Sarasin, 1992). Purine/pyrimidine tracts are targets for topoisomerase
II and have also been shown to be significantly over-represented close to deletion
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breakpoints (Spitzner et al., 1990;Abeysinghe et al., 2003). Purine/pyrimidine tracts 
can form stretches of Z-DNA, an alternative DNA conformation that may be 
recombinogenic (Wang et al., 1979;Weinreb et al., 1988;Boehm et a l, 
1989;Majewski and Ott, 2000).
Homopurine and homopyrimidine stretches of DNA can adopt unusual conformations 
and may be important in stimulating DNA breakage or recombination (Amott et al., 
1983;Moser and Dervan, 1987;Konopka, 1988). Purine tracts of between 25-39 
nucleotides in length have been found to be significantly over-represented at deletion 
breakpoints, and at translocation breakpoints shorter polypurine tracts (2-23bp) and 
polypyrimidine tracts (2-44bp) have been found to be significantly over-represented 
(Abeysinghe et al., 2003). In this study, only homopurine, homopyrimidine or 
alternating purine/pyrimidine tracts of length lObp or greater were searched for close 
to the breakpoints, as this length of sequence equates to roughly one helical turn of the 
DNA (Ussery et a l, 2002).
4.9.2.2. Inverted repeats and secondary structures
It has been suggested that various types of small repeats near breakpoints could
contribute to rearrangements by creating secondary structures that stabilise loops
between strands of DNA (Chuzhanova et al., 2003). Secondary structure present in
the DNA may also lead to rearrangements by causing breakages in the DNA
molecule. DNA hairpin structures, which are formed by adjacent inverted repeated
sequences, can be specifically cleaved by topoisomerase II (Froelich-Ammon et al.,
1994). Several different types of repeats were searched for in the lOObp surrounding
each breakpoint, as well as in the rearranged junction sequence, using the Oligorep
algorithm (see section 2.2.10.5. and Table 2.3.). These types of repeat were classified
as direct (e.g. 5'ACGTA3'....5ACGTA3'), inverted (e.g. 5'ACGTA3'....5'TACGT3,))
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symmetric (e.g. 5ACGTA3 ....5 ATGCA3) and complementary repeats (e.g. 
5ACGTA3'. . ..5TGCAT3') (Chuzhanova et al., 2003).
4.10. In silico analysis of sequence in 5Kb regions around breakpoints
4.10.1. Recombination/rearrangement-associated motifs
Many short DNA sequence motifs thought to be involved in various rearrangements
and recombination events were found in the 5Kb regions centred on both the
duplication breakpoints in family 1 (see section 4.9.1.1., Table 2.3. and Appendix C).
Some of the motifs searched for were found at a higher rate than expected within the
5Kb regions flanking the breakpoints. These included scaffold attachment sequences
and Saccharomyces cerevisiae autonomously replicating sequence (ARS) consensus
(WTTTATRTTTW) in the 5Kb region around the proximal duplication breakpoint
(Broach et al., 1983;Dobbs et al., 1994). More sequence motifs present within the
5Kb of genomic sequence surrounding the distal duplication breakpoint in family 1
were found to be over-represented, based on the nucleotide frequency in this region
(Appendix C). Most of these motif sequences (Yeast ARS, scaffold attachment
regions) were not located particularly close to the duplication breakpoint, so it was
considered unlikely that these sequences could have been involved in the duplication
mechanism (Appendix C). Some of the sequence motifs were found relatively close
to the breakpoint including a copy of the heptamer V(D)J joining m otif (CACTGTG),
160bp 5' to the breakpoint and a chi-like sequence known to occur within the repeat
units of human minisatellites (GCWGGWGG), 224bp 5' from the breakpoint (Max et
al.y 1979;Akira et al., 1987;Krowczynska et al., 1990). A few 3bp sequence motifs,
such as topoisomerase I cleavage sites (CTY, GTY) and DNA polymerase a pause
(GAG, GCS) were found close to the breakpoint, as well as occurring frequently
throughout the surrounding sequence (Appendix C) (Been et al., 1984;Kunkel, 1985).
Although these short sequences are found very frequently in genomic sequence, it is
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still possible that these motifs could be important in generating DSBs and 
rearrangements in this region. One copy of the murine MHC recombination hotspot 
sequence (CAGRCAGR) was found to overlap with the proximal duplication breakpoint 
(Appendix C) (Steinmetz et al., 1986;Shiroishi et al., 1995). One half of this motif 
(CAGR) has also been associated with deletions in the mouse genome, and a copy of 
this sequence also overlaps with the distal breakpoint (Steinmetz et al., 1986).
4.10.2. Potential MARs near duplication breakpoints in family 1
The MAR-Wiz program was used to search for potential matrix attachment sites close 
to both breakpoints. No regions that reached the threshold MAR potential set by 
MAR-Wiz were found near the proximal breakpoint, but a potential MAR was located 
1.2Kb distal from the distal duplication breakpoint (Figure 4.13.). This MAR- 
potential value can be quite dependent on the local sequence context, so a larger 
(20Kb) region around the distal breakpoint was also tested for the presence of MARs 
(data not shown), and the same region was still predicted to be a MAR (Namciu et al., 
2004).
4.11. In silico analysis of sequence from lOObp regions flanking breakpoints
4.11.1. Alternating purine/pyrimidines, polypurine and polypyrimidine tracts
lOObp regions surrounding the proximal and distal duplication breakpoint were 
examined for the presence of purine/pyrimidine, homopurine and homopyrimidine 
tracts of lObp or greater (see 4.9.2.1.). Around the proximal breakpoint, there was 
one polypyrimidine tract 11 bp in length located 26bp 5' to the breakpoint and one 
lObp alternating purine/pyrimidine tract found 18bp distal to the breakpoint within the 
duplicated region (Figure 4.14.). Only one polypurine tract was found near the distal 
duplication breakpoint, an llb p  region that started within the 3bp of overlapping
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sequence at the breakpoint and extended into the non-duplicated sequence distal to the 
breakpoint (Figure 4.14.).
4.11.2. Repeats and secondary structures
Few repeats with the potential to form secondary structures were found in the lOObp 
surrounding the two duplication breakpoints from family 1 using the Oligorep 
program (see section 4.9.2.2.). Near the proximal breakpoint, two short symmetric 
repeats, each 7bp in length, were found, but no repeats were found near the distal 
breakpoint (Figure 4.15.). When the sequence spanning the duplication breakpoint 
was considered, as well as one of the short symmetric repeats already described, a 
longer direct repeat was also present, with one copy either side of the breakpoint, 14 
nucleotides in length, with 11 of the bases having identity between the two repeats 
(Figure 4.15.). Overall, slightly more nucleotides were within repeated regions in the 
rearranged sequence than the original genomic sequence (Figure 4.15.). It is possible 
that the presence of some of these repeats, which have the potential to form secondary 
structures, may have helped to stabilise the rearrangement (Chuzhanova et a l , 2003).
195
1 . 0 0
0 .7 5
f
'i 0 .2 5 "
-FOCL
CL
■Xr:
2500500 1000 4000 4500 5000
B A S E  P A I R S
Figure 4.13. MAR potential in the 5Kb surrounding the distal duplication breakpoint 
in family 1 (at position 2500 in this sequence) as found by MAR-Wiz.
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Proximal duplication breakpoint 69160-69259bp in dJ635G19
TGAGTGCACCCCGCCCCCTTCCCCAACCACCATTGTTGTTGGAGAGTTGGCAGGCAGAGTGCCCCACCCGTGTGCGTGGAAATGGCCTCCAGGTGCGAAA
YRRRYRYRYYYYRYYYYYYYYYYYRRYYRYYRYYRYYRYYRRRRRRYYRRYRRRYRRRRYRYYYYRYYYRYRYRYRYRRRRRYRRYYYYYRRRYRYRRRR
Distal duplication breakpoint 10759-10858bp in dJ839Ml 1
GTCCACCATTCTCCATGTGTCAAAGCCATCACAGGCTTGTCGGGAGCCCAGAGGGAGGGGCAAACAGATGCGACCAATGGGCCAACGGGAAGAGCATTCA
RYYYRYYRYYYYYYRYRYRYYRRRRYYRYYRYRRRYYYRYYRRRRRYYYRRRRRRRRRRRYRRRYRRRYRYRRYYRRYRRRYYRRYRRRRRRRRYRYYYR
Figure 4.14. Purine and pyrimidine content of lOObp regions surrounding the proximal and distal duplication breakpoints in family 1. The lOObp of 
sequence flanking the two duplication breakpoints is shown on the top of the pairs, and the classification of each nucleotide (R -  purine, Y -  
pyrimidine) is shown on the lower line of the pairs. Tracts of alternating purines/pyrimidines (R/Y), or pyrimidines/purines (Y/R), of 4 nucleotides or 
greater, are underlined. Homopurine and homopyrimidine runs of 10 nucleotides or greater are in bold type. Sequence from dJ635G19 that is 
duplicated at the proximal duplication breakpoint is shaded red, while duplicated sequence from the distal breakpoint region is shaded blue. The 3 
nucleotides that overlap at the breakpoint are shaded purple, and sequence that is not duplicated in family 1 is shaded grey.
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Proximal duplication breakpoint 69160-69259 in dJ635G 19
TGAGTGCACCCCGCCCCCTTCCCCAACCACCATTGTTGTTGGAGAGTTGGCAGGCAGAGTGCCCCACCCGTGT6CGTGGAAATGGCCTCCAGGT6CGAAA 
 *     >• < -----------
Distal duplication breakpoint 10759-10858 in dJ839Ml 1
GTCCACCATTCTCCATGTGTCAAAGCCATCACAGGCTTGTCGGGAGCCCAGAGGGAGGGGCAAACAGATGCGACCAATGGGCCAACGGGAAGAGCATTCA 
Duplication junction
GTCCACCATTCTCCATGTGTCAAAGCCATCACAGGCTTGTCGGGAGCCCAGGCAGAGTGCCCCACCCGTGTGCGTGGAAATGGCCTCCAGGTGCGAAA
 > <--------
Figure 4.15. Inverted repeats around the duplication breakpoints in family 1, the duplication junction fragment and the reciprocal rearrangement. The 
normal sequence is shown, from the proximal duplication breakpoint (dJ635G19) and also from the distal duplication breakpoint (dJ839Mll). The 
recombinant deletion breakpoint is shown with the proximal half in red (originating from bA346E8) and the distal half shown in blue (originating from 
dJ203P18). The 3 nucleotides that form the duplication breakpoint are shaded purple. Nucleotides that form part of repeat sequences are shown in bold. 
The type of repeat found is shown by the arrows above and below the sequence: direct (— ►) and symmetric (— > ). Repeats within the sequence were 
searched for using Oligorep (see section 4.9.2.2.).
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4.12. Discussion
From analysis of the duplication breakpoint in family 1, it seems most likely that the 
rearrangement in this family was mediated by non-homologous end joining, as has 
been found to be the case in most other PMD rearrangements where the breakpoints 
have been sequenced (Inoue et a l , 2002;Iwaki et a l , 2003;Woodward et a l , in 
preparation).
4.12.1. Interphase FISH and duplication mapping
The distal duplication breakpoint in family 1 has been shown in this study to be in the 
proximal third of dJ839Mll (Figures 4.3. and 4.9.), but this contradicts the previous 
work done with interphase FISH that had shown that the next most distal clone, 
cU240C2, was duplicated in this family (Figure 4.1.) (Woodward et al., 
1998;Woodward et al., 2000).
One possible explanation for the apparent duplicated signals seen for cU240C2 is 
DNA replication. Scoring replicated signals as duplicated signals is a common 
problem associated with interphase FISH (see section 4.2.1.). Additionally, if there is 
a replication origin in this region, this may lead to a higher frequency of duplicated 
signals originating from DNA replication, especially if  this region tends to replicate 
before the X centromere region, because if extra copies of the X centromere are 
visible, the nucleus is not scored (see section 4.2.1.). cU240C2 contains two copies of 
the Xrep motif, within the distal LCR PMDB as part of repeat units A3 and Alb, 
which has been suggested to function as an origin of DNA replication (see section
4.12.1.2. and Figure 3.4.) (Riley etal., 1986).
Possibly the most likely explanation for the discrepancy between the FISH and
breakpoint sequence data, however, is the existence of the various distal LCRs.
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Additional hybridisation signals during interphase FISH could result from 
hybridisation of cU240C2 (containing most of LCR-PMDB) to genomic sequence 
from LCR-PMDA (Figure 3.4.). The distal duplication breakpoint is located within 
one of the repeats that make up LCR-PMDA, Ala, so a substantial part of this repeat 
unit (17.3Kb) is duplicated in family 1 (Figure 4.7., Table 4.5.). Much of repeat unit 
A lb maps to within cU240C2, and A la and A lb are over 99% identical at the 
sequence level (Figure 3.4., Table 3.3.). It therefore seems probable that the 
duplicated signals seen when using cU240C2 in interphase FISH on this family were 
due to the cosmid hybridising to the partially duplicated copy of the A la repeat unit, 
which is probably large enough to result in a good signal. In normal circumstances, 
although cU240C2 might also be hybridising to sequences from the more proximal 
LCR-PMD, this would be too close to the actual cU240C2 signal for the additional 
signals to be resolved in interphase nuclei, but in family 1, where the duplicated 
region is relatively distant from the original copy, the extra signal is visible. If the 
genomic DNA were examined with a higher resolution using fibre-FISH, as has been 
carried out in this study using different genomic clones, then the additional 
hybridisations to LCR-PMDA that have been postulated may be detectable. Fibre- 
FISH using the cosmid cV362H12 (which contains part of repeat unit Ala) on normal 
individuals did show an additional smaller signal separated from the main signal for 
this probe, which could correspond to sequence from the A lb repeat unit (see section 
4.3.1.4., Figures 3.4. and 4.4.). It is likely that the reciprocal situation does occur 
when cU240C2, which contains the repeat unit A lb, is hybridised to DNA, with 
additional ectopic signals corresponding to cU240C2 sequence additionally 
hybridising to A la (Figure 3.4.).
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4.12.2. NHEJ
NHEJ, as opposed to homologous recombination, is the predominant pathway for the 
repair of double-strand breaks (DSBs) in humans (Lieber et a l, 2003). The 
breakpoint in family 1 bears all the hallmarks of the NHEJ repair process, as the two 
sequences joined together at the duplication junction share no appreciable homology, 
apart from a short (3bp) overlap at the actual junction (Figures 4.9. and 4.11.). Such 
microhomologies between sequences may help to stabilise the two ends during the 
process of NHEJ (Roth and Wilson, 1986). Microhomologies are not necessary for 
NHEJ to occur, but the NHEJ process favours joining at short regions of homology 
(Lieber et al., 2003). DSBs are usually processed before repair by NHEJ, as the ends 
of the DSBs may be incompatible. This end-processing step may involve removal of 
nucleotides by nucleases and also the filling in of gaps on one or both strands by 
polymerases (reviewed in Lieber et al.9 2003).
4.12.2.1 Mechanisms for DSB formation
As it appears that NHEJ has occurred in this instance to join the two ends of the
duplication breakpoint together in this family, it follows that when the rearrangement
occurred, it will probably have been triggered by DSBs, either at one end of the
duplication or at both. When the two ends of a DSB remain in close proximity
following breakage, the NHEJ pathway is able to join the correct ends together,
thereby maintaining genomic integrity, albeit with the likely loss of a few nucleotides
(reviewed in Lieber et a l , 2003). However, if DNA ends from two different DSBs
are aberrantly joined together, then a large-scale rearrangement such as described in
family 1 in this chapter may result. Due to the mechanisms involved in processing
ends during NHEJ, it is likely that any DSBs triggering the duplication event will
have occurred 5' of the proximal duplication breakpoint and 3' of the distal
breakpoint. Some motifs and other features of the sequence have been found that
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could conceivably be involved in the formation of DSBs, such as a sequence present 
in a murine recombination hotspot (CAGRCAGR), and an 11 bp polypurine tract (see 
sections 4.10.1. and 4.11.1.). However, it is also possible that DSBs could be caused 
by another factor, such as ionising radiation, or intracellular compounds like reactive 
oxygen species (reviewed in Lieber et al., 2003).
4.12.2.2. Xrep, replication origins and DSBs
However, there is one feature of the sequence around the distal breakpoint that may 
be implicated in the mechanisms behind the rearrangment. The distal duplication 
breakpoint lies within one of the distal LCRs (Ala), and over 50% of the other 
duplication breakpoints that have been mapped so far in PMD families are also within 
the distal LCRs (Woodward et al., in preparation) (Figure 3.4.). It is possible that 
these LCRs could be involved in the initiation of DSBs in this region and thereby 
stimulate rearrangements (Inoue et a l , 2002). The proximity of the Xrep enhancer­
like sequence to the distal duplication breakpoint may not be coincidental, as this 
short stretch of 973bp, could be involved in stimulating the rearrangement (Table 
4.4.) (Riley et a l , 1986). It has been suggested that Xrep could function as an origin 
of replication (see section 3.4.6.) (Riley et a l , 1986). One potential source of DSBs 
during the cell cycle is from the collapse of replication forks, which can occur if the 
DNA polymerase encounters a single strand nick, or a damaged nucleotide 
(Kuzminov, 2001). However, Xrep has not been shown as yet to act as an origin of 
replication in human or even mammalian cells, although the collapse or stalling of a 
replication fork does not necessarily have to be close to an origin of replication (Riley 
et a l , 1986). Some mammalian origins of replication have been shown to overlap 
with MARs, and there is a region with the potential to form a MAR 800bp 3' to the 
distal duplication breakpoint in family 1, so it is possible that collapse of replication
forks proceeding from this point could also lead to a DSB (Girard-Reydet et a l,
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2004). However, this potential MAR has only been predicted according to the 
sequence data from the region, and predicted MARs do not necessarily correspond to 
genuine MARs (Namciu et al., 2004)
4.12.3. Origin of the duplication in family 1
The event that led to the duplication event in family 1 must have occurred within cells 
leading to or part of the germ line to be transmitted to 1:4 and to her son 1:9. Most 
PLP1 duplications originate from male germ cells, with an estimated bias towards the 
male germ line of between 9-fold and 11-fold (Mimault et al., 1999). Previous 
analysis of polymorphic markers within the duplicated region has shown that 1:9 was 
homozygous at the microsatellite marker DXS1106, which is contained within the 
duplicated region, while his mother was heterozygous at this locus (Woodward et a l,
1998). Both 1:4 and 1:9 were homozygous for the other two markers which were 
genotyped in this family that do map to within the duplicated region (Woodward et 
al., 1998). Homozygosity of alleles at a polymorphic marker within the duplicated 
region suggests that the rearrangement may have been an intrachromosomal event, 
which is compatible with a mutational event taking place during spermatogenesis, as 
is most common for PLP1 duplications (Woodward et a l,  1998;Mimault et al., 1999). 
The production of germ cells and the process of meiosis differs between 
spermatogenesis and oogenesis, and this is reflected in a parental origin bias for 
different types of mutations. Chromosome non-disjunction, leading to aneuploidies, 
is much more likely to occur during oogenesis, during the first meiotic division 
(Chandley, 1991). Point mutations and structural rearrangements are events that more 
frequently originate in males during spermatogenesis (Chandley, 1991;Uematsu et al., 
2002).
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4.12.4. DSBs, recombination and meiosis
The production of DSBs is a process inherent to meiosis, as DSBs are necessary for
synapsis of homologous chromosomes and meiotic recombination (Mahadevaiah et
al., 2001). Recombination between chromosomes does not occur randomly
throughout a particular chromosome; instead recombination events have been found
to occur in small “hotspot” regions (l-2Kb), which are flanked by large regions of
recombination-suppressed DNA that form linkage disequilibrium blocks (reviewed in
(Kauppi et al., 2004)). The distribution and numbers of recombination hotspots in
yeast is similar to the number and distribution of DSBs in yeast meiosis, and it is
likely that recombination hotspots are equivalent to DSB hotspots (Baudat and
Nicolas, 1997;Kauppi et al., 2004). It is probable that recombination hotspots in
mammals, such as humans, are also correlated with meiotic DSB formation hotspots
(Kauppi et al., 2004). Although most of the genetic material in the sex chromosomes
does not recombine during male meiosis, as pairing can only occur within the
homologous psuedoautosomal region, DSB breaks are still initiated prior to synapsis
throughout the sex chromosomes, and appear to persist until mid pachytene (Ashley et
al., 1995;Plug et al., 1996;Mahadevaiah et a l, 2001). Most DSBs initiated prior to
synapsis and meiotic recombination, especially within the sex chromosomes, do not
lead to a crossing over event and are subsequently repaired (Kauppi et al., 2004). It is
tempting to suggest that duplications and some other rearrangements involving PLP1
could result from aberrant joining of meiotic DSBs within the X chromosome by
NHEJ. The documented higher frequency of PLP1 duplications in spermatogenesis
could be explained by this proposed mechanism, as the unpaired regions of the X
chromosome may be more susceptible to rearrangements of this type, which could
occur between sister chromatids (Mimault et al., 1999). However, it has been shown
that proteins essential for the major pathway of NHEJ are downregulated in early
meiosis in male mice, suppressing the error-prone NHEJ pathway and ensuring
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accurate repair of meiotic DSBs by homologous recombination (Goedecke et a l ,
1999). Recombination rates throughout the genome can be assessed by creating 
genetic maps based on genotyping large numbers of polymorphic markers in 
numerous families. A recent high resolution recombination map of the human 
genome based on over genotyping 5000 polymorphic markers in 1257 human meioses 
is available as an annotated track on the UCSC genome browser (Kong et a l , 2002). 
The average recombination rate on the X chromosome calculated from this genetic 
map is 1.19 cM/Mb (excluding the centromere), but the female recombination rate 
close to PLP1 is substantially less than this (the male recombination rate on the X 
chromosome, except for within pseudoautosomal regions, is zero) (Kong et al., 2002). 
In a 1Mb region including PLP1 (between 101-102Mb on the X chromosome, NCBI 
Build 34), the average recombination rate was 0.3 cM/Mb (UCSC genome browser) 
(Kong et a l , 2002). The two flanking 1Mb regions had even lower recombination 
rates, the proximal 1Mb region had a recombination rate of 0.2cM/Mb and the next 
most distal 1Mb region had a recombination rate of zero (UCSC genome browser) 
(Kong et a l , 2002). Although still a theoretical possibility, it seems unlikely that 
DSBs during meiosis I are responsible for the rearrangements seen in PMD 
duplication families, as the homologous recombination pathway appears not to be 
involved in most PMD duplications, and additionally there is no evidence for a 
meiotic recombination hotspot in the region, which could be a source of DSBs.
4.12.5. DSBs, strand invasion and replication
There are other alternative mechanisms for the generation of PLP1 duplications.
DNA rearrangements that are passed on through the germ line do not necessarily have
to take place during meiosis, as cells in the germ line undergo numerous meiotic
divisions. The higher frequency of duplications originating in the male germ line may
just be a function of the greater number of cell divisions in spermatogenesis as
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compared to oogenesis. Probably the least complicated mechanism for producing a 
tandem duplication such as seen in family 1, and several other PMD families, just 
involves misrepair, by NHEJ, of two DSBs (Woodward et al, in preparation). If two 
DSBs occur on sister chromatids, one located proximal to PLP1, and the other distal 
to PLP1, these could be mis-repaired, distal break to proximal break by aberrant 
NHEJ, resulting in a duplication of the sequence between the two breaks. The DSBs 
would probably have to occur almost simultaneously during S or G2 phases of the cell 
cycle for two free ends from each DSB to be ligated together by NHEJ. This is not an 
unlikely prospect, as it has been shown that DSBs do occur frequently in mammalian 
cells (Karanjawala et al., 1999). The simplicity of this model is appealing, although it 
does have some drawbacks. One problem is how two of the free ends created by 
DSBs are brought together prior to repair. It could be the case that the two ends are 
randomly associated closely together in the nucleus, or that the two genomic regions 
near the breakpoints were located in a particular domain within the nucleus prior to 
the production of the DSBs. However, the more accurate repair pathway of 
homologous recombination (HR), using the intact sister chromatid to repair damage, 
is a more frequently used pathway for DNA repair during late S/G2 phases (Takata et 
al., 1998). To generate a tandem duplication, typically two copies of the duplicated 
sequence need to be present, which could either originate from a homologous 
chromosome pair, or from a pair of sister chromatids. PMD duplications are 
generally intrachromosomal in origin and frequently originate in males, which 
strongly suggests that the rearrangement occurs during S/G2 phases when two sister 
chromatids from one X chromosome are present. The high likelihood of the 
rearrangement occurring during these later phases of the cell cycle, while HR is 
commonly utilised for DSB repair, suggests that HR could also have a role in PLP1 
duplications.
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One possible duplication mechanism invokes HR pathways, but also still uses NHEJ
in the repair process, which is important for PLP1 duplications as most breakpoints do
show characteristics of NHEJ repair (Woodward et al, in preparation). Break-induced
replication is a phenomenon mostly studied in yeast models which is initiated by a
single DSB (Morrow et al., 1997;Kraus et a l, 2001). Following the generation of a
DSB in a DNA molecule, just one of the free ends created by the break then invades
into homologous sequence on another chromosome or chromatid and then replication
is primed from the invading free end (Kraus et al., 2001). A similar process based on
recombination has been shown to be involved in restarting stalled and damaged
replication forks in E.coli (reviewed in Michel, 2000). The single replication fork
initiated from an invading end can then continue for a considerable distance, even up
to the end of the recipient chromosome (Morrow et a l, 1997). Alternatively, the
break-induced replication may only continue for a limited distance before being
terminated by a non-homologous rejoining of the end of the newly replicated region
to the other side of the initial DSB (Kraus et al., 2001). This process has also been
reported to occur in mammalian cells where it may lead to non-reciprocal gene
conversion or duplication of sequences (Richardson and Jasin, 2000;Johnson and
Jasin, 2000). PLP1 duplications could be produced by the following mechanism: A
DSB occurs in the PLP1 region, and a free DNA end 5' to the DSB then invades the
homologous sequence on the sister chromatid (Figure 4.16.). This invading end
primes DNA synthesis, which then proceeds along the chromosome, past the PLP1
gene (Figure 4.16.). At some point at the other side of PLP1, the replication fork is
stalled, or encounters an obstacle that stops replication and causes the newly
synthesised strand to dissociate from the template sister chromatid. As replication
factories are generally believed to be stationary in the nucleus, it is likely that the
progressing replication fork initially induced by one invading end of the DSB will still
be in the vicinity of the other end of the DSB, which will then be available as a
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substrate for NHEJ with the end of the replicated region (Figure 4.16.) (Cook, 
1999;Richardson and Jasin, 2000;Johnson and Jasin, 2000). There is some clustering 
of distal breakpoints in PMD duplications, with over 50% of duplication breakpoints, 
including family 1, mapping to the LCRs distal to PLP1 (Figure 3.4.) (Woodward et 
al, in preparation). The presence of the distal LCRs may cause secondary structure in 
the DNA, which could lead to replication termination (if the initial DSB had been 
proximal to PLP1). Alternatively sequences within these LCRs could be prone to 
DSB formation, which initiates a strand invasion event proximal to PLP1, with 
subsequent replication through PLP1 until termination of replication proximal to the 
gene.
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Figure 4.16. Diagram showing possible mechanism for PLP1 tandem duplications. 
X chromosome sister chromatids are shown schematically by the black horizontal 
lines, the X centromere is a white oval, and PLP1 is the white rectangle. Homologous 
strand invasion events are shown by solid arrows and non-homologous repair events 
are indicated by the dotted arrows. Newly synthesised DNA is shown as a thinner 
line. A DSB-causing event is shown by the grey cross and replication termination is 
shown by the grey zigzag.
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4.12.6. Interspersed repetitive elements
Both the proximal and distal duplication breakpoints in family 1 were within 
interspersed repetitive sequence elements (see section 4.5.). Several other sequenced 
PLP1 tandem duplication breakpoints have been found to map within interspersed 
repetitive elements, more than would be expected by chance, given the repeat content 
of the region (Woodward et a l , in preparation). It is possible that these common 
repeat elements may stimulate rearrangements, perhaps by being prone to DSBs. The 
proximal duplication breakpoint in family 1 is within an LI retrotransposon sequence 
(LIPA 13) and the distal duplication breakpoint is within a solo LTR element 
(MLT1H1) (Tables 4.3. and 4.4.). Interspersed repeat elements, including LI and 
LTR sequences have been found to be over-represented at sites of DNA 
rearrangement in other studies, suggesting that these sequences could be contributing 
to the mechanism behind these rearrangements (Toriello et al., 1996;Graw et al., 
2000;Rockwood et a l, 2004). Solo LTR elements have been found in some 
documented mammalian recombination hotspots, and it has been suggested that 
instead of creating DSBs, solo LTRs may be captured during the process of DSB 
repair, as has been found in some model systems (Shiroishi et a l , 1995;Lin and 
Waldman, 2001a). A similar mechanism of LI sequences being captured by or 
inserting into DNA lesions has also been proposed as a repair mechanism for DNA 
DSBs (Morrish et a l, 2002;Rockwood et a l, 2004). It is possible that the presence of 
some interspersed repeats may be a marker of past repair of a DSB by insertion of a 
retrotransposed sequence, so the repeat elements may not in themselves cause further 
rearrangements, but could be indicative of a predisposition towards DSBs, 
rearrangement or recombination in the region (Lin and Waldman, 2001a).
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4.12.7. Nucleotide content of breakpoints
Both duplication breakpoints had an elevated G+C content compared to the 
surrounding genomic region (see section 4.5.). Regions of high G+C content are 
more likely to be involved in translocations and segmental duplications, and have 
been found to have higher recombination rates, which may be due to recombination- 
promoting sequences such as Alus clustering in G+C rich regions (Eisenbarth et al., 
2000;Yu et a l , 2001;Abeysinghe et a l, 2003;Jurka et a l, 2004). The sequences 
around the breakpoints were examined for repeated sequences, polypurine, 
polypyrimidine and alternating purine/pyrimidine tracts, but only a limited number 
were found, so it was considered that these sequence features were unlikely to be 
important in the rearrangement mechanism (see Figures 4.14. and 4.15.).
4.13. Summary
During the course of this study a tandem duplication including the PLP1 gene has 
been characterised in a family with PMD. The duplication breakpoint has been 
sequenced with little homology evident between the proximal and distal ends of the 
duplication, implicating NHEJ in the rearrangement mechanism. Various different 
mechanisms for the rearrangement have been proposed, and it is also possible that a 
form of homologous recombination is also involved in the generation of duplications 
such as this one characterised in family 1.
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5.1. DUPLICATION BREAKPOINT MAPPING IN FAMILY 2
5.1.1. Previously published data
Patient 2:9 and his mother 2:5 have previously been shown to carry a duplication of 
Xq22.2 including PLP1, and the approximate extent of the duplication has also been 
mapped by interphase FISH (Figure 2.2.) (Family PMD3 in Woodward et a l (2000)). 
The size of the duplication in family 2 had been found to be approximately the same 
as in family 1, with cosmid cU65A4 duplicated at the proximal end and cosmid 
cU240C2 the most distal duplicated clone (see section 4.1.1. and Figure 4.1.) 
(Woodward et al., 2000).
5.2. FISH mapping proximal duplication breakpoint in family 2
5.2.1. Further mapping of proximal duplication breakpoint by interphase FISH
Additional interphase FISH experiments were carried out to further localise the 
proximal duplication endpoint. Adjacent genomic clones including cU65A4 
(previously found to be duplicated) from near the end of the duplicated region were 
hybridised to interphase nuclei from individual 2:9 (Figure 5.1. and Table 5.1.). 
These data indicated that the duplication breakpoint was likely to be contained within 
the cosmid cU177E8, just distal to cU65A4 (Figure 5.1. and Table 5.1.). In contrast 
to the previously published results, the interphase FISH score for cU65A4 was 
consistent with this clone not being contained within the duplicated region (Table
5.1.). However, in the nuclei where there was a double cU65A4 signal, one signal 
was frequently smaller than the other, which could be an indication of a very small 
part of cU65A4 being included in the duplicated region. The clone just centromeric 
to cU65A4, dJ635G19, also was scored as not being duplicated, whereas the cosmid 
mapping just distal to cU65A4, cU177E8, could not be classified as either duplicated 
or single-copy (Table 5.1. and Figure 5.1.). In addition, when a double signal was
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seen, one of the dots was smaller than the other (Figure 5.1.)* These data from cosmid 
cU177E8 were consistent with a duplication breakpoint being present within the 
genomic sequence in this clone.
5.3. Mapping of proximal duplication breakpoint by UPQFM-PCR
As some of the interphase FISH results were inconsistent, another method was used to 
assay dosage in the presumed proximal duplication breakpoint region. Finer mapping 
of the extent of the duplication was carried out using UPQFM primer pairs in the 
region (Figure 5.2.). UPQFM-PCR data narrowed down the region to just over 2Kb, 
between primer pairs 38464-38658 and 36491-36712 in human genomic clone 
cU177E8 (Figure 5.2. and Table 5.2.). However, there was one apparently discordant 
result found, but this was only for one individual compared against one control probe, 
and it was considered likely to be a false positive result (Table 5.2.).
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101.20Mb 101.24Mb 101.28Mb
Figure 5.1. Interphase FISH results from the proximal duplication breakpoint using a
cell line from the affected boy in family 2. Genomic clones around the proximal
breakpoint region and their relative size are shown underneath the images of
interphase nuclei. The position of the clones on the X chromosome is shown, taken
from the NCBI Build 34 version of the human genome sequence. In each image, the
X centromere is labelled red, and the genomic clone used in the experiment is labelled
green.
0,1 0,2 0,3 0,4 Other
Clone • • • •,A Conclusions
dJ635G19 74.76% 20.39% 4.85% 0 0 Notduplicated
CU65A4 68.47% 26.13% 0.91% 0 4.50% Notduplicated
CU177E8 45.28% 44.34% 6.60% 0 3.77% Breakpoint?
Table 5.1. Interphase FISH scores for 2:9 near the proximal duplication breakpoint. 
The percentage of nuclei falling into each category is shown for each clone. Results 
are taken from a single slide for each probe, and an average of 107 interphase nuclei 
were scored for each slide.
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Figure 5.2. UPQFM-PCR mapping of proximal breakpoint in family 2. Genomic clones from the region are shown as shaded boxes labelled with the 
clone name, those shaded dark grey are orientated centromere —» telomere, those in light grey have been sequenced on the opposite strand. Locations of 
UPQFM-PCR primers in the region are indicated by arrows, and the position within each clone for each pair of primers is shown. (+) indicates a 
sequence that appeared to be duplicated, (-) a sequence with normal copy number. Position on the X chromosome is shown by the scale bar in (a.) and is 
taken from the Ensembl human genome browser, release 21.34d.l. A more detailed view of 20Kb around the duplication breakpoint is shown in (b.).
Clone Position in clone of 
UPQFM primer pairs
Mean ratio of UPQFM PCR 
product compared to ...
Number of 
experiments 
performedPLP1 CF
dJ635G19 30902-31157 0.67 0.95 1
dJ635G19 48059-48309 0.56 (0.77) 0.89 (0.86) 2(1)
dJ635G19 60570-60728 0.54 (0.28) 1.21 (1.05) 4(1)
cU65A4 11590-11756 0.47 1.18 1
.
cU65A4 9959-9747 0.51 0.84 2
cU65A4 6833-7109 0.44 0.98 2
CU65A4 4480-4704 0.54 0.84 2
CU177E8 38464-38658 0.43 (0.75) 1.09 (1.47) 3(3)
CU177E8 36491-36712 0.94 (0.98) 2.31 (2.07) 3(3)
CU177E8 32435-32693 0.92 (1.46) 2.74 (1.67) 2(1)
CU177E8 20484-20744 1.11 2.47 2
CU177E8 5951-5698 1.03 1.63 2
Table 5.2. UPQFM ratios for the proximal duplication breakpoint in family 2 (as 
compared against both PLP1 exon 6 and CF control primers). Average ratios were 
taken from all experiments carried out that included that primer pair, and the number 
of experiments is indicated. Values are for dosage measurements from the affected 
male, where experiments had been carried out on the carrier mother as well, these 
results are shown in brackets. Ratios consistent with duplication are highlighted in 
bold, and the zigzag lines show the assumed location of the breakpoint regions. The 
position of each target sequence within the relevant genomic clone is shown. Data 
obtained from UPQFM-PCR experiments carried out by Dr Karen Woodward are 
shown in italics.
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5.4. Inverse PCR to obtain breakpoint sequences
Initial attempts to clone the breakpoint in family 2 using long-range PCR were 
unsuccessful (data not shown). A tandemly duplicated rearrangement (similar to that 
found in family 1) was assumed but not demonstrated. Therefore an alternative 
approach was taken, in case there was a more complicated rearrangement present. A 
strategy using inverse PCR was pursued to obtain unknown sequence from the 
duplication breakpoint in this family, utilising DNA sequence known at the well 
mapped proximal breakpoint region (see sections 5.2. and 5.3.). Inverse PCR is a 
technique that can be used to generate sequence from an unknown region using 
primers specific for adjacent known sequence orientated in divergent directions in 
genomic DNA (see section 2.2.1.4.) (Ochman et a l, 1988).
5.4.1. Inverse PCR strategy
Two 30mer oligonucleotide primers were used close to the end of the duplicated 
sequence within clone cU177E8 (Figure 5.3.). A restriction enzyme was chosen, in 
this case NlaTV, that would cut close to the reverse primer sequence, but as far away 
from the other primer as possible, to maximise the chances of amplifying the 
breakpoint sequence following circularisation. The NlaTV site that was in the known 
duplicated sequence for this experiment was just a couple of nucleotides after the end 
of the reverse primer, at position 35938 within cU177E8 (Figure 5.3a.). Genomic 
DNA that had been fully digested by NlaTV was ligated at a low concentration to 
promote self-ligation and circularisation of individual DNA fragments. This ligated 
DNA was used as the substrate for PCR using the specially designed oligonucleotide 
primers (Figure 5.3a.).
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5.4.2. Inverse PCR results
Following the inverse PCR procedure, the size of the PCR product that was expected 
from normal genomic DNA was 1785bp, and a band of approximately this size was 
seen in both normal male controls and members of family 2 carrying the duplication 
(Figure 5.3b.). An additional band, slightly shorter than the expected band, was seen 
for just the affected boy and his carrier mother, and not in normal genomic DNA 
(Figure 5.3b.). This was assumed to be amplification of a novel junction fragment 
formed by the duplication event. This PCR product was gel purified and sequenced in 
both directions using the inverse PCR primers (see sections 2.2.1.4.4. and 2.2.4.).
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a.
38464-38658 
Not duplicated
NlaYV
38040
NlaYV
37219F
_____________ i ______________________ i t _______________
36264F
<4
35970R
36491-36712
Duplicated
b.
2027b p-------- ►
1785bp-------------- ►
1333bp---------------------►
4 --------- 2072bp
•4-----------------1500bp
Figure 5.3. Inverse PCR strategy to clone the proximal duplication breakpoint for 
family 2. (a.) shows the approximate position of primers and NlaYV cut sites used for 
inverse PCR (not to scale). Positions within cU177E8 sequence are shown, and the 
region which the proximal duplication breakpoint has been mapped by UPQFM-PCR 
is shown by the dashed line, (b.) shows inverse PCR products run on an agarose gel 
along with X/HmdYLl and lOObp ladder size standards. The sizes of the expected band 
(1785bp) and the altered band (1333bp) are shown in bold, whereas the sizes of 
nearby bands in the two size standards are shown in normal type.
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5.4.3. Sequencing of inverse PCR products.
Sequencing of the additional inverse PCR products in the patient and his mother 
revealed a breakpoint junction, that surprisingly only involved sequences proximal to 
PLP1 (Figures 5.3., 5.4. and 5.6.). Sequencing from the additional inverse PCR band 
using the 35970R primer and a nested primer, 36264F, showed that the breakpoint 
within cU177E8 was at position 37339 (Figures 5.4. and 5.5.). There was a 4 base 
pair overlap (AGAG) at the breakpoint and then the adjacent sequence was a 49bp 
stretch of DNA, also originating from cU177E8, between positions 36006 and 36054 
(Figure 5.4.). The following sequence in the junction originated from a region more 
proximal to PLP1, within human genomic clone dJ1055C14 (Figures 5.4. and 5.5.). 
The sequence began at position 59809 in dJ1055C14, where there was a two base pair 
(TT) overlap with sequence from cU177E8 at position 36053 (Figure 5.4.). 22 
nucleotides into the dJ1055C14 sequence there was an additional small rearrangement 
in the sequence, a 13bp deletion within dJ1055C14 sequence (Figure 5.4.). There was 
a 3bp overlap (ATG) flanking this short deletion (Figure 5.4.). To verify that these 
rearrangements were not just an artefact generated by the inverse PCR procedure, a 
junction fragment was amplified from DNA from patient 2:9, using primers flanking 
the sequenced junction (cU177E8 F37219 and dJ1055C14 F60006). DNA extracted 
from lymphoblastoid cell lines was used, as a DNA sample from blood was not 
available. Sequencing of this PCR product gave the same sequence in both directions 
as that obtained from the inverse PCR product (Figure 5.4.).
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59809
up to 37339 in cU177E8
37339
36006
between 36006 and 36054 in cU177E8
^  36054 
 ►
between 59809 and 59832 in dJ1055C14
59843
59832 
->
59843 and onwards in dJ1055C14
Figure 5.4. Electropherogram showing sequence from the cU177E8-dJ1055C14 breakpoint junction in family 2. The regions of homology to the 
different Xq22 sequences are shown underneath the sequence data, numbers indicate positions within the sequence of each genomic clone.
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Figure 5.5. Diagram illustrating the location of the breakpoints sequenced from the 
family 2 inverse PCR reaction and a large-scale view of the rearrangement found, (a.) 
shows the sequenced contig (adapted from the Ensembl genome browser) proximal to 
and including the PLP1 gene and the locations of the sequence found at the 
breakpoint. The two genomic clones involved in the rearrangement, cU177E8 and 
dJ1055C14, are shaded in red and blue respectively. The other genomic clones in the 
region are shaded in dark grey (for clones sequenced on the forward strand) or light 
grey (clones sequenced on the reverse strand). The PLP1 gene (shaded pink), and a 
gene that spans the breakpoint within dJ1055C14, MORF4L2 (shaded black), are 
shown as arrows, with the orientation of the arrow indicating the direction of 
transcription. The scale bar shows the position along the X chromosome in megabase 
pairs (taken from the Ensembl genome browser, release 22.34d.l). The dashed lines 
show the locations of the breakpoints, (b.) illustrates the rearrangement that has 
occurred at this breakpoint in this family, with sequences from cU177E8 and 
dJ1055C14 brought together, resulting in inversion of one of the sequences relative to 
the original (just one orientation is shown in (b.), but the opposite orientation is also 
possible.
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5.5. Verification of cU177E8-1055C14 breakpoint by long-range PCR
The junction found using inverse PCR, which involved sequences from human 
genomic clones cU177E8 and dJ1055C14, was also checked by PCR. Long-range 
PCR was carried out using a single primer close to the breakpoint in cU177E8 
(37219F, see Figure 5.3a) and different oligonucleotide primers mapping between 3.2 
and 9Kb from the start of the sequence homologous to dJ1055C14 (Figure 5.6.). 
There was no indication of further large-scale rearrangements at this breakpoint for at 
least 9Kb into dJ1055C14 sequence from the breakpoint.
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a. N orm al
37219F
cU177E8
------------ VSSSSS/SSSSSSSSSSSSSSJ/SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS/SSTSSSSSSSSSSSSSSSSSSSJSSl
M M M M
63105R 64761R 6 7331R 68849R
i i i  i i i i i i i i
6okb 62kb 64kb 66k b  ' 68kb
dJ1055C14
Re^rranked
37219F
Y / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / A
3448bp
63105R 64761R 67331R 68849R
63105R 
2:9 2:5 N N
64761R 
2:9 2:5 N N
5104bp
67331R 68849R
7674bp 9192bp
Figure 5.6. Confirmation of cU177E8-dJ1055C14 breakpoint by long-range PCR. 
Legend on next page
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Figure 5.6. Legend
(a.) Diagrams of normal sequence within both cU177E8 (2Kb shown) and dJ1055C14 
(10Kb shown). DNA not involved in the breakpoint is shown as a black line, the 
duplicated sequence from cU177E8 is represented by a shaded box, and the 49bp 
sequence from cU177E8 inserted at the breakpoint is shaded black. Sequence 
duplicated originating from dJ1055C14 is shown as a striped box. The orientation of 
primers used is shown by the arrowheads, and their respective positions within each 
genomic clone is shown, (b.) Diagram of the rearrangements around the breakpoint, 
as found by direct sequencing, (c.) Agarose gels showing long-range PCR products, 
each reaction using the same primer from cU177E8 (37219F) and a different reverse 
primer from (01O55C14, which is indicated above the gel picture. The first and last 
lane in each gel contains a X/Hindlll ladder, and DNA used in the reactions was either 
cell line DNA from the affected boy (2:9), his mother (2:5), genomic DNA from 
normal males (N), and a no DNA control (-).
5.6. Determination of sequence copy number around dJ1055C14 in family 2
5.6.1. UPQFM-PCR
Following the unexpected discovery of a breakpoint junction between two relatively 
distant areas of sequence, but both proximal to PLP1, the copy number of sequences 
near to the breakpoint within dJ1055C14 was examined. This had not been carried 
out previously as the proximal breakpoint had initially been mapped centromeric to 
this region, and the rearrangement in this family had been assumed to be a simple 
tandem duplication including PLP1 (Woodward et a l , 2000). UPQFM-PCR primer 
pairs throughout genomic clone dJ1055C14 were used to assay copy number. This 
revealed that sequences distal to the breakpoint within dJ1055C14 at position 59809
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were duplicated in both the boy and mother, whereas target sequences proximal to this 
breakpoint, further away from PLP1, were just present in normal copy number in both 
the affected boy and carrier mother (Figure 5.7., Table 5.4.). More UPQFM-PCR 
primer pairs, mapping to genomic clones located proximal to dJ1055C14, were then 
used to ascertain copy number (Figure 5.7., Table 5.4.). This showed that the 
sequence copy number was normal for approximately 100Kb, between two non­
contiguous sections of duplicated sequence, one from cU177E8 down to the most 
proximal part of cV857G6 sequence, the other starting within (01O55C14 and 
possibly continuing to PLP1 and beyond (Figure 5.7.).
5.6.2. Interphase FISH around dJ1055C14
Interphase FISH results for the genomic clones mapping to this region were 
supportive of the UPQFM-PCR data (Figure 5.7., Tables 5.3a,b). The FISH results 
for the clone containing the sequenced breakpoint, dJ1055C14, were consistent with 
the breakpoint being within this clone (Tables 5.3a,b). Although more nuclei were 
scored as duplicated than not, the difference between the two classifications was not 
great, and in many cases where a duplicated signal was seen, the additional signal was 
smaller than the other, which is also an indication that the clone is only partially 
duplicated (Figure 5.7.). The breakpoint is positioned within the sequenced portion of 
dJ1055C14 so that less than half of the clone is duplicated, but this equates to about 
40Kb of sequence, which is enough to give a good signal in interphase nuclei.
UPQFM-PCR data indicated that only a small part of cV857G6 sequence was 
duplicated, and all of the sequence from the next clone upstream, cU246D9, was 
probably duplicated (Figure 5.7., Table 5.4.). Over half of nuclei in both 2:9 and 2:5 
only contained signals that were consistent with one copy of cV857G6 being present
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on each X chromosome and about a quarter of nuclei had duplicated signals (Tables 
5.3a,b). In these nuclei where duplicated signals were seen, the second signal was 
generally much smaller than the other signal in the pair (Figure 5.7.). Interphase 
FISH data from cU246D9 had fairly similar numbers of single-copy and duplicated 
signals, although the scores from the affected boy and carrier mother for this clone 
were tending towards different outcomes (2:9 -  more nuclei scored as not duplicated, 
2:5 -  more nuclei scored as duplicated) (Tables 5.3a,b). This did not agree with 
UPQFM-PCR data, which had indicated that the whole of the sequence from 
cU246D9 was duplicated (Table 5.4.). However, the sequence submitted for each 
genomic clone is often not the whole cloned insert, and data based on restriction 
digestion analysis of genomic clones shows that cV857G6 and cU246D9 do overlap, 
and about half of the length of cU246D9 overlaps with cV857G6 (Figure 5.8.). It is 
quite likely that only part of the genomic insert cloned in cU246D9 is actually 
duplicated in family 2, which would explain why the interphase FISH results did not 
show that this clone was duplicated. This discrepancy between FISH results may be 
due to poor hybridisation in the female sample, with a higher proportion of nuclei 
interpreted as having a signal from just one X chromosome ((0,1), (0,2), and (0,3)), 
which could be attributed to poor hybridisation to one of the X chromosomes on these 
slides (Table 5.3.).
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a.
Clone
CU246D9
0,1
51.73%
0,2
42.95%
0,3 0,4
3.87%
Other
1.45%
0
0
Conclusions
Breakpoint?
 Not...
duplicated
Breakpoint?
CV857G6 74.26% 24.04% 0.99%
dJ1055C14 45.00% 45.00% 10.00%
b.
Clone
CU246D9
CV857G6
dJ1055C14
1,1
25.96%
49.11%
27.78%
1,2 1,3
41.35%
21.43%
50.00%
7.69%
0.89%
2.78%
1,4
0.96%
2,2
6.73%
2 .68%
6.48%
2,3 2.4
2 .88%
0
2.78%
Other
•«r
13.46%
25.89%
10.19%
Conclusions
Duplicated?
 Not...
duplicated
Breakpoint?
Table 5.3. Interphase FISH scores, expressed as percentages, from family 2 near to the second proximal breakpoint, (a.) shows the interphase FISH 
scores from the male, 2:9, and (b.) gives the interphase FISH scores from the carrier female (2:5). All scores are from a single slide, except for clone 
cU246D9 on individual 2:9 (a.), which is the mean percentage score from two experiments. An average of 105 nuclei were scored on each slide.
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Figure 5.7. UPQFM-PCR and interphase FISH data mapping two breakpoints within dJ 1055C14 and cV857G6. Legend on next page.
Figure 5.7. Legend
The locations of the human genomic clones in the region are shown by the grey boxes 
in the centre of the diagram; clones on the forward strand (oriented left to right) are 
coloured in dark grey, those oriented in the opposite direction are shaded light grey. 
The black arrows show locations of UPQFM-PCR primer pairs within the genomic 
clones, (+) underneath the contig indicates that sequence was duplicated, (-) that the 
sequence is single-copy. Interphase FISH nuclei are shown for three of the clones in 
the region. In all pictures the X centromere probe is red, and the Xq22.2 genomic 
clone is green. Nuclei from the affected male in family 2 are shown above the contig 
and UPQFM-PCR data, the pictures underneath are from the mother in family 2.
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Clone Position in clone of 
UPQFM primer pairs
Mean ratio of UPQFM PCR 
product compared to ...
Number of 
experiments 
performedPLP1 CF
dJ43H13 12256-12507 1.01 (0.92) 2.54 (1.51) 2(2)
CU246D9 8349-9530 0.89 (1.04) 2.41 (1.53) 2(2)
CU246D9 16048-16277 0.96 (0.94) - 1(1)
CV857G6 41850-42081 0.85 (1.12) 2.01 (2.01) 2(3)
CV857G6 32969-33205 0.32 (0.47) 0.83 (0.85) 1(2)
CV857G6 11085-11289 0.52 (0.54) 1.05 (0.95) 4(2)
dJ1055C14 18844-19070 0.51 (0.54) 1.16(0.95) 3(2)
dJ1055C14 46009-46237 0.56 (0.56) 1.37(1.02) 3(3)
dJ1055C14 54449-54682 0.53 (0.63) 1.21 (0.97) 1(1)
dJ1055C14 62946-63105 0.78 (0.95) 1.78 (1.47) 1(1)
dJ1055C14 67104-67331 1.04 (1.06) 2.37 (1.64) 1(1)
dJ1055C14 68598-68849 0.95 (0.90) 2.17(1.40) 1(1)
cU35G3 5631-5805 1.55 2.80 1
Table 5.4. UPQFM ratios for the proximal duplication breakpoint in family 2 (as 
compared against both PLP1 exon 6 and CF control primers). Average ratios were 
taken from all experiments carried out that included that primer pair, and the number 
of experiments is indicated. Values are for dosage measurements from the affected 
male, where experiments had been carried out on the carrier mother as well, these 
results are shown in brackets. Ratios consistent with duplication are highlighted in 
bold, and the zigzag lines show the assumed location of the breakpoint regions. The 
position of each target sequence within the relevant genomic clone is shown.
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Detailed view: X:99.0Mbp-101.0Mbp
X98.QMbp-10Q.QMbp < n i n « r H  X:100.0Mbp-102.0Mb£cV857G6 dJ1055C14
C U 2 4 6 D 9
Figure 5.8. Screenshot from Sanger Institute X chromosome FPC map based on 
restriction analysis of the whole clones showing relative positions and sizes of the 
genomic clones, cU246D9, cV857G6 and dJ1055C14, in a 2Mb window. Relative 
sizes of genomic clones are shown by the horizontal boxes, which are colour-coded 
according to the sequencing status at the time this map was last modified (on 
12/12/2002 according to information on the website).
URL: http://w w w .sanger.ac.uk/cgi-bin/hum ace/fpcwebm ap.cgi?m ode=m ap& m ap=bac.X .98.htm l
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5.7. Analysis of genomic sequence around the two proximal breakpoints in
family 2
5.7.1. Genes near breakpoint closer to PLP1
The distal breakpoint, at position 59809 within the sequence originating from 
dJ1055C14 falls within the third exon of a known gene, MORF4L2 (Mortality factor 
4-like 2) (Figure 5.9.). This gene has also been known as MRGX  (MORF-related 
gene X), and is part of a gene family of transcription factors that seem to have roles in 
transcriptional activation and repression (Bertram and Pereira-Smith, 2001;Tominaga 
et a l , 2003). MORF4L2 contains various motifs including a leucine zipper, helix- 
loop-helix domain, ATP/GTP binding domain and nuclear localisation signal 
(Tominaga et al., 2003). MORF4L2 has four exons, but only the longer fourth exon 
contains the coding sequence; the first three short exons together make up part of the 
5' UTR, and it is transcribed from the reverse strand of dJ1055C14. The breakpoint 
falls before the coding sequence of MORF4L2, which remains single copy, therefore 
it is unlikely that this protein would be overexpressed as a result of the duplication in 
this family.
5.7.2. Genes near proximal breakpoint
The breakpoint within cU177E8 did not interrupt any known genes. The closest 
annotated gene to this breakpoint is also within cU177E8, 8.7Kb distal to the 
breakpoint and therefore expected to be within the duplication. This nearby gene is 
uncharacterised and annotated into the Ensembl genome browser under the identifier 
NM_153333. The gene shows sequence similarities to TCEAL1, which is a nuclear 
phosphoprotein that may modulate transcription (see section 3.5.4.1.) (Pillutla et a l , 
1999). Interestingly, TCEAL1 is mapped within genomic clone dJ1055C14, but is 
nearly 50Kb 5' to the breakpoint in family 2 (Table 3.11.).
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5.7.3. Proximal region-specific repeats
Neither of the genomic regions brought together in the breakpoint sequenced in 
family 2 are particularly close to any of the repeated sequences that have been 
described in the region proximal to PLP1 (see Figure 3.8.). The nearest repeat units 
are part of the “P4” grouping, a family of repeated sequences which all include coding 
sequences related to TCEAL1 (see sections 3.5.4. and 5.7.2. and Table 3.10.).
5.7.4. Interspersed repetitive elements and G+C content
5Kb of sequence centred on the major sequenced breakpoints in family 2 (position 
37339 in cU177E8 and position 59809 in dJ1055C14) was analysed by Repeatmasker 
to determine the numbers and types of common interspersed repeats. Both breakpoint 
regions contained a low proportion of interspersed repeats compared to the average 
proximal to PLP1 (see section 3.5.1.). The 5Kb around the cU177E8 breakpoint 
contained 24.24% interspersed repeats (Figure 5.9. and Table 5.5.). The 5Kb centred 
on the dJ1055C14 breakpoint contained a similar percentage of interspersed repeats, 
26.76% (Figure 5.9. and Table 5.6.). Neither of the two breakpoints fell within a 
known interspersed repetitive element (Tables 5.5. and 5.6.). The G+C content near 
both breakpoints was slightly below the average for the region (40.60% G+C in the 
1Mb region proximal to PLP1), at 40.24% near the cU177E8 breakpoints and 39.36% 
near thedJ1055C14 breakpoint.
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Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation
(-) 2492-2280 LIME (LINE/LI) 5319-5545 (227/6121) -
(-) 1977-1813 MIR (SINE/MIR) 10-204 (195/262) +
(-) 1821-1764 L2 (LINE/L2) 3254-3313 (60/3313) -
(-) 1739-1695 (CA)n (Simple repeat) 2-46 +
(-)819-527 AluY (SINE/Alu) 1-296 (297/311) -
(-) 526-342 LlME4a (LINE/LI) 5901-6103 (203/6121)
(-) 246-65 L1MC/D (LINE/LI) 2270-2452(183/6215) +
(+) 18-93 CT-rich (Low complexity) 1-76 +
(+) 2288-2328 (CA)n (Simple repeat) 2-42 +
(+) 2328-2357 (GA)„ (Simple repeat) 2-31 +
(+) 2376-2693 AluSx (SINE/A/u) 1-317(318/318) -
Table 5.5. Interspersed repetitive elements from the 5Kb region surrounding the 
breakpoint in cU177E8 (at position 37339bp in this genomic clone). The first column 
shows how far in base pairs each repeat element is from the breakpoint, (-) indicates 
that the repeat element is proximal to the breakpoint and (+) that the repeat is distal 
relative to the breakpoint. The type of repeat and the class of repeat element to which 
it belongs are given in the second column. The third column shows which portions 
within the appropriate repeat consensus sequence each repeat has similarity to, and 
also how many bases out of the total repeat unit consensus is present in the sequence. 
In the fourth column, the orientation of each repeat is shown; + indicates a repeat is 
on the forward strand (i.e. running from centromere to telomere), - the repeat is on the 
reverse strand. One interspersed repeat in the region, an AluSx copy, overlapped with 
the boundary of the 5Kb region, and the adjacent sequence was also searched for 
repeated sequences until the end of this Alu element was found. Interspersed repeat 
sequences were searched for using Repeatmasker software (Repbase update v7.4). 
The other short section from cU177E8 that is inserted in the breakpoint in family 2 is 
between 1285-1333bp distal to the centre of the 5Kb region.
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Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation
(-) 205-135 L2 (LINE/L2) 3201-3272 (72/3272) -
(+) 229-543 L2 (LINE/L2) 1939-2275 (337/3314) -
(+) 910-1060 MIR (SINE/MIR) 63-230 (168/262) +
(+) 1082-1270 LlMC4a (LINE/LI) 5679-5878 (200/7808) +
(+) 1331-1639 AluSg (SINE/yf/w) 1-292 (293/310) +
(+) 1968-2007 (A)n (Simple repeat) 1-40 +
(+) 2011-2313 AluSx (SJNE/Alu) 1-305 (306/312) +
Table 5.6. Interspersed repetitive elements from the 5Kb region surrounding the 
breakpoint in dJ1055C14 (at position 59809bp in this genomic clone). The first 
column shows how far in base pairs each repeat element is from the breakpoint, (-) 
indicates that the repeat element is proximal to the breakpoint and (+) that the repeat 
is distal relative to the breakpoint. The type of repeat and the class of repeat element 
to which it belongs are given in the second column. The third column shows which 
portions within the appropriate repeat consensus sequence each repeat has similarity 
to, and also how many bases out of the total repeat unit consensus is present in the 
sequence. In the fourth column, the orientation of each repeat is shown; + indicates a 
repeat is on the forward strand {i.e. running from centromere to telomere), - the repeat 
is on the reverse strand. Interspersed repeat sequences were searched for using 
Repeatmasker software (Repbase update v7.4).
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Figure 5.9. Interspersed repeat content around breakpoints in family 2. 5 Kb around 
each breakpoint (dashed vertical line) is shown. The upper part of the figure shown 
the repeat content centred on position 37339bp in cU177E8, and the lower half of the 
diagram shows the region centred on position 59809bp in dJ1055C14. The different 
types of human interspersed repetitive elements are represented by the patterned and 
shaded boxes above each genomic clone. The original location of the short stretch of 
additional sequence from cU177E8 (36054-36006bp) present at the breakpoint is 
shown by the blue box. The locations of exons from a gene spanning the breakpoint 
(MORF4L2) are shown underneath dJ1055C14, unfilled boxes are non-coding 
sequence and the green box shows the coding sequence of MORF4L2. This gene is 
transcribed from the reverse strand, i.e. from right to left on this diagram.
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5.7.5. Comparisons of sequence around cU177E8 and dJ1055C14 breakpoints
The 5Kb of sequence around both ends of the sequenced breakpoint in family 2 were 
compared against each other using the BLASTz algorithm, to determine if there were 
any similarities between the breakpoint regions that may have mediated the 
rearrangements (see section 2.2.10.1.3.) (Schwartz et a l , 2000). The only parts of the 
sequence that were found to be similar near the two breakpoints corresponded to 
copies of Alu elements (Figure 5.10.). In addition, lOObp regions flanking the 
breakpoints were also aligned together, using ClustalW. There was no extensive 
homology found between these sequences outside of the short (4bp and 2bp) sequence 
overlaps at the junctions (Figure 5.11.).
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Figure 5.10. Comparison of 5Kb around breakpoints by BLASTz (Pipmaker dotplot 
output). The results of the comparison are shown as a dotplot, where any similarities 
are shown as black dots on the white background. The human genomic clones and 
interspersed repeat content are shown in the relevant positions next to the dotplot. 
The position of each breakpoint is indicated by the dashed lines. For more 
explanation of the repeat content, see Figure 5.9., Tables 5.5. and 5.6. Upwards- 
facing diagonal lines on the dotplot (/) are indicative of directly repeated sequences; 
downwards-sloping lines on the dotplot (\) represent areas present in both sequences 
in an inverted orientation.
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Junction sequence GAGGAGGAGAAAGAGGAGGAGAAAGAGGAGGAGAAGAAAAGTGTCCAGAAGAGACAGGCTAGTGTCTGGCCCAGAGGATGAGGGGGAGAAAG
cU 177E8 37289 GAGGAGAAAGAGGAGGAGAAAGAGGAGGAGAAGAAAAGTGTCCAGAAGAGATTTTTAAAAATT-------------- AAGAAATAAATTTAGAGTA
cU 177E8 36104 TTCCTCTTATTCAGGTCTTTTTTATTTTTGCAGCACTCCCCTTTTCTGTTGAGACAGGCTAGTGTCTGGCCCAGAGGATGAGGGGGAGAAAG
(U1055C14 59759 ATGGTACATGACACCACTGTCAGTGATTGTTTAAGAAGGTAAAAAAAAGA-----
Junction sequence ACACTTT GGTGAGGGAGGAGTCAGTGATG----------------------------GGTGATTAGGTTATTAGTATTATCACCAAATGATAATACTCCTCCAT
CU177E8 ATGCATC GGATGAAAAGA 37388
cU 177E8 ACACTTTCCCAGAATGGAGCAGGTCTGCG-TG-------------------------AGCAACTGGACTTGGAGCTGTG-CATC 35956
dJ 1055C 14  TT------GGTGAGGGAGGAGTCAGTGATGACTCCCAGGTATGGGTGATTAGGTTATTAGTATTATCACCAAATGATAATACTCCTCCAT 59892
Figure 5.11. Alignment of breakpoint junction and lOObp flanking the sequenced breakpoint in family 2. Each breakpoint region was individually 
aligned by ClustalW to the sequence from the junction breakpoint and the alignments were then combined together manually. Junction sequence that 
originated from the more centromeric part of cU177E8 (37289-37339) is highlighted in red, and nucleotides aligned with this sequence from the 
genomic sequence around the distal breakpoint are also highlighted in red. Junction sequence from the slightly more distal sequence within cU177E8 
(36006-36054) is shaded blue, and bases aligned with this sequence are also shaded blue. The 4bp overlap between these two sequences is shaded 
purple. Junction sequence originating from dJ1055C14 (59809-59832; 59843-59892) is light green, and any bases from the genomic sequences 
matching this part of the junction sequence in the alignment with this are also shown in green. The 2bp overlap at the junction between dJ1055C14 and 
cU177E8 is coloured pink. The 3bp overlap in sequence between the ends of the short duplication in dJ1055C14 sequence is coloured a darker green
5.7.6. Recombination/rearrangement-associated motifs
5.7.6.1. 5Kb around breakpoint in cU177E8
Only a few sequence motifs (S. pombe ARS, scaffold attachment regions) were found 
to be over-represented in the 5kb around the major breakpoint in cU177E8, which 
also included the short sequence from cU177E8 inserted at the junction, but none 
were very close to the various breakpoints (Appendix C). One motif, (TTTAAA) that 
can induce curvature in the double helix, was present just 2bp distal to the duplication 
breakpoint (see Appendix C, Figure 5.14.) (Crothers et al., 1990;Toffolatti et a l ,
2002). Some sequence motifs were found near the 34bp stretch of sequence that was 
inserted at the breakpoint (Appendix C). Two copies of the murine parvovirus 
genome deletion hotspot (CTWTTY) were located upstream of the breakpoint, the 
nearest ending 4bp before the junction sequence (Appendix C) (Hogan and Faust, 
1986). One short sequence motif, (CAGR), which has been associated with deletion 
breakpoints in mice, was found near both ends of the inserted sequence (Appendix C, 
Figure 5.14.) (Steinmetz et a l, 1986).
5.7.6.2. 5kb around breakpoint in dJ1055C14
Several sequence motifs (the chi sequence GCTGGTGG, the V(D)J nonamer motif 
ACAAAAACC, the S.cerevisiae ARS, scaffold attachment consensus sequences and the 
murine MHC recombination hotspot sequence CAGRCAGR) were also over­
represented in the region around the breakpoint in dJ1055C14, but were not located 
close to the breakpoint (Appendix C) (Smith et al., 1981;Steinmetz et al., 1986;Akira 
et al., 1987;Krowczynska et al., 1990;Shiroishi et al., 1995). A single copy of the 
budding yeast consensus replication origin sequence (WTTTATRTTTW), which was 
over-represented relative to the expected frequency, was just 161bp distal to the 
breakpoint (Appendix C).
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Some sequence motifs were very close to the major breakpoint in dJ1055C14 in 
family 2. These included a DNA polymerase p frameshift hotspot (TTTT) and the 
murine parvovirus recombination hotspot (CTWTTY), all of which were either just 
proximal to or overlapping with the cU177E8-dJ1055C14 breakpoint in family 2 
(Figure 5.14. and Appendix C) (Been et a l, 1984;Hogan and Faust, 1986).
5.7.7. Matrix attachment regions
Both 5Kb regions around the breakpoints were searched for potential MARs by the 
MAR-Wiz program (see section 4.9.1.2.) (Singh et a l, 1997). Regions of high MAR 
potential were located close to the breakpoints in both cU177E8 and dJ1055C14 
(Figure 5.13.). It is possible that normally distant sequences could be brought into 
closer association if  both regions were associated with the chromosome scaffold with 
intervening sequences looped out, which could facilitate rearrangement of these 
sequences. As the MAR potential predicted using MAR-Wiz can be dependent on the 
sequence context, a larger (20Kb) region surrounding the breakpoint was also tested 
for the presence of MARs (Namciu et a l, 2004). When this was attempted, neither of 
the two potential MARs from the 5Kb regions were predicted to have the highest 
MAR potential in the region, but there was still a peak present at the relevant location 
in both regions, although eclipsed by other nearby regions of greater MAR potential. 
Although the MAR-Wiz program is only a predictor of MAR regions, and these 
would need to be experimentally verified for confirmation, it is still possible that the 
two breakpoints do fall within genuine scaffold associated regions.
242
5.7.8. In silico analysis of sequence from lOObp regions flanking breakpoints
Three separate short regions of sequence immediately flanking the breakpoints and 
inserted sequence were analysed in family 2, the main cU177E8 breakpoint (37289- 
37388bp), the additional sequence from cU177E8 (36104-35956bp) and the 
dJ1055C14 breakpoint (59759-59892bp) (Figure 5.4.).
5.7.8.I. Alternating purine/pyrimidines, polypurine and polypyrimidine tracts
The most striking feature of the purine/pyrimidine content close to the breakpoints in 
family 2 is a long homopurine tract just before the first breakpoint in cU177E8 
(Figure 5.14.). This 85bp run of purines ends just 9bp before the 4bp breakpoint 
region and contains 97.6% purine residues (Figure 5.14.). This region of low 
sequence complexity was identified by Repeatmasker as a CT rich sequence 
(Repeatmasker was using sequence from the other strand in these analyses) (Table 
5.5.). No other homopurine, homopyrimidine or alternating purine/pyrimidine tracts 
of lObp or greater were present in this lOObp region from cU177E8 (Figure 5.14.).
A single polypurine tract (14bp) and one polypyrimidine tract (12bp) were noted in 
the 134bp that included the short sequence inserted at the breakpoint from cU177E8, 
with each type accounting for about half this percentage amount (Figure 5.14.). The 
polypurine tract was within the sequence inserted at the breakpoint (Figure 5.14.).
The sequence from around the more distal breakpoint in dJ1055C14 just contained 
two lObp polypurine tracts, each just either side of the cU177E8-dJ1055C14 
breakpoint (Figure 5.14.).
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To determine whether the occurrence of a polypurine tract near the breakpoint in 
cU177E8 was unusual, a 100Kb region (centred on the breakpoint at 37339bp in 
cU177E8) was searched for polypurine tracts of between 40-140bp in length on both 
DNA strands using the DNA Pattern Find program (see section 2.2.10.3.). 3 regions 
with at least 40 contiguous purine residues were found, including the region nearest to 
the breakpoint. One of the other tracts consisted of a 59bp homopurine run (mainly 
adenines), associated with the 3' end of an AluSg/x repeat located in dJ635G19, 18Kb 
proximal to the breakpoint. This A-rich sequence was probably derived from the 
poly(A) tail during retrotransposition. The other long homopurine.homopyrimidine 
tract was positioned more proximal to the breakpoint (43Kb), also within dJ635G19. 
This region consisted of 116bp of pure pyrimidines (or purines on the other strand), 
which comprised several short tandem repeats of sequence, including 39bp of 
(TTTTC)n tandem repeats and 56bp matching a (TTCC)n tandem repeat array, as found 
by the Tandem Repeats Finder programme (see section 2.2.10.8.) (Benson, 1999). 
This homopurine.homopyrimidine tract was also located close to the 3' end of a 
partial AluVo element, and could have been derived from a poly(A) sequence 
associated with this repeat, with a subsequent expansion of the homopurine tract by 
either slipped strand mispairing during DNA replication, or by misaligned intra-allelic 
recombination (Arcot et al., 1995).
Polypurine.polypyrimidine tracts of 40bp or longer were also searched for in a 100Kb 
region around the breakpoint in dJ1055C14. Four regions were found, one of which 
was 2Kb distal to the breakpoint, a 40bp A-rich sequence that had also been identified 
by Repeatmasker analysis of the region (Table 5.6.). One of the polypurine tracts, 
which was 18Kb proximal to the breakpoint, was 138bp in length, and was located 
within an MSTA LTR element sequence.
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This analysis indicates that homopurine.homopyrimidine tracts of greater than 40bp in 
length, such as the one found close to the cU177E8 breakpoint, are not particularly 
common within these regions of genomic sequence, occurring 3-4 times per 100Kb, 
so the association of one of these regions of low complexity sequence with one of the 
breakpoints in family 2 may be important.
5.7.8.2. Repeats and secondary structures
Both the original genomic sequences from the breakpoint regions and junction 
sequences were searched for the presence of various types of repeats (Figure 5.15.). 
Repeated sequences in the DNA may predispose to the formation of secondary 
structures, which could be involved in stimulating the rearrangements, or alternatively 
the presence of repetitive sequences could help to stabilise the DNA during the 
rearrangement processes (see section 4.9.2.2.) (Chuzhanova et al., 2003). A few 
different types of repeats were found in the original genomic sequence (Figure 5.15.). 
In the junction sequence, however, many different repeats, of all the different types 
(direct, inverted, symmetric, complementary) were present (Figure 5.15b.). Many of 
these repeated sequences were associated with the polypurine tracts in the junction 
sequence (Figures 5.14. and 5.15.).
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Figure 5.12. Position of potential MARs near the proximal breakpoints in family 2. 
(a.) is centred on the breakpoint in cU177E8 and (b.) shows the 5Kb region around 
the breakpoint in dJ1055C14. MAR potential is as found by the MAR-Wiz program 
(Singh et al., 1997).
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Main breakpoint in cU 177E8 (37289-37388bp)
GAGGAGAAAGAGGAGGAGAAAGAGGAGGAGAAGAAAAGTGTCCAGAAGAGATTTTTAAAAATTAAGAAATAAATTTAGAGTAATGCATCGGATGAAAAGA
RRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRYRYYYRRRRRRRRYYYYYRRRRRYYRRRRRRYRRRYYYRRRRYRRYRYRYYRRRYRRRRRRR
49bp insertion from cU177E8 into the breakpoint (36104-35956bp)
TTCCTCTTATTCAGGTCTTTTTTATTTTTGCAGCACTCCCCTTTTCTGTTGAGACAGGCTAGTGTCTGGCCCAGAGGATGAGGGGGAGAAAGACACTTTC
YYYYYYYYRYYYRRRYYYYYYYYRYYYYYRYRRYRYYYYYYYYYYYYRYYRRRRYRRRYYRRYRYYYRRYYYRRRRRRYRRRRRRRRRRRRRRYRYYYYY
CCAGAATGGAGCAGGTCTGCGTGAGCAACTGGACTTGGAGCTGTGCATC
YYRRRRYRRRRYRRRYYYRYRYRRRYRRYYRRRYYYRRRRYYRYRYRYY
Main breakpoint and short deletion from dJ1055C14 (59759-59892bp)
ATGGTACATGACACCACTGTCAGTGATTGTTTAAGAAGGTAAAAAAAAGATTGGTGAGGGAGGAGTCAGTGATG V/TC' ATGGGTGATTAGGTTA
RYRRYRYRYRRYRYYRYYRYYRRYRRYYRYYYRRRRRRRYRRRRRRRRRRYYRRYRRRRRRRRRRYYRRYRRYR RYRRRYRRYYRRRYYR
TTAGTATTATCACCAAATGATAATACTCCTCCAT
YYRRYRYYRYYRYYRRRYRRYRRYRYYYYYYYRY
Figure 5.13. Nucleotide composition of short regions surrounding the breakpoints sequenced from family 2. 50bp either side of the various 
breakpoints are shown on the top of the pairs, and the classification of each nucleotide (R -  purine, Y -  pyrimidine) is shown on the lower line of the 
pairs. Tracts of alternating purines/pyrimidines (R/Y), or pyrimidines/purines (Y/R), of 10 nucleotides or greater, are underlined. Homopurine and 
homopyrimidine runs of 10 nucleotides or greater are in bold type. Sequences not found at the breakpoint are shaded grey, sequences present in the 
rearrangement are shaded in various colours, as in Figure 5.13.
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Main breakpoint in cU177E8 (37289-37388bp)
GAGGAGAAAGAGGAGGAGAAAGAGGAGGAG^AGAAAAGTGTCCAGAAGAGATTTTTA&AAATTAAGAAATAAAT^'TAGAGTAATGCATCGGATGAAAAGA 
-  *  K >  <     ---------
49bp insertion from cU177E8 into the breakpoint (36104-35956bp)
-> ------
TTCCTCTTATTCAGGTC^TTTTTATTTTTGCAGCACTCCCCTTTTCT^TTGAGACAGGCTAGTGTCTGGCCCAGAGGATGAGGGGGAGAA^GACACTTTC 
-----------= ^ ------>  < -----------   ► 4 ----------------
CCAGAATGGAGCAGGTCTGCGTGAGCAACTGGACTTGGAGCTGTGCATC
<----------
Main breakpoint and short deletion from dJ1055C14 (59759-59892bp)
a t g g t a c a t g a c a c c a c t g t c a g t g ^ t t g t t t a a g a a g g t a a a a a a a a g a t t g g t g a g g g a g g a g t c a g t g S I t g  * . C T C C  a t g g g t g a t t a g g t t a
 ►  ► <----------
TTAGTATTATdACCAAATGATAATACTCCTCCAT
^ —   * = —<■
Figure 5.14a. Location of internal sequence repeats around the breakpoint regions in family 2.
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Junction sequence
>
— ► >
GAGGAGAAAGAGGAGGAGAAAGAGGAGGAGAAGAAAAGTGTCCAGAAGAGACAGGCTAGTGTCTGGCCCAGAGGATGAGGGGGAGAAAGACACTTTGG
  > „ ~    ►  ► < ^ ------------
* *  ^
 >   >  >    - >  ^
TGAGGGAGGA^TCAGTGATGGGTGATTAGGTTATTAGTATTATCACCAAATGATAATACTCe^CCAT
 ►  -  — * --------------------------------------------►   <  ~
Figure 5.14b. Location of internal sequence repeats within the junction sequence from family 2. Legend on next page.
Figure 5.14. Legend. Internal repeats around the breakpoints and junction fragment 
in family 2. Figure 5.14a. shows the normal sequence, with 50bp on either side from 
around the breakpoints in cU177E8 and dJ1055C14, and Figure 5.15b. shows the 
junction sequence. Sequences found at the breakpoint are coloured as before in 
Figure 5.11., and the sequences not found in the final rearrangement are shaded grey. 
Nucleotides that form part of repeat sequences are shown in bold. The type of repeat 
found is shown by the arrows above and below the sequence: direct (— ►), inverted 
( — ► ), symmetric ( — >. ) and complementary ( — >  ). Repeats were searched for 
using Oligorep (see sections 4.9.2.2. and 2.2.10.5.).
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5.8. Discussion
5.8.1. Sequencing of a breakpoint in family 2 has revealed a complex 
rearrangement
This work has demonstrated that the affected boy and carrier mother from family 2 
carry a complicated rearrangement of the PLP1 genomic region that has resulted in 
the duplication of PLP1, and a phenotype of PMD in the affected boy(2:9. Previous 
studies had mapped the most proximal and distal extent of the duplicated regions in 
this family without detailed investigation of the dosage of sequences within the 
apparently duplicated region (apart from PLP1), and had assumed that this family 
carried a simple tandem duplication, as already described in family 1 (Figure 4.1.) 
(Woodward et al., 2000). It has now been shown that there are at least two non­
contiguous regions of duplicated sequence within Xq22.2 in this family. The 
breakpoint sequenced from this family so far only includes sequence proximal to 
PLP1 on the X chromosome, and as PLP1 is duplicated there must also be at least one 
breakpoint distal to PLP1. The probable location of another breakpoint proximal to 
PLP1 in family 2 has been mapped by UPQFM-PCR in this study to the centromeric 
portion of genomic clone cV857G6 (Figure 5.7. and Table 5.4.). It is tempting to 
speculate that the breakpoint junction in this region may be joined to sequence distal 
to PLP1, which would result in an inversion of the cU177E8-cV857G6 duplicated 
region, with the duplicated sequence including PLP1 remaining in the original 
orientation (Figure 5.15.). Until further sequence from the other breakpoint(s) in this 
family is obtained, the true nature of the rearrangement cannot be fully determined. 
The putative rearrangement suggested in Figure 5.15. is probably the simplest 
scenario based on the sequence and dosage data from this family so far, but it is just 
as likely that there are several more undetermined breakpoints involved in this 
rearrangement. The X chromosomes from this family appear to have a normal
morphology, so large-scale rearrangements involving the X or other chromosomes are 
unlikely to be present. Previous interphase FISH data using clones distal to PLPl 
indicated that this family had a duplication that extended to a similar region as in 
family 1, with a breakpoint possibly near or within the distal LCRs (Figures 3.4., 4.1. 
and 4.7.) (Woodward et al., 2000).
CV857G6 dJ 1055C14
<cen
im PLPl tel >
Duplicated 
and inverted Duplicated
Normal
<cen tel >
CU177E8 CV857G6 dJ1055C 14 PLPl PLPl
Sequenced
breakpoint Rearranged
Figure 5.15. Diagram showing a possible rearrangement in family 2, based on the 
sequencing, UPQFM-PCR and interphase FISH data gathered on this family to date. 
The upper part of the diagram shows a normal X chromosome (not to scale), with the 
various coloured boxes indicating regions involved in the rearrangement. Dashed 
lines show the position of breakpoints (either based on sequence and UPQFM-PCR 
data, or just theoretical). cU177E8 is red, cV857G6 is lilac, dJ1055C14 is blue, PLPl 
is coloured pink, and a region around a theoretical distal breakpoint is yellow. The 
grey areas show the areas of the sequence that have may have been duplicated in the 
rearrangement. The lower part of the diagram shows the possible rearrangement. A 
length of sequence from cU177E8 to cV857G6 is duplicated and inverted, with 
sequence from cU177E8 joined to dJ1055C14, as has been found by sequencing 
(Figure 5.4.). A breakpoint distal to PLPl joins on to the end of the duplicated 
sequence from cV857G6, resulting in inverted and duplicated sequence originating 
proximal to PLPl being between two directly repeated stretches of sequence 
including PLPl.
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5.8.2. Nature and possible mechanisms of the rearrangement
As with the duplication breakpoint in family 1, the breakpoint sequenced from family 
2 appeared most compatible with a mechanism of non-homologous end joining. 
There was no major sequence homology found between any of the breakpoints or 
flanking sequences involved in the rearrangement, and the different breakpoints 
contain a short sequence overlap (2-4bp), all of which is typical of repair by NHEJ 
(Figures 5.4. and 5.13.) (reviewed in (Lieber et al., 2003)). As discussed before, in 
chapter 4, NHEJ is a mechanism used for the repair of double-strand breaks in DNA, 
and the unusual rearrangement in family 2, which has been partially characterized in 
this chapter, may have resulted from illegitimate joining of the ends of different DSBs 
on the X chromosome by NHEJ (see section 4.12.4.). It is also a possibility that a 
similar mechanism to that proposed for the simple tandem duplications, with 
homologous strand invasion and non-homologous repair could also be involved in the 
rearrangement in family 2 (see section 4.12.5.). The sequence close to the sequenced 
breakpoints has been investigated for the presence of various sequence motifs and 
other factors that may have contributed to the generation of DSBs. Some intriguing 
possibilities have been noted and are discussed further in sections 5.8.2.2., 5.8.2.3. 
and 5.8.2.4.
5.8.2.I. Insertion of a short sequence at the breakpoint
The junction between cU177E8 and dJ1055C14 sequence also contains 49bp of 
additional inserted sequence, from cU177E8, originating from a sequence expected to 
lie 1.3Kb distal to the breakpoint within the duplicated region (see section 5.4.3.). 
Although the majority of breakpoints repaired by NHEJ are joined at sites of 
microhomology, approximately 10-20% of NHEJ junctions in mammalian cells 
contain insertions of extra nucleotides at the breakpoint, termed “filler DNA” (Roth et
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a l , 1989;Roth et a l , 1991;Lieber et a l , 2003). Most filler DNA sequence is very 
short, typically just consisting of a single nucleotide, but in rarer cases it can be much 
longer, with tens or hundreds of extra nucleotides added between the two sequences 
(Roth et a l , 1989;Merrihew et a l , 1996). As has been found with the breakpoint in 
family 2, filler DNA sequences can originate from elsewhere in the genome (Williams 
and Fried, 1986;Merrihew et a l , 1996;Sargent et a l , 1997;Lin and Waldman, 
2001a;Little and Chartrand, 2004). Inserted filler DNA can also originate from 
extrachromosomal DNA, such as viral genomes present in transformed cell lines, 
retrotransposable elements, introduced oligonucleotide fragments and plasmids (Roth 
et al., 1991;Sargent et a l , 1997;Lin and Waldman, 2001a;Lin and Waldman, 2001b).
5.8.2.2. Recombination/rearrangement associated motifs
Various short sequence motifs that have been found to be involved in recombination, 
rearrangements and DNA breaks were searched for near the breakpoints and some 
were found at higher than expected frequencies (see sections 5.7.7.1. and 5.7.9.1). 
However, it is unclear whether any of these motifs could be involved in the breakage 
and rearrangements in this family. Generally, each breakpoint region examined had a 
different complement of motifs in the vicinity, whether at an increased frequency or 
not (see section 5.7.7.2. and 5.7.9.1., Appendix C). It is difficult to determine if any 
of these motifs could be involved in the breakage and rearrangement, but this cannot 
be discounted at this stage.
5.8.2.3. Polypurine tracts and short repeats
One of the most striking features of the sequence near the breakpoint in family 2 is the 
polypurine tract just within the duplicated sequence from cU177E8 (Figure 5.13.). As 
well as this sequence having low nucleotide complexity (83bp of either adenine or
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guanine, interspersed by two isolated thymines), there are also some internal repeat 
sequences, both direct and symmetric, found near the breakpoint (see section 5.7.9.3, 
Figures 5.13. and 5.14.). The analysis in Figure 5.14a. is only concerned with the 
38bp region of the purine tract closest to the breakpoint and does not include the 
whole of the tract. When the 85bp of purine-rich sequence is looked at in isolation 
using the same method and settings to find internal repeated sequences, a large 
overlapping direct repeat (27 nucleotides in length, with 4 mismatches) was found, as 
well as a perfect symmetric repeat 16bp in length (Figure 5.16a.). There does seem to 
be an association between stretches of purine residues and the other breakpoint 
regions so far identified in family 2, with polypurine tracts greater than lObp in length 
found close to most breakpoints (Figure 5.14.). Polypurine tracts have been found to 
be over-represented at both deletion and translocation breakpoints and may 
themselves be involved in the mechanisms of DNA rearrangement (Abeysinghe et al.,
2003).
5.8.2.4. Triplex DNA and secondary structure
The presence of a perfect symmetric (or mirror) repeat is interesting, as sequences of 
this nature have been shown, under various conditions to form a DNA triplex 
structure (Mirkin et al., 1987;Kohwi and Kohwi-Shigematsu, 1988;Kohwi, 
1989;Bemues et a l , 1990;Dayn et al., 1992;Kohwi and Kohwi-Shigematsu, 
1993;Gilbert and Feigon, 1999). The triplex formation of DNA involves the binding 
of single stranded DNA in the major groove of the conventional B-DNA double helix, 
with the third DNA strand able to specifically bind to the base pairs in the double 
helix via Hoogsteen hydrogen bonds (Figure 5.16c.). There are several different 
possible types of DNA triplex, including one where a third homopyrimidine strand 
binds to the homopurine strand within the double helix in a parallel orientation,
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forming the triplet bases (T-A-T and C+-G-C), and another possible triplex structure 
occurs when a single homopurine strand binds within the major groove in an 
antiparallel orientation, forming the triplets (A-A-T and G-G-C) (Reviewed in 
(Gilbert and Feigon, 1999)). The pyrimidine-purine-pyrimidine triplex structure 
forms more readily under acidic conditions, as one of the triplex base pairs requires a 
protonated cytosine (C*) on the third strand (Mirkin et al., 1987;Gilbert and Feigon, 
1999). Other factors can affect the propensity of susceptible sequences to form triplex 
structures, such as the degree of DNA supercoiling and the presence of some metal 
ions, eg Mg2+, in vitro (Kohwi and Kohwi-Shigematsu, 1988;Kohwi, 1989;Bemues et 
a l , 1990;Dayn et a l , 1992;Kohwi and Kohwi-Shigematsu, 1993).
The mirror repeat near the breakpoint in cU177E8 could lead to the formation of a 
DNA triplex, as described above, and one possible triplex conformation of this DNA 
sequence is shown in Figure 5.16b. DNA replication has been shown to terminate at 
triplex structures associated with homopurine tracts and other triplex-forming 
sequences (Lapidot et a l , 1989;Dayn et a l , 1992). One source of a double-strand 
break in this sequence could possibly be as a result of replication termination at a 
secondary structure formed at the mirror repeat in the polypurine tract. The triplex- 
forming potential of some sequences within human DNA has been proposed as a 
mechanism in the pathogenesis of some disorders. The formation of cysts during the 
progression of autosomal dominant polycystic kidney disease has been suggested to 
be triggered by the loss of function of the normal allele of the PKD1 gene, and the 
high rate of cyst formation has been attributed to the presence of a long (2.5Kb) 97% 
pyrimidine tract, within which replication blockage has been shown to occur 
frequently in vitro (Patel et a l, 2004). Triplex DNA has also been suggested to be 
involved in large-scale mitochondrial DNA rearrangements and may also trigger
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recombination (Kohwi and Panchenko, 1993;Rooney and Moore, 1995;Rocher et a l , 
2002;Napierala et al., 2004). Triplex forming DNA sequences may be involved in 
bringing distant sequences together in the nucleus and in other aspects of chromatin 
structure (Ohno et a l, 2002).
Another way in which a triplex secondary DNA structure could be involved in the 
rearrangement seen at the cU177E8-dJ1055C14 breakpoint in family 2 is by 
stabilizing the rearrangement. As well as the perfect mirror repeat in the polypurine 
tract, there is an imperfect copy (13/16 identical nucleotides) of one of the repeat units 
within the 49bp inserted between the two main sequences at the breakpoint (also from 
cU177E8, but originating from 1.3Kb away distal to the breakpoint) (Figure 5.16a.). 
It is possible that this short sequence containing the partial copy of the repeat could 
interact with the triplex-forming mirror repeat, and the resultant proximity of these 
sequences may have been important in the rearrangement, or the formation of a triplex 
may have stabilized the rearrangement (Chuzhanova et a l, 2003). Some possible 
interactions between the various repeats are shown in Figures 5.16d and 5.16e. A 
triple helix could form between the two sequences, e.g. double stranded DNA from 
one of the mirror repeats could form a triple helix with the one of the DNA strands 
with a partial copy of the repeat (Figure 5.16d.). Another potential configuration 
could be a triplex forming from the symmetric repeat sequence in the polypurine tract, 
as described before in Figure 5.16b, and one strand of the partial repeat could perhaps 
form a short double helix with the unpaired strand (Figure 5.16e.).
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Figure 5.16. Symmetric repeats, Hoogsteen base pairs, and possible triplex DNA configurations. Figure legend on next page.
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Figure 5.17. Legend. Figure showing location of repeats within the polypurine tract 
close to the breakpoint in family 2, and some possible secondary structures resulting 
from the symmetrical repeats, (a.) shows the sequence from the cU177E8-dJ1055C14 
breakpoint, and all of the polypurine tract near the major breakpoint in cU177E8. The 
various sequences are shaded as in Figure 5.12., sequence up to position 37335 in 
cU177E8 is red, between 36010-36052bp in cU177E8 (inserted sequence) is blue and 
sequence from dJ1055C14, starting at position 5981 lbp is green. Overlaps between 
the sequence at the breakpoints are shaded purple or pink. Internally repeated 
sequences within the polypurine tract are shown by arrows, grey and above the 
sequence for direct repeats, black and underneath the sequence for symmetric repeats. 
Nucleotides contained in the repeats are highlighted in bold type. A partial match to 
one of the symmetric repeats within the inserted cU177E8 sequence is also 
underlined, (c.) Some Hoogsteen base pairings that occur in triplex DNA structures. 
Taken from (Vetcher et a l, 2002). (b.) A triplex DNA structure that could be formed 
by one (single-stranded) half of the mirror repeat folding back on itself and forming 
Hoogsteen bonds with the other (double-stranded) half of the homopurine symmetric 
repeat, in an antiparallel orientation, leaving the remaining strand single-stranded. 
The various sequences are coloured as in (a.), and sequences from the complementary 
polypyrimidine strand are coloured black. Watson-Crick hydrogen bonds are shown 
as pink vertical lines and Hoogsteen bonds as lilac double dots, (d.) A possible triplex 
secondary structure involving part of the inserted cU177E8 sequence and one of the 
two halves of the mirror repeat, (e.) Another possible secondary structure that could 
be formed between the two cU177E8 sections of sequence. A triplex involving the 
mirror repeat is formed (as in b.) and the partial copy of one of the repeats from the 
inserted sequence could base-pair with the unpaired loop containing the 
complimentary copy of one of the mirror repeats.
259
5.8.2.5. DNA replication and rearrangement in family 2
Near the main junction sequence in family 2 from dJ1055C14 sequence, there was 
found to be a short deletion of 13bp, which in the genomic sequence for this clone is 
flanked by a 3bp (ATG) direct repeat (Figures 5.4. and 5.12.). While this deletion 
could result from repair of a DSB by NHEJ, another possible cause of this type of 
small sequence deletion is replication slippage, which may occur following 
polymerase pausing or stalling on the template (Viguera et al., 2001). It is also a 
possibility that the other breakpoints could be attributed to replication termination at 
secondary structural motifs causing a DSB.
5.8.2.6. Capture of long sequences at DSBs
Most studies of sequence capture at DSBs have only characterised short sequences 
inserted into a few NHEJ repair events (Roth et al., 1989;Merrihew et al., 1996;Lin 
and Waldman, 2001b). However, many of the protocols used to identify filler 
sequence capture at DSBs have been PCR-based, so if a large-scale rearrangement or 
large insertion of sequence into the DSB has occurred this may either be too large to 
be amplified by PCR, or may no longer be flanked by the appropriate primer-binding 
sites. The occurrence of these types of events would hence be underestimated, and 
other reports have suggested that a significant proportion of NHEJ DSB repair events 
may involve either a large insertion of filler sequence at the break, or may trigger a 
large-scale rearrangement (Lin and Waldman, 200la;Allen et al., 2003). The 
rearrangement discovered in family 2 could be a result of a large DNA fragment, e.g. 
one originating from between cU177E8 and cV857G6, being involved in NHEJ repair 
of a more distal DSB event (Figure 5.15.). There is at least one more, as yet 
unsequenced, breakpoint in the PLPl region in this family, and as the sequences just 
proximal to the breakpoint and end of the duplicated region in dJ1055C14 are not
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duplicated, it is unlikely that the proximal cU177E8-cV857G6 duplicated segment is 
simply inserted into a DSB in this region (Figure|5.7., Tables 5.3. and 5.4.). Fragile 
sites are loci where gaps or breaks in chromosomes can be induced under certain 
conditions (Rassool et a l, 1991). It has been shown that exogenous DNA integrates 
preferentially into some fragile sites, which may be as a result of capture of sequences 
during DSB repair (Rassool et a l , 1991;Lin and Waldman, 2001a).
It is still possible that the rearrangement in family 2 could result from a process of 
strand invasion by free DNA ends, followed by replication, similar to that described 
in section 4.12.4. Although the microhomologies observed at the breakpoints in 
family 2 have been attributed to NHEJ repair, a “copy-join” model has been proposed 
for random integration of extrachromasomal or transfected DNA, where the ends of 
the transfected DNA prime synthesis on a single-stranded chromosomal region by 
binding to a few homologous nucleotides within the single stranded region (Merrihew 
et a l, 1996). In this manner, segments of genomic sequence from several different 
sites could be picked up by a single free end, initially generated by a DSB, and joined 
together by regions of microhomology (Allen et al., 2003).
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5.9. Summary
Through a combination of experimental techniques, a rearrangement breakpoint has 
been sequenced in family 2. Contrary to expectations based on existing data, the 
PLPl-containing duplication in this family was discovered not to be an 
uncomplicated tandem duplication event (as found in several other cases of PLPl 
duplications) (Woodward et al., in preparation;Iwaki et a l , 2003). Instead the 
rearrangement involved at least two non-contiguous duplicated regions, one of which 
was inverted with respect to the original sequence during the rearrangement. These 
data from family 2 demonstrate the importance of determining the actual sequence 
present at these types of duplications for enabling understanding of the mechanisms 
behind these events.
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6.1. ANALYSIS OF FAMILY 3
Previous work had found that an affected male (3:6) and his carrier mother (3:4) had an 
unusual duplication of PLPl, with the duplicated copy of PLPl located in Xq26 (Figure
2.2.) (Hodes et al., 2000;Woodward et a l , 2003). This rearrangement was not visible on 
G-banded chromosomes. In addition, the female carrier was found to carry a mosaic 
deletion of part of Xq in the chromosome that harboured the duplication (Hodes et al., 
2000;Woodward et al., 2003). This deletion encompassed both copies of PLPl. Various 
strategies were pursued in an attempt to characterise the various duplication and deletion 
breakpoints in this family, to gain insight into the molecular mechanisms involved, and 
also to determine if the duplication and Xq deletion were unrelated events, or if they were 
connected in some way.
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6.2. Xq26 PLPl insertion family mosaic deletion analysis
6.2.1. Metaphase FISH
Mapping of the size of the deletion and the position of the breakpoints in the mosaic 
female carrier with a PLPl duplication and a large deletion was initially carried out using 
metaphase FISH. Previous work had shown that both an XIST  FISH probe mapping to 
Xql3.3, and an Xq subtelomeric FISH probe, gave a signal on the X chromosome 
containing the deletion (Woodward et al., 2003). Biotinylated genomic PAC and BAC 
clones were hybridised to metaphase chromosomes, and fluorescently detected using 
FITC conjugated to avidin. Using this strategy, the proximal breakpoint was found to lie 
within bA346E8 located in Xq21.1 (Table 6.1a, Figure 6.1.). The distal breakpoint was 
found to be between the adjacent clones bA183K14 and bA79A21, in the Xq27.3 
cytogenetic band (Table 6.1b, Figure 6.2.). According to data from the Ensembl genome 
browser, this interstitial deletion included approximately 65Mb, and comprised over half 
of the long arm of the X chromosome.
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(a) (b)
Distal clones band +/-
dJ260J9 (.FGF13) Xq26.3 -
bA51C14 (SOX3) Xq27.1 -
dJ177G6 Xq27.1 -
dJ507I15 Xq27.1 -
dJ406C18 Xq27.2 -
dJ73H14 Xq27.2 -
dJ357K22 Xq27.3 -
bG256022
.....
Xq27.3 -
dJ145B12 Xq27.3 -
bA550B3 Xq27.3 -
bA159A24 Xq27.3 -
bG278N14 Xq27.3 -
bA183K14 Xq27.3 -
bA79A21 Xq27.3 +
dJ203P18 Xq27.3 +
Proximal clones band +/-
dJ570L12 {PGK1) Xq21.1 +
(U795G23 Xq21.1 +
bA102P23 (SH3BGRL) Xq21.1 +
bA346E8 Xq21.1 +/-
bB52K8 Xq21.1 -
dJ2A2 Xq21.1 -
dJ717L12 Xq21.1 -
dJ326L13 (POU3F4) Xq21.1 -
dA43C13 (REP1) Xq21.2 -
Tables 6.1a and b. Results of deletion breakpoint analysis. Clones are listed in order 
along the X chromosome, centromere to Xq telomere. + indicates that a FISH signal was 
seen for that clone on the X chromosome containing the deletion, - indicates that a FISH 
signal was not seen for that clone on the X chromosome containing the deletion. Some of 
the known genes located in the clones are in brackets after the clone name.
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■------— -H—iSH3BGRL
79.2Mb 79.3Mb 79.4Mb 79.5Mb 79.6Mb
Figure 6.1. FISH mapping of the proximal deletion breakpoint. Metaphase 
chromosomes from the mother in the Xq26 insertion family, with probe bA346E8 signal 
shown in green (Xq21.1) and a red X centromere probe. The signal for bA346E8 is much 
fainter on the deleted X chromosome, making it likely that this clone contains a deletion 
breakpoint. The positions of bA346E8 and adjacent clones are shown as dark grey boxes, 
the scale shows the position on the X chromosome according to the Ensembl genome 
browser (version 21.34d.l). The location of the SH3BGRL gene, which is close to the 
breakpoint-containing clone, is shown, and interspersed repeat content (as displayed on 
the Ensembl genome browser, calculated using Repeatmasker) is shown just above the 
scale bar.
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4 4
Q8NAQ8
bA183K14
H  dJ203P18
bA79A21
144.25Mb 144.30Mb 144.35Mb 144.40Mb
Figure 6.2. FISH mapping the distal deletion breakpoint. Metaphase spreads are shown 
from the mother in the family with an insertion of PLPl into Xq26. The X centromere 
probe is shown in red and the two genomic clones are each shown in green on the 
metaphase chromosomes. The positions of bA183K14, bA79A21 and the proximal 
portion of an adjacent clone, dJ203P18, are shown as grey boxes, the scale shows the 
position on the X chromosome according to the Ensembl genome browser (version 
21.34d.l). The location of a nearby transcript, Q8NAQ8, which is close to the 
breakpoint-containing clone, is shown, and interspersed repeat content (as displayed on 
the Ensembl genome browser, calculated using Repeatmasker) is shown just above the 
scale bar.
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6.2.2. STS analysis on flow-sorted chromosomes
A cell line from the carrier female that was known to contain both the deleted and 
duplicated cells was flow-sorted (by Nigel Carter, Sanger Institute), so that the two 
differently sized populations of X chromosomes were separated. This enabled further 
mapping of the precise locations of the ends of the deletion using STS mapping 
(sequence tagged site), as STS sequences that were contained within the deletion would 
only be able to be amplified from the full sized chromosomes, not from the chromosome 
with the deletion. Flow sorting was not able to separate the normal X and the X with the 
duplication, as they only differed in size by approximately 600kb. Only a small amount 
of DNA was recovered following flow sorting (approximately 50 chromosomes), so to 
provide more material for analysis, the DNA from the flow-sorted chromosomes was 
further amplified using degenerate oligonucleotide primed PCR (DOP-PCR, see section
2.2.1.2.) (Telenius et al., 1992). Primer pairs were then designed to amplify short 
regularly spaced stretches of sequence (STSs), that were within the genomic regions 
where the ends of the deletion had been mapped using metaphase FISH. These STS 
primers were then used in PCRs with the DOP-PCR amplified flow-sorted chromosomes 
as a template. This made it possible to narrow down the location of the breakpoints 
further, as STSs that failed to amplify from the deleted chromosome but that did give a 
PCR product from the full size X chromosomes were most probably included in the 
mosaic deletion (Table 6.2.). For the proximal breakpoint, the PCR results agreed with 
the FISH results, placing the breakpoint within bA346E8, between positions 1142— 
8732bp in the submitted sequence for this clone. bA346E8 had shown a reduced signal 
on the deleted X by FISH (Figure 6.1.).
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6.2.2.1. Disparity between FISH and STS mapping of deletion breakpoint
At the distal breakpoint the FISH and STS-PCR results were apparently discordant. By 
metaphase FISH bA79A21 was present on the deleted X, with no obvious reduction of 
signal intensity (Figure 6.2.). However, the STS used that was within the published 
sequence for bA79A21 did not amplify by PCR from the deleted X chromosome, which 
was consistent with bA79A21 being within the deleted region (Table 6.2.). STS-PCR 
results for the adjacent distal clone, dJ203P18, showed that the proximal deletion 
breakpoint was within that clone, between positions 97926-98798bp in Z97180, the 
sequence submitted for this clone (Table 6.2.). A substantial overlap between these 
clones was confirmed by using some of the STS primers that had been used for the 
deletion mapping on DNA from the two clones bA79A21 and dJ203P18 (Figures 6.3a 
and 6.3b). This mapped the telomeric end of clone bA79A21 to between 52464bp and 
4928bp in Z97180, which is within the telomeric half of the submitted sequence for 
dJ203P18 (Figure 6.3b). This indicated that at least 40Kb of the human genomic DNA 
present in BAC bA79A21 fell beyond the deleted region, which would probably be 
enough to account for the metaphase FISH results showing that this clone was not 
reduced in signal intensity on the deleted X chromosome (Figure 6.2. and Table 6.2.). In 
addition, data showing the relative sizes of the clones in this region, based on restriction 
fragment fingerprint data available from the Sanger Institute shows that bA79A21 and 
dJ203P18 do overlap substantially (Figure 6.4.).
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Clone Strand Position of STS in clone
Full size 
chromosomes
Deletion
chromosome
Proximal deletion breakpoint
bA102P23
|
+ 132693-132870 + +
bA102P23 + 133192-133394 + +
bA346E8 + 952-1142 + +
bA346E8 + 8386-8763 + -
bA346E8 + 17767-17970 + -
bA346E8 + 26616-26815 + -
bA346E8 + 69417-69621 + -
bA52K8 + 23495-23699 + -
Distal deletion breakpoint
bG278H4 + 159160-159378 + -
bA183K14 + 84019-84233 + -
bA183K14 + 129708-129900 + -
bA79A21 + 10058-10260 + -
dJ203P18 - 126544-126349 + -
dJ203P18 - 116587-116365 + -
dJ203P18 - 106044-105705 + -
dJ203P18 - 98827-98450 + -
dJ203P18 - 97926-97768 + +
dJ203P18 - 96946-96708 + +
dJ203P18 - 95757-95518 + +
dJ203P18 - 95565-95369 + +
dJ203P18 - 87934-87737 + +
dJ203P18 - 79512-79234 + +
dJ203P18 - 75170-74970 + +
dJ203P18 - 52664-52464 + +
dJ203P18 - 4928-4745 + +
Table 6.2. Results for STS mapping of Xq deletion breakpoint. (+) indicates that an 
STS did amplify from the flow-sorted chromosomes, (-) that it failed to amplify.
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Figure 6.3. bA79A21 overlaps substantially with dJ203P 18. Figure 6.3a shows agarose 
gel electrophoresis of PCRs using selected STS primers from within Z97180 (Z97180, 
the sequence submitted for dJ203P18, is on the reverse strand). Lanes 1-4 are using 
primers that amplify sequence between 75170-74970bp, lanes 5-8 are using primers for 
52664-52464bp and lanes 9-12 is using primers for sequence between 4928-4745bp (All 
positions given within Z97180). PCR product was seen in all reactions using clone 
dJ203P18 and human genomic DNA as a substrate, but for bA79A21 product was only 
seen for the two proximal sets of primers, and not for the primers from the most telomeric 
end of dJ203P18. lOObp ladder size marker is in the two outside lanes. Figure 6.3b 
shows a 200Kb region including bA79A21 and dJ203P18, with the approximate location 
of the STS primers used indicated by the arrows underneath dJ203P18. A plus sign (+) 
underneath a primer pair indicates that it did amplify from bA79A21, a minus sign (-) 
indicates that the primer pair did not amplify from bA79A21 DNA. Clones that have 
been sequenced on the forward strand are shown as dark grey boxes, dJ203P18 has been 
sequenced on the reverse strand and is shown as a lighter grey box.
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Detailed view: X:144.0Mbp-146.0Mbp
X:143.QMbp-145.0Mbp X:145.0Mbp-147.0Mbp
bA79A21
Figure 6.4. Screenshot from Sanger Institute X chromosome fingerprinted contig map 
based on restriction analysis of the whole clones showing relative positions and sizes of 
genomic clones, including dJ203Pl 8 and cU79A21, in a 2Mb window. Relative sizes of 
genomic clones are shown by the horizontal boxes, which are colour-coded according to 
the sequencing status at the time this map was last modified (on 12/12/2002 according to 
information on the website).
URL: http://www.sanger.ac.uk/cgi-bin/humace/fpcwebrnap.cgi?mode=rnap&map=bac.X. 144.html
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6.2.3. Amplifying deletion breakpoint by LR-PCR
As the two deletion breakpoints were mapped to relatively short genomic regions (just 
over 7.5Kb for the proximal end, and 872bp at the distal end), long-range PCR was 
carried out to obtain a junction product spanning the deletion breakpoint (Figure 6.5.). 
Three primers were designed in the 7.5Kb candidate region for the proximal breakpoint 
in clone bA346E8 and each was used in a separate reaction with a single reverse primer 
from dJ203P18 (Figure 6.5.). Products were seen for all three reactions after PCR and 
agarose gel electrophoresis using DNA template from 3:4 who carried the mosaic 
deletion and also a cell line from that individual (Figure 6.5b). As expected, no PCR 
products were produced from a reaction containing normal male control DNA, 
confirming that a novel breakpoint junction was being amplified (Figure 6.5b).
6.2.4. Sequencing of deletion breakpoint
The junction PCR products from the carrier female were gel-purified, and the shortest 
product was sequenced (see sections 2.2.1.4.4. and 2.2.4.) (Lane 11 in Figure 6.5b). 
Initial sequencing did not reveal the deletion breakpoint, so further nested primers were 
designed (starting at positions 4815 in bA346E8 and 98454 in dJ203P18). These primers 
amplified a shorter fragment (485bp) from carrier female genomic DNA and also from 
the previous 1.8Kb LR-PCR product, and they were used to completely sequence the 
breakpoint in the shorter nested PCR product (see section 2.2.4.).
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Figures 6.5a and 6.5b. Long PCR across the Xq deletion breakpoint, (a.) shows the 
position of the primers used for long PCR and sequencing relative to the proximal and 
distal deletion breakpoint regions (not to scale). The reverse primer used within 
dJ203P18 had previously been used for the deletion breakpoint mapping and was used in 
all three reactions. The names of the two primers that were used to sequence the 
breakpoint are shown in bold type, (b.) shows the PCR products using these primers after 
agarose gel electrophoresis and staining with ethidium bromide. G, genomic DNA from 
3:4; CL, DNA from a cell line from 3:4 with a large proportion of cells containing the 
deletion; N, normal male genomic DNA; no DNA; L, A/Hind III ladder. Lanes 1-4 are 
from a reaction using the 1446F primer, and show PCR products of approximately 4.6Kb 
in the genomic and cell line DNA, but not in a reaction using normal control DNA. 
Similarly, lanes 6-9 were from reactions containing the 2596F primer and lanes 11-14 
used the 4250F primer, and showed PCR products at sizes of approximately 3.4Kb and 
1.8Kb respectively, only in DNA from 3:4.
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A T T T  T G T G  T G C A T  A G  A A G T  G A T G T
cen tel-
ATTTCTTCTAGGTTTTCCATTTTGTGTGCATAjGAAGTGATGTCAGCAAAAAGGAACATAG
j Sequence up to nucleotide 98769 
in dJ203P18Sequence up to nucleotide 4987 
in bA346E8
4bp overlap between sequences 
at deletion breakpoint
Figure 6.6. Sequence from the deletion breakpoint in the female carrier. The 
electropherogram shows the breakpoint and ten nucleotides on either side from a 
sequencing reaction using a proximal breakpoint primer. More of the sequence found 
around the breakpoint is shown underneath, with sequence that originated frombA346E8 
(Xq21.1) highlighted in red, and sequence from dJ203P18 (Xq27.3) coloured blue. At 
the breakpoint there is a 4bp overlap between the two clones, which is in purple type.
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6.2.5. Analysis of deletion breakpoints
6.2.5.I. Interspersed repeats and G+C content
Analysis of the sequence of the deletion breakpoint, using BLASTn, showed that the 
485bp junction fragment consisted of 173bp of sequence originating from the proximal 
clone bA346E8 and 316bp of sequence from the distal clone dJ203P18, with a 4 
nucleotide overlap at the junction between the two sequences (Figure 6.6.). At the 
proximal end, the breakpoint fell within a long interspersed repeat element (L1P4), at 
position 3414 in the repeat consensus (Figure 6.7., Table 6.3.). The distal end of the 
deletion was in apparently unique sequence, with the nearest sequence features that were 
picked up by Repeatmasker analysis being an almost complete ^ 4/mSx element, which was 
320bp proximal to the breakpoint, and a (TA)n simple repeat, which was 1092bp distal to 
the breakpoint (Figure 6.7., Table 6.4.). Both the proximal and distal breakpoint regions 
contained numerous repetitive elements. In the 5Kb surrounding the proximal breakpoint 
interspersed repeat sequences made up almost all of the sequence (99.42% interspersed 
repetitive elements, 0.46% simple repeats, with 6 nucleotides remaining unmasked by 
Repeatmasker), and 57.08% of the 5Kb of sequence around the distal breakpoint was also 
characterised as belonging to interspersed repetitive elements by Repeatmasker software 
(Tables 6.3. and 6.4.). The especially high repeat content near the proximal deletion 
breakpoint consisted mainly of fragments of an L1P4 repeat element (Table 6.3.). The 
5kb surrounding the proximal deletion breakpoint had a G+C content of 36.66%, slightly 
lower than the average for the surrounding 1Mb (37.01%), and the 5Kb region around the 
distal deletion breakpoint had a G+C content of 39.82%, higher than the 36.55% G+C 
content in the surrounding 1Mb.
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6.2.5.2. Comparing sequences near the deletion breakpoints
There was no obvious sequence similarity, apart from the 4bp overlap, between the 
sequences around the proximal and distal deletion breakpoints. Both BLAST2 and 
BLASTz were used to compare 5kb centred on each breakpoint against each other, and 
no large regions of similarity were found between the two sequences (Figures 6.8. and 
6.9.). The only major similarities between the two sequences corresponded to regions 
containing Alu repetitive elements (Figure 6.9.). Alignment of the normal genomic 
sequences immediately surrounding the two deletion breakpoints by ClustalW did not 
show any great similarity between the two sequences, with no contiguous alignments of 
greater than four nucleotides seen (Figure 6.8.). In total there was 40.82% identity 
between the two sequences over the regions that were compared immediately around the 
breakpoint, and not including the 4bp overlap at the junction (Figure 6.8.).
6.2.5.3. Gene content near deletion breakpoints
Both the proximal and distal deletion breakpoints were located in gene-poor regions of 
the genome. At the proximal end, a 1Mb region centred on the deletion breakpoint only 
contained one annotated gene, SH3BGRL (SH3 domain-binding glutamic acid-rich-like 
protein), which was located 55.6Kb centromeric to the breakpoint (the location of this 
gene is shown in Figure 6.1.). The 1Mb region around the distal breakpoint contains 
similarly few potential genes, with just one predicted gene annotated, Q8NAQ8, which 
was 24.9Kb centromeric to the breakpoint (Figure 6.2.). Q8NAQ8 is a single exon 
transcript, coding for a protein of unknown function, without any significant homology to 
other known proteins.
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Proximal deletion breakpoint (Xq21.1)
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Figure 6.7. Figure showing 5Kb around the proximal and distal deletion breakpoint and 
the interspersed repeat content of these regions. The scale bars show distances from the 
start of the available sequence for each clone. The dashed vertical lines indicate the 
position of both breakpoints. Shaded and patterned boxes show the various types of 
repeats present.
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1 Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation
(-) 2493-1922 LIP (LINE/LI) 4212-4788 (577/6146) -
(-) 1931-1738 L1P4 (LINE/LI) 5307-5498 (192/6165)
(-) 1737-1423 AluJb (SINE/^/w) 3-308 (306/312) -
(-) 1422-1031 L1P4 (LINE/LI) 4906-5303 (398/6165) -
(-) 1030-330 L1P4 (LINE/LI) 3714-4399 (686/6146) -
(-) 339-307 (TTG)n (simple repeat) 2-24 +
(-) 306-4683 (+) L1P4 (LINE/LI) 5-3714 (3710/6146) -
Table 6.3. Repeat content (using Repeatmasker software, Repbase version 7.4) of the 
5Kb genomic region centred on the proximal deletion breakpoint (at position 4987) 
within bA346E8. The first column shows how far in base pairs each repeat element is 
from the deletion breakpoint, (-) indicates that the repeat element is proximal to the 
breakpoint and (+) that the repeat is distal relative to the breakpoint. The type of repeat 
and the class of repeat element to which it belongs are given in the second column. The 
third column shows which portions within the appropriate repeat consensus sequence 
each repeat has similarity to, and also how many bases out of the total repeat unit are 
present in the sequence. In the fourth column, the orientation of each repeat is shown; + 
shows a repeat is on the forward strand (i.e. running from centromere to telomere), - the 
repeat is on the reverse strand. If a repeat element was found to coincide with the 
beginning or end of the 5kb segment, the adjacent sequence was also analysed with 
Repeatmasker, until the true end of the repeat was found.
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Distance from 
breakpoint Repeat type
Position in repeat 
consensus sequence Orientation
(-) 2500-2030 THElD-int (LTR/MaLR) 630-1095 (466/1580) +
(-) 2025-1670 THE IB (LTR/MaLR) 6-364 (359/364) +
(-) 1669-1186 THElD-int (LTR/MaLR) 1090-1580 (491/1580) +
(-) 1185-812 THE1D (LTR/MaLR) 1-381 (381/381) +
(-) 769-657 L3 (LINE/CR1) 412-535 (124/1577) +
(-) 615-319 AluSx (SINEA4/w) 1-297 (297/312) -
(+) 1093-1203 (TA)n 1-111 +
(+) 1203-1224 (GA)n 2-23 +
(+) 1439-1725 AluSg (SINEM/w) 1-299 (299/310) +
(+) 2020-2493 L2 (LINE/L2) 2268-2755 (488/3314) +
Table 6.4. Repeat content (using Repeatmasker software, Repbase version 7.4) of the 
5Kb genomic region centred on the distal deletion breakpoint (at position 98769) within 
dJ203P18. The first column shows how far in base pairs each repeat element is from the 
deletion breakpoint, (-) indicates that the repeat element is proximal to the breakpoint and 
(+) that the repeat is distal relative to the breakpoint. The type of repeat and the class of 
repeat element to which it belongs are given in the second column. The third column 
shows which sections within the appropriate repeat consensus sequence each repeat has 
similarity to, and also how many bases out of the total repeat unit are present in the 
sequence. In the fourth column, the orientation of each repeat is shown; + shows a repeat 
is on the forward strand (i.e. running from centromere to telomere), - the repeat is on the 
reverse strand.
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bA346E8 4937 - TGTTTCCATGAATTTATTCATTTCT- TCTAGGTTTTCCATTTTGTGTGCA
Junction -TGTTTCCATGAATTTATTCATTTCT-TCTAGGTTTTCCATTTTGTGTGCA
dJ203pl8 98818 C C A G G C C A G A C A A T A A A G A A A A T G A T A T T T A T G G T C A C A T T T A T G T G A C C A
bA346E8 T A C T T G T G T T C T T G G T A G T C T C T G A G G G T T T T A G T - - A T T T C T G T G T G T T C A A  5036
Junction TAGAAGTGATGTCAGCAAA AAGGAACATAGCTGGATACTAAGTAAAAAA
dJ203p 18 TAGAAGTGATGTCAGCAAA AAGGAACATAGCTGGATACTAAGTAAAAAA 98719
Figure 6.8. Alignment of deletion breakpoint junction and lOObp flanking the two 
deletion breakpoints. Each breakpoint region was individually aligned by ClustalW to 
the sequence from the junction breakpoint and the two alignments were then combined 
together manually. Junction sequence that originated from bA346E8 (Xq21.1) is 
highlighted in red, and nucleotides aligned with this sequence from the genomic sequence 
around the distal breakpoint are also highlighted in red. Similarly, junction sequence 
originating from dJ203P18 (Xq27.3) is highlighted in blue, and any bases from the 
proximal genomic sequence aligned with this sequence are also shown in blue. The 4bp 
overlap at the junction between the two sequences is shaded purple.
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Figure 6.9. Dotplot output from Pipmaker comparing 5kb regions around the proximal 
and distal deletion breakpoints. Regions of sequence similarity are shown by black lines 
in the dotplot. Scale bars show the position within the two genomic clones bA346E8 (at 
the proximal end) and dJ203P18 (at the distal end). The position of the two breakpoints 
is shown by the dashed lines. Interspersed repeat content of these regions is shown by 
the shaded and patterned boxes. Similarities between the two sequences are shown as 
diagonal lines on the dotplot, upwards facing diagonals (/) indicate directly repeated 
sequences, and inverted repeated sequences are downwards-sloping diagonals (\).
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6.2.5.4. Analysis of deletion breakpoint regions for recombination-associated motifs
As for the other sequenced breakpoints in families 1 and 2, various motifs previously 
found to be associated with different genomic rearrangements were searched for in 5Kb 
regions around the breakpoints (see section 4.9.1.1. and Table 2.4.).
6.2.5.4.I. 5Kb regions around deletion breakpoints
Within the proximal 5Kb region centred on the deletion breakpoint in bA346E8, none of 
the sequence motifs looked for were found many more times than would be expected by 
chance (Appendix C). Two preferred topoisomerase cleavage sites were located at (CAT) 
or just distal to the proximal deletion breakpoint (CTY) (Appendix C) (Been et al., 1984). 
Within the 5Kb region surrounding the distal deletion breakpoint in clone dJ203P14 some 
sequence motifs were found more than five times as would be expected. Two of these 
were AT rich motifs that were not found close to the breakpoint, the S. cerevisiae ARS 
consensus (WTTTATRTTTW), and a consensus scaffold attachment region sequence 
(WADAWAYAWW) (Appendix C) (Broach et al., 1983;Maundrell et al., 1988;Dobbs et 
al., 1994). Two copies of an 8bp motif (CAGRCAGR) which has been found to correspond 
to a recombination hotspot found in the murine MHC locus were present near the distal 
deletion breakpoint (Appendix C) (Steinmetz et al., 1986;Shiroishi et al., 1995). One 
copy of the motif was 371bp proximal to the breakpoint, and the other was just 82bp 
distal to the breakpoint. Although not found to be over-represented, two short 
topoisomerase cleavage sites were overlapping the distal deletion breakpoint, (CAT) and 
(GTY) (Appendix C) (Been et al., 1984).
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6.2.5.4.2. Matrix attachment regions
Both 5Kb regions around the two deletion breakpoints were searched for potential MAR 
regions using MAR-Wiz. The proximal deletion breakpoint region did not contain any 
regions that reached the threshold matrix-binding potential of 0.6, but the distal deletion 
breakpoint within dJ203P18 did contain one region that was a potential MAR, starting 
700bp downstream of the deletion breakpoint, and spanning 900bp (Figure 6.10.). As the 
MAR potential predicted using MAR-Wiz can be dependent on the sequence context, a 
larger (20Kb) region surrounding the breakpoint was also tested for the presence of 
MARs, and an area of increased MAR potential was observed in the same approximate 
location (Namciu et al., 2004). This potential MAR included an 11 lbp stretch of (TA)n 
simple repeats, which had been detected by Repeatmasker (Table 6.4.).
6.2.5.4.3. Detailed analysis of lOObp around each deletion breakpoint
6.2.5.4.3.1. Alternating purine/pyrimidines, polypurine and polypyrimidine tracts
One 1 lbp purine/pyrimidine tract was found at the proximal deletion breakpoint, which 
included the 4bp overlap at the breakpoint (Figure 6.11.). No homopurine or 
homopyrimidine tracts of greater than or equal to lObp were found close to either 
deletion breakpoint. Alternating purine/pyrimidine tracts can cause DNA to adopt 
alternative conformations, such as Z-DNA, and have been shown to be over-represented 
at deletion breakpoints (see section 4.9.2.2.) (Abeysinghe et a l , 2003).
6.2.5.4.3.2. Inverted repeats and secondary structures
Using a program that searches for various types of repeats in DNA sequences - direct, 
direct complementary, inverted and symmetric repeats (Oligorep), some repeats were 
found (Figure 6.12.). As before, lOObp centred on both breakpoints was analysed, as
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well as the actual recombinant breakpoint sequence (Figure 6.12.). The longest repeat 
found was an inverted repeat, one half of which included the distal deletion breakpoint 
and covered 19 nucleotides, with four mismatches (Figure 6.12.). Inverted repeats could 
potentially form secondary structures such as hairpin loops, which could be cleaved by 
topoisomerases (Froelich-Ammon et a l , 1994). Other types of repeat are also present 
within the sequences examined, including some inversions of inverted repeats, which 
could potentially be involved in stabilising the rearrangement (Chuzhanova et al., 2003).
1 . 0 0
0 .7 5
0 .5 0
4500500 1000 1500 2500 3000 35 0 0 4000 50 0 0
B A S E  P A I R S
Figure 6.10. MAR potential in the 5Kb surrounding the distal deletion breakpoint (at 
position 2500 in this sequence) as found by MAR-Wiz.
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Proximal deletion breakpoint bA 346E8 4937-5036bp
TGTTTCCATGAATTTATTCATTTCTTCTAGGTTTTCCATTTTGTGTGCATACTTGTGTTCTTGGTAGTCTCTGAGGGTTTTAGTATTTCTGTGTGTTCAA
RYRRRRRYRYYYRRRYRRRYRRRRRRRRYYYRRRRRRYRRRRYRYRYRYRYRRRYRYRRRRRYYRYYRRRRRYYYYYRRRRYYRYRRRRRYRYRYRRRYY
Distal deletion breakpoint dJ203P18 98818-98719bp
CCAGGCCAGACAATAAAGAAAATGATATTTATGGTCACATTTATGTGACCATAGAAGTGATGTCAGCAAAAAGGAACATAGCTGGATACTAAGTAAAAAA
RRYYYRRYYYRYYRYYYYYYYYRYYRYRRRYRYYRRYRYRRRYRYRYYRRYRYYYYYRYYRYRRYYRYYYYYYYYYRYRYYRRYYYRYRRYYYRYYYYYY
Figure 6.11. Purine/pyrimidine content in the region immediately surrounding both deletion breakpoints. The lOObp of sequence flanking 
the two deletion breakpoints is shown on the top of the pairs, and the classification of each nucleotide is shown on the lower line of the pairs. 
Tracts of alternating purines/pyrimidines (R/Y), or pyrimidines/purines (Y/R), of 10 nucleotides or greater, are underlined.
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Proximal deletion breakpoint bA346E8 4937-5036bp
TGTTTCCATGAATTT^TTCATTTCTTCTAGGTTTTCCATTTTGTGTGCATACTTGTGTTCTTGGTAGTCTCTGAGGGTTTTAGTATTTCTGTGTGTTCAA
Distal deletion breakpoint dJ203P18 98818-98719bp
CCAGGCCAGACAATAAAGAAAATGATATTTATGGTCACATTTATGTGACCATAGAAGTGATGTCAGCAAAAAGGAACATAGCTGGATACTAAGTAAAAAA
 ► <----------------------------
Deletion junction
TGTTTCCATGAATTTATTCATTTCTTCTAGGTTTTCCATTTTGTGTGCATAGAAGTGATGTCAGCAAAAAGGAACATAGCTGGATACTAAGT.
 ► <--------------
a aJC’a a
Figure 6.12. Inverted repeats around the deletion breakpoints, the deletion junction fragment and the reciprocal rearrangement. The normal 
sequence is shown from the proximal deletion breakpoint (bA346E8) and from the distal deletion breakpoint (dJ203P18). Also shown is the 
recombinant deletion breakpoint, with the proximal half (shown in red) originating from bA346E8 and the distal half (shown in blue) 
originating from dJ203P18. The 4 nucleotides that form the deletion breakpoint are shaded purple. Repeats were searched for using Oligorep 
(see section 2.2.10.6.).
6.3. Xq26 insertion mapping
6.3.1. Metaphase FISH
Mapping of the insertion site of the duplicated copy of PLP1 was carried out using 
metaphase FISH with direct dual colour labelling of cosmid, PAC and BAC clones. In 
experiments containing a Spectrum Red labelled PLP1 clone and a Spectrum Green 
labelled Xq clone, the position of the inserted copy of PLP1 could be deduced with 
respect to the genomic clone by observing if the green signal was telomeric or 
centromeric to the duplicated copy of PLP1 on metaphase chromosomes. This mapped 
the inserted sequence to between Xq26.2 and Xq27.1 (Table 6.5., Figure 6.13.). A clone 
positioned in Xq26.3 (dJl 19E23) was not able to be mapped with respect to the insertion 
as on most metaphases examined the red PLP1 signal and the green signal were co­
localised, making it likely that the duplicated copy of PLP1 was located very near this 
clone.
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(a) (b)
Figures 6.13a and 6.13b. Metaphase spreads showing dual labelling to map Xq26 PLP1 
insertion. PLP1 probe is labelled red, X centromere is aqua. Figure 6.13a shows 
dJ 154J13 (Xq26.2) with a green signal and Figure 6.13b has dJ656F14 (Xq27.1) labelled 
in green.
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Clone Band above or below distal copy of PLP1
dJ75H8 Xq23 above
dJ378P9 Xq24 above
dJ404F18 Xq24 above
(U136017 Xq26.1 above
dJ297J13 Xq26.2 above (5/7)
dJ154J13 Xq26.2 above (7/10)
dJ119E23 Xq26.3 3/8 below, 4/8 were on top, 1/8 above
dJ656F14 Xq27.1 below (8/10)
bA51C14 Xq27.2 below
dJ507I15 Xq27.2 below
Table 6.5. Table showing results from insertion mapping using dual FISH. A clone was 
recorded as being above the distal PLP1 signal if the order of signals on the metaphase X 
chromosome was: centromere probe (aqua)/red/green/red, as shown in Figure 6.13a; and 
below if the order of signals was: centromere probe (aqua)/red/red/green, as shown in 
Figure 6.13b. Number of metaphase spreads scored is shown in brackets, with the 
number of spreads that showed that arrangement indicated. Unless otherwise stated, in 
the other metaphase spreads examined the green signal could not be resolved from the 
more distal PLP1 signal. Where numbers of metaphase spreads scored is not given, only 
a small number (<5) were scored due to lack of metaphases on the slide or poor 
hybridisation and faint signals.
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6.3.2. Duplication mapping
6.3.2.1. Metaphase FISH
The extent of the duplication in this family was initially characterised using interphase 
and metaphase FISH with genomic clones known to map to the PLP1 region. This 
appeared to show that the duplication breakpoint proximal to PLP1 was contained within 
the genomic clone dJ1055C14, which is located 58.5kb upstream relative to PLP1. In 
most metaphase spreads using this clone for FISH, the additional copy of this clone could 
be seen in Xq26, but the second signal was noticeably weaker than the copy in Xq22, 
suggesting that only part of the clone was contained in the duplication (Figure 6.14.). In 
support of this, FISH results showed that the clone immediately proximal to dJ1055C14 
was not duplicated, and the next distal clone appeared to be entirely duplicated (Figure 
6.14.).
6.3.2.2. UPQFM-PCR and fine mapping of proximal duplication breakpoint
Finer mapping of the proximal duplication breakpoint was carried out using universal 
primer quantitative multiplex PCR using primers along the clone suggested by FISH to 
contain the breakpoint, dJ1055C14 (see section 2.2.1.3. and Table 6.6.). This narrowed 
the region containing the breakpoint down to 1474bp (Table 6.6.).
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1
CV857G6 □ dJ764D10
CU25D11
1 1 1 1 1-----------------------
101.60Mb 101.64Mb 101.68Mb 101.72Mb 101.76Mb
Figure 6.14. FISH on metaphase chromosomes from 3:4 using probes around the 
proximal duplication breakpoint, (a) cU25Dll shown in green, X centromere is red. 
cU25Dl 1 maps just proximal to dJ1055C14, but also maps to the Xq telomere, as can be 
seen on this metaphase spread, where there is a green signal at the end of the deleted Xq 
arm, and also on the telomere of the normal X chromosome, which also has a signal for 
this probe at Xq22. (b) From the same hybridisation as (a) above, but with two full sized 
chromosomes, one of which contains the PLP1 duplication. Both X chromosomes have 
cU25Dll signals at Xq22 and near the telomere, with no clear signals showing a 
duplicated copy at Xq26-27. (c) dJ 1055C14 shown in red, X centromere probe shown in 
aqua. The duplicated copy of dJ1055C14 (white arrow) gives a reduced signal compared 
to the full-length copy in Xq22. (d) cU35G3 shown in green, X centromere is red. The 
additional copy of this clone appears to be of equal or greater strength than the signal at 
Xq22, suggesting that this whole clone is contained within the duplication. Contig data 
was adapted from the Ensembl human genome browser, release 22.34d.l., and shows a 
200Kb region just upstream of PLP1.
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Position in dJ1055C14 
of UPQFM primer pairs
Mean ratio of dJ1055C14 PCR 
product compared to...
Number of 
experiments 
performedPLP1 CF
46009-46237bp 0.59 1.15 4
54449-54682bp 0.62 1.31 3
62946-63105bp 0.55 1.01 2
67104-6733 lbp 0.55 0.87 2
68598-68849bp 1.12 1.57 2
69896-69955bp 1.16 2.83 1
75773-76033bp 1.01 2.05 3
88473-88702bp 1.01 1.68 2
Table 6.6. UPQFM-PCR results for primers amplifying sequences within (U1055C14, 
the genomic clone thought to contain the proximal duplication breakpoint. Dosage 
quotient ratios were calculated as described (see section 2.2.1.3.1.) and compared to the 
PLP1 and CF primer pairs. The mean dosage ratios that were within the duplicated range 
are highlighted in bold type. The presumed location of the breakpoint is indicated by the 
zigzag line.
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6.3.2.3. Inverse PCR and sequencing of insertion breakpoint
6.3.2.3.I. Inverse PCR strategy
Inverse PCR (iPCR) was carried out to obtain the sequence for the proximal duplication 
and insertion junction using knowledge of the sequences close to the end of the 
duplication (see section 2.2.1.4.) (Triglia et al., 1988). Primers closest to the proximal 
duplication breakpoint but still within the duplicated region were chosen from the 
UPQFM-PCR experiment (Table 6.6.). The primers used for inverse PCR were the 
reverse complement of the closest primers to the breakpoint used in the UPQFM-PCR 
experiments (without the universal tag sequences) that were known to be duplicated, 
which amplified the DNA between positions 69896 and 69955bp in the human genomic 
clone dJ1055C14 (Figure 6.15.). Two restriction enzymes, Eael and Mspl, were used 
because they both had restriction sites that were very near the forward inverse PCR 
primer (within the known duplicated sequence) and also each had another site within the 
duplication breakpoint region, as close as possible to the centromeric boundary of the 
duplicated region. Following digestion of genomic DNA with either enzyme, the DNA 
was ligated, and the inverse PCR primers were used in a PCR reaction to only amplify 
the ligated products that contained the target sequences. As the normal sequence in the 
region was known, the exact size of the inverse PCR product for each enzyme digestion 
could be predicted, and if there were a breakpoint between the two restriction sites in the 
genomic DNA, then an altered sized band should be seen as well as the expected size 
band. The digestion, ligation, and PCR procedure was expected to produce a 1095bp 
band for Mspl, and a 1324bp band for Eael digestion. For both restriction enzymes, a 
smaller band was seen in the carrier mother and the affected boy after agarose gel 
electrophoresis of the inverse PCR reactions (Figure 6.16.). These bands were gel- 
extracted and sequenced in a reaction using the iPCR primers (see sections 2.2.1.4.4. 
and 2.2.4.). 294
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67104-67331 
Not duplicated
M
_.L
67552
M E
68850/1
69896-69955
Duplicated
Figure 6.15. Diagram showing strategy for inverse PCR. The dashed line indicates the 
breakpoint region within dJ1055C14 as defined by UPQFM-PCR results. The positions 
of amplicons used in UPQFM-PCR, and the duplication status of these regions, are 
shown underneath. The locations of restriction sites for Eael and Mspl enzymes are 
indicated by E and M  respectively.
i-i<DT3
C3 u <zuno Ql-H o•0 £
<L>
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3:6 3:4 3:6 3:4
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Figure 6.16. Inverse PCR run on agarose gel. Bands of the expected size are seen for 
the genomic DNAs for both digests (1095bp for Mspl, 1324bp for Eael), altered bands 
(~750bp for Mspl; ~900bp for Eael) are only seen for the mother and son who carry the 
duplication. Faint larger bands, about 1500bp in size, were are also present after inverse 
PCR using Mspl digestion, in both 3:4 and 3:6, but not in the normal males. These 
products may be concatamers formed during the ligation reaction.
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6.3.2.3.2. Sequence results for inverse PCR
Sequencing results for the inverse PCR products revealed a complex breakpoint at the 
insertion point. Over 280bp of readable sequence was obtained from the Mspl inverse 
PCR band, which was compared against all human sequences using BLASTn. The 
results showed that there were four matches to different stretches of human genomic 
DNA within this sequence, three hits to sequences located in Xq26.2 (dJ453F18, 
dJ197017 and dJ305B16), and one match to dJ1055C14, where the primers used in the 
inverse PCR procedure mapped (Figures 6.15. and 6.17.). The breakpoint region was 
then also sequenced from genomic DNA from the family, using a PCR product from a 
reaction using a primer in dJ1055C14 (R68208) and a primer in bA453F18 (R24491) as 
template. The same sequence as found from the inverse PCR product was produced from 
the genomic DNA from 3:6 in both directions, showing that the complicated nature of the 
breakpoint was not just an artifact of the inverse PCR reaction.
6.3.2.3.3. Confirmation of insertion by PCR
For confirmation that there were no further rearrangements in the vicinity of the insertion, 
oligonucleotide PCR primers were designed, one within dJ1055C14 close to the 
breakpoint, and two within bA453F18 sequence, distant from the breakpoint (Figure
6.18.). Products of the expected sizes of 887bp and 2264bp were seen following PCR 
and ethidium bromide stained agarose gel electrophoresis using genomic DNA from 
individuals in this family carrying the duplication/insertion (Figure 6.18.). This 
suggested that there were probably no further rearrangements within the next 2.25Kb of 
bA453F18, although other more distant rearrangements could not be ruled out.
296
g g t c a g g c t g g t c t t g a a c t c c c g a c c t c a g g t a a t c c a c c c g c c t t g g c c t c c c a a a g g g c t g a g a t t a a a g g c g t g a g
< -25075-24955 in bA453F18 ------------------------------------
c c a c t g c t c c a g g t t g c t g a t a c a t t t g t a t a a t a c t t c t t  | t | a g t a g t a t g g t a g t g g c a a g c a c a g c a t g c t g t t g g
------------------------------------------------------► M------------69379-69433 in dJ197017
g a a t t a g a g g a g g g a c a g c  | c t g t  t t t a c t c a a t g t g g a a g t a c t a g g a g c c t t c c c a c t a a a a t c a a g a g g  | a g e  | c t g
------------------------► <--------------44079-44028 in dJ305B 1 6 ------------------- ► 4-
a t g g c a g a a a g g g c a c t a c a a t t a g c g a a t t t a t a t a a t t t a t a a -
*468184-68231 in dJ 1055C14 and onwards. -------
bA512H23
dA213H19 dJ305B16
bA453F18 dJ197017
mini mini m in i i h i
129.60Mb 129.70Mb 129.80Mb 129.90Mb
>\
vj
130.00Mb 
> :
 *
(U1055C14
Figure 6.17. The annotated sequence from the Mspl iPCR band. The arrows and 
annotation beneath the sequence data show which human genomic clones these sections 
of the breakpoint have a similarity to as picked up by BLASTn. Underneath is the 
relevant section of Xq26.2, adapted the Ensembl human genome browser (Release 
22.34d.l), showing the clones, position on the chromosome and repeat content of this 
region. Arrows beneath show the approximate locations of the sequences from the 
breakpoint junction and the dotted lines indicate how these sections of sequence have 
joined to the proximal end of the Xq22.2 duplication in dJ1055C14.
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Figure 6.18. Agarose gel showing long-range PCR from dJ1055C14 to bA453F18. Two 
combinations of primers spanning the breakpoint were used; both reactions used the same 
primer from dJ1055C14 (68617R) and a different primer from bA453F18 (25585R or 
26962R). PCR products of the expected size were only seen in individuals carrying the 
duplication/insertion and not in normal males (M). Sizes of the products as calculated 
from sequence data are shown, and the sizes of the closest bands in the ladder
are shown. There is an extra band seen in the size standard lane, this is presumed to be 
overspill from the adjacent lane in the gel.
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6.3.3. Analysis of sequences around the duplication and insertion breakpoints
To determine whether there were any features of the sequences near the breakpoints 
involved in the Xq26.2 duplication insertion, sequences at both ends of the breakpoints 
were analysed using a variety of bioinformatic tools.
6.3.3.1. Genomic features near Xq22.2 proximal duplication breakpoint
The duplication/insertion breakpoint within clone (U1055C14 falls within the first intron 
of the MORF4L2 gene (Figure 6.19.). The Xq22 breakpoint was near, but not contained 
within, interspersed repeat sequences (Figure 6.19.) and was located between a partial 
L1MC5 repeat and an MIR repeat (Table 6.7.). The G+C content of the 5Kb of sequence 
around the breakpoint was 41.44% and the interspersed repeat content amounted to 
21.52%. The G+C content was close to the average for the 1.1Mb proximal to PLP1 
(40.47%), but the interspersed repeat content was low compared to the rest of the region 
(55.67%), due to the coding sequence present in this region.
6.3.3.2. Genomic features near Xq26.2 insertion breakpoints
Much of the sequence from Xq26.2 that was found at or near the insertion breakpoints 
consisted of repetitive elements. The G+C content of a 1Mb region centred on the 
insertion point and including the two short inserted sequences was 39.08% and the 
interspersed repeat content was 52.88%.
6.3.3.2.I. Genomic features near dJ305B16 inserted sequence
Most of the 52 nucleotides that mapped to the clone dJ305B16 were part of a partial 
L1M4 repeat (4034-4079 in the repeat consensus), which maps between postions 43631 
and 44073 in this clone (Table 6.8.). The 5Kb examined from this clone contained a
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variety of interspersed repetitive elements, making up 64.38% of the sequence, which had 
a G+C content of 36.90% (Repeatmasker data, Repbase version 7.4) (Figure 6.19. and 
Table 6.8.).
6.3.3.2.2. Genomic features near dJ197017 inserted sequence
The 55bp that had homology to dJ197017 is part of an L2 interspersed repeat (3076-3093 
in the L2 repeat consensus), located between bases 69215 and 69757 in this clone (Figure
6.19. and Table 6.9.). This was located in a 5Kb region that was 82.70% interspersed 
repeats, and had a G+C content of 35.20% (Repeatmasker data, Repbase version 7.4).
6.3.3.2.3. Genomic features near bA453F18 insertion point
The region surrounding the breakpoint in bA453F18 is rich in interspersed repeats 
(Figure 6.19.). In the 5Kb region around the insertion sequence, 95.86% of the sequence 
is classified as being interspersed repeats by Repeatmasker (Table 6.10.). The actual 
insertion breakpoint sequence is within an LTR element (MER51, at position 2330 in the 
consensus) and is also very close to an almost complete ^4/wSp copy, which starts less 
than 30 bases after the breakpoint (Table 6.10.). This region had a G+C content of 
40.76%.
6.3.3.3. Comparison of sequences surrounding breakpoints
6.3.3.3.I. 5Kb surrounding breakpoint sequences
The 5Kb of sequence surrounding each breakpoint from the Xq26.2 insertion were all 
compared against each other using BLASTz, to determine if there was any large-scale 
sequence homology present at the breakpoints. Only very limited amounts of sequence 
similarity was found between two pairs of sequences, and this was all accounted for by
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sequences present in common repetitive elements. When 5Kb from bA453F18 and 5Kb 
surrounding the inserted sequence mapping to clone dJ305B16 were compared, some 
regions of sequence similarity were seen, all of which were within the Alu repeats present 
in both of these regions (Figure 6.19.). The only other pair of sequences that showed any 
sequence similarity were dJ1055C14 and dJ305B16, but this similarity only extended for 
60bp and was part of an LI repeat in both sequences.
6.3.3.3.2. lOObp surrounding breakpoints
Alignments were created using ClustalW of the lOObp of genomic sequence immediately 
flanking a breakpoint or inserted sequence and the sequenced insertion junction (Figure
6.20). Extensive sequence similarities were not present either side of the breakpoints in 
these sequences. The greatest percentage similarity seen between a junction and flanking 
sequence was between dJ197017 and the sequence from bA453F18 from the junction 
sequence, at 51% of the aligned nucleotides, but most of the aligned nucleotides in this 
comparison were not contiguous and were not very close to the actual breakpoint (Figure
6 .20).
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Figure 6.19. Diagram showing interspersed repeat content and genes in 5kb regions 
centred on the breakpoints associated with the Xq26 insertion. The locations of the 
breakpoints are shown by the dashed vertical lines. The positions of the first two exons 
of the MORF4L2 gene within clone dJ1055C14 are indicated, and the patterned and 
shaded boxes represent repetitive sequences. All regions shown are in the same 
orientation, with more centromeric sequence at the left-hand side of the figure.
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Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation
(-) 1727-1705 AT rich (Low complexity) 1-23 +
(-) 1597-1386 MIR (SINE/MIR) 2-241 (240/262) -
(-) 825-654 L1MC5 (LINE/LI) 7783-7949 (166/7961)
'
(-) 602-187 L1MC5 (LINE/LI) 7527-7915 (388/7961)
(+) 30-52 AT rich (Low complexity) 1-23 +
(+) 108-268 MIR (SINE/MIR) 48-227 (179/262) -
(+) 814-846 T„ (Low complexity) 1-33 +
(+) 2383-2486 MIR (SINE/MIR) 30-136 (107/208) +
Table 6.7. Repeat content (using Repeatmasker) of the 5Kb genomic region surrounding 
the proximal duplication breakpoint within dJ1055C14. The first column shows how far 
in base pairs each repeat element is from the duplication breakpoint, (-) indicates that the 
repeat element is proximal to the breakpoint and (+) that the repeat is distal relative to the 
breakpoint. The type of repeat and the class of repeat element to which it belongs are 
given in the second column. The third column shows which portions within the 
appropriate repeat consensus sequence each repeat has similarity to, and also how many 
bases out of the total repeat unit are present in the sequence. In the fourth column, the 
orientation of each repeat is shown; + shows a repeat is on the forward strand (i.e. 
running from centromere to telomere), - the repeat is on the reverse strand.
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Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation
(-) 2689-2384 AluSg (SINEM/w) 1-306 (306/306) -
(-) 2268-1920 MLT1B (LTR/MaLR) 26-370 (345/390) +
(-) 1919-1472 MSTB2 (LTR/MaLR) 2-457 (457/457) +
(-) 1471-1451 MLT1B (LTR/MaLR) 370-390 (22/390) +
(-) 1434-1239 L1MC5 (LINE/LI) 7617-7820 (204/7961) -
(-) 1238-820 Tigger2a (DNA/MER2 type) 1-434 (434/434) +
(-) 819-532 L1MC5 (LINE/LI) 7356-7617 (262/7961) -
(-) 397-45 (+) L1M4 (LINE/LI) 4034-4475 (442/6146) -
(+) 282-356 MIR (SINE/MIR) 74-149 (76/208) +
(+) 360-517 FRAM (SINEA4/w) 1-155 (156/176) -
(+) 525-618 MIR (SINE/MIR) 159-252 (94/262) +
(+) 1404-1695 AluJb (SINE/Alu) 9-298 (290/312) +
(+) 1781-1804 (TA)n (Simple repeat) 2-25 +
(+) 1816-2160 MER7A (DNA/MER2 type) 1-344 (344/346) +
(+) 2163-2294 (TA)n (Simple repeat) 2-138 +
Table 6.8. Interspersed repetitive elements from the 5Kb region surrounding the 
duplicated bases in the rearrangement from dJ305B16. For detailed explanation of 
categories, see Table 6.9. The L1M4 repeat that partially overlaps with the 52bp 
sequence of this genomic clone that is found within the rearrangement at the insertion 
breakpoint is highlighted in bold type, the L1M4 consensus sequence homology extends 
45bp into the duplicated sequence.
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Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation 1
(-) 2711-1602 L1MD5 (LINE/LI) 3174-4284(1111/6146) +
(-) 1531-706 L1MD5 (LINE/LI) 4394-5248 (855/6146) +
(-) 704-352 L1MD5 (LINE/LI) 5882-6242 (6242/6242) +
(-) 324 -164 (+) L2 (LINE/L2) 2752-3257 (506/3272) +
(+) 169-200 (TGAA)n (Simple repeat) 1-32 +
(+) 256-450 L2 (LINE/L2) 2433-2658 (226/3314) +
(+) 530-561 (CA)n (Simple repeat) 2-33 +
(+) 960-1557 LlM3e (LINE/LI) 1-1948 (1948/7030) +
(+) 1690-3086 L1MA9 (LINE/LI) 4873-6312 (1440/6312) +
Table 6.9. Interspersed repetitive elements from the 5Kb region surrounding the 
duplicated bases in the rearrangement from dJ197017. The first column shows how far 
in base pairs each repeat element is from the duplication breakpoint, (-) indicates that the 
repeat element is proximal to the breakpoint and (+) that the repeat is distal relative to the 
breakpoint. The type of repeat and the class of repeat element to which it belongs are 
given in the second column. The third column shows which portions within the 
appropriate repeat consensus sequence each repeat has similarity to, and also how many 
bases out of the total repeat unit consensus is present in the sequence. In the fourth 
column, the orientation of each repeat is shown; + shows a repeat is on the forward strand 
{i.e. running from centromere to telomere), - the repeat is on the reverse strand. If a 
repeat element was found to coincide with the beginning or end of the 5kb segment, the 
adjacent sequence was also analysed with Repeatmasker, until the true end of the repeat 
was found. The repeat element that the duplicated breakpoint segment is contained 
within is highlighted in bold type. The figures given in the first column for the distance 
from the breakpoint for this repeat are for the distance from the closest end of the 52bp 
breakpoint segment to the end of the repeat, i.e. the (-) and (+) distances are measured 
from different nucleotides.
Distance from 
breakpoint (bp) Repeat type
Position in repeat 
consensus sequence Orientation
(-) 2691-2068 MER51-int (LTR/ERV1) 512-1221 (709/7816) +
(-) 2041-1617 L1M2 (LINE/LI) 1578-2012 (435/6849) +
(-) 1527-1230 ,/4/wSgl (SINEA4/w) 1-296 (297/309) -
(-) 1162-1082 MER51-int (LTR/ERV1) 1038-1121 (84/8120) +
(-) 1081-798 y4/«Sq (SINE/ /^w) 40-329 (290/329) -
(-) 713-542 MER4A (LTR/ERV1) 276-517 (242/664) +
(-) 539-26 (+) MER51-int (LTR/ERV1) 1791-2357 (567/7816) +
(+) 27-328 ,4/wSp (SINEM/m) 3-305 (303/313) +
(+) 329-432 MER51-int (LTR/ERV1) 2357-2460 (104/7816) +
(+) 445-588 yl/wSp (SINE/^/m) 6-151 (146/313) -
(+) 590-707 MER51-int (LTR/ERV1) 2466-2589 (124/7816) +
(+) 701-1018 MER51-int (LTR/ERV1) 2923-3265 (343/7816) +
(+) 1037-1170 MER51-int (LTR/ERV1) 1660-1783 (124/6741) +
(+) 1171-1464 ^/ttSq (SINEM/w) 6-299 (294/313) +
(+) 1465-1996 MER51-int (LTR/ERV1) 1783-3823 (2041/6741) +
(+) 1994-2100 MER51-int (LTR/ERV1) 2340-2446 (107/5217) +
(+) 2110-2641 LTR10A (LTR/ERV1) 1-547 (548/609) +
Table 6.10. Interspersed repetitive elements from the 5Kb region centred on position 
24956 in clone bA453F18. For detailed explanation of categories, see Table 6.9.
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Junction sequence AGGCGTGAGCCACTGCTCCAGGTTGCTGATACATTTGTATAATACTTCTT-T-AGT
bA453F18 25004 AGGCGTGAGCCACTGCTCCAGGTTGCTGATACATTTGTATAATACTTCTTAT-TTT
dJ 197017  69329 AAGACTGAGCC -  T G A G T C T G A C A A G T T G A T - -  ATTTACAAAAGAGTACAG -TGAGT
Junction sequence AGTATGGTAGTGGCAAGCACAGCATGCTGTTGGGAATTAGAGGAGGGACAGCCTGT
bA453F18 ACTTTAATCAAGACTAAGAACTTTAACTATGAGAATGTTCATTAG 24905
dJ 197017  AGTATGGTAGTGGCAAGCACAGCATGCTGTTGGGAATTAGAGGAGGGACAGCTAAC
dJ305B16 43978 TGCCTAATCAAGTTTAAATGTGCTTTTTAAAAAGTTTCATTCAAAAGCCA--CTGT
Junction sequence TTTACTC AATGTGG-AAGTACTAGGAGCCTTCCCACTAAAATCAAG—AGGAG
dJ 197017  CCAGATTTGGGATGTGTTGAGTAATTAAAAGCTCCCAACAAGAGTG 6 9 4 8 3
dJ305B 16 TTTACTC--AATGTGG-AAGTACTAGGAGCCTTCCCACTAAAATCAAG—AGGGA
(JJ1055C14 68134  G G T A  A A A A T T G - G T A T A T C  T A T T T T A T C T T T A A T T T A T T C T A G G A A A G A A
CTTGATGGCAGAAAGGGCACT -  AC AATTAGCGAATTTATATAATTTATAATT Junction sequence
----------------------- A A A A A G G A T G C T C A C T C T T G C C A C T A T T A T G T A A C A A T G C A T T G A A G G  44029 dJ305B16
GTTGATGGCAGAAAGGGCACT-ACAATTAGCGAATTTATATAATTTATAATT 68233 dJ1055C14
Figure 6.20. Alignment of insertion breakpoint junction and 50bp either side of all the 
breakpoints or short inserted sequences. Legend on next page.
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Figure 6.20. Legend.
Each breakpoint region was individually aligned by ClustalW to the sequence from the 
junction breakpoint and the two alignments were then combined together manually. 
Junction sequence that originated from bA435F18 (Xq26.2) is highlighted in red, and 
nucleotides aligned with this sequence from the genomic sequence around the other 
breakpoints are also highlighted in red. Similarly, junction sequence originating from 
dJ197017 (Xq26.2) is highlighted in blue, dJ305B14 (Xq26.2) sequence is shaded 
purple, and dJ1055C14 (Xq22.2) sequence is shaded green. The 4bp overlap at the 
junction between the two sequences is shaded purple. Positions within the clone are 
shown at the start and end of each sequence. Nucleotides that appear to have been 
inserted at the junctions are coloured black and are in bold type.
6.3.3.4. Recombination/rearrangement associated sequence motifs
6.3.3.4.I. 5Kb around dJ1055C14 duplication breakpoint
Three of the different motifs that were found more often than the expectation within the 
5Kb region centred on the duplication breakpoint in dJ1055C14 were all associated with 
eukaryotic origins of replication. All three motifs (the human replication origin 
consensus (WAWTTDDWWWDHWGWHMAWTT); the S. cerevisiae ARS motif 
(WTTTATRTTTW); and the S. pombe ARS sequence (WRTTTATTTAW)) were each only 
found once within the 5Kb region (Appendix C) (Maundrell et ah, 1988;Dobbs et al., 
1994;Dechering et ah, 1998). This human replication origin motif, out of the three 
associated with replication origins, was the closest to the duplication breakpoint in family 
3, at 844bp proximal to the breakpoint (Appendix C).
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Other sequence motifs located in the 5Kb around the duplication breakpoint in 
(U1055C14 and found at a greater frequency than expected included 7 copies of a 
scaffold attachment consensus (TTWTWTTWTT) and 7 copies of an 8bp motif 
(GCCCWCCW), which is recognised and bound to by the translin protein and has been 
found at the breakpoints of chromosomal translocations in human lymphoid malignancies 
(Appendix C) (Dobbs et al., 1994;Aoki et a l , 1995).
6.3.3.4.2. 5Kb around dJ305B16 inserted sequence
Several different recombination or rearrangement-associated motifs were found at a 
higher frequency than was expected in the 5Kb region around the 52bp inserted at the 
junction originating from clone dJ305B16.
A match to the consensus binding site (PUR) of the Pura DNA binding protein 
(GGNNGAGGGAGARRRR) was located 1130bp proximal to the start of the 52bp sequence 
inserted at the breakpoint. The Pura protein was originally isolated as a factor that binds 
to the purine-rich strand of the consensus sequences found upstream of the human c-myc 
gene (Bergemann et al., 1992;Bergemann and Johnson, 1992). PUR sequences are also 
present in several promoter sequences and Pura binding sites have also been found at 
origins of replication in both mammalian genomic DNA and viral genomes (Bergemann 
and Johnson, 1992;Smith et al., 1998, reviewed in Gallia et al., 2000). This motif is 
predicted to occur by chance only rarely, approximately once every 29Mb in sequences 
with the same nucleotide composition as this 5Kb stretch from dJ305B16. There are no 
genes present in the near vicinity of this sequence element; the nearest known transcript 
(annotated on Ensembl as NM_194277) is 14Kb away (Figure 6.25.). Although the lack
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of proximity to gene and promoter sequences makes it less likely that this sequence has a 
function in the regulation of gene transcription in this region, it is also possible that this 
sequence may be involved in DNA replication in this region. Pura is able to destabilise 
the DNA double helix and was originally isolated as a factor binding to regions of 
initiation of DNA replication (Bergemann and Johnson, 1992;Darbinian et al., 2001). 
The presence of this PUR sequence may contribute to initiation of replication, a 
possibility that is increased by its localision within the first of two putative matrix 
attachment regions as predicted by the program MAR-Wiz (see sections 4.9.1.2., 6.3.3.5., 
Figure 6.21. and Table 6.11.) (Singh et al., 1997). Some origins of replication have been 
mapped to the same regions as matrix or scaffold attachment sites (Razin et a l , 
1991;Lagarkova et al., 1998;Girard-Reydet et al., 2004). As previously mentioned, 
rearrangements involving the PLP1 gene could be connected to the process of replication 
(see section 5.8.2.5. and 6.4.2.). Some other sequence motifs were found to be over­
represented within the 5Kb region centred on the inserted sequence from dJ305B16, but 
none of these were located in particular proximity to the breakpoints (Appendix C).
6.3.3.4.3. 5Kb around dJ197017 inserted sequence
Just one sequence motif was found at a higher frequency than expected in the 5kb region 
centred on the middle of the 53bp of sequence inserted into the Xq26.2 insertion 
breakpoint from this clone (also from Xq26.2), a 6bp sequence (ACCCCA) that is a DNA 
polymerase frameshift mutation hotspot (Kunkel, 1985a;Kunkel, 1985b). This motif 
occurred 6 times in the 5Kb examined, compared to the expected frequency of just over 1 
copy of this motif (Appendix C). The nearest copy of this sequence was 150bp distal 
from the inserted sequence and all the other copies were over 1Kb distal to the inserted 
sequence.
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6.3.3.4.4. 5Kb around bA453F18 insertion point
Several different sequence motifs were searched for in the 5Kb surrounding the 
sequenced insertion point within clone bA453F18 (see Table 2.4.). Some motifs that 
were over-represented in the region were the fission yeast ARS consensus 
(WRTTTATTTAW) and two scaffold attachment motif consensus sequences, 
(AATAAAYAAA, TTWTWTTWTT) (Maundrell et a l , 1988;Dobbs et a l , 1994). The closest 
of these three motifs to the breakpoint was one of the scaffold attachment motifs, 318bp 
distal to the insertion point.
6.3.3.5. Matrix attachment regions
Potential MARs were found near all of the 5Kb regions examined around the breakpoints 
(see section 4.9.1.2., Figure 6.21. and Table 6.11.). As the MAR potential predicted 
using MAR-Wiz can be dependent on the sequence context, a larger (20Kb) region 
surrounding the breakpoint was also tested for the presence of MARs, and areas of 
increased MAR potential were again observed in the same approximate locations 
(Namciu et a l , 2004).
6.3.3.6. In silico analysis of sequence from 50bp regions either side of breakpoints
6.3.3.6.I. Purine/pyrimidine content
The lOObp regions around the duplication and insertion breakpoints, and the inserted 
sequences were examined for purine and pyrimidine content (see section 4.9.2.2.). There 
were polypurine tracts (lObp or greater in length) found at or very close to three 
breakpoints, but no long tracts were found near the duplication breakpoint in dJ1055C14 
(Figure 6.22.). The longest polypurine tract was 16bp in length, and overlapped with one
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of the ends of the inserted sequence from dJ305B16 (Figure 6.22.). Purine tracts have 
been found to be over-represented at both translocation and deletion breakpoints and can 
form unusual DNA structures and may be able to stimulate homologous recombination 
(see section 5.8.2.4.) (Rooney and Moore, 1995).
6.3.3.6.2. Inverted repeats and secondary structure near breakpoints
The sequences around the breakpoints of the duplication/insertion and the sequenced 
junction were all searched for the presence of direct, inverted, symmetric and inversions 
of inverted repeats by the Oligorep program (see section 4.9.2.3.). Only a few repeated 
sequences were found in the areas searched (Figures 6.23. and 6.24.). Generally a few 
more repeats were seen in the junction than the original sequences, which may have been 
involved in mediating or stabilising the rearrangement, or this apparent increase may just 
have been related to the fact that a longer sequence was being examined (Figures 6.23. 
and 6.24.) (Chuzhanova et al., 2003).
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Figure 6.21. Regions of MAR potential in the regions around the duplication and 
insertion breakpoints in family 3 according to the MAR-Wiz program, (a.) shows 5Kb 
around the insertion point in bA453F18, (b.) is the 5Kb of sequence surrounding the short 
insertion from dJ197017, (c.) shows the results from the 5Kb of sequence around the 
short inserted sequence from dJ305B16, and (d.) shows the MAR-potential plot for 5Kb 
of sequence surrounding the proximal duplication breakpoint in family 3 in clone 
dJ1055C14. All breakpoints or inserted sequences are located at (or centred on) position 
2500bp on the plots.
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Clone Region within clone
Location of 
potential MAR
Average
strength
Integrated
strength
bA453F18 22455-27454 24055-24155 0.878 264.211
dJ197017 71905-66906 70705-70205 0.760 380.707 1
dJ305B16 41553-46552
42853-43053 0.808 162.396
43453-43653 0.655 131.684
dJ1055C14 65684-70683 67684-68084 0.793 318.085
Table 6.11. Regions of relatively high MAR potential near the sequences involved in the 
Xq26.2 insertion, as found by MAR-Wiz. Positions are given in base pairs from the start 
of the sequence of the relevant genomic clone. Average strength is defined by the MAR- 
Wiz program as the potential per 1Kb sequence window, and is worked out from all the 
contiguous windows that have a potential higher than the threshold normalised MAR- 
potential value of 0.6. Integrated strength is the total MAR potential over the whole 
length of the putative MAR.
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bA453F18 25004-24905
AGGCGTGAGCCACTGCTCCAGGTTGCTGATACATTTGTATAATACTTCTTATTTTACTTTAATCAAGACTAAGAACTTTAACTATGAGAATGTTCATTAG
RRRYRYRRRYYRYYRYYYYRRRYYRYYRRYRYRYYYRYRYRRYRYYYYYYRYYYYRYYYYRRYYRRRRYYRRRRRYYYYRRYYRYRRRRRYRYYYRYYRR
dJ 197017 69329-69483
AAGACTGAGCCTGAGTCTGACAAGTTGATATTTACAAAAGAGTACAGTGAGTAGTATGGTAGTGGCAAGCACAGCATGCTGTTGGGAATTAGAGGAGGGACAG
RRRRYYRRRYYYRRRYYYRRYRRRYYRRYRYYYRYRRRRRRRYRYRRYRRRYRRYRYRRYRRYRRYRRRYRYRRYRYRYYRYYRRRRRYYRRRRRRRRRRYRR
CTAACCCAGATTTGGGATGTGTTGAGTAATTAAAAGCTCCCAACAAGAGTG
YYRRYYYRRRYYYRRRRYRYRYYRRRYRRYYRRRRRYYYYYRRYRRRRRYR
dJ305B16 43978-44029
TGCCTAATCAAGTTTAAATGTGCTTTTTAAAAAGTTTCATTCAAAAGCCACTGTTTTACTCAATGTGGAAGTACTAGGAGCCTTCCCACTAAAATCAAGAGGG
A
YRYYYRRYYRRRYYYRRRYRYRYYYYYYRRRRRRYYYYRYYYRRRRRYYRYYRYYYYRYYYRRYRYRRRRRYRYYRRRRRYYYYYYYRYYRRRRYYRRRRRRR
R
AAAAAGGATGCTCACTC TTGCCACTATTATGTAACAATGCATTGAAGG 
RRRRRRRRYRYYYRYYYYYRYYRYYRYYRYRYRRYRRYRYRYYRRRRR
dJ1055C14 68134-68233
GGTAAAAATTGGTATATCTATTTTATCTTTAATTTATTCTAGGAAAGAAGTTGATGGCAGAAAGGGCACTACAATTAGCGAATTTATATAATTTATAATT
RRYRRRRRYYRRYRYRYYYRYYYYRYYYYYRRYYYRYYYYRRRRRRRRRRYYRRYRRYRRRRRRRRYRYYRYRRYYRRYRRRYYYRYRYRRYYYRYRRYY
Figure 6.22. Purine/pyrimidine content in the lOObp region immediately surrounding both the insertion/duplication breakpoints and the 
sequences inserted at the breakpoints. Sequence included in the breakpoint junction is coloured as in Figure 6.20., and flanking sequence is 
shaded grey. The genomic sequence around the breakpoints is shown on the top of the pairs, and the classification of each nucleotide is 
shown on the lower line of the pairs. Tracts of alternating purines/pyrimidines (R/Y), or pyrimidines/purines (Y/R), of 10 nucleotides or 
greater, are underlined, and stretches of polypurine or polypyrimidine nucleotides of lObp or greater are shown, bold type.
dJ 197017  69329-69483
AAGACTGAGCCTGAGTCTGACAAGTTGATATTTACAAAAGAGTACAGTGAGTAGTATGGTAGTGGCAAGCACAGCATGCTGTTGCjGAATTAGAGGAGGGACAG
c t a a c c c a g a t t t g g g a t g t g t t g a g t a a t t a a a a g c j c c c a a c a a g a g t g
dJ305B16 43978-44029
TGCCTAATCAAGTTTAAATGTGCTTTTTAAAAAGTTTCATTCAAAAGCCACTGTTTTACTCAATGTGGAAGTACTAGGAGCCTTCCCACTAA^ATCAAGAGGG
AAAAAAGGATGCTCAC’I'CTTGCCACTA'I’^ TGTAACAATGCATTGAAGG
dJ1055C14 68134-68233
GGTAAAAATTGGTATATCTATTTTATCTTTAATTTATTCTAGGAAAGAAGTTGATGGCAGAAAGGGCACTACAATTAGCGAATTTATATAATTTATAATT
=± — »  < — <  — —
Figure 6.23. Internally repeated sequences around the breakpoints in family 3, looking at the genomic sequence around the breakpoints or
inserted sequences. 50bp on either side of a breakpoint is shown. No repeats were found in the region around the bA453F18 insertion point.
Sequences found at the breakpoint are coloured as before in Figure 6.17., and the sequences not found in the final rearrangement are shaded
grey. Nucleotides that form part of repeat sequences are shown in bold. The type of repeat found is shown by the arrows above and below the
sequence: direct ( ►), inverted (— ►) and symmetric (---- ►). Repeats within the sequence were searched for using Oligorep (see section
2.2.2.10.6. and 4.9.2.3.).
Junction sequence
AGGCGTGAGCCACTGCTCCAGGTTGCTGATACATTTGTATi&TACTTCTTTAGTAGTATGGTAGTGGC^AGCACAGCATGCTGTTGGGAATTAGAGC^GGGAC
AGCCTGTTTTACTCAATGTGGAAGTACTAG^AGPCTTCCCACTAAAATC^AGA^AGCTTGATGGCAGAAAGGGCACTACAATTAGCGAATTTATATjiATTTA
TAATT
Figure 6.24. Internally repeated sequences around the sequenced breakpoint junctions in family 3. 50bp on either side of a breakpoint is 
shown. Sequences found at the breakpoint are coloured as before in Figure 6.17., and the sequences not found in the final rearrangement are 
shaded grey. Nucleotides that form part of repeat sequences are shown in bold. The type of repeat found is shown by the arrows above and
below the sequence: direct (--- ► ), inverted (— ►) and symmetric ( ----->). Repeats within the sequence were searched for using Oligorep
(see sections 2.2.10.6. and 4.9.2.3.).
6.3.3.7. Analysis of genomic features in the wider insertion region
6.3.3.7.I. Genes
The gene content of a 1Mb region including the insertion point in bA453F18 and the two 
short inserted sequences from dJ197017 and dJ305B16 was examined (Figure 6.25.). 
There were five known genes in this region, and two novel genes (as annotated on the 
Ensembl genome browser, version 22.34d.l). One gene overlapped with the proximal 
end of this region, and coded for a member of the olfactory receptor gene family, 
OR13H1 (Fuchs et al., 2002;Malnic et al., 2004). There are hundreds of copies of 
functional olfactory receptor genes and psuedogenes throughout the human genome, but 
this is the only one so far that has been mapped to the X chromosome (Malnic et al., 
2004). Transcripts corresponding to OR13H1 have been submitted to Genbank under 
accession numbers Q8NG92 and Q96R21.
There were two genes in the region between the inserted sequences from dJ197017 and 
dJ305B16 (Figure 6.25.). One, MST4, codes for a protein that is a member of the Ste20- 
like kinase family and contains an N-terminal kinase domain and a C-terminal regulatory 
domain (Qian et a l , 2001). There are two alternatively spliced isoforms of this gene, 
which are in the databases as accession numbers Q9BXC3 and Q8NBY1. The other 
gene, annotated as transcript NM_194277 on Ensembl, was less well characterised but 
contained a band 4.1/FERM domain at in its N-terminal region (Chishti et al., 1998). 
FERM domains are often involved in localising the protein to the plasma membrane 
(Chishti e ta l , 1998).
A known gene was located at the distal end of clone dJ305B16 (Figure 6.25.). This gene 
codes for a member of the Ras-like family of small GTPases, RAP2C. Members of this
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large protein family have diverse roles in signal transduction (Stork, 2003). One further 
annotated gene was just within the distal end of this 1Mb region (Figure 6.25.). MBNL3 
(Muscleblind-like protein 3) is involved in the regulation of myogenesis and may be 
involved in the pathogenesis of myotonic dystrophy (Squillace et al., 2002;Fardaei et al., 
2002). The MBNL3 protein contains 4 Cys3His zinc finger domains, which may be 
involved in RNA binding (Squillace et al., 2002).
EZ3EZZZ>t
MST4
NM 194277 RAP2C MBNL3
11 r dJ197017 1b A324A3 bA453F18 dJ965E19
129.4Mb 129.6Mb 129.8Mb 130.0Mb 130.2Mb
Figure 6.25. Genes present in the insertion region, adapted from the Ensembl genome
browser. Genomic clones from a 1Mb region including the insertion sequence are shown
as grey boxes, dark grey when sequenced on the forward strand, light grey when
sequenced on the reverse strand. Distance from the Xp telomere is shown in Mb
underneath the contig. Genes in the region are shown as arrows above the contig, the
direction of transcription is the same as the orientation of the arrow. Known genes are
shaded red and labelled, novel uncharacterised genes are shaded black. The position of
the insertion of Xq22.2 sequence into Xq26.2 is shown by the blue arrow above the scale
bar and the two original locations of the two ~50bp sequences inserted at the breakpoint
are shown by the blue bars underneath dJ 197017 and dJ305B16.
319
6.3.3.7.2. Region -  specific repeats
1Mb of genomic sequence containing the insertion site was compared against itself using 
Pipmaker on sequence that had been masked for interspersed repeats by Repeatmasker 
(Figure 6.26.). This revealed that part of this region had a complex repetitive nature, with 
many repeats, both direct and inverted, and that the insertion of Xq22.2 sequence had 
occurred within this highly complex repetitive region (Figures 6.26. and 6.27.). Some of 
this repetitive region was contained within bA453F18, and part of the distal section is in 
another genomic clone involved in the breakpoint, dJ197017 (Figure 6.26.). The rest of 
the repeats were within the clone that separated bA453F18 and dJ197017, bA512H23 
(Figure 6.26.). Another Pipmaker dotplot, of just|bA453F18 (masked for interspersed 
repeat sequences) sequence against itself, to give a more detailed view of the local 
repeats in this region, showed that this clone contained six copies of a small inverted 
repeat, and also had large stretches of direct repeats (including the inverted repeat 
sequence) in the distal half of the clone (Figure 6.27.). Comparison with the track 
showing the location of interspersed repeat elements in this genomic clone, using the 
Ensembl genome browser, shows that almost all of the sequence in this clone is 
repetitive, either as interspersed repeats, or the region-specific repeats (Figure 6.28.). This 
highly repetitive region appears to be evolutionarily conserved, as similar patterns of 
repeated sequences are seen when either the syntenic regions of the Mus musculus or Pan 
troglodytes X chromosome are compared by BLASTz in a dotplot (Figure 6.28.). The 
human and chimpanzee repeats are similar in nature as when the syntenic regions from 
the two genome were compared the similarities between the two were very much like the 
pattern seen in Figure 6.28a (data not shown). However, when the mouse sequence was 
compared against either the human or chimpanzee sequence, hardly any similarities 
between these sequences were found by BLASTz comparisons (data not shown). The
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syntenic region of the rat X chromosome also contains a region including arrays of a 
short, directly repetitive sequence, revealed by BLASTz comparisons, with a very similar 
organisation to the repeats in the mouse (not shown). It seems that the repetitive nature 
of this genomic region is conserved between the three species, but that the actual 
sequence within the repeats may not be so well conserved. One obvious difference 
between the mouse and the two primate sequences is that the murine repeats appear to be 
purely direct repeats, whereas the human and chimpanzee repeats also contain some 
inverted repeat sequences (Figure 6.27., and 6.28.). Although the human and mouse 
sequences for this 200Kb region are contiguous, it is important to note that the 
chimpanzee genome sequence is not yet complete, and there are several gaps in the 
sequence in this region, so these regional repeats may be more extensive in this genome 
sequence, and also be present in the as yet unsequenced gaps (Figure 6.28a.). 
Interestingly, when this region is viewed on the Ensembl genome browser, it appears that 
some open reading frames predicted by Genscan, and an EST, coincide with many of the 
inverted repeats within bA453F18 (Figure 6.27.).
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bA512H23
dJ197017 □dJ965E19
129.4Mb 129.6Mb 129.8Mb 130.0Mb 130.2Mb
Figure 6.26. Dotplot (Pipmaker) of the region around the Xq26.2 insertion point. The 
contig for the region is shown underneath the Pipmaker output. The scale bar shows 
distances in Mb from the Xp telomere (NCBI Build 34). The positions of human genomic 
clones for this region are shown by the labelled grey boxes underneath the dotplot. 1Mb 
genomic sequence, including the insertion point (blue arrow) for the Xq22.2 duplication 
was used, masked for human repetitive elements before being compared against itself in 
the dotplot. The blue lines show the original locations of the two short sequences 
inserted at the breakpoint.
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Figure 6.27. Dotplot output from Pipmaker for the whole (Repeatmasked) sequence of 
human genomic clone bA453F18, with Ensembl genome browser tracks lined up 
underneath (Release 16.33.1), showing position in Mb on the X chromosome, 
interspersed repeats in grey, ESTs in purple, and Genscan predictions are shown in green. 
The location of the insertion of Xq22 sequence containing PLP1 is shown by the arrow.
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a. b.
Figure 6.28 The syntenic regions of the chimpanzee (a.) and mouse (b.) genomes also 
contain numerous directly repeated sequence arrays. 200Kb of genomic sequence (from 
Ensembl genome browsers, version 22.1.1. for chimp and version 22.32b. 1 for mouse) 
that appeared to be syntenic to the Xq26.2 insertion region were first masked for 
interspersed repetitive elements by Repeatmasker (Repbase version 7.4) then the masked 
sequence was compared against itself using Blastz/Pipmaker, and the resulting dotplot is 
shown here. Underneath the dotplot, parts of the Ensembl display for this region of the 
appropriate genome is shown, with the contig in blue, predicted genes in black, 
interspersed repeat content in grey, and the scale bar shows the position or this region in 
the chimpanzee and mouse genomes.
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6.4. Discussion
6.4.1. Summary of rearrangement in family 3
Individuals from this family carried an atypical duplication including PLP1, which was 
duplicated into another region of the X chromosome, Xq26.2. The proximal end of the 
duplication in this family was located 90.6Kb centromeric to the start of the PLP1 gene. 
The duplicated segment was also inverted in orientation with respect to the original 
sequence in Xq22.2 during the rearrangement (Figure 6.29.). The insertion of a segment 
of Xq22.2 sequence into Xq26.2 was also accompanied by the insertion of two short 
sequences (52bp and 55bp) into the breakpoint. These two short sequences were also 
from Xq26.2, distal to the insertion point, and both mainly consisted of known 
interspersed repetitive elements (Figure 6.19.). The other duplication/insertion 
breakpoint in this family has not been characterised, but previous work has shown that 
the distal duplication breakpoint may be in a similar region to that of family 1, and 
possibly family 2, and several other PMD duplications, i.e. in the region of the distal low- 
copy repeats (Woodward et al., 2000;Woodward et al., in preparation).
A mosaic deletion found in the carrier mother in family 3, which includes about half of 
the sequence from the long arm of the X chromosome, has been thoroughly characterised. 
The deletion breakpoints are both distant from the insertion region and the PLP1 locus, 
which makes it unlikely that the deletion is connected to the duplication and insertion. 
The sequences obtained from the various breakpoints in this family so far show 
characteristics of NHEJ repair of DSBs, without large regions of homology between 
sequences, and microhomologies and inserted nucleotides at the breakpoint junctions 
(Figures 6.6. and 6.17.) (Lieber et al., 2003).
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0 0
PLP1 Xq22.2
Xq21.1-
Xq26.2
Xq27.3-
Normal X 
chromosome
PLP1 duplication 
in Xq26.2
Xq interstitial 
deletion
Figure 6.29. Summary of X chromosome rearrangements found in family 3. The 
location and orientation of the duplicated segment containing PLP1 is shown by the pink 
chevron. X chromosome ideogram was adapted from the Ensembl genome browser.
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6.4.2. Matrix attachment regions
MARs were found near all of the breakpoint regions associated with the duplication and 
insertion, and one potential MAR was also found just distal to the distal deletion 
breakpoint (Figures 6.10. and 6.21.). All of the potential MARs associated with the 
insertion breakpoints were slightly proximal to the breakpoints or insertion sequences, 
(Figure 6.21., Table 6.11.). This association of breakpoint sequences in this family with 
MARs could be relevant to the rearrangement mechanisms. Topoisomerase II cleavage 
sites are found in close association with MARs, and the MAR-Wiz program looks for 
topoisomerase II consensus sites as one of the criteria for determination of MAR- 
potential (Sperry et a l , 1989;Singh et al., 1997). Cleavage of DNA by topoisomerase 
enzymes could be important for generating DSBs and stimulating rearrangements. Other 
genomic features that are sometimes associated with MARs are origins of replication 
(Singh et a l , 1997;Girard-Reydet et al., 2004). Sequences including the human 
replication origin consensus and the PUR protein binding consensus sequence reported to 
be associated with human origins of replication were also found near some of the 
insertion breakpoints (see sections 6.3.3.4.I. and 6.3.3.4.2.) (Bergemann and Johnson, 
1992;Dobbs et a l , 1994;Smith et a l , 1998;Darbinian et a l , 2001). DNA replication may 
occur in “replication factories”, distinct regions which are stationary within the nucleus 
and contain several polymerases and replication forks (Cook, 1999). The human genome 
is organised into groups of adjacent replicons which are replicated simultaneously and are 
associated with the same replication foci in the nucleus (Jackson and Pombo, 1998). 
Three of the sequences found at the insertion breakpoint originate from Xq26.2, and 
rearrangements such as those seen in family 3 involving these sequences could be due to 
different damaged and stalled replication forks associated with the same replication 
factory being misrepaired by NHEJ (Figure 6.17.).
327
6.4.3. Sequence motifs, G+C content and other features of the DNA sequence
Several sequence motifs that have been previously reported to be involved in other DNA 
rearrangements were found near the deletion and insertion breakpoints in family 3 (see 
section 6.3.3.4.). However, no single motif was observed to be particularly over­
represented close to all of the breakpoints, and while it is possible that some aspects of 
the local DNA sequence could be involved in the generation of rearrangements, this 
could not be determined by this analysis.
Some short (10-16bp) polypurine and alternating purine/pyrimidine tracts were noted 
close to the various breakpoints in family 3 (Figures 6.11. and 6.22.). Again, this is in 
concordance with previous studies that have found purine/pyrimidine tracts to be over­
represented at deletion breakpoints and polypurine tracts to be in excess at translocation 
breakpoints (Abeysinghe et al., 2003). Regions of unusual nucleotide composition may 
form alternative topological conformations which may stimulate rearrangements and 
recombination, and this may have been important for generating the rearrangements in 
this family (Abeysinghe et a l , 2003).
A small number of repeats were found in the sequence around the breakpoints, which 
could contribute to secondary structure that could promote DNA rearrangements or 
recombination, or could help to stabilise the DNA during the process of the 
rearrangement (Figures 6.23. and 6.24.) (Chuzhanova et al., 2003).
Gross deletion breakpoints are often located within A+T rich sequences (Abeysinghe et 
al., 2003). While both deletion breakpoints in family 3 were located in regions with 
generally high A+T content, a shorter stretch of sequence around the distal breakpoint
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had a higher G+C content than the surrounding 1Mb (see section 6.2.5.1.). Translocation 
breakpoints have been reported to be G+C rich (Abeysinghe et a l , 2003). Both the major 
duplication/insertion breakpoints in family 3, within clones dJ1055C14 and bA453F18 
were located in regions that had a G+C content slightly higher than the surrounding 1Mb 
region (see sections 6.3.3.1. and 6.3.3.2.3.). The two short inserted sequences from 
Xq26.2 had much lower G+C content than the surrounding region, and all the sequences 
from Xq26.2 that were involved in the PLP1 insertion event had a much higher 
interspersed repeat content than the surrounding 1Mb region (see section 6.3.3.2.). It is 
possible that some of the interspersed repeats found near these breakpoints could be 
involved in the breakpoint mechanism (see section 6.4.5.2.).
6.4.4. Insertion
One of the most intriguing aspects of the duplication in family 3 is the insertion of the 
duplicated sequence into an apparently unrelated region of the X chromosome. There 
does not appear to be any obvious similarity between the Xq22.2 and Xq26.2 sequences 
involved at the sequenced breakpoint. The distal duplication and insertion breakpoint 
from family 3 has not been characterised as yet, and further insights into the mechanism 
may be gained from investigation of this aspect of the rearrangements in this family.
6.4.5.I. Repetitive regions near Xq26.2 insertion
One interesting feature that has been noted in this study is the highly repetitive nature of 
some of the sequences close to the insertion point. The insertion breakpoint region in 
Xq26.2 is surrounded by a large array of direct and inverted repeated sequences in the 
human genomic sequence (Figures 6.26. and 6.27.). Arrays of repeated sequences are 
also evident in the syntenic genomic sequences of other primate and rodent genomes
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(Figure 6.28.). The repeat arrays do not necessarily show interspecific homology 
between more distantly related species such as human and mouse.
Tandemly repeated sequences are found throughout the human genome, and many of 
these repeated sequences have functional and evolutionary significance. Some genes, 
such as those for ribosomal RNAs and small nuclear RNAs (snRNA), such as U2 
snRNA, are found in extensive tandem arrays in the human genome (Van Arsdell and 
Weiner, 1984;Westin et al., 1984). Sequences important for chromosomal function, such 
as centromeric satellite DNA and telomeric DNA comprise tandemly repeated sequences, 
and many polymorphic regions of the genome, such as micro-, mini-, macro- and mega­
satellite sequences also occur in tandemly repeated sequence arrays. Concerted evolution 
is often noted to occur for tandemly repetitive sequences, where individual copies of a 
repeated sequence do not evolve independently but instead are subject to sequence 
homogenisation (Liao, 1999). Concerted evolution of a region containing an ancestral 
tandem repeat inherited from a common ancestor could result in tandemly repeated 
regions being present in syntenic regions of the genome in related species, but without 
any interspecies sequence homology found in the orthologous repeat units, as is observed 
for the repetitive sequences near the Xq26.2 insertion point in primate and rodent 
genomic sequence. Concerted evolution of tandem repeat arrays could occur by a 
process involving unequal crossover, either intra- or interchromosomal, or by gene 
conversion based mechanisms (Smith, 1976;Liao, 1999). Gene conversion has been 
proposed to occur by a process similar to the break induced repair/homologous strand 
invasion model (see section 4.12.5.), and to maintain homogenous tandem repeat arrays 
high levels of recombination or gene conversion are necessary (Pavelitz et al., 
1999;Lemmers et al., 2004). A high rate of gene conversion within a tandem sequence
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arrays may be driven by an excess of recombinogenic DSB formation within the array, 
and such regions could also be susceptible to other DSB-stimulated rearrangements, 
including insertions of DNA originating from elsewhere in the genome, as has occurred 
in family 3.
6.4.5.2. Mechanism of insertion
The two short Xq26.2 sequences inserted at the sequenced Xq22-Xq26.2 junction are 
both mainly composed of interspersed repetitive elements (see Figure 6.19.). It has been 
shown that retrotransposition of interspersed repetitive elements into pre-existing DSBs 
or repair of DSBs by capture of retrotransposable elements can occur (Lin and Waldman, 
2001a;Morrish et a l, 2002). The two short inserted sequences (L1M4 and L2 elements) 
from the insertion breakpoint are not members of currently active retrotransposon 
families, but these sequences could still have been retrotranscribed in trans prior to 
capture and insertion at the breakpoint (Tables 6.8. and 6.9.) (Smit et a l, 1995;Smit and 
Riggs, 1995;Ejima and Yang, 2003). An almost full-length Alu sequence is present just 
distal to the insertion point in bA453F18 (see Figure 6.19. and Table 6.10.). Alu- 
mediated recombination and rearrangement has been proposed to be instrumental in the 
formation of segmental duplications, and this process may also have been involved in this 
duplication event (Bailey et al., 2003;Babcock et al., 2003;Jurka et a l, 2004).
As already mentioned previously, as well as short sequences being captured during the 
process of DSB repair, more substantial stretches of DNA can be inserted into DSBs (see 
section 5.8.2.6.) (Lin and Waldman, 2001a;Allen et al., 2003). This type of mechanism 
could result in the insertion and duplication seen in family 3, either by NHEJ of isolated 
DNA ends, or possibly by a strand invasion and DNA synthesis model as has been
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proposed for other PMD breakpoints (see sections 4.12.5. and 5.8.2.6.) (Woodward et al., 
in preparation). A possible mechanism for the duplication and transposition of Xq22 
sequence into Xq26.2 could be initiated by a non-homologous strand invasion event from 
one end of a DSB in Xq26.2 into Xq22, and replication could then be primed from the 
invading strand. Stalling of the replication fork once the PLP1 region had been 
replicated, followed by non-homologous joining to the free end in Xq26.2, with the 
capture of some other short sequences from the region, would complete the insertional 
rearrangment.
6.4.6. Mild phenotype in family 3 -  a possible position effect?
The phenotype in the affected boy in family is relatively mild compared to some other 
duplications (see section 2.3.3.). The size of the duplication in this family is relatively 
small compared to some PLP1 duplications, and it is possible that smaller duplications 
may result in a milder phenotype (Inoue et al., 1999;Woodward et al., in preparation). 
Alternatively, the expression of the duplicated copy of PLP1 away from Xq22 may be 
reduced compared to the original copy of PLP1, perhaps due to the local chromatin 
environment by a position effect (Kleinjan and van Heyningen, 1998). One case of an 
apparent position effect has been reported involving PLP1 and a translocation (without 
duplication) to chromosome 19, where the autosomal copy appears to be expressed at 
either low levels, or not at all (Inoue et al., 2002).
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6.5. Conclusions
Characterisation of some of the breakpoints involved in the rearrangement in family 3 has 
shown that the duplication and insertion, and the mosaic deletion do not appear to be 
directly connected, as the various breakpoints are spatially separated and do not appear to 
share any obvious sequence characteristics. The breakpoints characterised so far do not 
exhibit much homology between the various sequences involved and it cannot be shown 
definitively from the breakpoint sequences how the rearrangement actually occurred, and 
several different pathways could have generated the observed breakpoints.
The occurrence of atypical PMD duplications such as in family 3 illustrates the 
importance of FISH as a diagnostic method for detecting duplications, as this is the only 
method that could detect the unusual nature of the duplication in this family. Due to the 
mosaic deletion in the carrier female, dosage detection methods such as quantitative PCR 
do not detect an increase in dosage at the PLP1 locus (Woodward et al., 1998). The 
carrier status of the mother in family 3 could only have been determined using a FISH 
methodology.
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7.1. MAPH RESULTS
MAPH is a quantitative technique that can be used to determine copy number of 
genomic sequences (see section 1.5.4.) (Armour et a l , 2000). The MAPH technique 
was applied to the PLP1 genomic region, with the aim of developing an alternative 
technique to interphase FISH for the diagnosis of duplications of PLP1. As well as 
assaying copy number of the PLP1 gene itself, additional MAPH probes were also 
designed within the flanking genomic region, in order to be able to characterise the 
extent of the duplication in a single experiment, as duplications involving PLP1 have 
been shown to be variable in size (Woodward et a l , 1998;Inoue et a l , 1999;Hobson 
et a l , 2003).
7.1.1 MAPH probe mix
A MAPH probe set was developed for the PLP1 region, containing probes for the 
PLP1 gene, the region flanking PLP1 and various control probes. This probe set was 
used in a number of experiments to assess whether MAPH was a suitable method for 
determining gene dosage in PMD patients.
The probe mix consisted of 4 probes from PLP1 - exons 3, 5, 6 and 7 (plp3, plp5, 
plp6, plp7); 6 autosomal control probes, one each from chromosomes 1, 4, 6 and 7 
(chlq24, ch4q26, ch6p24, ch7q31), and two from chromosome 17 (chl7q21, 
chl7pl3); two sex-linked control probes, one from X (Xql2) and one from Y (sry); a 
non-human control probe from a Xenopus genomic sequence (XLnkx) and 5 probes 
from around the region immediately flanking PLP1 (198p4, 79p ll, 43hl3, 240c2, 
144al0) (Table 2.2.) . For positions of probe target sequences in or near PLP1, see 
Figure 7.1.).
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Figure 7.1. Position of MAPH probes relative to PLP1 and the surrounding genomic 
region, (a.) shows a 2Mb region including PLP1 (position shown by the black arrow 
on the contig), taken from the EnsembI genome browser, version 22.34d.l. 
Chromosome bands, scale and predicted genes are shown. The locations of 5 MAPH 
probes (198p4, 79p 11, 43hl3, 240c2, 144al0) within the flanking region are shown 
by purple bars above the blue contig. Genomic clones are either yellow, red or 
orange, (b.) shows the positions of the 4 MAPH probes (plp3, plp5, plp6, plp7) 
(purple boxes) within the PLP1 gene, relative to the intron-exon structure (as Figure 
1.2 .).
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7.1.2. MAPH experiments
The MAPH procedure was carried out on 58 samples in total in 18 separate 
experiments. Each experiment used between 3 and 7 normal controls, and between 3 
and 10 test individuals, and the mean number of samples (normals and test) per 
experiment was 11.39. For the test samples, at least one result, but usually two 
measurements of dosage by MAPH, were obtained for 47 individuals, eight females 
and 39 males, hi total 99 individual dosage results were obtained for each probe in 
from the test samples, 16 from females and 83 from males. 11 samples were used as 
normal controls, which were all used in at least two experiments, and some were used 
all the experiments.
7.2. Autosomal control probes
Normalised ratios were obtained for each probe, using the four control probes that 
were nearest in size to calculate the dosage ratio and a mean was taken for each 
individual sample over all experiments. For the six autosomal control probes the 
values of the mean and standard deviation are shown in Table 7.1. and Figure 7.2., 
and a histogram for each individual control probe using the individual values is shown 
in Figure 7.3.. The results from the control probes were each near 1, as would be 
expected given the method of normalisation, but some probes were more variable than 
others. In particular, the ch7q31 probe and the chl7q21 probe had the greatest 
standard deviations (Table 7.1.) and their means were the furthest away from the 
expected value of a normalised ratio of 1 (Table 7.1. and Figure 7.2.). Additionally, 
when the frequency distribution was plotted as a histogram for each control probe 
(Figure 7.3.), these two probes, especially chl7q21, did not appear to be normally 
distributed whereas the other four probes showed an approximately normal 
distribution. Because the ch7q31 and chl7q21 control probes did not appear to be
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producing consistent results that were normally distributed, these two probes were not 
used when calculating normalised ratios for the other probes as they might skew the 
data. Instead, normalised ratios were obtained for all the test probes by using the four 
more reliable autosomal probes (chl7pl3, chlq24, ch6p24, ch4q26) as reference 
peaks instead of the four control probes that were nearest in size as had been used in 
the initial calculations.
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Autosomal MAPH probes
Figure 7.2. Graph showing the means +/- 1 standard deviation of the normalised ratio 
for the six autosomal control MAPH probes throughout all experiments.
Probe ch7q31 chi7p l3 chlq24 ch6p24 ch4q26 chl7q21
Mean 1.03 1.02 1.00 1.01 0.98 0.93
Standard deviation 0.21 0.12 0.16 0.11 0.14 0.21
Table 7.1. Means and standard deviations for 6 MAPH autosomal control probes, 
using data from all experiments.
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Figure 7.3. Histograms showing the frequency distribution of normalised ratios for 
the six MAPH autosomal control probes. The normal distribution curve that is closest 
to the data is shown superimposed on the histograms.
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7.3. Sex-linked control probes
Two of the control probes were sex-linked, one from the Y chromosome, mapping to 
the SRY gene, and the other from the X chromosome, from the chromosomal band 
Xql2. The mean normalised ratios for 12 females and 45 males from several 
experiments (including the control individuals) are plotted in Figure 7.4. for these two 
probes. A clear difference can be seen between the sexes, most notably for the SRY 
probe where all the females had a normalised ratio of 0 and the male mean ratio was 
0.82 (Figure 7.4.). Although the SRY probe did give some quite variable normalised 
ratios for males, the fact that it was never amplified in females showed that it was 
specific to its Y-linked target sequence. For the Xql2 probe (Figure 7.4.), the female 
mean was 0.97 and the male mean was 0.44, which were both close to the expected 
ratios of 1.00 for the normal female complement of two X chromosomes and 0.50 for 
the single male X chromosome. Similar results were also seen when looking at these 
data in just the control individuals. The SRY probe had a value of 0 for all female 
controls, and a mean of 0.97 for the male controls, and the Xql2 probe had a mean 
normalised ratio of 1.02 for the female controls and 0.48 for the male controls. The 
differences in normalised ratio between males and females for both Xql2 and SRY 
probes was significant using a t-test for equality of means (p<0.001) for the data using 
either just the control individuals or all samples.
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Figure 7.4. Mean normalised ratios +/- one standard deviation for the Xql2 and SRY 
MAPH probes for all samples. Male mean bars are shaded, females are unshaded.
7.4. Xq22 probes in control individuals
Mean values were taken for each of the Xq22 probes for each of the control
individuals used in the MAPH experiments (7 males and 4 females) and the means for
the males and females were then compared (Table 7.2., Figure 7.5.). Despite the
small sample size, most probes did show a significant difference between the male
and female controls. For the Xq22 probes where there was a significant difference in
normalised ratios between the sexes, the range of female control means were between
0.878 and 1.074, all close to the expected ratio of 1, and the male control means
ranged between 0.394 and 0.634. Two probes did not show a significant difference
(p<0.05) using a t-test for equality of means, between males and females, despite
containing X-linked sequences. These were PLP1 exon 3 and PLP1 exon 7. The
PLP1 exon 7 probe showed the least difference between sexes with the two means
being virtually the same (0.790 and 0.718). In addition, when MAPH was carried out
on a male with a deletion that included the whole of the PLP1 gene, the exon 7 probe
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was amplified from this sample, but the other three PLP1 probes in the mixture were 
not amplified as expected (Raskind et a l, 1991;Inoue et al., 2002). Further analysis 
was not carried out on the results for these two MAPH probes as they were unable to 
detect the differences in sex chromosome dosage reliably in normal individuals, and 
the exon 7 probe also appeared to hybridise to at least one other site in the genome 
that was not in the immediate vicinity of PLP1.
Probe 198p4 7 9 p ll 43hl3 PLP3 PLP5 PLP6 PLP7 240c2 144al0
Female mean 0.938 0.937 0.878 0.976 1.003 0.9916 0.790 1.075 1.053
Female SD 0.126 0.138 0.083 0.259 0.080 0.114 0.092 0.231 0.097
Male mean 0.513 0.465 0.634 0.601 0.523 0.473 0.718 0.518 0.394
Male SD 0.081 0.061 0.124 0.047 0.191 0.052 0.072 0.041 0.146
Significance p=0.003 p=0.003 p=0.004 p=0.061 p<0.001 P=0.001 p=0.234 p=0.023 P=0.016
Table 7.2. Means and standard deviations (SD) for the X- and Y-linked MAPH 
probes for 4 normal females and 7 normal males. The significance of the differences 
between the means was tested using a t-test for equality of means.
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Figure 7.5. Bar chart showing means +/- 1 standard deviation for Xq22 probes in 
normal controls. Male means are shaded bars, female means are white.
7.4.1. PLP1 probes
The two PLP1 probes that appeared to be producing consistent results (plp5 and plp6) 
using control males and females were looked at in a cohort of patients who had a 
probable diagnosis of PMD, or if female, were possible carriers of PMD. Interphase 
FISH using a cosmid containing PLP1 had been carried out on most of these 
individuals, so the PLP1 duplication status was already known. Figures 7.6. and 7.7. 
show the mean normalised ratios for the different categories of individuals for both 
probes. Male controls and male PMD patients who had been found not to have a 
duplication by interphase FISH had normalised mean ratios for the plp6 MAPH probe 
close to 0.5; female controls and males known to have a duplication had ratios close 
to 1, corresponding to two copies of PLPl\ and females who carried a duplication of
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PLP1 (three copies of the gene), had a mean normalised ratio near 1.5. The plp5 
probe had similar results, but the differences between the male controls and 
duplicated males, and between the female controls and duplication carriers was not as 
great, and also the results were much more variable, especially for the female 
duplication carriers (Figure 1.1.). The MAPH protocol was carried out on a male who 
has been found to have a deletion of the PLP1 gene, and a ratio of 0 was obtained for 
this individual for both PLP1 probes (Table 7.3.) (Raskind et al., 1991).
One family is suspected to carry a triplication of the gene, which has been detected by 
Southern blotting, quantitative PCR and interphase FISH (Ellis and Malcolm, 
1994;Woodward et al., 1998;Wolf et al., in preparation). MAPH was carried out on 
an affected boy from this family and his carrier mother. The ratios for the boy for 
both PLP1 probes were similar to the ratios for carrier females (Table 7.3.), and the 
results for the mother were a lot higher than the other carrier females (Table 7.3.), 
although considerably greater than the expected normalised ratio of 2, at 2.63 for 
plp5, and 2.33 for plp6. These data did support the idea that there is increased dosage 
of the gene in this family, greater than a duplication and most probably a triplication.
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Figure 7.6. Mean normalised ratios for the MAPH probe plp6, with +/- one standard 
deviation shown by the error bars.
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Figure 7.7. Mean normalised ratios for the MAPH probe plp5, with +/- one standard 
deviation shown by the error bars.
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N plp5 mean plp5 SD plp6 mean plp6 SD 1
Male controls 7 0.521 0.192 0.473 0.054
Males duplicated by 
FISH 16 0.882 0.158 1.03 0.092
Males not 
duplicated by FISH 16 0.439 0.185 0.474 0.085
Males not FISHed 4 0.473 0.178 0.448 0.098
Female controls 4 1.000 0.078 0.990 0.116
Females duplicated 
by FISH 6 1.340 0.558 1.510 0.252
Female not FISHed 1 1.06 - 1.04 -
Male deletion 1 0 - 0 -
Male triplication 1 1.33 - 1.38 -
Female triplication 
carrier 1 2.63 - 2.33 -
Table 7.3. Means and standard deviations for the different classes of PMD patients 
and controls for MAPH probes plp5 and plp6. N shows the number of individuals in 
each class.
7.4.1.1. Analysis of individual normalised ratios
Although when the results for each sample were averaged together, there was clearly 
a difference between the different categories, when carrying out a screen for changes 
in gene dosage, measures of significance need to be assigned to the quantitative 
results obtained for each individual (Figures 7.6. and 7.7.). A method that has been 
used to assess statistical significance of MLPA dosage quotients was adapted to 
analyse the dosage results using the PLP1 MAPH probe set (developed by Andrew 
Wallace, National Genetics Reference Laboratory, Manchester, see 
http://www.ngrl.org.uk/Manchester/Pages/mutationsdload.htm).
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This approach uses the standard deviation of the control probes from an individual 
experiment, and each normalised ratio is expressed as a number of standard deviations 
from the control mean normalised ratio for that probe. Significance for each probe for 
each individual was tested by using Student’s t-distribution, which allows for small 
sample sizes, to calculate the probability of that value being contained within the t- 
distribution. Each individual experiment had been carried out with a number of test 
samples (up to ten) and some normal individuals of both sexes (usually two to four of 
each sex). As well as the probability of each probe having a normalised ratio within 
the same range as normal individuals, the probability of each probe being duplicated 
was also calculated. For male samples, the value expected for a duplicated sample 
was estimated by doubling the male control mean value. Each test value was then 
compared against this estimated duplicated ratio, using the same standard deviation as 
before. Similarly for female samples the female control mean value was multiplied 
by 1.5, to get an expected value for duplications, and compared to the test normalised 
ratios, using the same standard deviation that had been calculated from the normalised 
ratios obtained from the control individuals.
Not all the normalised results obtained from the MAPH experiments could be tested 
in this way, as in two experiments data had been collected from only one male control 
individual, as the other male control samples in that experiment did not happen to 
work on that occasion. In these instances, as the standard deviation cannot be 
calculated from a single number, significance was not able to be tested in this manner 
for the eight male samples from those two experiments, so only 75 male dosage 
results were used in this analysis.
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7.4.1.2. Analysis of the significance of individual normalised ratios for MAPH 
probes plp5 and plp6
For both sexes, and also both PLP1 probes, there was a large overlap in many of the 
normalised ratios, some of these were significantly different from the normal means 
and some were not significantly different. This was also the case when the 
normalised ratios were compared against the simulated duplicated ratios. For 
instance, some male normalised ratios with values close to 1 were found not to be 
significantly different from the normal male mean, and some strikingly high 
(normalised ratios greater than 2.5) dosage results from females for the plp5 MAPH 
probe were still not found to be significantly different from normal female control 
normalised ratios.
To be able to classify a result as duplicated with confidence, the ratio has to be 
significantly different from the normal mean value, and also not be significantly 
different from the duplicated mean value, with the converse being necessary for a 
result to be classified as normal. Out of the 91 individual samples tested, 45 could be 
categorised in this way using the normalised ratios from the plp6 MAPH probe, and 
33 could be categorised using the plp5 dosage results. These results did not represent 
91 separate individuals, as 47 different samples were tested in total, with 41 being 
analysed by MAPH more than once. For the individuals where more than one result 
had been obtained, to be confident about a dosage result, it must have been found to 
be the same each time the individual was tested. For the plp6 probe, only five 
individuals who had been tested more than once had the same result each time 
(normal or duplicated), and for the plp5 probe, only two individuals had consistent 
non-equivocal results each time they had been tested.
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This difficulty in classifying dosage results adequately was mainly due to the high 
variability found in the control samples. The average standard deviation, taken from 
all experiments, for the MAPH probe plp5 was 0.14 for male controls and 0.27 for 
female controls. For the other PLP1 probe, plp6, the mean standard deviation was 
0.06 for male controls and 0.12 for female controls. The mean number of controls 
used in each experiment was 2.65 for males and 2.94 for females. For a difference in 
normalised ratios of 0.5 (the difference between the expected normalised ratio for 
normal and duplicated for both males and females) to give a p-value of less than 0.05, 
the difference expressed as a number of standard deviations must equal 4.30 or 
greater, using a two-tailed Student’s t test with two degrees of freedom. Two degrees 
of freedom has been used for this example due to the mean numbers of controls used 
in the MAPH experiments. A difference of 4.30 standard deviations equates to a 
standard deviation of 0.1163. Thus if a cut-off point is set for an acceptable standard 
deviation at about 0.10, or 10%, differences from the normal mean ratio by a 
magnitude of 0.5 should be classified as significant by this method of analysis. The 
standard deviations for the plp5 probe were frequently greater than 0.10, especially 
for females. Also for probe plp6, relatively few experiments had female control 
values with a standard deviation less than or equal to 0.10. However, for male dosage 
of plp6, most experiments did have a standard deviation of less than 10% (13/16 
experiments with at least two male controls). This high variability in the normalised 
control ratios in many experiments explains why many ratios, despite being very close 
to the expected value for a particular category {e.g. 1.0 for males with a duplication), 
are not classed as significantly different from the alternative {e.g. 0.5, normal male).
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7.4.2. Xq22 probes flanking PLP1
Five MAPH probes were used flanking PLP1 in Xq22 (Figure 7.1a). These were all 
included in the probe mix that was used in each experiment, with the aim of using 
dosage results from these probes to assess the extent of Xq22 duplications in a single 
test.
7.4.2.1. 198p4
This probe is the most centromeric to PLP1 and as such, had only been found to be 
duplicated by using interphase FISH in a few individuals out of those tested (Figure
7.1.). Figure 7.8. shows the differences in mean normalised ratio between females, 
males not believed to have a duplication including this probe, and 3 males with a 
known duplication thought to extend past this genomic clone. Some results were not 
included because the duplication status was not previously known. Although the 
mean of the three “duplicated” males for this probe is quite close to the expected 
value for duplications (0.87), when these results are examined individually two of the 
three samples have mean ratios that are more consistent with this region not being 
duplicated (Figure 7.8.).
Further analyses were carried out on dosage quotient data from this MAPH probe. 
Significance values for each 198p4 dosage result were calculated as before (see 
section 7.4.1.1.). 34 of the individual male dosage ratios, and 4 of the female
individual dosage ratios for this probe could be classified as either normal or 
duplicated in this way. 34 out of the 40 males were tested more than once, and of 
these, 7 had all dosage ratios classified as not duplicated. None of the three males that 
were affected with PMD and were duplicated for this clone by interphase FISH could 
be unambiguously classified in this way. For the sample with a mean dosage ratio
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above 1, one of the dosage ratios was called as being duplicated, as it was 
significantly different from the normal control ratio for this probe, but did not differ 
significantly from the “duplicated” control ratio. The other dosage measurement 
using MAPH probe 198p4 on this individual was relatively high (1.72) and was thus 
found to be significantly different from both the normal control and simulated 
duplicated control ratios. The dosage results for this individual are more consistent 
with being duplicated than not. The MAPH technique measures sequence copy 
number at a much higher resolution than interphase FISH so it is possible that the 
MAPH dosage results were genuinely reporting the dosage of the target sequence at 
the sequence level, and perhaps only part of the region hybridised to by this genomic 
clone was in fact duplicated in the two males that were thought to be duplicated. 
None of the 7 female test samples for which there were at least two MAPH dosage 
ratios for probe 198p4 were consistently shown to be either duplicated or not 
duplicated. There were a few presumed false positive ratios among the males tested, 
three of the dosage ratios for individual males who had either been found not to have 
a duplication at all or had a duplication of PLP1 which did not extend this far 
proximal to the gene. Although there is a possibility that there could be an additional 
duplication of this region, separate to the PLP1-containing duplication such as the 
complex rearrangement described in family 2 (Figure 5.15.), it was most likely that 
these were just spurious results, as other dosage results for this probe from these 
individuals did not appear duplicated.
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Figure 7.8. Mean normalised ratios for the MAPH probe 198p4, with +/- one 
standard deviation for the non-duplicated males and females shown by the error bars. 
The individual means from 3 males that had a duplication of this probe by FISH are 
shown as separate columns.
7.4.2.2. 79p ll
As for the 198p4 MAPH probe, there were few individuals who were known to have a 
duplication encompassing this probe. When the mean dosage quotients from all the 
individuals tested were separated into groups, there was a clear difference between the 
groups (Figure 7.9.). Normal males, and males without a duplication of this region by 
interphase FISH had a mean for this probe of approximately 0.5, whereas the females, 
none of which were believed to have a duplication of this probe, and the males known 
to have a duplication including this region by FISH had means close to a normalised 
ratio of 1 (Figure 7.9.).
These data were also examined in the same way as the other MAPH probes, by 
comparing each dosage ratio for this probe against the appropriate control mean for 
that experiment, and assessing if there was a significant difference from the mean by
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Student’s t-test. 38 male and 8 female individual dosage measurements were 
classified as normal copy number using this method (see section 7.4.1.1.).
Only a few individuals where two or more normalised ratios had been obtained were 
consistently classified as duplicated or not duplicated for this probe, just 6/34 males 
and 2/7 females (see section 7.4.1.1.). Of the 6 males that were classified in this way, 
four were males who did not have a duplication of PLP1, one was a male with a 
deletion including PLP1 but not the region of this probe, and the other was a male that 
did have a duplication of PLP1 by interphase FISH. All these 6 males were classed as 
not being duplicated by these criteria. The two females that were categorised were 
both found to have a normal copy number of this probe target sequence. One of the 
females did have a duplication of PLP1 from interphase FISH data whereas the other 
did not.
None of the 7 males that had been found by interphase FISH to have a duplication 
extending into the region contained in the MAPH probe 79pll were found to be 
duplicated using these strict conditions. However, many of these individuals did 
show normalised ratios close to 1 or even higher, which is what is expected for a 
duplicated sequence. 5 out of these 7 individuals had all but one of their normalised 
dosage ratios classed as duplicated (2-4 results per person). Another individual had 
normalised ratios much above 1 in both experiments (1.30, 1.16), but these two 
dosage ratios were both classed as significantly different from both normal and 
duplicated means. The other male thought to have a duplication of this probe had one 
relatively low result (0.63) and one high dosage one (1.14), which was again found to 
be significantly different from both normal and duplicated.
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In many of the experiments (12/15 for the male controls and 6/17 female controls) the 
standard deviation this probe was less than 0.1, so only a minority of experiments 
might be reasonably expected to classify normalised ratios by this method, as has 
been found to be the case for this probe. While an overview of these data shows that 
this MAPH probe (79pl 1) is able to detect a change in dosage of the target sequence 
on occasion, this is not particularly consistent. In general, the normalised ratios from 
this probe are too variable for effective statistical analysis. Data from this probe 
could be used as an indication as to whether this region proximal to PLP1 is 
duplicated, but would have to be followed up with another technique to confirm any 
changes in gene dosage.
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Figure 7.9. Mean normalised ratios for the MAPH probe 79pl 1, with +/- one standard 
deviation for the non-duplicated males and females shown by the error bars. The 
individual means from 5 males that had a duplication of this probe by FISH are shown 
as separate columns.
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7.4.2.3. 43hl3
This MAPH probe was the closest probe proximal to PLP1, located at 232Kb 
upstream to the transcription start site of the gene. Initial results for this probe were 
not promising, as although there was a significant difference between normal males 
and females in the normalised ratios obtained for this probe, the means of the two 
sexes were much closer together than the other MAPH probes (excluding the two 
PLP1 probes that did not show a significant difference between the sexes) (Figure 
7.5., Table 7.2.). The means from the controls also showed some of the greatest 
differences from the expected normalised ratios of 0.5 for males and 1.0 for females 
(Figure 7.5., Table 7.2.).
A similar analysis of the mean dosage frequencies in different categories of 
individuals was carried out, including cases that were believed on the basis of FISH 
and UPQFM-PCR data to have a duplication extending into the region where this 
probe hybridises (Figure 7.10.). As can be seen in Figure 7.10., any differences 
between the four groups (males, females, males with a duplication of this region, 
females with a duplication of this region) were not great. The difference in means 
between the males believed to have only a single copy of this genomic region and 
those known to be duplicated was only 0.107, and the range of values for the males 
with a normal copy number ranged from 0.2 to 1.9. Such variability in the normal 
individuals and the small differences between groups would make it very hard to be 
able to confidently ascertain the duplication status for this probe by MAPH. In 
accordance with this, there was very little difference apparent between individual 
dosage ratios that were classified in the various categories as assessed by a t-test (see 
section 7.4.1.1.). Only 4 of the 34 males where there were two or more dosage results
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obtained could be consistently categorised, all as having a normal copy number for 
this probe. When the standard deviations of the normal controls for each individual 
experiment were examined, they were generally high with the mean standard 
deviation across all experiments for the male controls equalling 0.15 and for the 
female controls the mean was 0.25.
In general, this MAPH probe is not reliable enough to give consistent results 
regarding the copy number at this locus, due to the high variability of normalised 
ratios.
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Figure 7.10. Mean normalised ratios for the MAPH probe 43hl3, with +/- one 
standard deviation shown by the error bars.
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7.4.2.4. 240c2
This MAPH probe contained sequence from the region containing all the distal low- 
copy repeats and mapped to the more proximal end of the sequence from human 
genomic clone cU240C2, between the LCRs PMDA and PMDB (Figure 3.4.). A 
large proportion of the distal boundaries of duplications including PLP1 in PMD 
families have been mapped to this region of distal LCRs using other techniques, so a 
reliable method of dosage detection in this region of Xq22.2 could be especially 
useful for mapping duplication size (Woodward et al., in preparation). When the 
mean dosage results for all the individuals (controls and PMD patients) were grouped 
appropriately and summarised, the means for the different groups were roughly as 
expected (Figure 7.17.).
However, for this MAPH probe to be useful, it needs to be able to reliably detect 
changes in dosage in individual normalised ratios. As before, this was assessed using 
a t-test on the difference between an individual normalised ratio and the mean of the 
controls of the same sex (see 7.4.1.1.). As a result of the generally quite high 
variability of the normalised ratios, few individual ratios could be satisfactorily 
classified; 6 out of the 16 dosage ratios for females could be classed as normal copy 
number or duplicated, and 28 out of 75 male normalised ratios in total could be 
classed using these criteria (see 7.4.1.1.). When all the results for each individual 
were considered, three males and one female had the same classification both times 
they were tested, all the males were not duplicated for the 240c2 MAPH probe, and 
the female did have a duplication of this region, in agreement with previous 
interphase FISH and other dosage data from this region for these individuals.
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For this probe 240c2, as with the other MAPH probes, statistical analysis and 
classification of normalised ratios was hampered by the high variability seen within 
individual experiments.
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Figure 7.11. Mean normalised ratios for the MAPH probe 240c2, with +/- one 
standard deviation for the non-duplicated males and females shown by the error bars. 
The individual means from 2 females and 5 males that had a duplication of this probe 
by FISH are shown as separate columns.
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7.4.2.5. 144al0
This probe was most distal to PLP1, and also maps within the cosmid clone that is 
routinely used as a control probe in interphase FISH, as it is only rarely found to be 
duplicated in PMD patients. However, amongst the cohort used in the MAPH 
experiments, there were two males and two females that were duplicated for this 
cosmid by interphase FISH, who did have increased mean normalised ratios for this 
probe (Figure 7.12.).
When individual normalised dosage ratios were assessed statistically, however, few 
results could be categorised (see section 7.4.1.1.). Just more than a quarter of male 
normalised ratios (20/75) were classed as either normal or duplicated, and 5/16 female 
normalised ratios could be similarly categorised. Only one male could be consistently 
classified (as having normal copy number) for this MAPH probe. This probe gave 
generally variable results, particularly in females, where the mean standard deviation 
across all experiments was 0.26. The mean standard deviation for the male normal 
controls was less than half this, at 0.12, but was still too large to produce consistent 
results. The four individuals who were known to have a duplication including this 
probe mostly did have normalised ratios within the range expected for a duplication, 
but only one of the ratios from the males and two of the ratios from the females were 
classed as being duplicated by the criteria used (see section 7.4.1.1.).
As with the other MAPH probes used in this study, dosage results from 144al0 did 
show an overall difference between normal males and females and those with 
duplications of this locus, but in most cases high variability of normalised ratios 
within an experiment has prevented a robust classification of individual dosage results 
as duplicated or normal copy number.
358
2Females Females duplicated Males Males duplicated by 
(n = 10) by FISH (n = 43) FISH
Figure 7.12. Mean normalised ratios for the MAPH probe 144al0, with +/- one 
standard deviation for the non-duplicated males and females shown by the error bars. 
The individual means from 2 males and females that had a duplication of this probe 
by FISH are shown as separate columns.
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7.5. Discussion
A MAPH probe set including probes for PLP1 and the surrounding genomic region 
was used on a cohort of individuals with a family history or symptoms consistent with 
PMD, as well as normal controls. Although changes in dosage were detected by 
MAPH, with increased normalised ratios seen for many different probes, high 
variability in dosage results has meant that most of these dosage changes are not 
statistically significant.
The MAPH protocol was shown to be specific, as a non-human probe (XLnkx) 
included in the probe mix was not amplified following hybridisation to human 
genomic DNA and stringent washing. Differences in male and female dosage ratios 
are apparent for X-linked probes, and the Y-linked control probe is not amplified from 
female samples (Figure 7.4. and 7.5.). Additionally, MAPH probes specific to PLP1 
were not recovered from genomic DNA from a male known to carry a PLP1 deletion 
(Table 7.3.).
The high variability found in the MAPH results for this probe mix could be as a result 
of a number of different factors. The MAPH protocol consists of several stages, and 
errors and variability could be introduced into the results at any one of these points. 
Other users of the MAPH technique have reduced variability in MAPH results by 
ensuring that the wash solutions are at a constant 65°C, and adjustment of PCR 
conditions (Jess Tyson and Tamsin Majerus, personal communication). Another area 
where errors could perhaps be minimised is in the detection of the amplified probes. 
In this study this has been carried out by electrophoresis of fluorescently labelled PCR 
products in a slab gel electrophoresis system, but imperfections in the gel could lead
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to errors in the results. Switching the detection stage to a capilliary electrophoresis 
format would eliminate any variability introduced by slab gel imperfections.
Another factor that has had an adverse effect on the MAPH dosage results has been 
the small number of control individuals. Due to the requirement for a relatively large 
amount of DNA from each individual to be used in each experiment (~lpg), and 
limited availability of normal control stocks with sufficient quantities of DNA, 
relatively small numbers of controls were used in each experiment (see section 7.1.1.).
Some of the probes showed different degrees of variability, which could be due to a 
number of factors (Figures 7.3., 7.4. and.7.5.). Although all potential probe sequences 
were checked for potential cross-hybridisation to other genomic sequences by 
BLASTn searches against human genomic sequence, there are some unsequenced 
regions of the human genome, such as heterochromatic regions, and uncloned gaps, 
that could be harbouring sequence with similarity to some of the MAPH probes. 
Hybridisation of MAPH probes to as yet unsequenced regions of the human genome 
could account for some variability and difficulties in detection of increases in dosage, 
such as those seen with one of the PLP1 probes, plp7 (Figure 7.5.).
Another factor which could be improved upon in the MAPH probe set is the number 
of control probes. Other MAPH probe sets in use in other laboratories can include 
approximately 40 probes, and contain several controls (Armour et a l , 2000;Hollox et 
a l , 2002;White et a l , 2002). In these larger probe sets, dosage quotients are 
calculated by dividing the area underneath each peak by the sum of the nearest 4 
autosomal control peak areas (Hollox et a l , 2002). This has the effect of controlling 
for any differences in PCR amplification of probes based on size, as shorter probes
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might be expected to amplify more efficiently. As the PLP1 MAPH probe set only 
contained 6 autosomal control probes, two of which were excluded from the 
calculation of normalised ratios because of high variability, all four remaining control 
probes were used in the calculation of normalised ratios, abandoning this mechanism 
of controlling for size-based differences in probe amplification. Including more 
autosomal control probes in the PLP1 MAPH probe set would eliminate this problem.
Only two of the PLP1 MAPH probes, plp5 and plp6, showed a reasonable amount of 
specificity and discrimination in determining copy number (Figure 7.5.). Ideally a 
MAPH probe set for this gene would include a probe for each exon, as this would 
enable detection of small-scale dosage changes within the gene. Deletions or 
duplications of a few exons of PLP1, could account for some cases of PMD where the 
mutation is undefined, particularly in the case of a small internal duplication, as this 
would probably be undetected by conventional sequence-based mutation detection, 
and would also be undetectable by interphase FISH. The addition of reliable probes 
for the other 5 exons of PLP1 would be a useful addition to this probe set.
Some of the results from MAPH probes flanking PLP1 contradicted previous findings 
from interphase FISH. Although these could be false positives and negatives, due to 
the high variation seen in the dosage ratios for these MAPH probes, it is also possible 
that some of these supposedly spurious results may in fact reflect genuine copy 
number changes in these regions. As has been found in some PMD families, 
including family 2, not all PLP1 duplications are simple tandem duplications and 
more complicated rearrangements may be present (see chapter 5). However, until the 
MAPH probes for this region have been made more reliable and show much less 
variation, these potential copy number changes will be not be consistently detected.
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7.6. Summary
Although MAPH can detect copy number changes in the PLP1 region, high 
variability in the results means that this probe set is not currently suitable for use in 
the diagnosis of copy number changes in this region. However, further refinements 
and improvements to the probe mix and protocol could make this method more suited 
to a diagnotic setting, where the potential for high throughput and low cost could be 
advantageous compared to other methods that can be used for assaying copy number 
of PLP1, such as MLPA and interphase FISH (see section 1.5.).
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8.1 SOX3 DUPLICATION SCREENING AND ANALYSIS OF FAMILY 4
Interphase FISH was used to screen individuals from 15 families with suspected X- 
linked hypopituitarism for duplication of the SOX3 locus (Figure 8.1.).
8.2 Interphase FISH screening
A BAC clone (bA51C14) mapping to Xq27.1 and containing the SOX3 gene was used 
as a FISH probe in all the interphase FISH experiments. A control probe was also 
used on most individuals, either a clone from the PLP1 region in Xq22, or another 
genomic clone from Xq27.1. At least 100 nuclei were scored for each probe, and 28 
individuals were screened in total. The interphase FISH screen identified one family 
(Family 4) that appeared to carry a duplication of the SOX3 locus (Figure 8.1.). This 
family included two half brothers (4:6, 4:7), both with a pituitary phenotype (see 
section 2.3.4.). Between 65-75% of the nuclei scored for each of the affected males 
contained 2-4 closely associated signals from the bA51C14 BAC FISH probe, which 
was consistent with this genomic region being duplicated in these two males (Figure
8.1. and Table 8.1.). The mother (4:4) and maternal grandmother (4:1) from family 4 
were also checked for duplications, using the same genomic clone as a FISH probe. 
The mother was also found to carry a duplication of a region including this FISH 
probe, with the majority of nuclei containing signals consistent with increased copy 
number for this clone (Figure 8.1. and Table 8.2.). Interphase FISH results were 
inconclusive for 4:1, with on average roughly equal numbers of nuclei counted as 
duplicated or not duplicated, approximately 40% in each category (Table 8.2.). These 
ambiguous data were from 3 separate experiments, but in two of these relatively few 
nuclei were scored (57 and 75) compared to the third experiment in which 100 nuclei 
were scored. Subsequent analysis on 4:1 by UPQFM-PCR has confirmed that she 
does not carry the duplication (see sections 8.4., 8.6. and Figure 8.5.).
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8.3. Interphase FISH mapping of Xq27.1 duplication
Interphase FISH was carried out using additional genomic clones mapping to Xq27.1 
on peripheral blood lymphocytes from the affected males in this family that had been 
demonstrated to have a duplication including the SOX3 locus. This mapped the 
centromeric end of the duplication to between genomic clone bA35F15 and 
bA364B14 and the distal telomeric boundary of this duplicated region to within the 
genomic clone dJ595A18 (Table 8.1.). dJ595A18, a clone mapping between
bA51C14 (duplicated) and dJ177G6 (not duplicated) gave ambiguous results, with 
one affected male having more duplicated signals and the other having more single­
copy signals (Table 8.1.). Ambiguous interphase FISH results such as these are 
possible if the clone used as a FISH probe is only partially duplicated, so it was 
considered that the distal breakpoint might be within this clone.
8.4. Further mapping of duplication breakpoints in family 4 using UPQFM- 
PCR.
As UPQFM-PCR had been successful in localising breakpoint regions in PMD 
families, this technique was also used to further map the location of duplication 
endpoints in Xq27.1 for family 4. Pairs of tagged primers were designed to amplify 
short regions throughout the genomic sequence corresponding to those clones that 
were thought to be near the ends of the duplicated region. UPQFM-PCR was carried 
out on the two affected males and their carrier mother, as well as the maternal 
grandmother. UPQFM-PCR dosage quotients for the maternal grandmother were 
consistent with normal copy number of the target sequences throughout this region 
(data not shown).
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8.4.1. UPQFM-PCR mapping of proximal duplication breakpoint
At the proximal end of the duplicated region, the UPQFM-PCR data was in 
concordance with what had been deduced from the interphase FISH results. All four 
UPQFM-PCR primer pairs mapping within bA364B14 were shown to be duplicated 
in 4:4, 4:6 and 4:7 (Figure 8.2., Table 8.3). A single primer pair mapping to the 
telomeric end of bA35F15 produced dosage quotient ratios consistent with this region 
being single-copy in this family (Figure 8.2., Table 8.3). These data localised the 
proximal duplication breakpoint in this family to a region of just over 20Kb, including 
the overlap between the sequences from these two genomic clones.
8.4.2. UPQFM-PCR mapping of distal duplication breakpoint
Around the distal end of the duplicated region most UPQFM-PCR results were similar 
in all three individuals carrying a duplication of Xq27.1. Four different primer pairs 
were used throughout the sequence from clone dJ595A18, and all had mean dosage 
quotients consistent with a duplication of the region (Figure 8.2., Table 8.3.). Two 
primer pairs were also used that were located within the adjacent distal clone XXyac- 
291B3. In the two affected males both of these primer pairs produced ratios 
consistent with these regions being single copy (Table 8.3.). For 4:4, the dosage 
quotient for the more proximal primer within this clone appeared duplicated when 
compared to the X-linked PLP1 primer pair, but did not give a high dosage quotient 
when compared to the autosomal primer pair CF (Table 8.3.). As this was only one 
elevated dosage quotient ratio, it is most likely that it is just a false positive, perhaps 
as a result of poor amplification of the PLP1 primer pair. Thus it seems most likely 
that the two sequences within XXyac-291B3 assayed for changes in dosage by 
UPQFM-PCR are not duplicated in this family, and the distal breakpoint is located 
somewhere within a 27.7Kb region including the overlap in sequence between the 
genomic clones dJ595A18 andXXyac-291B3 (Figure 8.2., Table 8.3.).
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Figure 8.1. A duplication including the SOX3 gene was detected in family 4 by 
interphase FISH. Nuclei from cultured peripheral blood lymphocytes are shown in a- 
d above, in all cases the SOXi-containing BAC, bA51C14 is labelled in green, while 
the X centromere is detected by a red fluorescent probe, (a.) is the younger affected 
boy, (4:7), (b.) is the older affected sibling (4:6), their carrier mother is in (c.) and an 
interphase nucleus from the maternal grandmother (4:1) is shown in (d.). Underneath, 
(e.) shows the location of bA51C14 in Xq27.1, position on the X chromosome is 
taken from the Ensembl genome browser, release 22.34d.l. The position of the SOX3 
gene within this clone, and a nearby polymorphic CA repeat microsatellite marker, 
DXS984 is also shown.
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Clone Individual
0,1• 0,2• 0,3•
0,4
•
Other
A Conclusions
bA35F15
4:6 78.43% 18.63% 0.98% 0 1.96% Notduplicated
4:7 71.58% 27.37% 1.05% 0 0 Notduplicated
bA364B14 4:6 35.24% 57.14% 6.67% 0 0.95% Duplicated
Duplicated
bA51C14
4:6 30.77% 52.88% 10.58% 2.88% 2.88%
4:7 36.12% 56.28% 5.61% 11.63% 1.99% Duplicated
dJ595A18
4:6 41.82% 47.27% 5.45% 0 5.45% Breakpoint?
4:7 61.90% 34.29% 1.90% 0 1.90% Notduplicated?
dJ177G6
4:6 75.00% 19.23% 0.96% 0 4.81% Notduplicated
4:7 84.52% 10.71% 0 0 4.76% Notduplicated
Table 8.1. Interphase FISH scores, expressed as percentages, from the affected males 
in family 4, for clone bA51C14 and other clones that were close to the boundaries of 
the duplicated region. All scores are from a single slide. An average of 101 nuclei 
were scored per slide.
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Clone
bA51C14
Individual
(4:4)
(4:1)
1,1
11.00%
36.24%
1,2
38.18%
35.81%
1,3
8.57%
2.61%
1,4
0.49%
0.44%
2,2
9.52%
4.42%
2,3
6.23%
0.58%
2.4 Other
1.91%
0.44%
24.11%
17.24%
Conclusions
Duplicated
 Not...
duplicated
Table 8.2. Interphase FISH scores, expressed as percentages, from females in family 4, for clone bA51C14. An average of 78 nuclei were scored per 
slide, the percentages shown are an average of two experiments for 4:4 and the average of three experiments for 4:1.
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Position in clone 4:7 4:6 4:4
Clone
of UPQFM Mean ratio of UPQFM PCR 
product compared to... Number o f  
experiments
Mean ratio of UPQFM PCR 
product compared to... Number o f  
experiments
Mean ratio of UPQFM PCR 
product compared to... Number o f  
experimentspnmer pairs PLP1 CF PLP1 CF PLPl CF
bA35F15 66750-66949 1.01 1.19 4 0.95 1.14 1 0.99 1.09 2
bA364B14 16714-16959 3.00 2.93 1 2.79 2.81 1 1.40 1.29 1
bA364B14 25512-25756 2.22 2.28 5 2.46 2.87 1 1.36 1.56 2
bA364B14 48225-48392 2.21 2.20 5 1.95 2.21 1 1.36 1.53 2
bA364B14 74126-74369 2.00 2.36 4 1.92 2.31 1 1.47 1.63 2
dJ595A18 26757-27039 2.18 2.27 5 3.26 3.70 1 1.15 1.33 2
dJ595A18 54671-54825 2.15 2.15 5 2.04 2.31 1 1.31 1.48 2
dJ595A18 101906-102140 2.29 2.07 3 1.74 1.94 3 2.03 1.97 3
dJ595A18 114741-114935 2.21 1.98 3 1.65 1.77 3 1.87 1.80 3
XXyac-291B3 26828-27044 1.06 1.06 2 0.90 0.93 2 1.82 0.91 2
XXyac-291B3 64796-65011 1.43 1.07 1 0.76 ■ 1 0.67 1.03 1
Table 8.3. UPQFM ratios for the duplication breakpoints in family 4 (as compared against both PLP1 exon 6 and CF control primers). Average ratios 
were taken from all experiments carried out that included that primer pair, and the number of experiments is indicated. Ratios consistent with 
duplication are highlighted in bold, and the zigzag lines show the assumed location of the breakpoint regions. The position of each target sequence 
within the relevant genomic clone is indicated.
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Figure 8.2. Diagram showing interphase FISH and UPQFM-PCR results around the proximal and distal duplication breakpoints in family 4. 
Legend on next page.
--a
Figure 8.2. Legend.
The genomic clones in the region are shown as grey boxes, and position on the X 
chromosome, from the Ensembl genome browser version 22.34d.l is shown 
underneath the contig in megabases. Locations of UPQFM-PCR primers in the region 
are indicated by arrows, and the position within each clone for each pair of primers is 
shown. (+) indicates a sequence that appeared to be duplicated, (-) a sequence with 
normal copy number. Genes in the region are shown as black boxes underneath the 
contig. Representative nuclei from interphase FISH experiments with the various 
breakpoint region clones are shown above the contig, these are taken from 
experiments using either of the two affected males (364B14 with 4:6, others with 4:7). 
Genomic clones are labelled green and the X centromere probe is labelled red, as 
before.
8.5. Determining the nature of the Xq27.1 duplication by dual probe interphase 
FISH
The orientation of the duplicated region with respect to the original Xq27.1 sequence 
was investigated. Two different genomic clones that had both been shown to be 
within the duplicated region by interphase FISH (bA51C14, and a more proximal 
clone, bA189F12) were labelled by nick translation with either biotin (bA51C14) or 
digoxigenin (bA189F12) and detected by FITC- (bA51C14) or Texas Red-labelled 
(bA189F12) antibodies. The distribution of red and green signals within over 100 
interphase nuclei were scored on a single slide (Table 8.4.). In more than one-third of 
nuclei scored, the signals were too close to resolve (Table 8.4). Three categories 
accounted for most of the other nuclei; those with an alternating red/green/red/green 
(or green/red/green/red) pattern were slightly more prevalent, followed by those with
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a red/green/red pattern, then those with a green/red/green distribution of signals 
(Figure 8.3. and Table 8.4.). The remaining nuclei were scored as having a 
red/red/green distribution of signals (Table 8.4.). Based on these data, it was decided 
that the most likely orientation of the duplication would be in tandem. Although the 
red/green/red/green distribution of signals was only detected in a few more nuclei 
than some of the other patterns of signals that were seen, the red/green/red and 
green/red/green patterns were seen in similar numbers of nuclei (Table 8.4.). The 
other, relatively simple possible orientation for the duplication in family 4 is an 
inverted duplication, for which patterns corresponding to either red/(green/green)/red 
or green/(red/red)/green would be seen depending on the orientation of the inversion. 
The central double green or double red signals that would be expected for this type of 
rearrangement are given in brackets as they could well be too close to separate at this 
resolution. However, if  the duplication truly was inverted with respect to the original 
copy of the sequence, one of the two inverted patterns would be expected to 
predominate over the other, depending upon the orientation of the inversion. A likely 
cause for the high number of pseudo-inverted signal patterns seen is failure of 
hybridisation or loss of signal of one of the outer red or green signals in the tandem 
array. Slightly more red/green/red signals were seen than the other way around, 
suggesting that the green signal was more likely to be lost in this experiment. The 
only other arrangement consistently seen on the slide was a red/red/green pattern, 
which could result from the loss of the internal green (bA189F12) signal in the 
tandem array (Table 8.4.).
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8.6. Long-range PCR across the duplication breakpoint junction
As the duplication in family 4 was most likely in a tandem, head to tail orientation, a 
PCR strategy using several different primers around the breakpoint regions to amplify 
the junction sequence was attempted. 25mer oligonucleotides were used as long- 
range PCR primers, and were selected from the genomic sequence between the 
positions of the UPQFM-PCR primers that defined the two breakpoint regions (Figure
8.2.). Four primers were designed within the 20Kb proximal duplication breakpoint 
regions, and five primers were designed within the 27.7Kb breakpoint region at the 
distal end of the duplication. All possible combinations of one proximal and one 
distal primer were then tried, and two of the UPQFM-PCR primers were also used as 
long-range primers in these reactions. The UPQFM-PCR tagged primers that were 
used were one from each of the primer pairs nearest the breakpoint region that had 
been found to be duplicated, and which would prime DNA synthesis heading towards 
the breakpoint region, and were used in case the duplication junction was located 
relatively close to either of the UPQFM-PCR primers (16959R from clone 
bA364B14, and 114741F from clone dJ595A18) (Figures 8.2. and 8.4.). Just one of 
the 30 possible combinations of long-range primers was successful in amplifying a 
product from duplication-carrying individuals in family 4 that was not present when 
normal control DNA was used. A 4-5Kb product resulted when the combination of 
the proximal long-range PCR primer 71430R (bA35F15) and the distal UPQFM-PCR 
primer 114741F (dJ595A18) was used (Figures 8.2. and 8.4.). This product was only 
seen when using genomic DNA from the affected boys and their obligate carrier 
mother was used as a template, and not when genomic DNA from the grandmother 
(thought not to carry the Xq27.1 duplication) or unrelated normal controls was used 
(Figure 8.4.). To check that this PCR product did contain the duplication junction in 
this family, the bands were excised from the gel and the bands were extracted from
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the gel (see section 2.2.1.4.4.). The eluted DNA (from 4:7) was then sequenced using 
either the proximal or distal primer (see section 2.2.4.). The sequence obtained using 
the proximal primer 7143OR (mapping within bA35F15), matched sequence from this 
clone and similarly sequence produced using the distal primer matched sequence from 
the appropriate region of dJ595A18. Further sequencing of this junction fragment is 
ongoing.
A BLASTz comparison of 10Kb from around the approximate locations of the two 
duplication breakpoints in family 4 showed no large regions of sequence similarity 
between the two regions (data not shown). The only regions of similarity 
corresponded to the positions of Alu sequences near both ends of the duplication, as 
has been found with similar comparisons of breakpoints on PMD families (see 
Figures 4.11., 5.11. and 6.9.). At this stage, it seems likely that the sequences at the 
SOX3 duplication breakpoint do not share much homology; although Alu-Alu 
mediated rearrangement is still a possibility.
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Figure 8.3. Interphase FISH using two genomic clones from within the duplication 
as probes indicates that the Xq27.1 duplication in family 4 is probably in a tandem 
orientation. An interphase nucleus from one of the affected males (4:7) is shown. 
The X centromere is detected by an Aqua-labelled probe, bA51C14 is red, and 
bA189F12 (a clone within the duplicated region, proximal to bA51C14) is green. A 
yellow signal is seen where the red and green signals overlap slightly.
Appearance 
of nuclei
Overlapping
•
R/G/R/G
©
G/R/G
©
R/G/R
©
R/R/G
•
% seen 34.91% 20.75% 16.98% 18.87% 8.49%
Table 8.4. Appearance of signals in interphase nuclei following hybridisation of two 
probes from within the duplication region in family 4. 106 nuclei were scored on one 
slide, and the percentage of nuclei within each category is shown. R = red signal, G = 
green signal.
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Figure 8.4. Long-range PCR across the tandem duplication breakpoint in family 4. Legend on next page.
Figure 8.4. Legend
40Kb from around the distal duplication breakpoint and 30Kb from around the 
proximal breakpoint is shown. Genomic clones in the region are represented by grey 
boxes, and the scale and location on the X chromosome is shown underneath the 
contig (taken from the Ensembl genome browser, version 22.34d.l.). Positions of 
various primers used to map the breakpoint are shown by arrows above the contig. 
Vertical arrows show the position of UPQFM-PCR primers, as previously shown in 
Figure 8.2., the location of long-range PCR primers are indicated by the larger 
labelled horizontal arrows. The smaller arrows show the positions of nested primers 
used for sequencing of the breakpoint fragment. An agarose gel is shown underneath 
the contig, showing the presence of a 4-5Kb band, using the combination of 
oligonucleotide primers highlighted in bold, seen in only the members of family 4 
who had the duplication, and not in the maternal grandmother or unrelated male (M) 
and female (F) controls. TJHindlll was used as a size standard.
8.7. Determining the inheritance of the duplication in family 4
Microsatellite markers along the length of the X chromosome were typed in family 4 
to determine the origin of the duplication in family 4. Genotyping was carried out 
using fluorescently labelled primers (FAM, TET or HEX) in a PCR, then the reactions 
were run on an ABI 377 automated DNA sequencer and results analysed using 
GENOTYPER software (Applied Biosystems). Three markers mapping close to the 
SOX3 gene, within the duplicated region were typed;jDXS1232, 305Kb proximal to 
SOX3, DXS8013, which is 99Kb proximal to the gene and DXS984, which is just 
44Kb distal from SOX3 (Figures 8.1. and 8.5.). Additional markers were chosen 
throughout the long arm of the X chromosome, and two markers near the Xp telomere 
were also used (Figure 8.5.). The two affected males shared the same alleles for
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11/13 of the X chromosome markers examined, including the three markers within the 
duplicated region (Figure 8.5.). There was no evidence for heterozygosity for the 
three duplicated markers in either male. Only one marker from the three within the 
duplicated region, DXS984, was informative regarding the inheritance of this region 
of the X chromosome in this family. The allele present in the two affected males 
(176bp) was carried by their mother, but the maternal grandmother did not carry this 
allele of DXS984 (Figure 8.5.). It is likely that this allele was inherited from the 
maternal grandfather. This corresponds with the finding that the maternal 
grandmother does not carry the duplication. Although DNA from the maternal 
grandfather is not available, it is unlikely that he had a duplication of this region, as he 
is believed to be asymptomatic, and it is most probable that the Xq27.1 duplication in 
this family has arisen de novo in the mother of the affected boys. This duplication 
event could have occurred at several different stages, including during 
spermatogenesis in the maternal grandfather, early during development of the mother, 
or another possibility is that the maternal grandfather was a gonadal mosaic for this 
duplication mutation. Several recombination events were found to have occurred 
during the transmission of the X chromosome from the mother (4:4) to her sons. 
There has been a recombination event between DXS6797 (Xq22.3) and DXS984 
(Xq27.1) during transmission of the X chromosome from the mother to both of her 
sons (Figure 8.5.). The location of this recombination event could not be localised 
further from these data, as the intervening markers used were not informative in this 
family. There had been an additional double recombination event in 4:7, as the two 
alleles amplified for the androgen receptor CAG repeat marker (Xql2) and DXS6800 
(Xq21.1) appeared to have originated from the grandpatemal chromosome, whereas 
surrounding markers had alleles found on the grandmatemal X chromosome (Figure
8.5.).
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Figure 8.5. Legend. Results of genotyping various X-linked polymorphic 
microsatellite markers in family 4. The pedigree is shown as in Figure 2.2. 
previously, and the allele sizes of the various microsatellites typed are shown 
underneath each individual, in the same order, Xp telomere going down to the Xq 
telomere, as they are found on the X chromosome. The ideogram in the top left-hand 
comer shows the approximate location of all the markers used on the X chromosome. 
The different alleles are colour coded according to which chromosome they were 
deduced to have originated from. The origin of alleles shaded in grey was unable to 
be determined due to lack of information about inheritance, mainly due to the lack of 
information on the genotype of the maternal grandfather, and the positioning of these 
alleles on one haplotype or the other is arbitrary in some cases. The DXS984 
microsatellite marker is located just distal to SOX3 (Figure 8.1.). AR is the 
polymorphic CAG repeat in the androgen receptor gene (Allen et al., 1992).
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8.8. Discussion
Increased dosage of a region including Xq27.1 and the SOX3 gene has previously 
been associated with hypopituitary phenotypes (see section 1.6) (Lagerstrom-Fermer 
et al., 1997;Hol et a l, 2000;Solomon et al., 2002). During this study, another family 
with a duplication involving the SOX3 gene has been identified. The duplication in 
family 4 has been shown in this study to include approximately 690Kb of genomic 
sequence, which is a much smaller region than the duplications of Xq that were 
previously reported to be associated with hypopituitarism (13Mb and 9Mb) 
(Lagerstrom-Fermer et al., 1997;Hol et al., 2000;Solomon et al., 2002).
The duplicated region in family 4 only includes 3 genes, SOX3 and two novel 
uncharacterised genes (Figure 8.2.). As a polyalanine tract expansion within SOX3 
has been associated with a phenotype including pituitary manifestations, and SOX3 
null mice have been shown to have abnormal pituitary development, increased dosage 
of SOX3 during development is the most likely cause for the pituitary phenotype in 
this family (Laumonnier et al., 2002;Rizzoti et al., 2004). One of the other two genes 
in the region, the one closest to the proximal duplication breakpoint, contains an RNA 
binding domain and belongs to a family of heterogeneous nuclear riboproteins, and 
ESTs from this transcript have been isolated from a wide range of tissues, including 
brain and ovary libraries. The remaining gene in the duplicated region is also as yet 
uncharacterised and contains no recognised protein motifs, and ESTs for this gene 
have been found from tissues including brain and testis.
The phenotypes seen in the two affected males in this family are quite discordant, 
with the older sibling exhibiting isolated growth hormone deficiency, pituitary 
hypoplasia and dysgenesis of the corpus callosum, whereas his younger half-brother
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has combined pituitary hormone deficiency and hypoplasia of the anterior pituitary, 
with no abnormalities of the corpus callosum. As they have different fathers, the 
divergence of the phenotypes is good evidence for the importance of genetic 
background effects in the development of pituitary disorders, and modifer loci may 
exist. However, this variability in phenotype may also be due to incomplete 
penetrance of the effects of SOX3 duplication, as studies using SOX3 null mice have 
reported a variable phenotype, with up to one-third of males showing no apparent 
phenotype, and a range of defects seen in those mice with a phenotype (Rizzoti et al., 
2004).
The duplication characterised in this study in Xq27.1 does not appear to be flanked by 
LCRs, as has been found to be the case with many genomic disorders, and in this 
aspect this duplication is similar to the duplications studied in PMD families (see 
section 1.4.1.). The Xq27.1 duplication may not share any homology between 
sequences at the duplication breakpoints, is tandem in orientation and is likely to have 
arisen on the grandpatemal X chromosome. It is interesting to note that duplications 
of PLP1 in PMD families are thought to predominantly arise in male germ cells, and 
it is tempting to speculate that duplications involving Xq22.2 or Xq27.1 could arise 
by a similar mechanism during spermatogenesis, although many more families with 
duplications of this region would have to be studied to determine this (Mimault et al., 
1999).
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8.9. Conclusions
This study has provided further evidence that SOX3 is part of the small but increasing 
group of genes recognised to be sensitive to an increase in gene dosage. Interphase 
FISH has proved to be a reliable technique for screening for SOX3 gene duplications. 
Although the tandem duplication breakpoint in family 4 has not yet been characterised 
at the sequence level, initial investigations suggest that the Xq26.2 duplication may 
have occurred by a similar mechanism to PLP1 duplications in Xq22
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9.0. DISCUSSION
9.1. Gene dosage
Gene dosage is increasingly being recognised as an important factor in human genetic 
disease (see section 1.4.). PLP1 has been known to be dosage sensitive for the past ten 
years, and now more genes, such as SOX3, are also being recognised as such (Ellis and 
Malcolm, 1994). Testing for changes in gene dosage may sometimes be neglected during 
the process of mutation screening, which is often based on PCR and direct sequencing. 
The advent of new methodologies for measuring gene dosage, such as MAPH, may 
ensure that changes in sequence copy number are more easily detected. Technologies that 
can be used to assess genome-wide gene dosage, such as array CGH, will be particularly 
useful for detecting previously unknown and possibly pathogenic changes in gene dosage 
throughout the genome (Ishkanian et a l , 2004).
9.2. MAPH for detecting gene dosage
MAPH is potentially a very powerful technique for the rapid detection of copy number 
changes, and this study has shown that it can detect dosage changes in and around PLP1. 
However, the probe set that has been developed so far has proved to be too unreliable for 
diagnostic use, with many probes not producing consistent results. Further refinements to 
the experimental procedure, the redesigning of some probes and the addition of other 
probes (particularly for the other PLP1 exons and extra control probes) may make the 
technique more suited for diagnostic use (see.section 7.5.). However, as an MLPA kit 
including all the exons of the PLP1 gene is now commercially available, it may be more 
cost effective to use this method to assay dosage of the gene, instead of making further 
modifications to the MAPH probe set.
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9.3. The importance of duplications in evolution
As well as making a substantial contribution to genetic disorders in the present, ancient 
duplication events have been important in shaping the evolution of all genomes. 
Duplication events can range between that of whole genomes to duplication of a single 
nucleotide. Segmental duplications (>90% sequence identity, >10Kb in length) account 
for approximately 5% of the human genome sequence (Lander et al., 2001). These 
segmental duplications represent relatively recent duplication events, and remnants of 
older duplication events can also be detected in the genomic sequence (Venter et al., 
2001). Segmental duplications are also associated with the process of chromosome and 
karyotype evolution and are frequently found at the boundaries of syntenic blocks in the 
genome (Bailey et al., 2004). Chromosome rearrangements, possibly associated with 
segmental duplications, can be important in driving speciation events (O'Brien and 
Stanyon, 1999;Samonte and Eichler, 2002;Capanna and Castiglia, 2004). Gene 
duplication is important in the evolution of new proteins, and may be a primary source of 
innovation in the proteome. Members of functionally redundant pairs of duplicated genes 
may thus be freed from selective constraints to evolve new functions, unless one member 
of the pair accumulates deleterious mutations and becomes a pseudogene (Ohno, 1970, 
reviewed in Prince and Pickett, 2002). It has been shown that some genes within recent 
segmental duplications exhibit an accelerated pattern of evolution, probably driven by 
positive selection (Samonte and Eichler, 2002).
9.4. Duplications involving the PLP1 genomic region
From examining the human genomic sequence around PLP1 it appears likely that
duplications of various parts of this region have occurred in the past, leaving behind a
legacy of repeated sequences. Some of these repetitive sequences may also be
contributing to the generation of novel duplications in the region today, such as the
duplications involving PLP1, which are detected because they cause a recognisable
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phenotype. However, it is quite possible that these local repetitive regions near PLP1 are 
not directly involved in the generation of duplications in the region, and other factors may 
be influencing these rearrangements. In all species where the syntenic region of the 
genome was examined, each had a unique organisation of repetitive sequences within the 
region (see section 3.6.). Some of the repeated sequences distal to PLP1 are probably 
unique to the primate lineage and may not even be present in our closest relatives, the 
chimpanzee (see section 3.6.1.). Duplications of a size comparable to the PLP1 
duplications may be occurring throughout the genome at a similar rate by the same 
mechanisms. It is only when a dosage-sensitive gene is involved that these events come 
to our attention, and studying rearrangements including PLP1 can provide a valuable 
system to increase our understanding of these types of rearrangements.
9.5. Possible clustering of breakpoints within clone dJ1055C14
Two duplication breakpoints characterised during the course of this study were found to
lie relatively close to each other within the same genomic clone dJ1055C14, and both are
actually located within intronic sequences of the same gene, MORF4L2 (Figure 9.1.).
Both these duplications, in family 2 and family 3, are unusual rearrangements, not the
tandem duplications that are found in most PMD families with PLP1 gene duplication
(Woodward et al., in preparation). A few other breakpoints in PMD families have been
sequenced within this clone, including 3 tandem duplications and one deletion
(Woodward et al., in preparation;Inoue et a l, 2002). Tandem duplication breakpoints
proximal to PLP1 are scattered throughout Xq22.1-2 (Woodward et al., in preparation).
The closest proximal duplication breakpoints to PLP1 are all mapped to within sequence
from clone dJ1055C4 (Woodward et al., in preparation). As over 100Kb of sequence
originates from this clone, it may not be surprising to find a substantial number of
breakpoints scattered within this sequence, if breakpoint locations are assumed to be
random. However, these six breakpoints are all located in a 28Kb region in the distal half
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of dJ1055C14, and if just the duplication breakpoints are considered, these cluster in a 
~15Kb region centred on the MORF4L2 gene (Figure 9.1.)- The 5Kb region around the 
proximal duplication breakpoint in family 3 contains a human replication origin 
consensus and this breakpoint is roughly in the middle of all 6 breakpoints (Figure 9.1.). 
The possible presence of an origin of replication in this region could be predisposing to 
replication-related rearrangements, creating a hotspot for duplications and deletions, 
triggered by DSBs (see section 6.4.2.). The MORF4L2 gene has been reported to be 
widely expressed in different tissues, and another possibility is that transcription of this 
gene could be indirectly involved in the clustering of some breakpoints in this region, by 
creating a more open chromatin structure that may be more susceptible to DSBs (Bertram 
and Pereira-Smith, 2001).
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Figure 9.1. Location of sequenced breakpoints within clone dJ1055C14. The whole of 
clone dJ1055C14 is shown, adapted from the Ensembl genome browser. The scale bar 
shows the distance from the start of the X chromosome genomic sequence at the Xp 
telomere (Ensembl version 22.34d.l). Genes within this clone are shown by the black 
horizontal arrows, and a pseudogene in the region is shown as a grey arrow. Interspersed 
repeat content (as shown in Ensembl) is represented by the grey areas above the scale bar. 
The vertical arrows show the relative positions of sequenced breakpoints, duplication 
breakpoints are black, and a deletion breakpoint is shaded grey. The two breakpoints that 
have been sequenced in families 2 and 3 are labelled, the other three duplication 
breakpoints are tandem duplications and taken from Woodward et al. (in preparation). 
The deletion breakpoint sequence was reported by Inoue et al. (2002).
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9.6. Mechanisms for gene duplication
Various different mechanisms that could be causing the genomic duplications described 
in this thesis have been postulated (see sections 4.12.2.2., 4.12.4-5., 5.8.2.5., 5.8.2.6. and
6.4.5.2.). The duplications described in PMD cases are definitely not caused by NAHR, 
as has been shown to be the case with many genomic disorders, but appear to have been 
mediated by non-homologous end-joining processes. Perhaps the most promising 
mechanism involves the repair of a double strand break by a homologous strand invasion 
event priming replication, followed by non-homologous rejoining of the newly 
synthesised strand to the other end of the DSB (Figure 4.16.). A mechanism of this sort 
can be used to explain all the breakpoints sequenced in this study, but cannot be proven at 
this point. Experimental evidence increasingly supports a substantial role for coupled 
homologous and non-homologous repair of DSBs in many systems (Morrow et al., 
1997;Richardson and Jasin, 2000;Michel, 2000;Johnson and Jasin, 2000;Kraus et al., 
2001). This type of aberrant repair process can easily be invoked in the generation of 
tandem duplications, such as described in family 1, but for more complicated 
rearrangements, such as have been partially characterised in families 2 and 3, this model 
may not be sufficient. A process involving capture of sequences into DSBs during the 
repair process may be important for generating these more complicated rearrangements, 
(see.sections 5.8.2.6. and 6.4.5.7.).
Although rearrangements involving Xq22 are not simply caused by NAHR between
LCRs, the association of these regions, particularly the highly homologous distal LCRs,
with some of the breakpoints sequenced in this and other studies shows that they may be
involved in the rearrangement in some other way (Inoue et al., 2002;Woodward et al., in
preparation). The presence of the distal LCRs, may contribute to genomic instability in
the region, and stimulate rearrangements, possibly by interactions between the repeat
sequences, or by an unusual chromatin organisation. Alternatively, a sequence element
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within the LCRs could initiate duplication events in this region, possibly by being prone 
to DSBs, and this could have also created the duplicated copies of the LCRs themselves. 
A complicated local repeat structure was also noted in Xq26.2 near the site of integration 
of an ectopic PLP1 -containing duplicated region in family 3, and the presence of these 
repeats may be related to genomic instability in this region (see section 6.4.5.1.)
Studies involving PLP1, SOX3 and some other dosage-sensitive genes in the human 
genome, and investigations of mechanisms of DNA rearrangement/DSB repair, are 
starting to produce an understanding of the mechanisms and significance of non-recurrent 
genomic duplication events. In contrast to the well-studied mechanisms of NAHR that 
mediate “genomic” disorders, non-homologous mechanisms of rearrangement are less 
well understood. Genomic disorders that are caused by NAHR between LCRs, such as 
CMT1A, VCFS and SMS, are more commonly seen than PMD by at least an order of 
magnitude. However, the highly homologous LCRs that predispose to particular genomic 
rearrangements may have originated by a similar non-homologous mechanism to the 
PMD duplications, particularly the duplication and insertion event described in family 3.
Although duplication and other rearrangement events involving non-homologous 
sequences at a one locus may be rarer than those caused by NAHR in a susceptible 
region, when the incidence of all such events at all loci in the genome is considered, such 
events may have a substantial but largely unrecognised effect on human health, disease, 
normal variation and evolution. Many genetic and congenital conditions have an as yet 
unknown aetiology and genomic copy number changes may be important in a number of 
these. Increased awareness of the importance of copy number changes and the 
availability of several methods to assess such changes should lead to more dosage- 
sensitive genes being recognised in the future.
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9.7. Future work
Further study of the in vivo characteristics of the PLP1 genomic region will provide more 
insight into the processes that may trigger rearrangements involving Xq22. Potentially 
interesting aspects of the organisation of this region, considered during the course of this 
study, and which it would be of interest to verify and investigate experimentally include 
matrix attachment regions, origins of replication and recombination hotspots.
The rearrangements in families 2 and 3 are not yet fully characterised, and elucidation of 
the sequences involved in these other breakpoints will enable a fuller understanding of the 
processes leading to these unusual rearrangements.
Completion of the sequencing of the duplication breakpoint in family 4 will be necessary 
to understand the exact nature of the rearrangement in this family. Screening of further 
patients with pituitary dysfunction may identify more families with SOX3 duplications, 
and further our knowledge of the mechanisms and prevalence of duplications in this 
region. The development of an animal model of Sox3 overdosage will be important in 
advancing understanding of the pathogenesis of increased copy number at this locus.
Pituitary development is sensitive to changes in gene dosage of SOX3, which is just one 
of numerous transcription factors and signalling molecules involved in this complex 
process. It is possible that increased dosage of other genes involved in pituitary 
development may also be pathogenic, and investigation of other genes known to be active 
during pituitary development may prove to be a productive line of investigation.
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APPENDIX A
List of primers used for this thesis. The sequence of each primer is given, the accession 
number and position where the primer hybridises, the size of the amplification product 
and the basic reaction contitions.
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Primer name Primer sequence Accession Position within clone
Annealing
temperature Enzyme
Size o f product 
(bp)
Other reaction 
conditions
Family 1 primers
CU65A4F14986 TCTGCCTTAATTTCATTATTTACCCAAGTG Z81014 14986-15015 60 H + PS - LR-PCR
CU65A4F15564 CCTCAGAATTTGCTTGTTTGAACAATATCT Z81014 15564-15593 60 H + PS - LR-PCR
dJ839Ml 1F 10232 CAAAATAGTAGCTGATGACCTACCCACAG AL034485 10232-10260 60 H + PS - LR-PCR
CV362H12F41101 GATCTTAAAAGTCTGACAGGAAACAGCATT Z70227 41101-41133 60 H + PS - LR-PCR
dJ839Ml 1F3171 AGTCAAACATTTTATCAGCTTTCCCTGTAA
..... . .............
AL034485 3171-3200 60 H + PS - LR-PCR
dJ839Ml 1F8857 CTCTGTGGAATACAGATCTAGAAGGTGGTT AL034485 8857-8886 60 H + PS - LR-PCR
dJ839Ml IF 10069 AGAGAAAGCTGTACGCAATAAAGACATAGG AL034485 10069-10098 60 H + PS - LR-PCR
dJ839Ml 1F12790 ATAAGTAATGATTCTTCTGAGGTGGCTCTG AL034485 12790-12819 60 H + PS - LR-PCR
dJ839Ml 1F13586 GAATCCGACTCCTAACCTCTCATCTCTATT AL034485 13586-13615 60 H + PS - LR-PCR
dJ839Ml 1F 19825 AGCATCCCTAAAACTAAAAGTGCTTTTCTC AL034485 19825-19854 60 H + PS - LR-PCR
dJ839Ml 1F25035 AACTTTCTCCCTGTAACCCTCTCTATGAAC AL034485 25035-25064 60 H + PS - LR-PCR
dJ635G19R67455 CTTGTCAGTCTTTCTCCTCTTAAGTTCTGG AL035494 67455-67426 60 H + PS - LR-PCR
CU65A4F11529 t c t t t t g g a g g t g a t t a a a g t g t t t g c t a t Z81014 11529-11558 60 H + PS - LR-PCR
CU65A4F10369 ATTTTGGGGGTTACTGTGAGTAATGTTATG Z81014 10369-10398 60 H + PS - LR-PCR
CU65A4F7943 GCTTAGTATGCTGTAGAGGCAAGAACCTAA Z81014 7943-7972 60 H + PS - LR-PCR
Family 2 primers
dJ1055C14R60006 GGGTACCCAGTTAGCTGGACAAAAC AL049610 60006-59982 55 H .....................................
177e8F37219 CCCATAGGCATGTCAATAACAATGA Z68694 37219-37243 55 H - -
177e8R36049 TGTCTTTCTCCCCCTCATCCTCT Z68694 36050-36028 55 H ........................................
iPCR177e8R35970 CCTGAATAAGAGGAATTTACTCACACCTTG Z68694 35970-35941 60 H _ iPCR
iPCR177e8F36264 ACATAGACCTGGGGGTAGCTTGTAAATAAT Z68694 36264-36293 60 H iPCR
Family 3 primers
6MW CCGACTCGAGNNNNNNATGTGG - - 55 H ........................................“ DOP-PCR
102P23AF GCCTTTCATTGCACATTTCA
AL357115
132693-132712
53 H 178
........................................
35 cycles102P23AR ACTTGGCATCCCACTTTCAT 132870-132851
RH63626F AAAAAGACAAGAAACAT GGCC
AL357115
133192-133212
55 H 203
....... ..........................
35 cyclesRH63626R GCAT AGCAT CAAGTTT GAAT CT CA 133394-133371
346E8CF CCTTT GGGCT GCT ACCATTA
AL359885
952-971
55 H 191 35 cycles346E8CR TTCGGACTGTGTGTGTGTGA 1142-1123
to
4^
242
Primer name Primer sequence Accession Position within clone
Annealing
temperature Enzyme
Size o f product 
(bp)
Other reaction 
conditions
346E8F8386........................ TAAGAGAGACTGGACCTCTCTCCATATAGT AL359885 8386-8415 60 H 377 40 cycles346E8R8763 T GGGAGGGT ACACAGT GATT AGAGAGT AAT 8763-8732
346E8F17767 T ATTTT CTGCTGTTTT ATTT CTTTTT CTC A
AL359885
17767-17796
60 H 204 35 cycles346E8R17970 AAGG AT AGACACAGACAT ATT CCT AAGGTT 17970-17941
346E8AF TCCCTGCCTGTCCTACACTT
AL359885
26616-26635
53 H 199 35 cycles346E8AR TCAATTTCCATTCCCCACAT 26814-26795
346E8BF AATT GGCAT CTT GCATTT CC
AL359885
69417-69436
55 B 205 35 cycles346E8BR GAT ACAT CCT GGGAGCT GG A 69621-69602
52K8AF TGC ATGGGGAATTAAGCATT
AL445213
23495-23514
55 B 205 35 cycles52K8AR TGTAGGGAAAATGGCAAACA 23699-23680
DXS8045F-TET ACT GCGGT GCT GACT AGG
AL109654
159160-159177
55 B 189-223 -DXS8045R CAGGTAAATCTGAGAAATGTTCTGC 159378-159354
183K14CF GGTTT CATTTTT GCCCCT CT
AL109913
66090-66109
55 B 222 -183K14CR AAGGGGAACTAAATGGTGA 66311-66292
183K14BF TTT AT GT GCT CCCCCT CAAC
AL109913
84019-84038
55 B 218 -183K14BR TT GT GGGAAAT GGAT GT G AA 84236-84217
183K14DF GAACGAAGGAAGCAAACAGG
AL109913
129708-129727
55 B 193 -183K14DR ACAAGCGGGTT CCT ACCT CT 129900-129881
79A21BF CT GAAACGAAGT GGGGAGAG
AL513491
10058-10077
55 B 203 _79A21BR GCATCTTGCA'11 ITTCTCCA 10260-10241
203P18CF AAGGGGAGCAGGACTAGCTT
Z97180
126349-126368
56 B 196 -203P18CR GGGAAAT CAGT CACAACAGGA 126544-126525
203P18DF GGCCCACATTAGCAATTCAC
Z97180
116365-116384
56 H 223 -203P18DR AC AA GATT CCT GGCCCCT AC 116587-116568
203P18F105705 GGT ATT AGAATT GCT AGT G ACCT CTT CT CT
Z97180
105705-105734
60 H 340 -203P18R106044 ACAT GTT CGAGT ACATT CT AACAGCT AAGT 106044-106015
203P18F98450 TATCTGCCATGAGTAGGGTTATTGTGACTA
Z97180
98450-98479
60 H 378 40 cycles203P18R98827 TATAGAGATCCAGGCCAGACAATAAAGAAA 98827-98798
203P18F97768 TT AAAAACT GAACT CATT GCCAT C
Z97180
97768-97791
57 H 159 40 cycles203P18R97926 GGCAAAATT GGGAAGATT GTT ACT A 97926-97902
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203P18F96708 GGACGAT AT CAACT AGGAT GTT GG A
Z97180
96708-96732
57 H 239 40 cycles203P18R96946 GATT CT GT GCAAGAAG AGCT AAACG 96946-96922
203P18F95518 ATTT GCCT CTTTT C AACTTT CT AAACT CT A
Z97180
95518-95547
60 H 240 40 cycles203P18R95757 TCT AAGACAT A ATGA ATTT AAAGCTG AGTTG 95757-95727
203P18IF TT AAT GT GAGCCCT GGGAAC
Z97180
95368-95387
55 H 390 -203P18IR CAGAACAAGGGCAAGGTAG 95757-95738
203P18GF TT CAAAAGT CT GAGGCACCA
Z97180
87737-87758
55 H 198 -203P18GR AATGGGGTGTCTGAATCTCCT 87934-87915
DXS1200F T ACACACCAAACAACAGAGCCT
Z97180
79512-79491
55 H 275-285 -DXS1200R-TET CTAGGGGCACTTGAAAACAA 79234-79254
203P18HF TT GAGT GTT GCAAGCCAGAT
Z97180
74979-74989
55 H 192 -203P18HR ACACT ACCGT GGT GCCAAAT 75170-75151
203P18FF T GT GCTTTT GTT GCCAAAT C
Z97180
53464-53484
55 B 200 -203P18FR GGAATT CT GAAACCCT GCAC 53663-53644
203P18BF AAGAGCTT CAT GCCAT GT CC
Z97180
4745-4764
55 H 184 -203P18BR T GGTTT GTT GACCCTTTT GG 4928-4909
346E8F1446 TAGTTTCACAAAAATGTCCTAAGCTGTCAA AL359885 1446-1475 63 H + PS - LR-PCR
346E8F2596 TCTTGGCTATACAGGCTCTTTTTAGTTCTG AL359885 2596-2625 63 H + PS - LR-PCR
346E8F4250 GAGAGACTGCATCCTTTTCTTGTTCTAGTC AL359885 4250-4279 63 H + PS - LR-PCR
346E8F4815 GCTGTGAATTTCCCTGGTTC AL359885 4815-4834 63 H + PS - LR-PCR
203P18F98454 TGCCATGAGTAGGGTTATTGTG Z97180 98454-98475 63 H + PS - LR-PCR
1055cl4ipcr68617 TTTACTATGGCGGTTGGAGG AE049610 68617-68598 55 H - 40 cycles
1055cl4ipcr68830 ACCAATCCTCTTCCTCCGTT AL049610 68830-68849 55 H - 40 cycles
305bl6R44033 GGAGCCTTCCCACTAAAATCA AL049792 44053-44033 55 H - -
197ol7F69387 GGT AGTGGCAAGCACAGCAT AL008629 69387-69406 55 H - -
453fl8R24991 TGCTCCAGGTTGCTGATACA AL513243 24991-24672 55 H - -
1055cl4R68328 TAATAGTGCGTATAAGGCACGTAATGTGAA AL049610 68328-68299 65 H + PS - LR-PCR
453fl8R25585 GCACATGACCAATATGTACTCCAACAGTAT AL513243 25585-25556 65 H + PS - LR-PCR
453fl8R26962 TTGATTTTGGGAATTCCAGATTACTACAAG AL513243 26962-26933 65 H + PS - LR-PCR
453fl8R29754 GTCTCTTGTAGAATCTATGCGTTTCCCTAA AL513243 29754-29725 65 H + PS - LR-PCR
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Family 4 primers
DXS6807F G AGCAAT GAT CT CATTT GCA
AC073617
56049-56030
55 B 250-273 -DXS6807R AAGT AAACAT GT AT AGGAAAAAGCT 55783-55807
DXS9895F TT GGGT GGGGACACAGAG
AC120338
39035-39018
55 B 140-161 -DXS9895R CCT GGCT CAAGGAATT ACAA 38893-38908
AR1 5'FAM GCTGTGAAGGTTGCTGTTCCTCAT
AL049564
104443-104420
60 B 269-306 -AR2 TCCAGAATCTGTTCCAGAGCGTGC 104156-104179
DXS6800F GT GGGACCTT GT GATT GT GT
AL009028
59056-59037
55 B 197-221 -DXS6800R CT GGCT GACACTT AGGGAAA 58863-58882
DXS1191F AACAGCT ATT GT GCCT GGCAGAGAA
Z73497
23844-23865
55 B 233-245 -DXS1191R GCCCCGTTT GAT GCTT CT AAATT G 24081-24058
DXS8075F GGGCTACCAAAGGACTGT
AL050401
66985-67002
55 B 167-177 !DXS8075R CT GGGTT GT GACT GTTT CAT 67155-67136
DXS6797F TT CCCT CT CT CCCT CT GT CT
AL136080
67519-67538
55 B 250-270 -DXS6797R ACACACACCCAAAACCAGAT 67787-67768
DXS1212R TGGCATTACAAGCCCTCAAGTC
Z82899
30107-30128
55 B 230-238 -DXS1212F-HEX TGGAAGCATGAGAAATCACATCCT 30338-30315
DXS1232F ACCAACAGCCTAATAATGC
AC004070
58530-58512
55 B 163-199 -DXS1232R-HEX AGAGATGGGAGCAGCA 58362-58377
DXS8013F CC A ACCCAACTGTCTATCAA
AL121875
6392-6373
55 B 193-229 -DXS8013R-FAM GTTTGGTTTTCCATTCCTGA 6169-6188
DXS984F-FAM TTT CT GT CT GCCAAGT GTTT
AL137016
3278-3297
55 B 154-184 -DXS984R TACTGNGCCCTACTCCATTC 3445-3426
291b3F17375 AGGCTGAGCTGATGAGGATAGGAGT AL844175 17375-17399 65 H + PS - LR-PCR
291b3F22910 TAATCCAGAGAGGTGTCGTTTTCCA AL844175 22910-22934 65 H + PS - LR-PCR
291b3F25483 TGTCCTGTTGAATTTCACTCACCTG AL844175 25483-25507 65 H + PS - LR-PCR
291b3F4486 ATTAAAGTCATTGCCGAGGAATCGT AL844175 4486-4510 65 H +  PS - LR-PCR
291b3F l1639 GAGCTGAAAGATCATGATGCAGGTT AL844175 11639-11663 65 H + PS - LR-PCR
35fl5R71430 TTGCTCTTCACAAACTCGACCATTT AL590077 71430-71406 65 H +  PS - LR-PCR
364bl4R15613 CCCTTGCCTGTATAGTGGCTCTTCT AL589987 15613-15589 65 H + PS - LR-PCR
364bl4R9239 TTTTGGAAGGAAAAAGGCCTCAGTA AL589987 9239-9215 65 H +  PS - LR-PCR
364bl4R6018 GTCTGTTGTCAGACCCGATCTAGGA AL589987 6018-5994 65 H + PS - LR-PCR
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UPQFM primers
dJ635gl9F8797 tccgtcttagctgagtggcgtaGTTGGGGCCTTCTGTGTTTA
AL035494
8797-8816
55 H 211 UPQFM-PCRdJ635gl9R8962 aggcagaatcgactcaccgctaACTCACCCTGGATGGTTCAG 8962-8943
dJ635gl9F30902 tccgtcttagctgagtggcgtaTCCTTCCTGCCTGACTCCTA
AL035494
30902-30921
55 H 301 UPQFM-PCRdJ635gl9R31157 aggcagaatcgactcaccgctaTCGCAGATGATGTCCCACTA 31157-31138
dJ635gl9F48059 tccgtcttagctgagtggcgtaGGTGGTCCCTCCCATTTAGT
AL035494 48059-48078 55 H 315 UPQFM-PCRdJ635gl9R48309 aggcagaatcgactcaccgctaATTGGTGTGCCAGATGTGAA 48328-48309
dJ635G19F60570 tccgtcttagctgagtggcgtaAGAGTGGGTCTCTGGCTCAA
AL035494
60570-60589
55 H 203 UPQFM-PCRdJ635gl6R60728 aggcagaatcgactcaccgctaGGTGCCTCCAACTTTTGTGT 60728-60709
dJ635G19F68207 tccgtcttagctgagtggcgtaAGGACAGCCAGCAAGAAAAA AL035494 68207-68226 55 H 293 UPQFM-PCRdJ635G19R68454 aggcagaatcgactcaccgctaCCAGTTTCCTCCCCCTTTAG 68454-68435
dJ635G19F69048 tccgtcttagctgagtggcgtaCCACCCCCAATATCACTTTG AL035494 69048-69067 55 H 263 UPQFM-PCRdJ635G19R69265 aggcagaatcgactcaccgctaGCTTAGTTTCGCACCTGGAG 69265-69246
cU65A4Fl 1590 tccgtcttagctgagtggcgtaATTTTGATTGCGGTCATGGT
Z81014 11590-11609 55 H 212 UPQFM-PCRcU65A4Rl 1756 aggcagaatcgactcaccgctaCCAAAACAGTTTGCCACTTTC 11756-11736
cU65A4F9959 tccgtcttagctgagtggcgtaGAAGCTTGGGGGAAAGAATC
Z81014 9959-9938 55 H 256 UPQFM-PCRCU65A4R9747 aggcagaatcgactcaccgctaCAATCAGGGCATGAATGAGA 9747-9766
CU65A4F6833 tccgtcttagctgagtggcgtaGGGCCATATGGAAGACAGAA
Z81014
6833-6852
55 H 320 UPQFM-PCRCU65A4R7109 aggcagaatcgactcaccgctaGCC ATCC AGTATT GGC ACTT 7109-7088
cU65a4F4480 tccgtcttagctgagtggcgtaGCTTGGAAGCTCCACTTGAC
Z81014
4480-4499
55 H 270 UPQFM-PCRcU65A4R4685 aggcagaatcgactcaccgctaCATGTGGAGGAAGTGTGTGG 4704-4685
CU177E8F36491 tccgtcttagctgagtggcgtaGTGAAACAGGGATGGGAAGAG
Z68694 36491 -3 6 5 1 0 55 H 267
............................................................
UPQFM-PCRCU177E8R36712 aggcagaatcgactcaccgctaCTAGTCCAGAGCATGGCACA 3 6 7 1 2 -3 6 6 9 3
CU177E8F38464 tccgtcttagctgagtggcgtaCTTCTCCCAACCCCAGTACA
Z68694
38464 -  38483
55 H 240 UPQFM-PCRCU177E8R38658 aggcagaatcgactcaccgctaCAGCACATGGCAGTTCCTTA 3 8 6 5 8 -3 8 6 3 9
CU177E8F20484 tccgtcttagctgagtggcgtaTCTTGGTGCACAAAAACAGG
Z68694
20484-20503
55 H 306 UPQFM-PCRCU177E8R20744 aggcagaatcgactcaccgctaAGGCCTTCACCTTCATCCTT 20744-20725
CU177E8F32435 tccgtcttagctgagtggcgtaCTTTGCCAGCAATGAGAACA
Z68694
32435-32454
55 H 304 UPQFM-PCRCU177E8R32693 aggcagaatcgactcaccgctaACCTCTGGCCCTTGTGTAAA 32693-32674
CU177E8F5951 tccgtcttagctgagtggcgtaAGACTCTAGCCCACCAGCAA
Z68694
5951-5932
55 H 299 UPQFM-PCRcU177e8R5698 aggcagaatcgactcaccgctaTGACGCTTGAGTCTG TGACC 5698-5717
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dJ43H13F12256 tccgtcttagctgagtggcgtaAGATGTGGATTTAGGGTCAACAGC
AL035444
12256-12279
55 H 297 UPQFM-PCRdJ43H13R12507 aggcagaatcgactcaccgctaCAAGCTCCTAACCTCCATCTGTC 12507-12485
cV857G6Fl 1085 tccgtcttagctgagtggcgtaCTGTGCTAAACTGCGTGGAA
Z73965
11085-11104
55 H 250 UPQFM-PCRcV857G6Rl 1289 aggcagaatcgactcaccgctaTGCAAAGCCAAGCTACAAGA 11289-11270
CV857G6F41850 tccgtcttagctgagtggcgtaCTTTCCTTGAGTCATTGAGGTTTT
Z73965
41850-41873
55 H 277 UPQFM-PCRCV857G6R42081 aggcagaatcgactcaccgctaTTGTTGAGTGATTCTGATCTCCAT 42081-42058
CV857G6F32969 tccgtcttagctgagtggcgtaCACAAATGTCCATCATTACAGGTT
Z73965
32969-32992
55 H 282 UPQFM-PCRCV857G6R33205 aggcagaatcgactcaccgctaGCATCTCTAGAGGGCAATATCACT 33205-33182
CU246D9F8349 tccgtcttagctgagtggcgtaGTTGGTATCAAATGGGCATATCAC
AL021308
8349-8372
55 H 249 UPQFM-PCRCU246D9R9530 aggcagaatcgactcaccgctaGAACTCATGTGGCTCCTGAACTG 8552-9530
CU246D9F16048 tccgtcttagctgagtggcgtaTGTCGATTGCATTATTCCTGTTA
AL021308
16048-16070
55 H 275 UPQFM-PCRCU246D9R16277 aggcagaatcgactcaccgctaCTGCTCAGTGTTGACATCCATTT 16277-16255
dJ1055C14Fl tccgtcttagctgagtggcgtaCATGCCCCACTGTTATAGGG
AL049610 18844-18863 55 H 270 UPQFM-PCRdJ1055C14Rl aggcagaatcgactcaccgctaGCCCATTTTCTATTGGGTGA 19070-19051
dJ1055C14F3 tccgtcttagctgagtggcgtaGTTAACACACGGGCCTCACT
AL049610
46009-46028
55 H 274 UPQFM-PCRdJ1055C14R3 aggcagaatcgactcaccgctaTTGCATGCGCTATGATCTTC 46237-46218
dJ1055C14F4 tccgtcttagctgagtggcgtaGCATTTTAGGGCAGCAAGAG
AL049610
5 4 4 4 9 . 5 4 4 6 8
55 H 279 UPQFM-PCRdJ1055C14R4 aggcagaatcgactcaccgctaTGGTTAGGGATGAGGTGCTC 54682-54663
dJ1055C14F5 tccgtcttagctgagtggcgtaAGAGCCAAGCTGGACAAAA
AL049610
62946-62965
55 H 205 UPQFM-PCRdJ1055C14R5 aggcagaatcgactcaccgctaGTAGGGAACAGGTGGCAAAA 63086-63105
dJ1055C14F8 tccgtcttagctgagtggcgtaGGAAGGTTCTGCAATCAGGA
AL049610
67104-67123
55 H 273 UPQFM-PCRdJ1055C14R8 aggcagaatcgactcaccgctaGTGGCCACAAGAAAGGAAAA 67331-67312
dJ1055C14F10 tccgtcttagctgagtggcgtaCCTCCAACCGCCATAGTAAA
AL049610
68598-68617
55 H 297 UPQFM-PCRdJ1055C14R10 aggcagaatcgactcaccgctaAACGGAGGAAGAGGATTGGT 68849-68830
dJ1055C14F7 tccgtcttagctgagtggcgtaGCTCTTACCTTTGCGTCCTG
AL049610
69896-69915
55 H 306 UPQFM-PCRdJ1055C14R7 aggcagaatcgactcaccgctaACCAAACAGCCAATCCTTTG 69955-69936
dJ1055C14F6 tccgtcttagctgagtggcgtaGGTTTGAAACTGGGGACAGA
AL049610
75773-75792
55 H 275 UPQFM-PCRdJ1055C14R6 aggcagaatcgactcaccgctaAAGGGCCAGGACTTTTGTTT 76033-76014
dJ1055C14F2 tccgtcttagctgagtggcgtaCGC AAT AGG A AAAGGGAT G A
AL049610
88473-88492
55 H 220 UPQFM-PCRdJ1055C14R2 aggcagaatcgactcaccgctaTCCTGCTGCAGATTCAAATG 88702-88683
cU35F15F5631 tccgtcttagctgagtggcgtaTCCATGGGGAAGTTCTTGAG
Z93848
5631-5650
55 H 220 UPQFM-PCRCU35F15R5805 aggcagaatcgactcaccgctaAGCCAGGAGAGTTTGCGTTA 5805-5786
247
CV362H12F34770 tccgtcttagctgagtggcgtaG TT G C A TC TG G TA G C C A TCC Z70227 34770-34963 55 H 239 UPQFM-PCR
c V362H12R34963 aggcagaatcgactcaccgctaA A C G TG G G G C A A A A C T A C T G 34963-34944
dJ839Ml 1F37922 tccgtcttagctgagtggcgtaG C TG TTC C TC A G A G G TC G TC AL034485
37922-37941
55 H 205 UPQFM-PCR
dJ839Ml 1R38082 aggcagaatcgactcaccgctaTC C A A T C A G A C G T G A A G C T G 38082-38063
cU240C4F29788 tccgtcttagctgagtggcgtaG A G G TG C C A A C A G G G A A TA G Z73497
29788-29807
55 H 240 UPQFM-PCR
CU240C2R29983 aggcagaatcgactcaccgctaG G TC AC G T G C C C C T T A CTT A 29983-29964
cU46Hl 1F32229 tccgtcttagctgagtggcgtaAT TC C AG AG G C TC C A T TC C T Z82254
32229-32248
55 H 221 UPQFM-PCRcU46Hl 1R32404 aggcagaatcgactcaccgctaTC C TTG C C AG TTTTG AC C TC 32404-32385
35F15tag66750F tccgtcttagctgagtggcgtaTA A C C A C C G TC C A C TC A C A A AL590077
6 6 7 50-66769
55 H 244 UPQFM-PCR
35F15tag66949R aggcagaatcgactcaccgctaG A G C C TTG G TT C TG TG G A A G 6 6 9 49-66930
364B14F16714 tccgtcttagctgagtggcgtaA G G A TC T G G A C C A A C A C A G G AL589987
16714-16733
55 H 290 UPQFM-PCR
364B14R16959 aggcagaatcgactcaccgctaTG AA G G CA G G G A AC TC C T TA 16959-16940
364B14F25512 tccgtcttagctgagtggcgtaAT G A TC C AA G G G TTC C A TG A AL589987
25512-25531
55 H 289 UPQFM-PCR
364B14R25756 aggcagaatcgactcaccgctaA C TG G C A G G A A TT G G C TA A C 2 5756-25737
364B14F48225 tccgtcttagctgagtggcgtaG A TTC C C AC C TA C TG CTG G A AL589987
4 8 2 25-48244
55 H 212 UPQFM-PCR364bl4R48392 aggcagaatcgactcaccgctaA A TG C TG C A G G A G C C TA A G A 48392-48373
364B14tag74126F tccgtcttagctgagtggcgtaTTTCCAG TG G G CTTG G TTAG AL589987
74126-74145
55 H 288 UPQFM-PCR364B14tag74369R aggcagaatcgactcaccgctaT  AG AG G G CTCTG CG G AATT A 74369-74350
595A18F26757 tccgtcttagctgagtggcgtaTTTG TTTG CTG CTTCAG TG G AL137016
26757-26776
55 H 327 UPQFM-PCR
595A18R27039 aggcagaatcgactcaccgctaTT G G A A G G C G G AT A C A A TTC 27039-27020
595A18F54671 tccgtcttagctgagtggcgtaAG G A AG G C CC A T C A A CTTC AL137016
54671-54689
55 H 199 UPQFM-PCR595A18R54825 aggcagaatcgactcaccgctaG A G G C A TC A TA G G G G C A G T A 54825-54806
595 a 18fl 01906 tccgtcttagctgagtggcgtaG A TG C C C C A G A TTG T A C C A C AL137016
101906-101925
55 H 279 UPQFM-PCR
595al8rl02140 aggcagaatcgactcaccgctaTA TTTG CC G A A TTTC A A C C A 102140-102121
595al8fl 14741 tccgtcttagctgagtggcgtaAC TC TATG C G G TG G A TG A C C AL137016
114741-114760
55 H 239 UPQFM-PCR
59 5 a l8r l14935 aggcagaatcgactcaccgctaG A A A G G TC T G A G C C A G T TG C 114935-114916
291b3f26828 tccgtcttagctgagtggcgtaTC C TA CA A A C G C G A TTA G C C AL844175
26828-26847
55 H 261 UPQFM-PCR291b3r27044 aggcagaatcgactcaccgctaA C CC TG G TC C C G A G A G TA G T 27044-27025
291B3F64796 tccgtcttagctgagtggcgtaAC TTG C C CC A C TC TG TA TG G AL844175
64796-64815
55 H 260 UPQFM-PCR
291B3R65011 aggcagaatcgactcaccgctaTG G G C TC A T A TG CA T G TT G T 65011-64092
UNIVF TCCG TCTTAG CTG AG TG G CG TA 55 H UPQFM-PCRUNIVR A G G C A G A A TC G A C T C A C CG CT A
MAPH primers
PZA AG TAACG G CCG CCAG TG TG CTG -
7
H MAPH
PZB CGAGCG G CCG CCAG TG TG ATG -
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PZAX A G TAACG G CCG CCAG TG TG CTG G AATTCTG CAG AT - - 65 - - -PZBX C G A G CG G CCG CCAG TG TG ATG G AT
ch7q31.2F C G A G G CTACAG CTTTG G AAC AC000111 51188-51207 56 B 185 -ch7q31.2R C A TC ACACTTG TG CCATTCC 51372-51353
XLNKXF A A A C A A G C A G C A G A A A G G G A AF283102 1245-1264 58 B 193 -XLNKXR A G G G A G A G C TG C C A TA C A G A 1437-1418
plp5F G G C C C C G T AA C T C C A TA A A G Z73964 17947-17966 58 B 199 -plp5R A A TTG AAG G CCATG G G TG TA 18145-18126
144alOF TTC C A G G TA TAA C A C C C C C A Z70224 9207-9226 56 B 205 -144alOR GGGGTTG AT AA G G G G A  A A A A 9411-9392
chl7pl3.1F A G C TTC A A G C A G C A A CC A C T AC004706 4720-4739 56 H 209 -chl7pl3.1R G G GCAGGGT A A A A G A T G G A T 4928-4909
240c2F T A A A A C C C TCG CA G G AG AG A Z73497 37375-37394 56 B 214 -240c2R C C C A G C AC A G TTA G TC A G C A 37588-37569
79plIF G CATG TG G G CCTCAG TATTT AL133348
...............
12909-12928 58 B 223 -79pl1R G G C A A A A C C A G A C A A C A C C T 13131-13112
chlq24.2F ACCTG CTTATG G G G ACCTCT Z97200 10517-10536 58 B 230 -chlq24.2R C A G C A G G G G C A G T A G C TA A G 10746-10727
plp6F A A A G A TA T C A A C A C A T T C A G Z73964 18796-18815 56 B 239 -plp6R TTG CCTTTCAG AATAG CTG T 19034-19015
ch6p24.2F CTCA C C A TG G G A A G C A TTTTT AL022098 245-264 58 B 263 -ch6p24.2R TC A C C C A TC AA G A C C TC A CA 507-488
sryF GCTG G G AT A C C A G TG G A A A A AC006040 63117-63098 58 B 271 -sryR T AAGTG G CCTAG CTG G TG CT 62847-62866
ch4q26F TGCG ACAG TTCTG ACCACTC AC027613 4489-4508 56 H 276 -ch4q26R CCCTG G ACTTG ACCTG TG TT 4764-4745
Xql2F TG G AAACAG TCCCTTCCTTG Z82212 6286-6267 58 B 281 -Xql2R CTTCCTGCTG CCTACACTCC 6006-6025
198p4F AGGG G ATCTATG TTG G G ACC AL008708 22496-22515 56 B 293 -198p4R TGTTGGTCATGCTGTGGTTT 22788-22769
43hl3F CA C C AG TATCCCTTG CCACT AL035444 22647-22666 58 B 300 -43hl3R CTTGG TTCTTGAGCCTGGAG 22946-22927
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plp2F TTCCCTGGTCTCGTTTG TCT Z73964 15993-16012 58 B 309 -
plp2R TGAG G ATG ATCACCTTG TCG 16301-16282
plp7F T C A C C C A C A G A A A G A G A G C A Z73964 20741-20760 58 B 314
plp7R G AG G G CCATCTCAG G TTACA 21054-21035
chl7q21.32F A AG G TCCTGG GCT AG A AGG A AC 103702 105825-105844. .................. 58 B 331 ~
chl7q21.32R A C C C AC A C A A G G A G G TT CA G 106155-106136
APPENDIX B
Genomic clones used or referred to within this thesis. The name of the clone, its 
accession number, position in Mb on the X chromosome (NCBI release 34), orientation 
(+, centromere to telomere; -, telomere to centromere) and the band to which it maps, are 
all shown.
Clone Accession Mb Orientation band
dJ570L12 AL049589 76.065-76.206 + Xq21.1
(0795G23 AL031000 77.976-78.108 - Xq21.1
bA102P23 AL357115 79.176-79.341 + Xq21.1
bA346E8 AL359885 79.340-79.417 + Xq21.1
bB52K8 AL445213 79.417-79.608 + Xq21.1
dJ2A2 AL645817 79.955-80.084 + Xq21.1
(U717L12 AL021706 81.141-81.237 + Xq21.1
dJ326L13 Z82170 81.448-81.575 + Xq21.1
dA43C13 AL009175 83.940-84.047 + Xq21.2
dJ769N13 AL035427 100.649-100.810 + Xq22.1
bA522L3 AL590407 100.810-100.890 + Xq22.1
CU157D4 Z95624 100.888-100.926 - Xq22.1
dJ1054G24 AL669904 100.925-100.931 + Xq22.1
CU237H1 Z95624 100.931-100.967 - Xq22.1
CU237H3 Z93943 100.968-100.983 - Xq22.1
CU61F10 Z75895 100.983-101.028 - Xq22.1
cU73E8 Z73361 101.025-101.066 - Xq22.1
dJ198P4 AL008708 101.066-101.101 + Xq22.1
CU221F2 Z57546 101.101-101.139 - Xq22.1
CU101D3 Z85997 101.138-101.179 - Xq22.1
(U635G19 AL035494 101.179-101.248 + Xq22.1
CU65A4 Z81014 101.248-101.265 - Xq22.1
CU177E8 Z68694 101.265-101.306 - Xq22.1
dJ79Pll AL133348 101.306-101.346 + Xq22.1
CU105G4 Z92846 101.346-101.390 + Xq22.1
bB349O20 AL606763 101.388-101.450 + Xq22.2
dJ823F3 AL079333 101.448-101.455 + Xq22.2
dJ421I20 AL117327 101.455-101.508 + Xq22.2
CU250H12 Z69733 101.508-101.549 - Xq22.2
(043H13 AL035444 101.549-101.576 + Xq22.2
CU246D9 AL021308 101.576-101.598 + Xq22.2
CV857G6 Z73965 101.598-101.640 - Xq22.2
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Clone Accession Mb Orientation band
CU25D11 Z68327 101.640-101.645 - Xq22.2
(U1055C14 AL049610 101.645-101.745 + Xq22.2
CU35G3 Z93848 101.745-101.784 + Xq22.2
dJ764D10 AL034409 101.785-101.797 + Xq22.2
CV698D2 Z73964 101.797-101.839 + Xq22.2
dJ540A13* AL139228 101.839-101.871 + Xq22.2
CV461C10 Z75896 101.871-101.909 + Xq22.2
dJ540A13+ AL139229 101.908-101.925 + Xq22.2
bA370B6 AL390022 101.925-101.934 + Xq22.2
CU116E7 Z70273 101.934-101.960 + Xq22.2
CV362H12 Z70227 101.960-102.002 + Xq22.2
dJ839Mll AL034485 102.002-102.050 + Xq22.2
CU240C2 Z73497 102.050-102.090 - Xq22.2
CV467E10 Z74620 102.090-102.101 + Xq22.2
CU46H11 Z82254 102.100-102.139 + Xq22.2
dJ513M9 AL049631 102.206-102.324 + Xq22.2
bA541I12 AL121868 102.324-102.442 + Xq22.2
CU144A10 Z70224 102.793-102.828 + Xq22.3
dJ75H8 AL158821 104.940-105.048 + Xq22.3
dJ378P9 AC005002 115.201-115.321 + Xq23
dJ404F18 AC004000 117.309-117.437 + Xq24
dJ136017 Z72001 126.611-126.696 - Xq25
dJ297J13 Z77723 129.009-129.036 - Xq26.1
dJ154J13 AL049734 129.263-129.390 + Xq26.2
b A324A3 AL355366 129.390-129.416 + Xq26.2
bA453F18* AL513242 129.416-129.431 + Xq26.2
dJ765F13 AL109853 129.431-129.538 + Xq26.2
bA453F18* AL513243 129.538-129.597 + Xq26.2
bA512H23 AL121572 129.596-129.638 + Xq26.2
dJ197017 AL008629 129.638-129.799 - Xq26.2
dA213H19 AL109749 129.799-129.938 + Xq26.2
dJ305B16 AL049792 129.939-130.048 + Xq26.2
dJ37M17 Z78022 130.048-130.149 + Xq26.2
dJ965E19 AL353676 130.149-130.173 + Xq26.2
dJ842K24 AL050310 130.173-130.282 + Xq26.2
dJ119E23 Z99570 131.749-131.815 + Xq26.2
dJ260J9 Z82193 136.447-136.545 + Xq26.3
(U656F14 AL034416 136.787-136.818 + Xq27.1
bA35F15 AL590077 137.697-137.768 + Xq27.1
bA364B14 AL589987 137.767-137.911 + Xq27.1
SA189F12* AL449183 137.912-137-927 + Xq27.1
bA189F12* AL449184 138.038-130.038 + Xq27.1
bA51C14 AL121875 138.186-138.334 + Xq27.1
431
Clone Accession Mb Orientation band
dJ595A18 AL137016 138.334-138.450 + Xq27.1
dJ177G6 AL078639 138.516-138.645 + Xq27.1
dJ507I15 Z98950 138.838-138.962 - Xq27.1
dJ406C18 AL023773 139.856-139.972 + Xq27.2
dJ73H14 AL080272 140.343-140.438 + Xq27.2
dJ357K22 AL022720 140.847-140.993 + Xq27.3
bG256022 AL080239 141.291-141.508 + Xq27.3
dJ145B12 AL008706 142.395-142.510 - Xq27.3
bA550B3 AL589671 143.396-143.425 + Xq27.3
bA159A24 AL356503 143.863-144.010 + Xq27.3
bG278N14 AL109654 144.021-144.203 + Xq27.3
bA183K14 AL109913 144.203-144.346 + Xq27.3
bA79A21 AL513491 144.346-144.360 + Xq27.3
dJ203P18 Z97180 144.360-144.493 - Xq27.3
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APPENDIX C
In each table the occurrence of various sequence motifs close to the different sequenced 
breakpoints from this study are shown. The actual sequences corresponding to each motif 
are given in Table 2.4. The number of times each motif was found in each 5Kb region is 
shown in the “Number found” column, and where this number is less than 10, the actual 
positions of each motif within the 5Kb region are shown, with (-) in front of a position 
indicating that the motif was on the reverse strand. The number of times each motif was 
expected to occur on both strands of the 5Kb sequence given the nucleotide frequencies 
and assuming random assortment of nucleotides is shown in the “Expected” column. The 
relative incidence of each sequence is shown in the final column, and is calculated as the 
difference between the observed and expected incidences, divided by the expected 
incidence, plus one. Where a motif was found at five times or greater than the expected 
incidence within the 5Kb region, the relative incidence is underlined. Motifs that were 
found within 50bp of a breakpoint have their positions highlighted in bold, where those 
positions within the 5Kb were already shown. In those cases where too many copies of 
the motif had been found in the 5Kb region to show all of them, the occurrences within 
the region around the breakpoint were shown bracketed in bold. Where a motif was 
found more than 10 times close to the breakpoint, just the number of occurrences was 
shown. For each motif occurrence table, the actual position of the 5Kb region within the 
relevant genomic clone is given, and the smaller region around the breakpoint is shown in 
brackets. For cU177E8 in family 2, there were two breakpoints within the 5Kb region, 
the region just around the short inserted sequence is shown in italics, and motif 
occurrences within this region are also italicised.
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Family 1 distal duplication breakpoint:
dJ839Ml 1 8310-13309 (10759-10858) (lOObp)
M o tif
N u m b er
foun d
P o sitio n s E x p ected
R elative
in c id en ce
S. p o m b e  A R S 1 3427 0 .0 3 3 1 .6 3
S c a ffo ld  m o tif  1 1 -3438 0 .0 3 3 1 .6 9
S c a ffo ld  m o tif  2 1 -4432 0 .1 3 7 .4 2
S c a ffo ld  m o tif  3 7 3453, 4 5 9 2 ,-3 4 3 8 ,-3 4 6 0 ,-3 4 8 5 ,-  3499,-3709
1.41 4 .9 8
S c a ffo ld  m o t if  4 4 -3270, -4432, -4483 1.49 2.01
T o p o iso m era se  I 1 199 (2456, 2463, 2476, 2544 ,-2466 , - 2519,-2528)
1 6 3 .2 6 1.22
T o p o iso m era se  I 2 3 6 3 (2460, 2485, -2 4 7 4 ,-2 4 9 5 ,-2 5 0 2 ,-  2506,-2541)
3 1 2 .3 4 1.16
T o p o iso m era se  I 3 2 4 3 (2450, 2 4 6 8 ,2 4 8 8 ,-2 5 1 4 ,-2 5 2 3 , - 
2535)
3 1 2 .1 9 0 .7 8
T o p o iso m era se  I 4 321 (2516, 2525,-2459, -2479, -2547) 3 4 4 .1 3 0 .93
V a c c in ia  to p o iso m era se  I 32 19 .58 1.63
H eptam er 5 1902, -2146, -2340, -3143,-3815 0 .5 7 8 .73
Ig c la ss  sw itch  1 11 9 .1 9 1.20
Ig c la ss  sw itch  2 18 (-2498) 8 .3 2 2 .1 6
Ig c la ss  sw itch  3 8 214, 605, 6 9 7 ,4 8 8 1 ,-1 2 6 3 ,-3 1 9 0 , -4090, -4689
8.31 0 .9 6
Ig c la ss  sw itch  4 21 8.31 2 .5 3
Ig c la ss  sw itch  5 12 9 .1 9 1.31
T ranslin  co n se n su s 3 5 113,597, 1268,-339, -4031 2 .41 2 .0 7
T ranslin  c o n se n su s 4 5 2045 ,-752 ,-2285 , -2300 ,-2364 1.97 2 .5 4
C h i-lik e  seq u en ce 3 1684,2276, -4029 0 .4 9 6 .1 0
D e le t io n  h o tsp o t co n sen su s 69 (-2464) 3 8 .8 2 1.78
M o u se  d e letio n  h o tsp ot 145 (2481,2498, 2514) 7 4 .0 7 1.96
P arvoviru s d e le tio n  h o tsp ot 17 11 .50 1.48
M o u se  M H C  reco m b in a tio n  hotsp ot 3 1571,2398,3286 0 .5 5 5 .4 2
P o ly m era se  a  pau se site  1 190 (2493, 2500, 2504, 2541 ,-2462) 147 .91 1.28
P o ly m era se  a  pau se site  2 42 (2534) 1 4 7 .8 6 0 .2 8
P o ly m era se  a  pau se site  3 186 (2474, 2495, 2519, 2530 ,-2485 , - 
2510,-2531)
2 6 6 .9 1 0 .7 0
P o ly m era se  arrest site 51 (-2464) 1 8 .4 4 2 .7 7
P o ly m era se  a  fra m esh ift site  1 3 935, 1918,-1845 1 .97 1.52
P o ly m era se  p fra m esh ift site  1 14 9 .2 3 1.52
P o ly m era se  P fram esh ift site  2 43 4 8 .6 8 0 .8 8
P o ly m era ses  a /p  fra m esh ift site  1 10 21 3 ,6 0 4 ,2 3 3 9 ,2 7 7 4 , 3315 ,4880 , - 1412, -3002,-3561,-4091
9 .2 4 1.08
P o ly m era ses  a /p  fra m esh ift site  2 4 4086, -218, -609,-4885 2 .1 9 1.83
D N A  b en d in g  m o tif 2 3829,4944 3 .2 6 0.61
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Family 1 proximal duplication breakpoint:
dJ635G19: 66710-69648 (69160-69259), cU65A4: 16814-14654 (lOObp)
M o tif
N u m b er
foun d
P o sitio n s E x p ected
R ela tive
in c id en ce
S. c e r e v is ia e  A R S 1 -1140 0 .0 8 12.01
S c a ffo ld  m o tif  2 4 -1302,-1312, -3129,-4975 0 .51 7 .82
S c a ffo ld  m o t if  3 2 1130,1549 2 .5 2 0 .7 9
S c a ffo ld  m o t if  4 6 1472, -1138, -1302, -1312, -3129, - 
4975
3 .1 3 1.92
T o p o iso m era se  I 1 164 (2481,-2534) 158 .21 1.04
T o p o iso m era se  I 2 3 5 0 (2468, 2537 ,-2454 ,-2494 , -2509) 3 2 0 .0 8 1.09
T o p o iso m era se  I 3 271 (2485, 2488, 2496, -2477) 3 2 1 .8 5 0 .8 4
T o p o iso m era se  I 4 3 1 5 (2531,-2453) 3 5 0 .9 6 0 .9 0
V a c c in ia  to p o iso m era se  I 2 4 (2466) 2 1 .7 2 1.11
Ig  c la ss sw itch  1 13 8 .0 4 1.62
Ig  c la ss sw itch  2 8 351, 575, 2 9 7 5 ,3 9 7 1 ,-5 7 ,-1 4 8 8 , - 
2051,-2158
7 .11 1.12
Ig  c la ss  sw itch  3 9 131, 1591, 1807, 1 9 3 0 ,-1 0 1 0 ,-  
1120 ,-1328 ,-2345 ,-2462
7 .1 4 1.26
Ig c la ss  sw itch  4 2 0 (-2475, -2516) 7 .1 4 2 .8 0
Ig  c la ss  sw itch  5 7 51, 1235, 211 7 ,3 0 2 2 ,-1 0 3 0 , - 
1918,-2616
8 .0 4 0 .8 7
T ranslin  c o n se n su s 3 4 1611 ,2177 ,-4238 , -4636 2 .2 0 1.82
T ranslin  c o n se n su s 4 2 2091,-445 1 .58 1 .26
C h i-lik e  seq u en ce 1 1863 0 .4 0 2 .53
D e le t io n  h o tsp ot co n sen su s 4 6 (2490 ,-2475 ,-2516) 3 5 .7 8 1.29
M o u se  d e le tio n  hotsp ot 127 (2501,2505, 2540) 7 2 .3 4 1.76
P arvoviru s d e letio n  hotsp ot 22 16 .85 1.31
M o u se  M H C  reco m b in a tio n  hotsp ot 3 1064, 1698, 2501 0 .6 0 4 .9 8
P o ly m era se  a  pau se site  1 169 (2452, 2492, 2507,-2539) 1 3 9 .0 0 1.22
P o ly m era se  a  pau se  site  2 2 7 (-2521,-2527) 1 3 9 .5 0 0 .1 9
P o ly m era se  a  pau se site  3 180 (2463, 2511, 2524, 2535, 2545, - 
2464,-2501, -2505 ,-2536)
2 2 9 .0 2 0 .7 9
P o ly m era se  arrest site 4 0 (2490,-2541) 1 7 .18 2 .33
P o ly m era se  a  fra m esh ift site  1 4 2011,2286, -950,-1735 1 .58 2.51
P o ly m era se  a  fra m esh ift site  2 3 2142,2445, -2407 1 .60 1.87
P o ly m era se  P fra m esh ift site  1 9 1395 ,2764 ,2789 , 3362, 3949, 
4 362 ,-21 ,-4647
9 .0 3 1.00
P o ly m era se  P fra m esh ift site  2 79 8 0  72 0 .9 8
P o ly m era ses  a /p  fra m esh ift site  1 8 66, 2 4 4 6 ,-1 0 1 1 ,-1 1 2 1 ,-1 3 2 9 , - 
1771,-1943 ,-2634
9 .3 3 0 .8 6
P o ly m era ses  a /p  fra m esh ift site  2 3 1006, 1116, 1324 2 .11 1.42
D N A  b en d in g  m o tif 1 839 3 .4 6 0 .2 9
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F am ily 2 CU177E8: 39838-34839 (37388-37289) lOObp (36104-35956) (149bp)
M o tif
N u m ber
found
P o sitio n s E x p ected
R ela tive
in c id en ce
S. p o m b e  A R S 2 4878,4890 0 .11 17.81
S c a ffo ld  m o tif  1 3 -4885, -4897, -4909 0 .1 0 3 0 .9 4
S c a ffo ld  m o tif  2 5 672, 995,1681,-2394, -3864 0 .4 8 1 0 .36
S c a ffo ld  m o tif  3 14 (-2487) 4 .0 6 3 .4 4
S c a ffo ld  m o tif  4 11 (2487) (-3864) 4 .9 0 2 .2 5
T o p o iso m era se  I 1 187 (2457, 2466, -2465) (3776, 3804, - 3738)
17 9 .0 9 1.04
T o p o iso m era se  I 2 3 6 4 (14 occurrences) (14 occurrences) 3 1 0 .0 9 1.17
T o p o iso m era se  I 3 2 1 8 (-2511) (3750, 3755, 3790, 3829, - 3769, -3820, -3836, -3869)
2 9 4 .4 1 0 .7 4
T o p o iso m era se  I 4 3 6 7
(2462, 2476, 2488, 2498, -2460, - 
2 4 6 9 ,-2 4 7 9 ,-2 4 8 3 ,-2 4 9 1 ,-2 5 0 1 )
(3735, 3858, 3873, -3779, -3807)
4 4 5 .0 6 0 .8 2
V a cc in ia  to p o iso m era se  I 38 (-3845) 2 0 .1 2 1.89
H eptam er 1 4302 0 .41 2 .4 3
Ig c la ss  sw itch  1 7 1 3 7 7 ,-1 3 9 4 ,-1 7 6 2 ,-2 7 1 4 ,-3 3 2 8 ,-  3746, -4451
7 .0 5 0 .9 9
Ig c la ss  sw itch  2 5 652, 4 9 8 6 ,-2 6 5 ,-2 3 8 3 ,-3 6 0 4 4 .8 0 1.04
Ig c la ss  sw itch  3 11 5 .5 4 1.98
Ig c la ss  sw itch  4 15 5 .5 4 2.71
Ig c la ss  sw itch  5 5 2335, 3196, -1395, -1752, -3762 7 .0 4 0.71
T ranslin  co n sen su s 3 5 2233, 3507, -296, -4357, -4754 2 .1 2 2 .3 5
T ranslin  co n sen su s  4 1 1104 0 .9 5 1 .06
C h i-lik e  seq u en ce 1 -612 0 .2 7 3 .71
D e le tio n  h o tsp ot co n sen su s 51 (3871, -3748, -3 777) 3 8 .4 1 1.31
M o u se  d e letio n  h o tsp ot 101 (-2508) (3765, 3816, 3836, -3772, 3782, -3812, -3829, -3872)
5 9 .1 0 1.71
P arvoviru s d e letio n  h o tsp ot 29 (2452, 2513) (-3843. -3867) 1 7 .17 1.69
M o u se  M H C  reco m b in a tio n  h o tsp ot 1 3523 0 .3 6 2 .8 0
P o ly m era se  a  pau se  site  1 179
(-2473, -2503, -2523, -2526, -2529, 
-2 5 3 5 ,-2 5 3 8 ,-2 5 4 1 ,-2 5 4 7 ,-2 5 5 0 )
(3846, 3878, -3746, -3761, -3775. - 
3798, -3804, -3810, -3833)
1 2 6 .6 0 1.41
P o ly m era se  a  pau se site  2 19 (3162) 1 1 7 .5 4 0 .1 6
P o ly m era se  a  pau se site  3 114 (3814, 3825, -3765, -3815) 1 5 8 .3 0 0 .7 2
P o ly m era se  arrest site 41 (-2525, -2537, -2549) (-3748, - 3777)
16 .18 2 .5 3
P o ly m era se  a  fra m esh ift site  1 3 3471,5797, -2886 1.32 2 .2 8
P o ly m era se  (3 fra m esh ift site  1 9 46, 1717, 4066, -566, -876, -1058, - 
1225,-2645,-3532
7 .3 6 1 .22
P o ly m era se  p fra m esh ift site  2 93 (2453, 2490, 2514, -2498) (-3842, - 3858, -3864)
8 1 .1 5 1.15
P o ly m era ses a /p  fra m esh ift site  1 11 7 .51 1.47
P o ly m era ses a /p  fra m esh ift site  2 4 4196, 425 3 ,-1 2 2 0 ,-1 3 6 6 1.61 2 .4 9
D N A  b en d in g  m o tif 7 75, 186, 745, 1559 ,2 1 3 5 ,2 4 9 1 , 
4363
7 .0 5 0 .9 9
436
Family 2 dJ1055C15: 57309-62308 (59759-59892) (lOObp)
M o tif
N u m ber
found
P o sitio n s E x p ected
R ela tive
in c id en ce
C hi 1 -496 0 .0 5 19 .10
S. c e r e v is ia e  A R S 1 -2661 0 .1 5 6.71
S. p o m b e  A R S 1 -4815 0 .1 3 7 .5 2
S c a ffo ld  m o tif  1 1 4804 0 .1 3 7 .6 2
S c a ffo ld  m o tif  2 8 1803, -360, -2725, -3966, -3976, - 
4138 ,-4477 ,-4487
0 .6 9 1 1 .60
S c a ffo ld  m o tif  3 10 118,389, 1 6 6 3 ,2 7 2 3 ,3 7 5 1 ,3 9 5 0 , 4804, -548 ,-1 8 1 3 ,-3 7 6 0
4 .81 2 .0 8
S c a ffo ld  m o tif  4 11 6 .0 2 1.83
T o p o iso m e r a se  I 1 180 (2457, 2 5 8 2 ,-2 4 5 3 ,-2 4 6 0 ,-2 5 2 4 , - 2537,-2569)
1 7 8 .2 8 1.01
T o p o iso m e r a se  I 2 3 3 7 (2526, 2576, 2579, -2485 ,-2488 , - 
2499, -2508, -2512, -2515)
3 0 4 .6 1 1.11
T o p o iso m e r a se  I 3 2 3 9 (2469, 2479, 2515, 2547,-2462 , - 2526)
2 9 8 .6 9 0 .8 0
T o p o iso m e r a se  I 4 3 9 4 (13 occurrences) 4 5 2 .9 5 0 .8 7
V a c c in ia  to p o iso m era se  I 23 19 .05 1.21
N o n a m er 1 239 0 .0 7 15 .04
Ig c la ss  sw itch  1 7 599,751, 1472,4070, -2 6 7 2 ,-  2736,-3458
6 .8 9 1.02
Ig c la ss  sw itc h  2 6 327, 773,1344, -661 ,-876 , -4368 4 .5 0 1.33
Ig c la ss  sw itch  3 4 1314, 1434 ,-1459 ,-2703 4 .5 0 0 .8 9
Ig  c la ss  sw itch  4 4 1018, 1313 ,-1460 ,-2704 4 .5 0 0 .8 9
Ig c la ss  sw itch  5 10 2 7 7 ,7 5 0 ,9 9 4 , 2973, 4069, 4736, 4 9 4 1 ,-7 7 0 ,-2 6 7 3 ,-4 5 2 9
6 .8 9 1.45
T ranslin  c o n se n su s 3 4 8 30 ,-56 8 ,-1 5 5 0 ,-2 3 2 3 2 .1 0 1.90
T ranslin  c o n se n su s 4 3 4365 ,-2809 ,-3986 0 .8 5 3.51
C h i-lik e  seq u en ce 1 -496 0 .2 2 4 .6 3
D e le t io n  h o tsp o t c o n sen su s 39 3 6 .7 8 1 .06
M o u se  d e le tio n  h o tsp ot 128 (2530) 5 9 .2 3 2 .1 6
P arvoviru s d e le tio n  hotsp ot 28 (-2499) 1 8 .27 1.53
M o u se  M H C  reco m b in a tio n  hotsp ot 3 3 387 ,3883 ,-1212 0 .3 7 8 .1 9
P o ly m era se  a  pau se site  1 146 (2506, 2510, 2513, -2528 ,-2578 , - 2581)
119 .01 1.23
P o ly m era se  a  pau se site  2 2 6 1 1 7 .1 7 0 .2 2
P o ly m era se  a  pau se site  3 123 152 .11 0.81
P o ly m era se  arrest site 3 0 (2511,-2580) 1 4 .34 2 .0 9
P o ly m era se  P fra m esh ift site  1 13 6 .9 2 1.88
P o ly m era se  p fra m esh ift site  2 100 (-2494, -2498) 9 1 .9 2 1.09
P o ly m era ses  a /p  fra m esh ift site  1 9 1313, 1 9 7 5 ,3 0 7 2 ,3 6 0 9 ,-1 4 6 0 ,-  2466, -2704 ,-4123 ,-4765
6 .9 2 1.30
P o ly m era ses  a /p  fra m esh ift site  2 3 1455 ,2699,-1318 1.36 2 .21
D N A  b e n d in g  m o t if 4 6 2 3 ,6 7 8 ,3 3 1 3 ,4 2 1 4 7 .4 3 0 .5 4
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Family 3 bA346E8 deletion breakpoint 2487-7486 (4937-5036) (lOObp)
M o tif
N u m ber
found
P o sitio n s E x p ected
R ela tiv e
in c id en ce
S. c e r e v is ia e  A R S 1 948 0 .4 4 2 .2 9
S c a ffo ld  m o t if  2 4 154 ,771 ,950 , 1697 3 .2 6 1.23
S c a ffo ld  m o t if  3 6 -284, -958 ,-1 7 0 1 ,-3 1 6 6 , -3341, - 
4502
9 .3 4 0 .6 4
S c a ffo ld  m o t if  4 8 154, 771 ,944 , 1693, 1989,2083, 
4321,-595
1 4 .7 0 0 .5 4
T o p o iso m era se  I 1 176 (2457, 2469, 2487, 2498 ,-2460) 1 6 1 .9 5 1 .09
T o p o iso m era se  I 2 3 2 4 ((2474, 2502, 2510, 2519, -2525) 2 9 8 .1 8 1 .09
T o p o iso m era se  I 3 2 7 7 (2452, 2481, 2507, 2517, 2527, 
2545)
3 2 0 .8 0 0 .8 6
T o p o iso m era se  I 4 4 3 6 (24 6 1 ,-2 4 6 4 ,-2 4 6 8 ,-2 4 7 2 ,-2 4 9 0 , 
-2537)
4 4 1 .7 6 0 .9 9
V a c c in ia  to p o iso m era se  I 35 1 8 .9 9 1 .84
N o n a m er 1 -4786 0 .31 3 .2 0
H eptam er 1 -14 0 .2 3 4 .3 7
Ig  c la ss  sw itch  1 8 6 6 8 ,-1 2 1 9 ,-2 3 0 3 ,-2 7 1 8 ,-2 7 7 7 ,-  
3458, -4397,-4531
5 .41 1.48
Ig c la ss sw itch  2 5 1008, 2226 ,2350 , -3627, -4306 3 .7 5 1.33
Ig c la ss sw itch  3 7 548, 630, 1413,3230, 4018 ,4569 , 
4895
4 .0 5 1.73
Ig c la ss sw itch  4 7 629, 3229, 4 0 1 7 ,4 5 6 8 ,-9 8 9 ,-  3248,3966 4 .0 5
1.73
Ig c la ss  sw itch  5 9 313 ,1061 ,3513 , -814, -8 5 3 ,-8 7 9 ,-  
1014, -2232,-4990
5 .41 1 .66
T ranslin  c o n se n su s  3 7 1208, 3696, -1437, -1775, -1956, - 3323,-4157 1 .67
4 .1 9
T ranslin  c o n se n su s 4 1 -1011 0 .61 1 .64
D e le t io n  h o tsp ot co n sen su s 38 (-2470) 3 0 .7 7 1.23
M o u se  d e letio n  h o tsp ot 101 (-2523, -2541) 5 6 .4 3 1 .79
P arvoviru s d e letio n  hotsp ot 25 2 7 .0 5 0 .9 2
M o u se  M H C  recom b in ation  hotsp ot 1 -3218 0 .4 0 2 .5 0
P o ly m era se  a  pau se site  1 114 (2523,-2521) 1 0 1 .6 4 1.12
P o ly m era se  a  pau se  site  2 12 1 0 5 .8 5 0 .11
P o ly m era se  a  pau se site  3 69 122 53 0 .5 6
P o ly m era se  arrest site 23 1 1 .62 1 .98
P o ly m era se  a  fra m esh ift site  1 2 983, 3242 0 .61 3 .2 9
P o ly m era se  P fra m esh ift site  1 6 -755, -1629, -2414, -3181 ,-3987 , - 
4727
7 .41 0 .81
P o ly m era se  p fra m esh ift site  2 106 (2482, 2489, 2528) 1 7 3 .9 2 0 .61
P o ly m era ses  a /p  fra m esh ift site  1 12 7 .9 5 1.51
P o ly m era ses  a /p  fra m esh ift site  2 4 -634, -3234, -4022, -4573 1 .54 2 .61
D N A  b en d in g  m o tif 4 146, 2918 ,3420 ,4923 6 .9 0 0 .5 8
438
Family 3 dJ203P18 deletion breakpoint 101270-96271 (98818-98719) (lOObp)
M o tif
N u m ber
found
P o sitio n s E x p ected
R ela tive
in c id en ce
S. c e r e v is ia e  A R S 1 -4056 0 .1 2 8 .17
S c a ffo ld  m o tif  2 2 1885,-4054 0 .4 9 4 .0 8
S c a ffo ld  m o tif  3 29 4 .31 6 .73
S c a ffo ld  m o tif  4 7 1624, 1885 ,2182 ,3309 , -28 3 8 ,-  
3008, -4054
5 .2 0 1.35
T o p o iso m era se  I 1 2 1 2 (2490, 2502,2529, -2476 ,-2485 , - 2497,-2514)
180 .11 1.18
T o p o iso m era se  I 2 323 (-2470, -2509, -2525, -2545) 2 9 9 .1 3 1.08
T o p o iso m era se  I 3 2 4 5 (2486, 2514 ,-2 4 6 3 ,-2 5 0 1 ,-2 5 2 9 ) 2 9 9 .5 0 0 .8 2
T o p o iso m era se  I 4 3 8 4 (2464, 2473, 2476, 2511, 2 5 3 7 ,-  2481,-2493)
4 5 2 .4 4 0 .8 5
V a c c in ia  to p o iso m era se  I 21 (-2527) 17.91 1.17
T o p o iso m era se  II c o n sen su s 1 -1399 0 .3 7 2 .7 0
H eptam er 1 673 0 .4 3 2 .3 5
Ig c la ss  sw itch  1 9 403, 918, 991, 4 1 5 1 ,4 3 3 9 ,-1 0 9 , - 142, -515,-4612
7 .1 2 1.26
Ig c la ss  sw itch  2 6 889. 1814 ,-1 7 0 ,-3 1 5 ,-3 6 9 , -2950 4 .7 3 1.27
Ig c la ss  sw itch  3 6 304 ,912 , 1412 ,20 7 1 ,-4 3 8 ,-1 1 1 0 4 .7 8 1 .26
Ig c la ss  sw itch  4 14 4 .7 8 2 .9 3
Ig c la ss  sw itch  5 10 2 1 6 3 ,2 2 5 1 ,3 0 6 7 ,3 2 1 8 ,4 1 2 5 , 4 181 ,-143 ,-1956 , -2626, -2866
7 .1 2 1 .40
T ranslin  co n sen su s  3 4 2 1 1 ,8 9 9 ,9 7 0 ,2 3 1 9 2 .1 4 1.87
T ranslin  co n sen su s  4 2 51 ,954 0 .9 0 2 .2 2
D e le t io n  hotsp ot co n sen su s 67 (2535) 3 7 .41 1.79
M o u se  d e letio n  h otspot 102 (2454, 2459) 5 9 .4 7 1.72
P arvoviru s d e letio n  hotsp ot 10 588, 3308, 3367 ,4 5 1 3 ,-8 4 9 , - 1 2 8 2 ,-2 2 8 4 ,-2 5 2 5 ,-2553 ,-3799
1 6 .2 9 0 .61
M o u se  M H C  recom b in ation  hotsp ot 2 -2129, -2582 0 .3 5 5 .65
P o ly m era se  a  pau se  site  1 159 1 1 9 .1 6 1.33
P o ly m era se  a  pau se site  2 20 11 8 .9 8 0 .1 7
P o ly m era se  a  pau se  site  3 138 (2457, -2458) 15 7 .3 7 0 .8 8
P o ly m era se  arrest site 2 7 1 4 .3 0 1.89
P o ly m era se  a  fra m esh ift site  1 1 -3189 0 .9 5 1.05
P o ly m era se  a  fra m esh ift site  2 1 4023 0 .9 4 1.07
P o ly m era se  P fra m esh ift site  1 17 7 .1 8 2 .3 7
P o ly m era se  P fra m esh ift site  2 71 (-2474, -2523, -2550) 8 2 .1 7 0 .8 6
P o ly m era ses  a /p  fra m esh ift site  1 11 7 .2 0 1.53
P o ly m era ses  a /p  fra m esh ift site  2 2 434,-2075 1 .44 1.39
D N A  b en d in g  m o tif 4 1 2 6 6 ,1630 ,3262 ,3909 7.41 0 .5 4
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Family 3 dJ1055C14 65684-70683 (68134-68233) (lOObp)
M o tif
N u m b er
foun d
P o sitio n s E x p ected
R ela tiv e
in c id en ce
A d e -M 2 6  heptam er 1 3184 0 .6 5 1.55
H u m an  rep lica tio n  or ig in  co n sen su s 1 1656 0 .0 0 3 3 5 7 .3 6
S. c e r e v is ia e  A R S 1 4953 0 .0 9 10.75
S. p o m b e  A R S 1 -658 0 .0 9 10 .84
S c a ffo ld  m o t if  2 7 5 1 0 ,7 8 3 ,3 2 0 4 , 331 6 ,3 3 3 5 ,-4 4 7 8 , -4577
0 .3 8 18 .40
S c a ffo ld  m o t if  3 8 809, 1713, 1 9 6 7 ,3844 ,4468 , -791, -1703,-2073
3 .4 3 2 .3 3
S c a ffo ld  m o t if  4 16 4 .0 3 3 .9 7
T o p o iso m e r a se  I 1 132 (-2506) 177 .41 0 .7 4
T o p o iso m e r a se  I 2 3 0 6 (2477 ,-24 9 7 ,-2 5 0 0 ,-2 5 1 4 ) 3 0 7 .0 9 1 .00
T o p o iso m e r a se  I 3 221 (2500) 3 0 0 .9 6 0 .7 3
T o p o iso m e r a se  I 4 4 2 0 (17 occurrences) 4 2 8 .1 2 0 .9 8
V a cc in ia  to p o iso m era se  I 34 (-2516) 19.21 1.77
T o p o iso m e r a se  II co n sen su s 1 4106 0 .41 2 .4 6
Ig c la ss  sw itc h  1 7 1310, 3 4 4 3 ,-6 3 3 ,-1 2 6 8 ,-1 8 6 8 ,-  2323,-2772
7 .5 4 0 .9 3
Ig c la ss  sw itc h  2 3 -1219, -3219, -3986 5 .3 6 0 .5 6
Ig c la ss  sw itc h  3 11 5 .6 6 1.94
Ig c la ss  sw itc h  4 14 5 .6 6 2 .4 7
Ig  c la ss  sw itc h  5 5 34 4 2 ,3 6 5 3 ,-2 2 ,-1 8 6 9 ,-4 5 4 3 7 .5 3 4 0 .6 6
T ranslin  c o n se n su s  3 1 -1118 2.21 0 .4 5
T ranslin  c o n se n su s  4 7 212, 3220, 3 6 5 9 ,3 9 8 3 ,-2 0 8 ,-  2743,-2991
1.09 6 .4 5
D e le t io n  h o tsp o t co n sen su s 4 7 3 8 .2 3 1.23
M o u se  d e le t io n  h o tsp ot 101 (2508) 6 2 .3 3 1.62
P arvoviru s d e le t io n  h otspot 33 (2468) 15 .65 2.11
P o ly m era se  a  pau se site  1 136 127 .9 3 1.06
P o ly m era se  a  pau se site  2 69 1 2 4 .3 9 0 .5 5
P o ly m era se  a  pau se  site  3 172 (2528,-2508, -2517) 176 .0 5 0 .9 8
P o ly m era se  arrest site 2 6 1 5 .90 1.64
P o ly m era se  a  fra m esh ift site  1 5 1 8 4 0 ,2 0 2 1 ,2 3 5 6 ,3 3 8 3 ,4 3 9 8 1.26 3 .9 8
P o ly m era se  a  fra m esh ift site  2 1 3704 1.09 0 .9 2
P o ly m era se  P fra m esh ift site  1 11 7 .6 5 1.44
P o ly m era se  p fra m esh ift site  2 101 (2471,-2457) 7 4 .0 6 1.36
P o ly m era ses  a /p  fra m esh ift site  1 8 2262, 3640, 3 7 0 5 ,4 8 8 1 ,-2 7 1 , - 1599 ,-1831 ,-4034
7.71 1.04
P o ly m era ses  a /p  fra m esh ift site  2 2 1826,-3645 1.64 1.22
D N A  b e n d in g  m o tif 4 42 5 ,1 0 7 1 ,1 9 0 6 , 3926 6 .2 8 0 .6 4
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Family 3 dJ305B16 51553-46552 (43978-44029) (152bp)
M o tif
N u m ber
found
P o sitio n s E x p ected
R ela tive
in c id en ce
Pur b in d in g  m o tif 1 -1344 0 .0 0 0 2 5 8 0 0 .5 1
S. c e r e v is ia e  A R S 1 2248 0 .2 0 4 .9 6
S c a ffo ld  m o t if  1 1 3577 0 .1 6 6 ,1 4
S c a ffo ld  m o tif  2 5 1696, 1 7 0 6 ,2 3 90 ,-4052 ,-4217 0 .8 4 5 .9 4
S c a ffo ld  m o t if  3 20 6 .4 7 3 .0 9
S c a ffo ld  m o tif  4 16 8 .2 4 1.94
T o p o iso m era se  I 1 2 0 9 (2435, 2443, 2464, 2513,2558, - 
2434,-2540)
1 8 2 .9 8 1.14
T o p o iso m era se  I 2 315 (13 occurrences) 2 9 3 .2 4 1.07
T o p o iso m era se  I 3 245 (2439,-2525, -2544, -2566) 2 9 0 .7 1 0 .8 4
T o p o iso m era se  I 4 3 8 8 (11 occurrences) 4 9 5 .8 8 0 .7 8
V a cc in ia  to p o iso m era se  I 31 (2466) 1 7 .3 6 1.79
H eptam er 3 52, 4020,-3664 0 .3 6 8 .3 0
Ig  c la ss sw itch  1 7 2 9 2 9 ,3 3 8 2 ,3 8 3 6 ,4 1 5 1 ,-2 7 8 4 ,-  2934,-3387
6 .2 2 1.13
Ig c la ss sw itch  2 4 -229, -877, -2585, -3994 3 .6 4 1.10
Ig  c la ss sw itch  3 10 648, 704, 3753, -1010 ,-1184 , - 1311, -3885, -4033, -4176, -4250
3 .6 5 2 .7 4
Ig c la ss sw itch  4 13 3 .6 5 3 .5 6
Ig c la ss sw itch  5 9 74,2460, 3381, 3 5 2 0 ,4 1 2 5 ,4 1 5 0 ,-  2935, -3388,-3941
6 .2 2 1.45
T ranslin  c o n se n su s  3 2 3929,-1270 1.97 1.02
T ranslin  c o n se n su s 4 1 3991 0 .6 3 1.59
C h i-lik e  seq u en ce 1 -41 0 .1 6 6 .3 2
D e le t io n  hotsp ot co n sen su s 54 (2516) 3 6 .2 9 1.49
M o u se  d e letio n  hotsp ot 69 5 3 .7 9 1.28
P arvoviru s d e letio n  hotsp ot 31 (2468 ,2544 ,-2555) 18 .82 1.65
M o u se  M H C  reco m b in a tio n  hotspot 1 4964 0 .2 9 3.41
P o ly m era se  a  pau se site  1 125 (2457, 2461, 2517, -2479 ,-2500) 1 0 8 .0 6 1.16
P o ly m era se  a  pau se site  2 11 1 0 7 .2 4 0 .1 0
P o ly m era se  a  pau se site  3 102 (-2454, -2498, -2531 ,-2576) 1 2 5 .4 2 0.81
P o ly m era se  arrest site 26 (-2502) 12 .65 2 .0 6
P o ly m era se  a  fra m esh ift site  1 3 832 ,1339 ,1814 0 .6 9 4 .3 3
P o ly m era se  p fra m esh ift site  1 12 6 .2 2 1.93
P o ly m era se  p fra m esh ift site  2 104 (2469, 2484, 2532, 2545, -2524m -  
2553)
1 0 1 .2 6 1.03
P o ly m era ses  a /p  fram esh ift site  1 11 6.21 1.77
P o ly m era ses  a /p  fra m esh ift site  2 7 1180 ,40 2 9 ,4 1 7 2 ,4 2 4 6 , -6 5 2 ,-  
708,-3757
1 .14 6.11
D N A  b en d in g  m o tif 8 274, 1091,2163 ,2546 , 2559,3202, 
3359,3570
9 .7 5 0 .8 2
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Family 3 d J197017 71905-66906 (69483-69329) (155bp)
M o tif
N u m ber
found
P o sitio n s E x p ected
R ela tiv e
in c id en ce
S. c e r e v is ia e  A R S 1 -1542 0 .3 2 3 .1 7
S c a ffo ld  m o t if  1 1 771 0 .2 7 3 .7 2
S c a ffo ld  m o t if  2 1 -1024 1.51 0 .6 6
S c a ffo ld  m o t if  3 8 163,771, 1011, 1 5 3 9 ,3 1 5 0 ,4 6 0 4 ,-  
1750,-3159
8 .6 4 0 .9 3
S c a ffo ld  m o t if  4 18 1 1 .82 1.52
T o p o iso m era se  I 1 2 0 0 (2455, 2499 ,2519 ,-2502) 1 8 0 .5 7 1.11
T o p o iso m e r a se  I 2 293 (13 occurrences) 2 8 3 .2 6 1.03
T o p o iso m e r a se  I 3 2 3 7 (2430, 2469, 2476, 2556, 2 5 7 2 ,-  
2 453 ,-2496 ,-2553 ,-2562)
2 9 2 .6 0 0.81
T o p o iso m era se  I 4 4 9 4 (2443, 2462, 2487, 2545, -2446, - 
2 458 ,-2465 ,-2490 ,-2550)
5 1 2 .8 9 0 .9 6
V a c c in ia  to p o iso m era se  I 25 1 6 .14 1.55
Ig  c la ss sw itc h  1 8 1 6 6 3 ,1 8 7 4 ,2435,3326, 3583, 
4501 ,-3911 ,-4405
5 .5 6 1.44
Ig  c la ss  sw itc h  2 6 2 9 4 6 ,3 9 9 2 ,-3 7 0 4 ,-3 8 2 7 ,-3 9 2 2 ,-  
3974
3 .1 8 1.89
Ig c la ss  sw itc h  3 6 2671, 4 4 8 2 ,-3801 ,-3865 , -3896, - 
4446
3 .3 5 1.79
Ig c la ss  sw itch  4 12 3 .3 5 3 .5 8
Ig c la ss  sw itc h  5 7 2080, 3325, 3 4 0 7 ,4 0 4 6 ,-2571, - 
2831,-4406
5 .5 6 1.26
T ranslin  c o n se n su s  3 6 492, 3715,4149, 4 2 8 0 ,-2 0 7 8 ,-  2207 1.78 3 .3 7
T ranslin  c o n se n su s 4 2 -3439,-4157 0 .5 0 4.01
D e le t io n  h o tsp ot co n sen su s 52 (-2451,-2529,-2565) 3 4 .5 3 1.51
M o u se  d e letio n  hotsp ot 80 (2558, 2564,-2467) 5 0 .3 9 1.59
P arvoviru s d e le tio n  hotsp ot 32 2 0 .5 0 1 .56
P o ly m era se  a  pau se  site  1 118 (2435, -2427, -2450, -2482, -2485, 
-2528, -2537, -2564, -2570)
9 8 .6 6 1 .20
P o ly m era se  a  pau se  site  2 11 9 9 .7 7 0.11
P o ly m era se  a  pau se  site  3 74 (2511,-2568) 1 0 8 .4 2 0 .6 8
P o ly m era se  arrest site 16 (-2484) 11 25 1.42
P o ly m era se  a  fra m esh ift site  1 1 2362 0 .5 5 1.83
P o ly m era se  p fra m esh ift site  1 13 (-2470) 6 .1 6 2.11
P o ly m era se  P fra m esh ift site  2 133 (2439, 2538) 1 2 4 .6 8 1.07
P o ly m era ses  a /p  fra m esh ift site  1 11 6 .3 3 1.74
P o ly m era ses  ct/p fra m esh ift site  2 6 3797, 3861, 3892, 4442 ,-2675 , - 
4486
1.15 5 .2 0
D N A  b en d in g  m o tif 9 9 0 ,1 5 8 ,4 1 4 , 535, 1215, 1674, 
2 113 ,3449 ,4657
1 0 .8 0 0 .8 3
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Family 3 bA453F18 22455-27454(24905-25004) (lOObp)
M o tif
N u m ber
found
P o sitio n s E x p ected
R ela tive
in c id en ce
S. p o m b e  A R S 3 1423,1435, 1447 0 .1 0 28 .81
S c a ffo ld  m o t if  1 4 -1430 ,-1 4 4 2 ,-1 4 5 4 ,-1 4 6 6 0 .0 9 4 5 .3 3
S c a ffo ld  m o t if  2 4 -2818,-2828, -3560, -3960 0 .4 2 9 .5 7
S c a ffo ld  m o t if  3 11 3 .7 8 2.91
S c a ffo ld  m o t if  4 11 4 .4 8 2 .4 5
T o p o iso m e r a se  I 1 145 (2459,2465, -2456, -2519) 1 7 8 .7 6 0.81
T o p o iso m era se  I 2 3 4 8 (2463, 2478, 2484, 2542, -2475, - 
2494 ,-2 5 0 3 ,-2 5 0 6 ,-2 5 3 5 )
3 0 1 .6 9 1.15
T o p o iso m era se  I 3 243 (2469, 2475, 2482, -2459, -2529) 3 0 1 .8 9 0 .8 0
T o p o iso m e r a se  I 4 4 1 5 (2453, 2487, 2498, 2516, -2462, - 
2490 ,-2510 ,-2523)
4 3 8 .5 7 0 .9 9
V a c c in ia  to p o iso m era se  I 2 9 18 .22 1.59
Ig c la ss  sw itc h  1 2 4452,-445 7.41 0 .2 7
Ig c la ss  sw itch  2 9 194,1751, 1757,4989, -88 ,-1134 , 
-2563 ,-3715 ,-3826
5 .1 2 1.76
Ig c la ss  sw itc h  3 8 1164, 1293, 1634, 2 9 8 6 ,-3 7 7 8 ,-  
4813 ,-4887 ,-4906
5 .1 8 1.55
Ig c la ss  sw itch  4 11 5 .1 8 2 .1 2
Ig c la ss  sw itch  5 12 (-2545) 7.41 1.62
T ranslin  c o n se n su s  3 1 3450 2 .1 9 0 .4 6
T ranslin  c o n se n su s 4 4 8 5 ,1 1 3 1 ,-7 8 0 ,-3 4 1 8 1.01 3 .9 8
C h i-lik e  seq u en ce 1 -3045 0 .2 5 3 .9 4
D e le t io n  h o tsp ot co n sen su s 4 8 (2531) 3 7 .7 6 1.27
M o u se  d e le tio n  h o tsp ot 120 (-2532) 6 1 .4 0 1.95
P arvoviru s d e le tio n  h otspot 2 0 1 5 .67 1.28
P o ly m era se  a  pau se  site  1 161 (2533 ,-2465 ,-2544) 1 2 3 .0 8 1.31
P o ly m era se  a  p au se  site  2 34 (2545) 122 81 0 .2 8
P o ly m era se  a  p au se  site  3 151 (2547 ,-2542 ,-2548) 1 6 9 .0 0 0 .8 9
P o ly m era se  arrest site 33 (2531) 1 4 .9 0 2.21
P o ly m era se  p fra m esh ift site  1 12 7 .4 7 1.61
P o ly m era se  p fra m esh ift site  2 112 (-2499) 7 7 .0 8 1.45
P o ly m era ses  a /p  fra m esh ift site  1 11 7 .5 0 1.47
P o ly m era ses  a /p  fra m esh ift site  2 3 -1168 ,-1297 ,-1638 1 54 1.95
D N A  b en d in g  m o tif 9 2 9 9 ,9 1 4 ,1 7 2 1 , 2419, 2853, 3533, 
4439, 4685,4913
6 .7 5 1.33
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